{u'LLRRLLRRLLRRLLRR': {'modifications': ['C-Terminal'], 'references': [u'Synthetic cationic amphiphilic ?-helical peptides as antimicrobial agents. Wiradharma N,Khoe U,Hauser CA,Seow SV,Zhang S Biomaterials. 2011 Mar;32(8):2204-12. doi: 10.1016/j.biomaterials.2010.11.054. Epub 2010 Dec 18.'], 'hemolysis': u'HC50 > ~12', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2053']}, u'KNWKGIAGMAKKLLGENWELM': {'modifications': [], 'references': [u'Design of a novel membrane-destabilizing peptide selectively acting on acidic liposomes. Machida S,Niimi S,Shi X,Ando Y Biosci Biotechnol Biochem. 2000 May;64(5):985-94.'], 'hemolysis': u'5.3% hemolytic at 10\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2523']}, u'GLPRKILCAIAKKKGKCKGPLKLVCKC': {'modifications': ['Cyclic'], 'references': [u'Lasiocepsin, a novel cyclic antimicrobial peptide from the venom of eusocial bee Lasioglossum laticeps (Hymenoptera: Halictidae). Monincova L,Slaninova J,Fucik V,Hovorka O,Voburka Z,Bednarova L,Malon P,Stokrova J Amino Acids. 2012 Aug;43(2):751-61. doi: 10.1007/s00726-011-1125-6. Epub 2011 Oct 29.'], 'hemolysis': u'<1% hemolytic at 200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2739']}, u'llgdefrkskekigkefkrivqrikdflrnlvprtes': {'modifications': [u'Stereochemistry: D'], 'references': [u'Anti-tuberculosis activity of ?-helical antimicrobial peptides: de novo designed L- and D-enantiomers versus L- and D-LL-37. Jiang Z,Higgins MP,Whitehurst J,Kisich KO,Voskuil MI Protein Pept Lett. 2011 Mar;18(3):241-52.'], 'hemolysis': u'HC50 = 125\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2806']}, u'KIGAKDCF3BpgKIGAKIKIGAKI': {'modifications': ['C-Terminal', u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'Stereochemical effects on the aggregation and biological properties of the fibril-forming peptide [KIGAKI]3 in membranes. Wadhwani P,Reichert J,Strandberg E,Burck J,Misiewicz J,Afonin S,Heidenreich N,Fanghanel S,Mykhailiuk PK,Komarov IV Phys Chem Chem Phys. 2013 Jun 21;15(23):8962-71. doi: 10.1039/c3cp50896j. Epub 2013 May 7.'], 'hemolysis': u'~10% hemolytic at 60\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2678']}, u'GQSQWRDVCRNFMRR': {'modifications': [], 'references': [u'Hemolysis of erythrocytes by granulysin-derived peptides but not by granulysin. Li Q,Dong C,Deng A,Katsumata M,Nakadai A,Kawada T,Okada S,Clayberger C Antimicrob Agents Chemother. 2005 Jan;49(1):388-97.'], 'hemolysis': u'~40% hemolysis 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1624']}, u'KNWKKIASIGKEVLKAL': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 >>100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3935']}, u'KWKSFLKTFKSAKKKVLHKALKAISK': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Effects of net charge and the number of positively charged residues on the biological activity of amphipathic alpha-helical cationic antimicrobial peptides. Jiang Z,Vasil AI,Hale JD,Hancock RE,Vasil ML Biopolymers. 2008;90(3):369-83.'], 'hemolysis': u'MHC <7.8\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1144']}, u'VCGETCVGGTCNTPGCSCSRPVCTRNGLP': {'modifications': ['Cyclic'], 'references': [u'Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif. Craik DJ,Daly NL,Bond T J Mol Biol. 1999 Dec 17;294(5):1327-36.'], 'hemolysis': u'50% hemolysis at ~20\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4013']}, u'KLLKLLLKLLLKLLK': {'modifications': [u'N-Terminal Modification: Dansylation'], 'references': [u'The amphipathic helix concept: length effects on ideally amphipathic LiKj(i=2j) peptides to acquire optimal hemolytic activity. Castano S,Cornut I,Buttner K,Dasseux JL Biochim Biophys Acta. 1999 Jan 12;1416(1-2):161-75.'], 'hemolysis': u'LD50 =0.3 \u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3831']}, u'LDVKKIIAbuVAAbuKIRPNPAAbuKKIAbuPK': {'modifications': ['Non-Natural'], 'references': [u'Panurgines, novel antimicrobial peptides from the venom of communal bee Panurgus calcaratus (Hymenoptera: Andrenidae). Cujova S,Slaninova J,Monincova L,Fucik V,Bednarova L,Stokrova J,Hovorka O,Voburka Z,Straka J Amino Acids. 2013 Jul;45(1):143-57. doi: 10.1007/s00726-013-1482-4. Epub 2013 Mar 13.'], 'hemolysis': u'LC50 >200\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3743']}, u'GLLGPLLKIAKKVGSNLL': {'modifications': ['C-Terminal'], 'references': [u'Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7. Conlon JM,Galadari S,Raza H Chem Biol Drug Des. 2008 Jul;72(1):58-64. doi: 10.1111/j.1747-0285.2008.00671.x. Epub 2008 Jun 12.'], 'hemolysis': u'LD50 = 350\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1961']}, u'KKKKKKAAFAAWAAFAA': {'modifications': ['C-Terminal'], 'references': [u'Cationic hydrophobic peptides with antimicrobial activity. Stark M,Liu LP Antimicrob Agents Chemother. 2002 Nov;46(11):3585-90.'], 'hemolysis': u'0% hemolysis at 50\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2249']}, u'ILGKLLSTAWkLLSNL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent. Conlon JM,Mechkarska M,Prajeep M,Arafat K,Zaric M,Lukic ML Amino Acids. 2013 Feb;44(2):715-23. doi: 10.1007/s00726-012-1395-7. Epub 2012 Sep 11.'], 'hemolysis': u'LC50 =21\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3184']}, u'KKkLLlLllLLLkKK': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'The consequence of sequence alteration of an amphipathic alpha-helical antimicrobial peptide and its diastereomers. Papo N,Oren Z,Pag U,Sahl HG J Biol Chem. 2002 Sep 13;277(37):33913-21. Epub 2002 Jul 10.'], 'hemolysis': u'3% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2205']}, u'IISTIGDLVKWIIKTV': {'modifications': [], 'references': [u'Generation of analogs having potent antimicrobial and hemolytic activities with minimal changes from an inactive 16-residue peptide corresponding to the helical region of Staphylococcus aureus delta-toxin. Dhople VM Protein Eng. 1995 Mar;8(3):315-8.'], 'hemolysis': u'100% hemolysis at ~90\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3604']}, u'KWKSFLkTFkSLKkTVLHTLLkAISS': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', u'Stereochemistry: Mix'], 'references': [u'Role of helicity on the anticancer mechanism of action of cationic-helical peptides. Huang YB,He LY,Jiang HY Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849. Epub 2012 Jun 5.'], 'hemolysis': u'MHC = 325.20 \xb1 0.82\u03bcmol/L', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2641']}, u'KWKSFLKTFKSAKKKVLHKALKAISS': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Effects of net charge and the number of positively charged residues on the biological activity of amphipathic alpha-helical cationic antimicrobial peptides. Jiang Z,Vasil AI,Hale JD,Hancock RE,Vasil ML Biopolymers. 2008;90(3):369-83.'], 'hemolysis': u'MHC <7.8\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1143']}, u'QRSVSNAATRVCRTGRSRWRDVCRNFMRR': {'modifications': [], 'references': [u'Hemolysis of erythrocytes by granulysin-derived peptides but not by granulysin. Li Q,Dong C,Deng A,Katsumata M,Nakadai A,Kawada T,Okada S,Clayberger C Antimicrob Agents Chemother. 2005 Jan;49(1):388-97.'], 'hemolysis': u'>80% hemolysis 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1621']}, u'GWGSIFKHGRHAAKHIGHAAVNHYL': {'modifications': ['C-Terminal'], 'references': [u'The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents. Morash MG,Douglas SE,Robotham A,Ridley CM,Gallant JW Dis Model Mech. 2011 Sep;4(5):622-33. doi: 10.1242/dmm.007310. Epub 2011 Jul 4.'], 'hemolysis': u'50% hemolytic at >256 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2921']}, u'FRGLAKLLKIGLKSFARVLKKVLPKAAKAGKALAKSMADENAIRQQNQ': {'modifications': [], 'references': [u"Pore formation of phospholipid membranes by the action of two hemolytic arachnid peptides of different size. Belokoneva OS,Satake H,Mal'tseva EL,Pal'mina NP,Villegas E,Nakajima T Biochim Biophys Acta. 2004 Aug 30;1664(2):182-8."], 'hemolysis': u'60% hemolysis at 25\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4070']}, u'KKALLOHALHOLALLAOHLAHOLKKA': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Structural determinants of antimicrobial and antiplasmodial activity and selectivity in histidine-rich amphipathic cationic peptides. Mason AJ,Moussaoui W,Abdelrahman T,Boukhari A,Bertani P,Marquette A,Shooshtarizaheh P,Moulay G,Boehm N,Guerold B,Sawers RJ,Kichler A,Metz-Boutigue MH,Candolfi E,Prevost G J Biol Chem. 2009 Jan 2;284(1):119-33. doi: 10.1074/jbc.M806201200. Epub 2008 Nov 4.'], 'hemolysis': u'HC50 =179.2\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3570']}, u'GFCRCLCRRGVCRCLCTK': {'modifications': [], 'references': [u'Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework. Tam JP,Lu YA Biochem Biophys Res Commun. 2000 Jan 27;267(3):783-90.'], 'hemolysis': u'EC25 =2350\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2538']}, u'LCYTHHHFTVCV': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'0-3% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1215']}, u'KDLHTVVSAILQAL': {'modifications': ['C-Terminal'], 'references': [u'Venom peptides from solitary hunting wasps induce feeding disorder in lepidopteran larvae. Baek JH,Ji Y,Shin JS,Lee S Peptides. 2011 Mar;32(3):568-72. doi: 10.1016/j.peptides.2010.12.007. Epub 2010 Dec 22.'], 'hemolysis': u'Non-hemolytic', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2057']}, u'HFLLTLVNLAKkIL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Strategies for transformation of naturally-occurring amphibian antimicrobial peptides into therapeutically valuable anti-infective agents. Conlon JM,Al-Ghaferi N,Abraham B Methods. 2007 Aug;42(4):349-57.'], 'hemolysis': u'LD50 = 500\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1809']}, u'LLPIVGNLLKSLL': {'modifications': ['C-Terminal'], 'references': [u'Temporins, small antimicrobial peptides with leishmanicidal activity. Mangoni ML,Saugar JM,Dellisanti M,Barra D,Simmaco M J Biol Chem. 2005 Jan 14;280(2):984-90. Epub 2004 Oct 28.'], 'hemolysis': u'LC50 >120\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4111']}, u'GLGSLLGKAFKFGLKTVGKMMGGAPREE': {'modifications': [], 'references': [u'Peptidomic analysis of skin secretions demonstrates that the allopatric populations of Xenopus muelleri (Pipidae) are not conspecific. Mechkarska M,Ahmed E,Coquet L,Leprince J,Jouenne T,Vaudry H,King JD Peptides. 2011 Jul;32(7):1502-8. doi: 10.1016/j.peptides.2011.05.025. Epub 2011 Jun 1.'], 'hemolysis': u'LC50 =105\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3138']}, u'ILPWKLPLLPLRR': {'modifications': ['C-Terminal'], 'references': [u'Antibacterial and hemolytic activities of single tryptophan analogs of indolicidin. Subbalakshmi C,Bikshapathy E,Sitaram N Biochem Biophys Res Commun. 2000 Aug 11;274(3):714-6.'], 'hemolysis': u'0% hemolysis at 100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1039']}, u'GLGSLLGKAFKFGLKTVGKMMGGAPREQ': {'modifications': [], 'references': [u'Peptidomic analysis of skin secretions demonstrates that the allopatric populations of Xenopus muelleri (Pipidae) are not conspecific. Mechkarska M,Ahmed E,Coquet L,Leprince J,Jouenne T,Vaudry H,King JD Peptides. 2011 Jul;32(7):1502-8. doi: 10.1016/j.peptides.2011.05.025. Epub 2011 Jun 1.'], 'hemolysis': u'LC50 =70\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3137']}, u'RWRWRWRWRW': {'modifications': ['C-Terminal'], 'references': [u'Length effects in antimicrobial peptides of the (RW)n series. Liu Z,Brady A,Young A,Rasimick B,Chen K,Zhou C Antimicrob Agents Chemother. 2007 Feb;51(2):597-603. Epub 2006 Dec 4.'], 'hemolysis': u'HD50  =76\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1081']}, u'APCFACPCLAPCLACPCFAPCFACPCKACPCLAPC': {'modifications': ['C-Terminal', 'Cyclic', 'Non-Natural'], 'references': [u'Interplay among folding, sequence, and lipophilicity in the antibacterial and hemolytic activities of alpha/beta-peptides. Schmitt MA,Weisblum B J Am Chem Soc. 2007 Jan 17;129(2):417-28.'], 'hemolysis': u'>10% hemolysis at 1.6 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1096']}, u'FLPLVLGALSGILPKILGK': {'modifications': [], 'references': [u'Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata. Ma Y,Liu C,Liu X,Wu J,Yang H,Wang Y,Li J,Yu H Genomics. 2010 Jan;95(1):66-71. doi: 10.1016/j.ygeno.2009.09.004. Epub 2009 Sep 22.'], 'hemolysis': u'95.7\xb14.12% hemolysis at 100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4028']}, u'CWKWKWKWGSGWKWKWKWC': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', 'Cyclic'], 'references': [u'De novo design of potent antimicrobial peptides. Frecer V,Ho B Antimicrob Agents Chemother. 2004 Sep;48(9):3349-57.'], 'hemolysis': u'EC50 = 45000 nM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2379']}, u'RRRRRRRRRRGIGKFLHSAKKFGKAFVGEIMNS': {'modifications': [], 'references': [u'Augmentation of the antibacterial activity of magainin by positive-charge chain extension. Bessalle R,Haas H,Goria A,Shalit I Antimicrob Agents Chemother. 1992 Feb;36(2):313-7.'], 'hemolysis': u'4% hemolysis at 200\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3440']}, u'PKLKTFLSKWIG': {'modifications': [], 'references': [u'Addition and omission analogs of the 13-residue antibacterial and hemolytic peptide PKLLKTFLSKWIG: structural preferences, model membrane binding and biological activities. Bikshapathy E,Sitaram N J Pept Res. 1999 Jan;53(1):47-55.'], 'hemolysis': u'0% hemolysis at 300\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3841']}, u'GILSSFKGVAKGVAKDLAGKLLETLKCKITGC': {'modifications': [], 'references': [u'Peptide defenses of the Cascades frog Rana cascadae: implications for the evolutionary history of frogs of the Amerana species group. Conlon JM,Al-Dhaheri A,Al-Mutawa E,Al-Kharrge R,Ahmed E,Kolodziejek J,Nowotny N, Nielsen, Per ,Nielsen PF Peptides. 2007 Jun;28(6):1268-74. Epub 2007 Mar 27.'], 'hemolysis': u'LD50 =150\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1128']}, u'GWKKWFTKGERLSQRHFA': {'modifications': [], 'references': [u'The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents. Morash MG,Douglas SE,Robotham A,Ridley CM,Gallant JW Dis Model Mech. 2011 Sep;4(5):622-33. doi: 10.1242/dmm.007310. Epub 2011 Jul 4.'], 'hemolysis': u'50% hemolytic at >256 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2933']}, u'KKLFKkilkyl': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Improvement of the efficacy of linear undecapeptides against plant-pathogenic bacteria by incorporation of D-amino acids. Guell I,Cabrefiga J,Badosa E,Ferre R,Talleda M,Bardaji E,Planas M,Feliu L Appl Environ Microbiol. 2011 Apr;77(8):2667-75. doi: 10.1128/AEM.02759-10. Epub 2011 Feb 18.'], 'hemolysis': u'3\xb11.0% hemolytic at 250\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2866']}, u'FAPLIGRVLSGIL': {'modifications': ['C-Terminal'], 'references': [u'Alanine scanning analysis and structure-function relationships of the frog-skin antimicrobial peptide temporin-1Ta. Grieco P,Luca V,Auriemma L,Carotenuto A,Saviello MR,Campiglia P,Barra D,Novellino E J Pept Sci. 2011 May;17(5):358-65. doi: 10.1002/psc.1350. Epub 2011 Feb 18.'], 'hemolysis': u'0% hemolytic at 1.25\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2884']}, u'KLllLLKlLlWK': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Structure and organization of hemolytic and nonhemolytic diastereomers of antimicrobial peptides in membranes. Hong J,Oren Z Biochemistry. 1999 Dec 21;38(51):16963-73.'], 'hemolysis': u'44.2% hemolysis at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3760']}, u'WKSYVRRW': {'modifications': [], 'references': [u'Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide. Wu YS,Liao ZJ,Wang KS Bioorg Med Chem Lett. 2013 May 15;23(10):2929-32. doi: 10.1016/j.bmcl.2013.03.053. Epub 2013 Mar 25.'], 'hemolysis': u'2.0 \xb10.3% hemolytic at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2584']}, u'VIPFVASVAAEMMHHVYCAASKRC': {'modifications': [], 'references': [u'Structure-activity relationships of antimicrobial peptides from the skin of Rana esculenta inhabiting in Korea. Won HS,Kim SS,Jung SJ,Son WS,Lee B Mol Cells. 2004 Jun 30;17(3):469-76.'], 'hemolysis': u'0.32% hemolysis at 100\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1605']}, u'LLKKLLKKLLKK': {'modifications': ['C-Terminal'], 'references': [u'Synthetic cationic amphiphilic ?-helical peptides as antimicrobial agents. Wiradharma N,Khoe U,Hauser CA,Seow SV,Zhang S Biomaterials. 2011 Mar;32(8):2204-12. doi: 10.1016/j.biomaterials.2010.11.054. Epub 2010 Dec 18.'], 'hemolysis': u'HC50 > 500', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2051']}, u'yPVKLKyPKVKL': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Modulation of structure and antibacterial and hemolytic activity by ring size in cyclic gramicidin S analogs. Kondejewski LH,Farmer SW,Wishart DS,Kay CM,Hancock RE J Biol Chem. 1996 Oct 11;271(41):25261-8.'], 'hemolysis': u'100% hemolysis at 250\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3667']}, u'CGESCVWIPCISAALGCSCKNKVCYRNGIP': {'modifications': ['Cyclic'], 'references': [u'Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif. Craik DJ,Daly NL,Bond T J Mol Biol. 1999 Dec 17;294(5):1327-36.'], 'hemolysis': u'50% hemolysis at ~20\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4010']}, u'GFKDLLKGAAKALKKTVLF': {'modifications': ['C-Terminal'], 'references': [u'Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7. Conlon JM,Galadari S,Raza H Chem Biol Drug Des. 2008 Jul;72(1):58-64. doi: 10.1111/j.1747-0285.2008.00671.x. Epub 2008 Jun 12.'], 'hemolysis': u'LD50 >500\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1949']}, u'MLQDWLSSLGDLLKSLLDTVNKFTKK': {'modifications': [], 'references': [u'Interaction of staphylococcal delta-toxin and synthetic analogues with erythrocytes and phospholipid vesicles. Biological and physical properties of the amphipathic peptides. Alouf JE,Dufourcq J,Siffert O,Thiaudiere E Eur J Biochem. 1989 Aug 1;183(2):381-90.'], 'hemolysis': u'24% hemolysis at 75\u03bcg', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3372']}, u'GLKKIFKKGLGSLVKGIAAHVAS': {'modifications': [], 'references': [u'Potent and rapid bactericidal action of alyteserin-1c and its [E4K] analog against multidrug-resistant strains of Acinetobacter baumannii. Conlon JM,Ahmed E,Pal T Peptides. 2010 Oct;31(10):1806-10. doi: 10.1016/j.peptides.2010.06.032. Epub 2010 Jul 11.'], 'hemolysis': u'LC50 >400\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3078']}, u'ILGKIWKGIKSLF': {'modifications': ['C-Terminal'], 'references': [u'Antibiotic activity and structural analysis of the scorpion-derived antimicrobial peptide IsCT and its analogs. Lee K,Shin SY,Kim K,Lim SS,Hahm KS Biochem Biophys Res Commun. 2004 Oct 15;323(2):712-9.'], 'hemolysis': u'~50% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2398']}, u'KWKEFLKTFKEAKKEVLHTALKAISS': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Effects of net charge and the number of positively charged residues on the biological activity of amphipathic alpha-helical cationic antimicrobial peptides. Jiang Z,Vasil AI,Hale JD,Hancock RE,Vasil ML Biopolymers. 2008;90(3):369-83.'], 'hemolysis': u'MHC =250.0\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1139']}, u'KLAKKLAKLAKLAKAL': {'modifications': ['C-Terminal'], 'references': [u'Effect of cholesterol on the membrane interaction of Modelin-5 isoforms. Dennison SR Biochemistry. 2011 Dec 20;50(50):10898-909. doi: 10.1021/bi201267v. Epub 2011 Nov 21.'], 'hemolysis': u'<2% hemolytic at 300\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2988']}, u'RGGRLCYCRRRFCICV': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'>50% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1172']}, u'LKLIPRKIVTAL': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial and hemolytic activities of crabrolin, a 13-residue peptide from the venom of the European hornet, Vespa crabro, and its analogs. Krishnakumari V J Pept Res. 1997 Aug;50(2):88-93.'], 'hemolysis': u'Non-hemolytic', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3381']}, u'QLKVDLWGTRSGIQPEQHSSGKSDVRRWRSRY': {'modifications': [], 'references': [u'Purification and cloning of a novel antimicrobial peptide from salivary glands of the hard tick, Ixodes sinensis. Liu Z,Liu H,Liu X Comp Biochem Physiol B Biochem Mol Biol. 2008 Apr;149(4):557-61. doi: 10.1016/j.cbpb.2007.10.002. Epub 2007 Oct 16.'], 'hemolysis': u'Little hemolysis upto 200\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3706']}, u'GLLSGILGAGKHIICGLSGLC': {'modifications': [], 'references': [u'Anti-infection peptidomics of amphibian skin. Li J,Xu X,Xu C,Zhou W,Zhang K,Yu H,Zhang Y,Zheng Y,Rees HH,Lai R,Yang D Mol Cell Proteomics. 2007 May;6(5):882-94. Epub 2007 Jan 31.'], 'hemolysis': u'65.5\xb17.7% hemolysis at 50\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3651']}, u'ZERRLCYKQRCVTYKRGR': {'modifications': ['C-Terminal', 'Cyclic', 'Non-Natural'], 'references': [u'Structure-activity relationship studies of gomesin: importance of the disulfide bridges for conformation, bioactivities, and serum stability. Fazio MA,Oliveira VX Jr,Bulet P,Miranda MT,Daffre S Biopolymers. 2006;84(2):205-18.'], 'hemolysis': u'~ 32% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4201']}, u'EMLKKKEVKMERKT': {'modifications': [], 'references': [u'Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs. Yang X,Lee WH J Proteome Res. 2012 Jan 1;11(1):306-19. doi: 10.1021/pr200782u. Epub 2011 Nov 18.'], 'hemolysis': u'Non-hemolytic upto 50 \u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3023']}, u'FKCRRWQWRMKKLG': {'modifications': [], 'references': [u'Fungicidal effect of three new synthetic cationic peptides against Candida albicans. Nikawa H,Fukushima H,Makihira S,Hamada T Oral Dis. 2004 Jul;10(4):221-8.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1873']}, u'VHVPPICSHRECRK': {'modifications': [], 'references': [u'Venom peptides from solitary hunting wasps induce feeding disorder in lepidopteran larvae. Baek JH,Ji Y,Shin JS,Lee S Peptides. 2011 Mar;32(3):568-72. doi: 10.1016/j.peptides.2010.12.007. Epub 2010 Dec 22.'], 'hemolysis': u'Non-hemolytic', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2066']}, u'MASRAAGLAARLARLALRAL': {'modifications': [], 'references': [u'Modification of a synthetic antimicrobial peptide (ESF1) for improved inhibitory activity. Dykes GA,Aimoto S Biochem Biophys Res Commun. 1998 Jul 20;248(2):268-72.'], 'hemolysis': u'0.5% hemolysis at 200\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3282']}, u'IPHAVKAISDLI': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial and cytolytic properties of the frog skin peptide, kassinatuerin-1 and its L- and D-lysine-substituted derivatives. Conlon JM,Abraham B,Galadari S,Knoop FC,Sonnevend A Peptides. 2005 Nov;26(11):2104-10.'], 'hemolysis': u'0% hemolysis at 400\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4072']}, u'RLYRRLYRRLYRRLYRRLYRRLYRRLYRRLYR': {'modifications': [], 'references': [u'Antimicrobial dendrimeric peptides. Tam JP,Lu YA Eur J Biochem. 2002 Feb;269(3):923-32.'], 'hemolysis': u'EC50 = 48\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2409']}, u'RAYCRRRFCVAR': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'0-3% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1179']}, u'KWKSFLKTFKSPARTVLHTALKPISS': {'modifications': [], 'references': [u'Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides. Zhang L,Benz R Biochemistry. 1999 Jun 22;38(25):8102-11.'], 'hemolysis': u'MHC >128\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3598']}, u'AKKVFKRLEKSFSKIQNDK': {'modifications': [], 'references': [u'Design of novel analogue peptides with potent antibiotic activity based on the antimicrobial peptide, HP (2-20), derived from N-terminus of Helicobacter pylori ribosomal protein L1. Lee DG,Kim HN,Park Y,Kim HK,Choi BH,Choi CH Biochim Biophys Acta. 2002 Jul 29;1598(1-2):185-94.'], 'hemolysis': u'0% hemolysis at 100\u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2385']}, u'KWKSFLKTFKSAAKTVLHTALKAISS': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC =31.3\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3973']}, u'KKLFkKILKYL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Improvement of the efficacy of linear undecapeptides against plant-pathogenic bacteria by incorporation of D-amino acids. Guell I,Cabrefiga J,Badosa E,Ferre R,Talleda M,Bardaji E,Planas M,Feliu L Appl Environ Microbiol. 2011 Apr;77(8):2667-75. doi: 10.1128/AEM.02759-10. Epub 2011 Feb 18.'], 'hemolysis': u'3\xb1 0.6% hemolysis at 250\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2852']}, u'ECYCRRRFCVCVGR': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'3-6% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1202']}, u'GRSRWRDVCRNFMRR': {'modifications': [], 'references': [u'Hemolysis of erythrocytes by granulysin-derived peptides but not by granulysin. Li Q,Dong C,Deng A,Katsumata M,Nakadai A,Kawada T,Okada S,Clayberger C Antimicrob Agents Chemother. 2005 Jan;49(1):388-97.'], 'hemolysis': u'40% hemolysis 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1623']}, u'LCAIAKKKGKCKGPLKLVCKC': {'modifications': ['C-Terminal', 'Cyclic'], 'references': [u'Lasiocepsin, a novel cyclic antimicrobial peptide from the venom of eusocial bee Lasioglossum laticeps (Hymenoptera: Halictidae). Monincova L,Slaninova J,Fucik V,Hovorka O,Voburka Z,Bednarova L,Malon P,Stokrova J Amino Acids. 2012 Aug;43(2):751-61. doi: 10.1007/s00726-011-1125-6. Epub 2011 Oct 29.'], 'hemolysis': u'<1% hemolytic at 200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2743']}, u'KWKSFLKTFKSPVKTVFYTALKPISS': {'modifications': [], 'references': [u'Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides. Zhang L,Benz R Biochemistry. 1999 Jun 22;38(25):8102-11.'], 'hemolysis': u'MHC >128\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3596']}, u'IFGAILPLALGALKNLIK': {'modifications': ['C-Terminal'], 'references': [u'Hylin a1, the first cytolytic peptide isolated from the arboreal South American frog Hypsiboas albopunctatus ("spotted treefrog"). Castro MS,Ferreira TC,Cilli EM,Crusca E Jr,Mendes-Giannini MJ,Sebben A,Ricart CA,Sousa MV Peptides. 2009 Feb;30(2):291-6. doi: 10.1016/j.peptides.2008.11.003. Epub 2008 Nov 13.'], 'hemolysis': u'HC50 =18\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3707']}, u'GNleAibOrnOrnAibOrnOrnAibNleOrnOrnNleGY': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Amphipathic alpha helical antimicrobial peptides. Giangaspero A,Sandri L Eur J Biochem. 2001 Nov;268(21):5589-600.'], 'hemolysis': u'30% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2140']}, u'APCLACPCKACPCLAPCLACPCKACPCLAPCLACPC': {'modifications': ['C-Terminal', 'Cyclic', 'Non-Natural'], 'references': [u'Interplay among folding, sequence, and lipophilicity in the antibacterial and hemolytic activities of alpha/beta-peptides. Schmitt MA,Weisblum B J Am Chem Soc. 2007 Jan 17;129(2):417-28.'], 'hemolysis': u'>10% hemolysis at 3.1 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1091']}, u'GFLSALKKYLPIVLKHV': {'modifications': ['C-Terminal'], 'references': [u'Structural identification by mass spectrometry of a novel antimicrobial peptide from the venom of the solitary bee Osmia rufa (Hymenoptera: Megachilidae). Stocklin R,Favreau P,Thai R,Pflugfelder J,Bulet P Toxicon. 2010 Jan;55(1):20-7. doi: 10.1016/j.toxicon.2008.12.011. Epub 2008 Dec 14.'], 'hemolysis': u'Hemolytic activity i.e. 16.6HU/mg', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3496']}, u'GLVTGLLKTAGKLLGDLFGSLSG': {'modifications': ['C-Terminal'], 'references': [u'Membrane association, electrostatic sequestration, and cytotoxicity of Gly-Leu-rich peptide orthologs with differing functions. Vanhoye D,Bruston F,El Amri S,Ladram A,Amiche M Biochemistry. 2004 Jul 6;43(26):8391-409.'], 'hemolysis': u'48% hemolytic at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2497']}, u'GLLSGILGAGKHIVCGLSGLC': {'modifications': [], 'references': [u'Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami. Conlon JM,Al-Ghaferi N,Abraham B,Jiansheng H,Cosette P,Leprince J,Jouenne T Peptides. 2006 Sep;27(9):2111-7. Epub 2006 Apr 18.'], 'hemolysis': u'LC50 = 295\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1678']}, u'FLPLVTMLLGKLF': {'modifications': ['C-Terminal'], 'references': [u'Purification and characterization of antimicrobial peptides from the skin secretions of the carpenter frog Rana virgatipes (Ranidae, Aquarana). Conlon JM,Abraham B,Sonnevend A,Jouenne T,Cosette P,Leprince J,Vaudry H Regul Pept. 2005 Nov;131(1-3):38-45.'], 'hemolysis': u'LD50 =30\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3892']}, u'GILKTIKSIASKVANTVQKLKRKAKNAV': {'modifications': [], 'references': [u'Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin. Sanchez-Vasquez L,Silva-Sanchez J,Jimenez-Vargas JM,Rodriguez-Romero A,Munoz-Garay C,Rodriguez MC,Gurrola GB Biochim Biophys Acta. 2013 Jun;1830(6):3427-36. doi: 10.1016/j.bbagen.2013.01.028. Epub 2013 Feb 9.'], 'hemolysis': u'EC50 =47\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3254']}, u'GLLGPLLKIAAKVGKNLL': {'modifications': ['C-Terminal'], 'references': [u'Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7. Conlon JM,Galadari S,Raza H Chem Biol Drug Des. 2008 Jul;72(1):58-64. doi: 10.1111/j.1747-0285.2008.00671.x. Epub 2008 Jun 12.'], 'hemolysis': u'LD50 = 110\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1962']}, u'AVVKVPLKKFKSIRE': {'modifications': [], 'references': [u'Antimicrobial peptides derived from pepsinogens in the stomach of the bullfrog, Rana catesbeiana. Minn I,Kim HS Biochim Biophys Acta. 1998 Jul 1;1407(1):31-9.'], 'hemolysis': u'0.40% hemolysis at 200\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3811']}, u'KKKKKKAAFALWLAFAA': {'modifications': ['C-Terminal', 'Cyclic'], 'references': [u'Membrane interactions of designed cationic antimicrobial peptides: the two thresholds. Glukhov E,Burrows LL Biopolymers. 2008 May;89(5):360-71. doi: 10.1002/bip.20917.'], 'hemolysis': u'MHC <81\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1148']}, u'KKlFKKILkYL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Improvement of the efficacy of linear undecapeptides against plant-pathogenic bacteria by incorporation of D-amino acids. Guell I,Cabrefiga J,Badosa E,Ferre R,Talleda M,Bardaji E,Planas M,Feliu L Appl Environ Microbiol. 2011 Apr;77(8):2667-75. doi: 10.1128/AEM.02759-10. Epub 2011 Feb 18.'], 'hemolysis': u'0\xb10% hemolytic at 250\u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2859']}, u'kklfkkilkyl': {'modifications': ['C-Terminal', u'Stereochemistry: D'], 'references': [u'Improvement of the efficacy of linear undecapeptides against plant-pathogenic bacteria by incorporation of D-amino acids. Guell I,Cabrefiga J,Badosa E,Ferre R,Talleda M,Bardaji E,Planas M,Feliu L Appl Environ Microbiol. 2011 Apr;77(8):2667-75. doi: 10.1128/AEM.02759-10. Epub 2011 Feb 18.'], 'hemolysis': u'50\xb12.1% hemolytic at 250\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2878']}, u'GLASTIGSLLGKFAKGGAQAFLQPK': {'modifications': [], 'references': [u'Host-defense peptides in skin secretions of the tetraploid frog Silurana epitropicalis with potent activity against methicillin-resistant Staphylococcus aureus (MRSA). Conlon JM,Mechkarska M,Prajeep M,Sonnevend A,Coquet L,Leprince J,Jouenne T,Vaudry H Peptides. 2012 Sep;37(1):113-9. doi: 10.1016/j.peptides.2012.07.005. Epub 2012 Jul 16.'], 'hemolysis': u'LC50 >160\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3154']}, u'GFMKYIGPLIPHAVKAISKLI': {'modifications': [], 'references': [u'Antimicrobial and cytolytic properties of the frog skin peptide, kassinatuerin-1 and its L- and D-lysine-substituted derivatives. Conlon JM,Abraham B,Galadari S,Knoop FC,Sonnevend A Peptides. 2005 Nov;26(11):2104-10.'], 'hemolysis': u'LD50 =120\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4079']}, u'GILGKLWEGFKSIV': {'modifications': ['C-Terminal'], 'references': [u'Three new antimicrobial peptides from the scorpion Pandinus imperator. Zeng XC,Zhou L,Shi W,Luo X,Zhang L,Nie Y,Wang J,Wu S,Cao B Peptides. 2013 Jul;45:28-34. doi: 10.1016/j.peptides.2013.03.026. Epub 2013 Apr 23.'], 'hemolysis': u'21% hemolysis at 64 \u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3268']}, u'kklfkkilkyL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Improvement of the efficacy of linear undecapeptides against plant-pathogenic bacteria by incorporation of D-amino acids. Guell I,Cabrefiga J,Badosa E,Ferre R,Talleda M,Bardaji E,Planas M,Feliu L Appl Environ Microbiol. 2011 Apr;77(8):2667-75. doi: 10.1128/AEM.02759-10. Epub 2011 Feb 18.'], 'hemolysis': u'3\xb12.7% hemolytic at 250\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2877']}, u'GIINTLQKYYARVRGGRAAVLSALPKEEQIGKASTRGRKAARRKK': {'modifications': [], 'references': [u'Linear analogues of human beta-defensin 3: concepts for design of antimicrobial peptides with reduced cytotoxicity to mammalian cells. Liu S,Zhou L,Li J,Suresh A,Verma C,Foo YH,Yap EP,Tan DT Chembiochem. 2008 Apr 14;9(6):964-73. doi: 10.1002/cbic.200700560.'], 'hemolysis': u'1.5-2.3% hemolysis at 3-100 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1159']}, u'HYRIKPTFRRLKWKYKGKFW': {'modifications': ['Cyclic'], 'references': [u'Cyclic antimicrobial peptides based on Limulus anti-lipopolysaccharide factor for neutralization of lipopolysaccharide. Andra J,Lamata M,Martinez de Tejada G,Bartels R,Koch MH Biochem Pharmacol. 2004 Oct 1;68(7):1297-307.'], 'hemolysis': u'~20% hemolysis at 100\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2393']}, u'SIITTTKEAKLPQLWKQIACRLYNTC': {'modifications': ['Cyclic'], 'references': [u'A new family of antimicrobial peptides from skin secretions of Rana pleuraden. Wang X,Song Y,Li J,Liu H,Xu X,Lai R Peptides. 2007 Oct;28(10):2069-74. Epub 2007 Jul 22.'], 'hemolysis': u'Little hemolysis at 200mg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3641']}, u'GFGSLFKFLAKKVAKTVAKQAAKQGAKYVANKHME': {'modifications': [], 'references': [u'Cupiennin 1, a new family of highly basic antimicrobial peptides in the venom of the spider Cupiennius salei (Ctenidae). Kuhn-Nentwig L,Muller J,Schaller J,Walz A,Dathe M J Biol Chem. 2002 Mar 29;277(13):11208-16. Epub 2002 Jan 15.'], 'hemolysis': u'EC50 = 14.5\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3427']}, u'GLFGKILGVGKKVLCGLSGMC': {'modifications': [], 'references': [u'Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami. Conlon JM,Al-Ghaferi N,Abraham B,Jiansheng H,Cosette P,Leprince J,Jouenne T Peptides. 2006 Sep;27(9):2111-7. Epub 2006 Apr 18.'], 'hemolysis': u'LC50 = 40\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1677']}, u'tleKtleAtleAtleA': {'modifications': ['Cyclic', u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'Pharmacodynamic synergy strictly dependent on the co-operative aggregation of enantiomers of cyclic peptides in the bacterial cell membrane. Danielsson M,Rosenthal-Aizman K,Bergsson G Bioorg Med Chem Lett. 2011 Sep 15;21(18):5262-5. doi: 10.1016/j.bmcl.2011.07.032. Epub 2011 Jul 19.'], 'hemolysis': u'HC50 =17\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2960']}, u'LkLKSIVSWAKKVL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Enhancing the hypotensive effect and diminishing the cytolytic activity of hornet mastoparan B by D-amino acid substitution. Ho CL,Shih YP,Wang KT Toxicon. 2001 Oct;39(10):1561-6.'], 'hemolysis': u'85-85% hemolysis at 15 \xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1978']}, u'GABAFTicOicGABAKTicOicGABAFTicOicGABAKTicKKKK': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', 'Non-Natural'], 'references': [u'De novo design of selective antibiotic peptides by incorporation of unnatural amino acids. Hicks RP,Bhonsle JB,Venugopal D,Koser BW J Med Chem. 2007 Jun 28;50(13):3026-36. Epub 2007 Jun 5.'], 'hemolysis': u'1% hemolysis at 25\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1768']}, u'ILGKLLSTAWALLSkL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent. Conlon JM,Mechkarska M,Prajeep M,Arafat K,Zaric M,Lukic ML Amino Acids. 2013 Feb;44(2):715-23. doi: 10.1007/s00726-012-1395-7. Epub 2012 Sep 11.'], 'hemolysis': u'LC50 =27\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3186']}, u'KWKSFLkTFKSLKkTVLHTLLkAISS': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', u'Stereochemistry: Mix'], 'references': [u'Role of helicity on the anticancer mechanism of action of cationic-helical peptides. Huang YB,He LY,Jiang HY Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849. Epub 2012 Jun 5.'], 'hemolysis': u'MHC = 81.31 \xb1 0.17\u03bcmol/L', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2640']}, u'KKFFLKVLTKIRCKVAGGCRT': {'modifications': [], 'references': [u'Effects of thioredoxin: SUMO and intein on soluble fusion expression of an antimicrobial peptide OG2 in Escherichia coli. Xie YG,Luan C,Zhang HW,Han FF,Feng J,Choi YJ,Groleau D Protein Pept Lett. 2013 Jan;20(1):54-60.'], 'hemolysis': u'10% hemolytic at 256 \u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2668']}, u'YCYCRRRFCVCVGR': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'25-50% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1195']}, u'LCYCRRRFCGCV': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'0-3% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1219']}, u'SWLRDIWDWECEVLSDFK': {'modifications': [], 'references': [u'Rational design of peptides with anti-HCV/HIV activities and enhanced specificity. Li GR,He LY,Liu XY,Liu AP,Huang YB,Qiu C,Zhang XY,Xu JQ,Yang W Chem Biol Drug Des. 2011 Nov;78(5):835-43. doi: 10.1111/j.1747-0285.2011.01201.x. Epub 2011 Sep 26.'], 'hemolysis': u'MHC =217.91\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2958']}, u'FFHHIFRGIVHVGKTIHKLVTG': {'modifications': ['C-Terminal'], 'references': [u'Discovery and characterization of two isoforms of moronecidin, a novel antimicrobial peptide from hybrid striped bass. Lauth X,Shike H,Burns JC,Westerman ME,Ostland VE,Carlberg JM,Van Olst JC,Nizet V,Taylor SW,Shimizu C J Biol Chem. 2002 Feb 15;277(7):5030-9. Epub 2001 Dec 5.'], 'hemolysis': u'100% hemolysis at 80\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3424']}, u'FLPVLAGVLSRA': {'modifications': [], 'references': [u'Identification and characterization of two novel antimicrobial peptides, temporin-Ra and temporin-Rb, from skin secretions of the marsh frog (Rana ridibunda). Asoodeh A,Zardini HZ J Pept Sci. 2012 Jan;18(1):10-6. doi: 10.1002/psc.1409. Epub 2011 Sep 29.'], 'hemolysis': u'1.1% hemolysis at 60\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3610']}, u'VOLfPVOLfP': {'modifications': [u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC =12.5\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3943']}, u'LFKEILEKIKAKL': {'modifications': ['C-Terminal'], 'references': [u'Identification and characterization of a novel antimicrobial peptide from the venom of the ant Tetramorium bicarinatum. Rifflet A,Gavalda S,Tene N,Orivel J,Leprince J,Guilhaudis L,Genin E,Vetillard A Peptides. 2012 Dec;38(2):363-70. doi: 10.1016/j.peptides.2012.08.018. Epub 2012 Sep 7.'], 'hemolysis': u'Inactive', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3167']}, u'INWLKLGKKMMSAI': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 >100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3917']}, u'GIMRVFKGVLKTAGKSVAKNVAGSFLDRLKCKISGGC': {'modifications': ['Cyclic'], 'references': [u'Molecular cloning and functional characterization of novel antimicrobial peptides from the skin of brown frog, Rana zhenhaiensis. Xu B,Che H,Kang L,Zheng S,Mu S,Wan Zoolog Sci. 2012 Sep;29(9):553-8. doi: 10.2108/zsj.29.553.'], 'hemolysis': u'HC50 =52\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3163']}, u'NLWAGILKHIIK': {'modifications': ['C-Terminal'], 'references': [u'Panurgines, novel antimicrobial peptides from the venom of communal bee Panurgus calcaratus (Hymenoptera: Andrenidae). Cujova S,Slaninova J,Monincova L,Fucik V,Bednarova L,Stokrova J,Hovorka O,Voburka Z,Straka J Amino Acids. 2013 Jul;45(1):143-57. doi: 10.1007/s00726-013-1482-4. Epub 2013 Mar 13.'], 'hemolysis': u'LC50 >200\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3718']}, u'AhxFTicOicAhxKTicOicAhxFTicOicAhxKTicKKKK': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', 'Non-Natural'], 'references': [u'De novo design of selective antibiotic peptides by incorporation of unnatural amino acids. Hicks RP,Bhonsle JB,Venugopal D,Koser BW J Med Chem. 2007 Jun 28;50(13):3026-36. Epub 2007 Jun 5.'], 'hemolysis': u'26.6% hemolysis at 25\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1784']}, u'KLALKLALKALKaaLKLA': {'modifications': [u'Stereochemistry: Mix'], 'references': [u'Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes. Dathe M,Schumann M,Wieprecht T,Winkler A,Beyermann M,Krause E,Matsuzaki K,Murase O Biochemistry. 1996 Sep 24;35(38):12612-22.'], 'hemolysis': u'EC50 = 260\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3464']}, u'AAAKAALNAVLVGANA': {'modifications': [], 'references': [u'Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity. Feder R,Dagan A J Biol Chem. 2000 Feb 11;275(6):4230-8.'], 'hemolysis': u'LC50 =40\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1014']}, u'RWKIFKKIEKVGRNVRDGIIKAGPAVAVVGQAATVVKG': {'modifications': [], 'references': [u'Characterization and cDNA cloning of a cecropin-like antimicrobial peptide, papiliocin, from the swallowtail butterfly, Papilio xuthus. Kim SR,Hong MY,Park SW,Choi KH,Yun EY,Goo TW,Kang SW,Suh HJ,Kim I Mol Cells. 2010 Apr;29(4):419-23. doi: 10.1007/s10059-010-0050-y. Epub 2010 Mar 4.'], 'hemolysis': u'0% hemolysis at 3 - 50\u03bcM  (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1494']}, u'GKKLLKKWKKLWKKW': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Bioactivity and the first transmission electron microscopy immunogold studies of short de novo-designed antimicrobial peptides. Azad MA,Huttunen-Hennelly HE Antimicrob Agents Chemother. 2011 May;55(5):2137-45. doi: 10.1128/AAC.01148-10. Epub 2011 Feb 7.'], 'hemolysis': u'5% hemolytic at 3.4mg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2830']}, u'QRSVSNAATRVSRTGRSRWRDVSRNFMRR': {'modifications': [], 'references': [u'Hemolysis of erythrocytes by granulysin-derived peptides but not by granulysin. Li Q,Dong C,Deng A,Katsumata M,Nakadai A,Kawada T,Okada S,Clayberger C Antimicrob Agents Chemother. 2005 Jan;49(1):388-97.'], 'hemolysis': u'No hemolysis at 10\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1887']}, u'KWKSFLKTFKSAKKKVLHTALKAISS': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Effects of net charge and the number of positively charged residues on the biological activity of amphipathic alpha-helical cationic antimicrobial peptides. Jiang Z,Vasil AI,Hale JD,Hancock RE,Vasil ML Biopolymers. 2008;90(3):369-83.'], 'hemolysis': u'MHC =250.0\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1142']}, u'GIAKFGKAAAHFGKKWVGELMNS': {'modifications': ['C-Terminal'], 'references': [u'Influence of the angle subtended by the positively charged helix face on the membrane activity of amphipathic, antibacterial peptides. Wieprecht T,Dathe M,Epand RM,Beyermann M,Krause E,Maloy WL,MacDonald DL Biochemistry. 1997 Oct 21;36(42):12869-80.'], 'hemolysis': u'EC25=159\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3585']}, u'GLLKPLLKIAAKVGSNLL': {'modifications': ['C-Terminal'], 'references': [u'Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7. Conlon JM,Galadari S,Raza H Chem Biol Drug Des. 2008 Jul;72(1):58-64. doi: 10.1111/j.1747-0285.2008.00671.x. Epub 2008 Jun 12.'], 'hemolysis': u'LD50 >500\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1959']}, u'KKLFKKILkYL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Improvement of the efficacy of linear undecapeptides against plant-pathogenic bacteria by incorporation of D-amino acids. Guell I,Cabrefiga J,Badosa E,Ferre R,Talleda M,Bardaji E,Planas M,Feliu L Appl Environ Microbiol. 2011 Apr;77(8):2667-75. doi: 10.1128/AEM.02759-10. Epub 2011 Feb 18.'], 'hemolysis': u'0\xb1 0% hemolytic at 250\u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2850']}, u'FSISASKVLDKFGKIVGKVLKQLKKVSAVAKV': {'modifications': [], 'references': [u'Lytic activity and structural differences of amphipathic peptides derived from trialysin. Martins RM,Sforca ML,Amino R,Juliano MA,Oyama S Jr,Juliano L,Pertinhez TA,Spisni A Biochemistry. 2006 Feb 14;45(6):1765-74.'], 'hemolysis': u'LD50=28.1\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4193']}, u'INWLRLGRRILGAL': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 =25\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3908']}, u'GLADYWRTAFRANFANLGPGIRCKSARC': {'modifications': [], 'references': [u'Molecular cloning and functional characterization of novel antimicrobial peptides from the skin of brown frog, Rana zhenhaiensis. Xu B,Che H,Kang L,Zheng S,Mu S,Wan Zoolog Sci. 2012 Sep;29(9):553-8. doi: 10.2108/zsj.29.553.'], 'hemolysis': u'HC50 >64\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3164']}, u'GALRGCWTKSYPPKPCK': {'modifications': ['C-Terminal', 'Cyclic'], 'references': [u'Ranacyclins, a new family of short cyclic antimicrobial peptides: biological function, mode of action, and parameters involved in target specificity. Mangoni ML,Papo N,Mignogna G,Andreu D,Shai Y,Barra D Biochemistry. 2003 Dec 2;42(47):14023-35.'], 'hemolysis': u'20% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3770']}, u'IFGAIAGLLKNIF': {'modifications': ['C-Terminal'], 'references': [u'Structural and functional characterization of two genetically related meucin peptides highlights evolutionary divergence and convergence in antimicrobial peptides. Gao B,Sherman P,Luo L,Bowie J FASEB J. 2009 Apr;23(4):1230-45. doi: 10.1096/fj.08-122317. Epub 2008 Dec 16.'], 'hemolysis': u'>90% hemolysis at 25\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3615']}, u'ILGKLLKTAAKLLSNL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent. Conlon JM,Mechkarska M,Prajeep M,Arafat K,Zaric M,Lukic ML Amino Acids. 2013 Feb;44(2):715-23. doi: 10.1007/s00726-012-1395-7. Epub 2012 Sep 11.'], 'hemolysis': u'LC50 =38\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3177']}, u'KFKSFIKKLTSKFLHSAKKF': {'modifications': ['C-Terminal'], 'references': [u'The Design and Construction of K11: A Novel ?-Helical Antimicrobial Peptide. Jin-Jiang H,Jin-Chun L,Min L,Qing-Shan H Int J Microbiol. 2012;2012:764834. doi: 10.1155/2012/764834. Epub 2012 Feb 16.'], 'hemolysis': u'MHC = 250 \u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2719']}, u'IWRIFRRIFRIF': {'modifications': ['C-Terminal'], 'references': [u'Biochemical property and membrane-peptide interactions of de novo antimicrobial peptides designed by helix-forming units. Ma QQ,Dong N,Shan AS,Lv YF,Li YZ,Chen ZH,Cheng BJ Amino Acids. 2012 Dec;43(6):2527-36. doi: 10.1007/s00726-012-1334-7. Epub 2012 Jun 15.'], 'hemolysis': u'MHC = 19.6 \u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2664']}, u'ALWKTMLKKLGTMALHAGKAALGAAANTISQGTQ': {'modifications': [], 'references': [u'The vertebrate peptide antibiotics dermaseptins have overlapping structural features but target specific microorganisms. Mor A,Hani K J Biol Chem. 1994 Dec 16;269(50):31635-41.'], 'hemolysis': u'100% hemolysis at 70\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3691']}, u'SWKSFLKTFSSAKSTVLHTALKAISS': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Effects of net charge and the number of positively charged residues on the biological activity of amphipathic alpha-helical cationic antimicrobial peptides. Jiang Z,Vasil AI,Hale JD,Hancock RE,Vasil ML Biopolymers. 2008;90(3):369-83.'], 'hemolysis': u'MHC =125.0\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1140']}, u'RQKDKRPYSERKNQYTGPQFLYPPERIPP': {'modifications': [], 'references': [u'Lumbricin I, a novel proline-rich antimicrobial peptide from the earthworm: purification, cDNA cloning and molecular characterization. Cho JH,Park CB,Yoon YG Biochim Biophys Acta. 1998 Oct 22;1408(1):67-76.'], 'hemolysis': u'0.21% hemolysis at 100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3395']}, u'FLPLIARVLSGIL': {'modifications': ['C-Terminal'], 'references': [u'Alanine scanning analysis and structure-function relationships of the frog-skin antimicrobial peptide temporin-1Ta. Grieco P,Luca V,Auriemma L,Carotenuto A,Saviello MR,Campiglia P,Barra D,Novellino E J Pept Sci. 2011 May;17(5):358-65. doi: 10.1002/psc.1350. Epub 2011 Feb 18.'], 'hemolysis': u'1% hemolytic at 1.25\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2892']}, u'LNLKSIVSWAKKVL': {'modifications': ['C-Terminal'], 'references': [u'Structural requirements for the edema-inducing and hemolytic activities of mastoparan B isolated from the hornet (Vespa basalis) venom. Ho CL,Lin YL,Chen WC,Hwang LL,Yu HM Toxicon. 1996 Sep;34(9):1027-35.'], 'hemolysis': u'~4% hemolysis at 20\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3500']}, u'klksllktlskakkkklktllkalsk': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', u'Stereochemistry: D'], 'references': [u"Rational design of ?-helical antimicrobial peptides to target Gram-negative pathogens, Acinetobacter baumannii and Pseudomonas aeruginosa: utilization of charge, 'specificity determinants,' total hydrophobicity, hydrophobe type and location as design parameters to improve the therapeutic ratio. Jiang Z,Vasil AI,Gera L,Vasil ML Chem Biol Drug Des. 2011 Apr;77(4):225-40. doi: 10.1111/j.1747-0285.2011.01086.x. Epub 2011 Feb 2."], 'hemolysis': u'HC50 =1342.0\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2825']}, u'KKLFKKilkYL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Improvement of the efficacy of linear undecapeptides against plant-pathogenic bacteria by incorporation of D-amino acids. Guell I,Cabrefiga J,Badosa E,Ferre R,Talleda M,Bardaji E,Planas M,Feliu L Appl Environ Microbiol. 2011 Apr;77(8):2667-75. doi: 10.1128/AEM.02759-10. Epub 2011 Feb 18.'], 'hemolysis': u'5\xb11.6% hemolytic at 250\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2862']}, u'ILPWKWPWLPYRR': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship of indolicidin, a Trp-rich antibacterial peptide. Ando S,Mitsuyasu K,Soeda Y,Hidaka M,Ito Y,Matsubara K,Shindo M,Uchida Y J Pept Sci. 2010 Apr;16(4):171-7. doi: 10.1002/psc.1217.'], 'hemolysis': u'12% hemolysis at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1485']}, u'fPOAdaGlyOfPOAdaGlyO': {'modifications': ['Cyclic', u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'An adamantyl amino acid containing gramicidin S analogue with broad spectrum antibacterial activity and reduced hemolytic activity. Kapoerchan VV,Knijnenburg AD,Niamat M,Spalburg E,de Neeling AJ,Nibbering PH,Mars-Groenendijk RH,Noort D,Otero JM,Llamas-Saiz AL,van Raaij MJ,van der Marel GA,Overkleeft HS Chemistry. 2010 Oct 25;16(40):12174-81. doi: 10.1002/chem.201001686.'], 'hemolysis': u'HC50=107\xb11.07\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2799']}, u'HAEHKVKIKVKQKYGQFPQGTEVTYTCSGNYFLM': {'modifications': [], 'references': [u'High therapeutic index of factor C Sushi peptides: potent antimicrobials against Pseudomonas aeruginosa. Yau YH,Ho B,Tan NS,Ng ML Antimicrob Agents Chemother. 2001 Oct;45(10):2820-5.'], 'hemolysis': u'37% hemolysis at 100 \xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2134']}, u'FKRLEKLFSKIQNDK': {'modifications': [], 'references': [u'Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions. Park SC,Kim MH,Hossain MA,Shin SY,Kim Y,Stella L,Wade JD,Park Y Biochim Biophys Acta. 2008 Jan;1778(1):229-41. Epub 2007 Oct 2.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1934']}, u'LCYCRRRFCVCVGR': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'>50% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1169']}, u'FVQWFSKFLLRIL': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship, conformational and biological studies of temporin L analogues. Mangoni ML,Carotenuto A,Auriemma L,Saviello MR,Campiglia P,Gomez-Monterrey I,Malfi S,Marcellini L,Barra D,Novellino E J Med Chem. 2011 Mar 10;54(5):1298-307. doi: 10.1021/jm1012853. Epub 2011 Feb 14.'], 'hemolysis': u'80% hemolytic at 6\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2834']}, u'ALWKTLLKKVLKAAAK': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity. Feder R,Dagan A J Biol Chem. 2000 Feb 11;275(6):4230-8.'], 'hemolysis': u'LC50 =10\xb10.5\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1016']}, u'RGLRRLGRKIAHGVKKYGPTVLRIIRIA': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity analysis of SMAP-29, a sheep leukocytes-derived antimicrobial peptide. Shin SY,Park EJ,Yang ST,Jung HJ,Eom SH,Song WK,Kim Y,Hahm KS Biochem Biophys Res Commun. 2001 Jul 27;285(4):1046-51.'], 'hemolysis': u'60.8% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1046']}, u'GFFALIAKIISSPLFKTLLSAVGSALSSSGEQE': {'modifications': [], 'references': [u'Solution conformations of peptides representing the sequence of the toxin pardaxin and analogues in trifluoroethanol-water mixtures: analysis of CD spectra. Thennarasu S Biopolymers. 1997 May;41(6):635-45.'], 'hemolysis': u'Conc. Required for hemolysis =0.6nmols', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3794']}, u'PKLlKTFlSKWIG': {'modifications': [u'Stereochemistry: Mix'], 'references': [u'Biological activities of retro and diastereo analogs of a 13-residue peptide with antimicrobial and hemolytic activities. Subbalakshmi C,Nagaraj R J Pept Res. 2001 Jan;57(1):59-67.'], 'hemolysis': u'~10% hemolsis at 60 \xb5g/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2098']}, u'GSKKPVPIIYCNRRSGKCQRM': {'modifications': [], 'references': [u'Selective toxicity of antimicrobial peptide S-thanatin on bacteria. Wu G,Wu H,Fan X,Zhao R,Li X,Wang S,Ma Y,Shen Z Peptides. 2010 Sep;31(9):1669-73. doi: 10.1016/j.peptides.2010.06.009. Epub 2010 Jun 22.'], 'hemolysis': u'low hemolytic activity up to 400\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3074']}, u'SIGTAVKKAVPIAKKVGKVAIPIAKAVLSVVGQLVG': {'modifications': [], 'references': [u'Antibacterial activity and pore-forming properties of ceratotoxins: a mechanism of action based on the barrel stave model. Bessin Y,Saint N,Marri L,Marchini D Biochim Biophys Acta. 2004 Dec 15;1667(2):148-56.'], 'hemolysis': u'Hemolytic at 84\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2371']}, u'AAGMGFFGAR': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial effect and membrane-active mechanism of Urechistachykinins, neuropeptides derived from Urechis unicinctus. Sung WS,Park SH FEBS Lett. 2008 Jul 9;582(16):2463-6. doi: 10.1016/j.febslet.2008.06.015. Epub 2008 Jun 18.'], 'hemolysis': u'0% hemolysis at 3-100 \u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1227']}, u'ILPWKAPAAPARR': {'modifications': ['C-Terminal'], 'references': [u'The effects of tryptophan and hydrophobicity on the structure and bioactivity of novel indolicidin derivatives with promising pharmaceutical potential. Podorieszach AP Org Biomol Chem. 2010 Apr 7;8(7):1679-87. doi: 10.1039/b921248e. Epub 2010 Feb 11.'], 'hemolysis': u'MHC = >6.4x10-3 g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1499']}, u'ALLHHGLNCAKGVLAALLHHGLNCAKGVLA': {'modifications': [], 'references': [u'Halocidin: a new antimicrobial peptide from hemocytes of the solitary tunicate, Halocynthia aurantium. Jang WS,Kim KN,Lee YS,Nam MH FEBS Lett. 2002 Jun 19;521(1-3):81-6.'], 'hemolysis': u'0% hemolysis at 100\u03bcg/ml (non hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3542']}, u'VKLKVyPLKVKLYP': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Dissociation of antimicrobial and hemolytic activities in cyclic peptide diastereomers by systematic alterations in amphipathicity. Kondejewski LH,Jelokhani-Niaraki M,Farmer SW,Lix B,Kay CM,Sykes BD,Hancock RE J Biol Chem. 1999 May 7;274(19):13181-92.'], 'hemolysis': u'100% hemolytic at 12.5 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2560']}, u'MESVSDAVQLMLGFGTFVLMLLGLVVELIKNSNKK': {'modifications': [], 'references': [u'Functional characterization of a new holin-like antibacterial protein coding gene tmp1 from goat skin surface metagenome. Rajesh T,Anthony T,Saranya S,Pushpam PL Appl Microbiol Biotechnol. 2011 Feb;89(4):1061-73. doi: 10.1007/s00253-010-2907-6. Epub 2010 Oct 7.'], 'hemolysis': u'0% hemolysis at 50\u03bcM  (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1546']}, u'INMKASAAVAKKLL': {'modifications': [], 'references': [u'Antimicrobial peptides from the venoms of Vespa bicolor Fabricius. Chen W,Yang X,Yang X,Zhai L,Lu Z,Liu J Peptides. 2008 Nov;29(11):1887-92. doi: 10.1016/j.peptides.2008.07.018. Epub 2008 Aug 3.'], 'hemolysis': u'2.7% hemolysis at 200\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3979']}, u'VRRFPAAAPFLRR': {'modifications': [], 'references': [u'Conformation-dependent antibiotic activity of tritrpticin, a cathelicidin-derived antimicrobial peptide. Yang ST,Yub Shin SY,Kim YC,Kim Y,Hahm KS Biochem Biophys Res Commun. 2002 Sep 6;296(5):1044-50.'], 'hemolysis': u'0% hemolysis at 200\xb5g/ml (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2211']}, u'ILPWKWPKLPWRR': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship of indolicidin, a Trp-rich antibacterial peptide. Ando S,Mitsuyasu K,Soeda Y,Hidaka M,Ito Y,Matsubara K,Shindo M,Uchida Y J Pept Sci. 2010 Apr;16(4):171-7. doi: 10.1002/psc.1217.'], 'hemolysis': u'0% hemolysis at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1483']}, u'WKSYVRRWRS': {'modifications': [], 'references': [u'Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide. Wu YS,Liao ZJ,Wang KS Bioorg Med Chem Lett. 2013 May 15;23(10):2929-32. doi: 10.1016/j.bmcl.2013.03.053. Epub 2013 Mar 25.'], 'hemolysis': u'-0.4 \xb1 0.5%hemolytic at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2581']}, u'RAGLQFPVGRLLRRLLRRLLR': {'modifications': [], 'references': [u'A cancer specific cell-penetrating peptide, BR2, for the efficient delivery of an scFv into cancer cells. Lim KJ,Sung BH,Shin JR,Lee YW,Kim da J,Yang KS PLoS One. 2013 Jun 11;8(6):e66084. doi: 10.1371/journal.pone.0066084. Print 2013.'], 'hemolysis': u'34.3% hemolysis at 200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3277']}, u'SNWKKIASIGKEVLKAL': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 >>100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3936']}, u'GFKDLLKGAAKALVKTVkF': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7. Conlon JM,Galadari S,Raza H Chem Biol Drug Des. 2008 Jul;72(1):58-64. doi: 10.1111/j.1747-0285.2008.00671.x. Epub 2008 Jun 12.'], 'hemolysis': u'LD50 >500 \xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1955']}, u'CIAKGNGCQPSGVQGNCCSGHCHKEPGWVAGYCK': {'modifications': ['C-Terminal'], 'references': [u'Antifungal properties and mode of action of psacotheasin, a novel knottin-type peptide derived from Psacothea hilaris. Hwang B,Hwang JS,Lee J Biochem Biophys Res Commun. 2010 Sep 24;400(3):352-7. doi: 10.1016/j.bbrc.2010.08.063. Epub 2010 Aug 22.'], 'hemolysis': u'0% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3091']}, u'EGKGLG\u03b2Ala\u03b2AlaKTicOic\u03b2AlaFTicOic\u03b2AlaETicOic\u03b2AlaFTicOicELMNS': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'De novo design of selective antibiotic peptides by incorporation of unnatural amino acids. Hicks RP,Bhonsle JB,Venugopal D,Koser BW J Med Chem. 2007 Jun 28;50(13):3026-36. Epub 2007 Jun 5.'], 'hemolysis': u'27% hemolysis at 25\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1756']}, u'INWLKLGKKNleNleSAL': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 =43\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3913']}, u'SLLSLINKLIT': {'modifications': ['C-Terminal'], 'references': [u'Decoralin, a novel linear cationic alpha-helical peptide from the venom of the solitary eumenine wasp Oreumenes decoratus. Konno K,Rangel M,Oliveira JS,Dos Santos Cabrera MP,Fontana R,Hirata IY,Hide I,Nakata Y,Mori K,Kawano M,Fuchino H,Sekita S Peptides. 2007 Dec;28(12):2320-7. Epub 2007 Sep 29.'], 'hemolysis': u'EC50 = 80 \xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1859']}, u'RRGWVLRLALAY': {'modifications': [], 'references': [u'Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity. Rathinakumar R, Walkenhorst, William ,Walkenhorst WF J Am Chem Soc. 2009 Jun 10;131(22):7609-17. doi: 10.1021/ja8093247.'], 'hemolysis': u'0.14 fractions hemolysis at 15\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1325']}, u'LCLKKRRWKYCV': {'modifications': ['Cyclic'], 'references': [u'Macrocyclic hairpin mimetics of the cationic antimicrobial peptide protegrin I: a new family of broad-spectrum antibiotics. Shankaramma SC,Athanassiou Z,Zerbe O,Moehle K,Mouton C,Bernardini F,Vrijbloed JW,Obrecht D Chembiochem. 2002 Nov 4;3(11):1126-33.'], 'hemolysis': u'3% hemolysis at 100\xb5g ml-1', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2276']}, u'FLSLALAALPKFLCLVFKKC': {'modifications': [], 'references': [u'Cytolytic peptides belonging to the brevinin-1 and brevinin-2 families isolated from the skin of the Japanese brown frog, Rana dybowskii. Conlon JM,Kolodziejek J,Nowotny N,Leprince J,Vaudry H,Coquet L,Jouenne T Toxicon. 2007 Nov;50(6):746-56. Epub 2007 Jul 4.'], 'hemolysis': u'LC50 <5\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3643']}, u'EWGRRCCGWGPGRRYCRRWC': {'modifications': ['Cyclic'], 'references': [u'Antifungal activity of synthetic peptides derived from Impatiens balsamina antimicrobial peptides Ib-AMP1 and Ib-AMP4. Thevissen K,Francois IE,Sijtsma L,van Amerongen A,Schaaper WM,Meloen R,Posthuma-Trumpie T, Broekaert, Willem ,Broekaert WF Peptides. 2005 Jul;26(7):1113-9. Epub 2005 Feb 16.'], 'hemolysis': u'no hemolysis upto 100\u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1893']}, u'LCYCRRRFCVC': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'6-12% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1188']}, u'RCYCRRRFCVCR': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'0-3% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1174']}, u'AGWGSIFKHIFKAGKFIHGAIQAHND': {'modifications': ['C-Terminal'], 'references': [u'The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents. Morash MG,Douglas SE,Robotham A,Ridley CM,Gallant JW Dis Model Mech. 2011 Sep;4(5):622-33. doi: 10.1242/dmm.007310. Epub 2011 Jul 4.'], 'hemolysis': u'50% hemolytic at >256 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2929']}, u'SLTFEVLDKVLGELGKVSRK': {'modifications': [], 'references': [u'Correlations between differences in amino-terminal sequences and different hemolytic activity of sticholysins. Cilli EM,Pigossi FT,Crusca E Jr,Ros U,Martinez D,Lanio ME,Alvarez C Toxicon. 2007 Dec 15;50(8):1201-4. Epub 2007 Aug 3.'], 'hemolysis': u'Hemolytic activity expresssed as the initial rate (\u2206A/\u2206t, min- 1) i.e. at above 100 \xb5M activity is  ~0.004 min-1', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1817']}, u'KNLRRIIRKGIHIIKKYG': {'modifications': [], 'references': [u'Impact of single-residue mutations on the structure and function of ovispirin/novispirin antimicrobial peptides. Sawai MV,Waring AJ,Kearney WR,McCray PB Jr,Forsyth WR,Lehrer RI, Tack, Brian ,Tack B Protein Eng. 2002 Mar;15(3):225-32.'], 'hemolysis': u'1.8% hemolysis at 40\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2179']}, u'KNLRRIIRKGIHIIKKYF': {'modifications': [], 'references': [u'Membrane interactions of novicidin, a novel antimicrobial peptide: phosphatidylglycerol promotes bilayer insertion. Dorosz J,Gofman Y,Kolusheva S,Otzen D,Ben-Tal N,Nielsen NC J Phys Chem B. 2010 Sep 2;114(34):11053-60. doi: 10.1021/jp1052248.'], 'hemolysis': u'IC50 >50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1530']}, u'VKLnVyPLKVKLyP': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Effects of single D-amino acid substitutions on disruption of beta-sheet structure and hydrophobicity in cyclic 14-residue antimicrobial peptide analogs related to gramicidin S. Lee DL,Powers JP,Pflegerl K,Vasil ML,Hancock RE J Pept Res. 2004 Feb;63(2):69-84.'], 'hemolysis': u'MHC =62 \xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1588']}, u'RLCYTRGRFTVCV': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'12-25% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1211']}, u'RAGLQFPVGRLLRRLLR': {'modifications': [], 'references': [u'A cancer specific cell-penetrating peptide, BR2, for the efficient delivery of an scFv into cancer cells. Lim KJ,Sung BH,Shin JR,Lee YW,Kim da J,Yang KS PLoS One. 2013 Jun 11;8(6):e66084. doi: 10.1371/journal.pone.0066084. Print 2013.'], 'hemolysis': u'Inactive', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3275']}, u'GLWSKIKEAAKAAGKAALNAVTGLVNQGDQPS': {'modifications': [], 'references': [u'Peptides with differential cytolytic activity from skin secretions of the lemur leaf frog Hylomantis lemur (Hylidae: Phyllomedusinae). Conlon JM,Woodhams DC,Raza H,Coquet L,Leprince J,Jouenne T,Vaudry H Toxicon. 2007 Sep 15;50(4):498-506. Epub 2007 May 3.'], 'hemolysis': u'LC50 =200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4019']}, u'NWKGIAAMAKKLL': {'modifications': [], 'references': [u'Design of a novel membrane-destabilizing peptide selectively acting on acidic liposomes. Machida S,Niimi S,Shi X,Ando Y Biosci Biotechnol Biochem. 2000 May;64(5):985-94.'], 'hemolysis': u'24% hemolytic at 10\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2521']}, u'KWKSFIKKLTKKFLHSAKKF': {'modifications': ['C-Terminal'], 'references': [u'The Design and Construction of K11: A Novel ?-Helical Antimicrobial Peptide. Jin-Jiang H,Jin-Chun L,Min L,Qing-Shan H Int J Microbiol. 2012;2012:764834. doi: 10.1155/2012/764834. Epub 2012 Feb 16.'], 'hemolysis': u'MHC >500\u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2726']}, u'YKLFKKILKKL': {'modifications': ['C-Terminal', u'N-Terminal Modification: Tosylation'], 'references': [u'A library of linear undecapeptides with bactericidal activity against phytopathogenic bacteria. Badosa E,Ferre R,Planas M,Feliu L,Besalu E,Cabrefiga J,Bardaji E Peptides. 2007 Dec;28(12):2276-85. Epub 2007 Sep 25.'], 'hemolysis': u'81\xb13.7% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1854']}, u'KSLVRRWRSRW': {'modifications': ['C-Terminal'], 'references': [u'Discovery of potent antimicrobial peptide analogs of Ixosin-B. Lung FD,Wang KS,Liao ZJ,Hsu SK,Song FY,Liou CC Bioorg Med Chem Lett. 2012 Jun 15;22(12):4185-8. doi: 10.1016/j.bmcl.2012.04.018. Epub 2012 Apr 20.'], 'hemolysis': u'0% hemolytic at 100\u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2765']}, u'GMWSKIKNAGKAAKAAAKAAGKAALGAVSEAM': {'modifications': [], 'references': [u'Dermaseptin DA4, although closely related to dermaseptin B2, presents chemotactic and Gram-negative selective bactericidal activities. Auvynet C,Joanne P,Bourdais J,Nicolas P,Lacombe C FEBS J. 2009 Nov;276(22):6773-86. doi: 10.1111/j.1742-4658.2009.07392.x. Epub 2009 Oct 16.'], 'hemolysis': u'0% hemolysis at 1-100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1459']}, u'LKLFKKILKFL': {'modifications': ['C-Terminal'], 'references': [u'A library of linear undecapeptides with bactericidal activity against phytopathogenic bacteria. Badosa E,Ferre R,Planas M,Feliu L,Besalu E,Cabrefiga J,Bardaji E Peptides. 2007 Dec;28(12):2276-85. Epub 2007 Sep 25.'], 'hemolysis': u'65\xb11.5% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1849']}, u'KNLRRITRKIIHIIKKYG': {'modifications': [], 'references': [u'Impact of single-residue mutations on the structure and function of ovispirin/novispirin antimicrobial peptides. Sawai MV,Waring AJ,Kearney WR,McCray PB Jr,Forsyth WR,Lehrer RI, Tack, Brian ,Tack B Protein Eng. 2002 Mar;15(3):225-32.'], 'hemolysis': u'3.0% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2181']}, u'SVDMVMKGLKIWPL': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Structural and functional characterization of N-terminally blocked peptides isolated from the venom of the social wasp Polybia paulista. Ribeiro SP,Mendes MA,Dos Santos LD,de Souza BM,Marques MR,de Azevedo WF Jr Peptides. 2004 Dec;25(12):2069-78.'], 'hemolysis': u'0% hemolysis at 100\u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2388']}, u'KKKKKKKKKKGIGKLFLHAAKKFAKAFVAEKMNS': {'modifications': [], 'references': [u'Augmentation of the antibacterial activity of magainin by positive-charge chain extension. Bessalle R,Haas H,Goria A,Shalit I Antimicrob Agents Chemother. 1992 Feb;36(2):313-7.'], 'hemolysis': u'2% hemolysis at 200\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3453']}, u'GOrnOrnAibOrnOrnAibNleOrnOrnNleGY': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Amphipathic alpha helical antimicrobial peptides. Giangaspero A,Sandri L Eur J Biochem. 2001 Nov;268(21):5589-600.'], 'hemolysis': u'25% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2144']}, u'FFRRFFRR': {'modifications': ['C-Terminal'], 'references': [u'Synthetic cationic amphiphilic ?-helical peptides as antimicrobial agents. Wiradharma N,Khoe U,Hauser CA,Seow SV,Zhang S Biomaterials. 2011 Mar;32(8):2204-12. doi: 10.1016/j.biomaterials.2010.11.054. Epub 2010 Dec 18.'], 'hemolysis': u'HC50 > 500', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2045']}, u'LKWLKKWLK': {'modifications': ['C-Terminal'], 'references': [u'De novo generation of short antimicrobial peptides with simple amino acid composition. Lee SH,Kim SJ,Lee YS,Song MD,Kim IH Regul Pept. 2011 Jan 17;166(1-3):36-41. doi: 10.1016/j.regpep.2010.08.010. Epub 2010 Aug 22.'], 'hemolysis': u'0-5% hemolysis at 320\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3105']}, u'TLLKKVLKAAAK': {'modifications': [], 'references': [u'Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity. Feder R,Dagan A J Biol Chem. 2000 Feb 11;275(6):4230-8.'], 'hemolysis': u'LC50  >80\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1011']}, u'KWKKLLKKaLKLaKKLLK': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues. Song YM,Park Y,Lim SS,Yang ST,Woo ER,Park IS,Lee JS,Kim JI,Hahm KS,Kim Y Biochemistry. 2005 Sep 13;44(36):12094-106.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1897']}, u'NFLGTLVNLAKKIL': {'modifications': ['C-Terminal'], 'references': [u'Peptide defenses of the Cascades frog Rana cascadae: implications for the evolutionary history of frogs of the Amerana species group. Conlon JM,Al-Dhaheri A,Al-Mutawa E,Al-Kharrge R,Ahmed E,Kolodziejek J,Nowotny N, Nielsen, Per ,Nielsen PF Peptides. 2007 Jun;28(6):1268-74. Epub 2007 Mar 27.'], 'hemolysis': u'LD50 =50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1133']}, u'KWKLFKKILKFLHLAKKF': {'modifications': ['C-Terminal'], 'references': [u'Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs. Shin SY,Lee SH,Yang ST,Park EJ,Lee DG,Lee MK,Eom SH,Song WK,Kim Y,Hahm KS J Pept Res. 2001 Dec;58(6):504-14.'], 'hemolysis': u'88.6% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2156']}, u'GFLSSLKKSLAKSXAHSK': {'modifications': ['C-Terminal'], 'references': [u'Effect of hydrocarbon stapling on the properties of ?-helical antimicrobial peptides isolated from the venom of hymenoptera. Chapuis H,Slaninova J,Bednarova L,Monincova L,Budesinsky M Amino Acids. 2012 Nov;43(5):2047-58. doi: 10.1007/s00726-012-1283-1. Epub 2012 Apr 17.'], 'hemolysis': u'LC50  = 39.5\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2754']}, u'VNWKKILGKSIKVSK': {'modifications': ['C-Terminal'], 'references': [u'Effect of hydrocarbon stapling on the properties of ?-helical antimicrobial peptides isolated from the venom of hymenoptera. Chapuis H,Slaninova J,Bednarova L,Monincova L,Budesinsky M Amino Acids. 2012 Nov;43(5):2047-58. doi: 10.1007/s00726-012-1283-1. Epub 2012 Apr 17.'], 'hemolysis': u'LC50  = 69\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2757']}, u'LLAGLAANFLPKIFCKITKRC': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity analysis of brevinin 1E amide, an antimicrobial peptide from Rana esculenta. Kwon MY,Hong SY Biochim Biophys Acta. 1998 Sep 8;1387(1-2):239-48.'], 'hemolysis': u'HD50=110\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3288']}, u'YGAKAKAAKAAKAKAAKA': {'modifications': [u'N-Terminal Modification: Conjugated with lauric acid'], 'references': [u'Promotion of peptide antimicrobial activity by fatty acid conjugation. Chu-Kung, Alexander ,Chu-Kung AF,Bozzelli KN,Lockwood NA,Haseman JR,Mayo KH Bioconjug Chem. 2004 May-Jun;15(3):530-5.'], 'hemolysis': u'<15% hemolysis at 500\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1023']}, u'FMPIIGRLMSGSL': {'modifications': [], 'references': [u'Antimicrobial peptides from the venoms of Vespa bicolor Fabricius. Chen W,Yang X,Yang X,Zhai L,Lu Z,Liu J Peptides. 2008 Nov;29(11):1887-92. doi: 10.1016/j.peptides.2008.07.018. Epub 2008 Aug 3.'], 'hemolysis': u'3.2% hemolysis up to 200\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3977']}, u'LCYTRRRFTVCV': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'3-6% hemolysis at 80\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1182']}, u'PAICQRATATLGTVGSNTSGTTEIEAAILL': {'modifications': [], 'references': [u'Potent inhibition of the classical pathway of complement by a novel C1q-binding peptide derived from the human astrovirus coat protein. Gronemus JQ,Hair PS,Crawford KB,Nyalwidhe JO,Cunnion KM Mol Immunol. 2010 Nov-Dec;48(1-3):305-13. doi: 10.1016/j.molimm.2010.07.012. Epub 2010 Aug 21.'], 'hemolysis': u'90% hemolysis at 0.77mM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1534']}, u'FVRWFSKFLGRIL': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship, conformational and biological studies of temporin L analogues. Mangoni ML,Carotenuto A,Auriemma L,Saviello MR,Campiglia P,Gomez-Monterrey I,Malfi S,Marcellini L,Barra D,Novellino E J Med Chem. 2011 Mar 10;54(5):1298-307. doi: 10.1021/jm1012853. Epub 2011 Feb 14.'], 'hemolysis': u'52% hemolytic at 6\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2842']}, u'AVGIGALFLGFLGAAGSTMGARS': {'modifications': ['C-Terminal'], 'references': [u'Membrane-perturbing domains of HIV type 1 glycoprotein 41. Mobley PW,Pilpa R,Brown C,Waring AJ AIDS Res Hum Retroviruses. 2001 Mar 1;17(4):311-27.'], 'hemolysis': u'90% hemolysis at 100 \xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1968']}, u'ILPLKLPLLPWRR': {'modifications': ['C-Terminal'], 'references': [u'Antibacterial and hemolytic activities of single tryptophan analogs of indolicidin. Subbalakshmi C,Bikshapathy E,Sitaram N Biochem Biophys Res Commun. 2000 Aug 11;274(3):714-6.'], 'hemolysis': u'0% hemolysis at 100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1041']}, u'gigkflhsakkfgkafvgeimns': {'modifications': [u'Stereochemistry: D'], 'references': [u'All-D-magainin: chirality, antimicrobial activity and proteolytic resistance. Bessalle R,Kapitkovsky A,Gorea A,Shalit I FEBS Lett. 1990 Nov 12;274(1-2):151-5.'], 'hemolysis': u'2% hemolysis at 200\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3309']}, u'KLL\u03a8[CH2OCONH]LKLLLKLLK': {'modifications': ['C-Terminal'], 'references': [u'Design and synthesis of novel antimicrobial pseudopeptides with selective membrane-perturbation activity. Lee KH Bioorg Med Chem. 2000 Apr;8(4):833-9.'], 'hemolysis': u'100% hemolysis at 200\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2032']}, u'fPLOLOfPOLOL': {'modifications': ['Cyclic', u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'Modulation of structure and antibacterial and hemolytic activity by ring size in cyclic gramicidin S analogs. Kondejewski LH,Farmer SW,Wishart DS,Kay CM,Hancock RE J Biol Chem. 1996 Oct 11;271(41):25261-8.'], 'hemolysis': u'100% hemolysis at 170\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3672']}, u'GSKKPVPIIYCNRRKCQRM': {'modifications': [], 'references': [u'Role of amino acid residues within the disulfide loop of thanatin, a potent antibiotic peptide. Lee MK,Cha L,Lee SH J Biochem Mol Biol. 2002 May 31;35(3):291-6.'], 'hemolysis': u'0% hemolysis at 20.8\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2216']}, u'SADLVKKIWDNPAL': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Structural and functional characterization of N-terminally blocked peptides isolated from the venom of the social wasp Polybia paulista. Ribeiro SP,Mendes MA,Dos Santos LD,de Souza BM,Marques MR,de Azevedo WF Jr Peptides. 2004 Dec;25(12):2069-78.'], 'hemolysis': u'0% hemolysis at 100\u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2387']}, u'GFGTILKALAKIAGKVVKKLATKPGATYMLKENLK': {'modifications': ['C-Terminal'], 'references': [u'N-terminal aromatic residues closely impact the cytolytic activity of cupiennin 1a, a major spider venom peptide. Kuhn-Nentwig L,Sheynis T,Kolusheva S,Nentwig W Toxicon. 2013 Mar 21. pii: S0041-0101(13)00089-5. doi: 10.1016/j.toxicon.2013.03.003.'], 'hemolysis': u'EC50 =2.6\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3264']}, u'KKllKLLlKlLK': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation (CH3(CH2)6CO)', u'Stereochemistry: Mix'], 'references': [u'Effect of the hydrophobicity to net positive charge ratio on antibacterial and anti-endotoxin activities of structurally similar antimicrobial peptides. Rosenfeld Y,Lev N Biochemistry. 2010 Feb 9;49(5):853-61. doi: 10.1021/bi900724x.'], 'hemolysis': u'19% hemolytic at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2779']}, u'GIGAvLKvLAlISWIkRKR': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Micelle-bound structures and dynamics of the hinge deleted analog of melittin and its diastereomer: implications in cell selective lysis by D-amino acid containing antimicrobial peptides. Saravanan R,Bhunia A Biochim Biophys Acta. 2010 Feb;1798(2):128-39. doi: 10.1016/j.bbamem.2009.07.014. Epub 2009 Jul 25.'], 'hemolysis': u'12 % hemolysis at 23\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1463']}, u'LCYCFRRRCVCV': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'12-25% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1192']}, u'INWSSIFESVSNLV': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 >100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3901']}, u'VDIHVWsGV': {'modifications': [u'Stereochemistry: Mix'], 'references': [u'Therapeutic potential of peptides with neutralizing ability towards the venom and toxin (CaTx-I) of crotalus adamanteus. Samy RP,Thwin MM,Stiles BG,Bow H,Chow VT Curr Top Med Chem. 2011;11(20):2540-55.'], 'hemolysis': u'1.03% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3147']}, u'FVDLKKIANIINSIF': {'modifications': ['C-Terminal'], 'references': [u'Antitumor effects and cell selectivity of temporin-1CEa, an antimicrobial peptide from the skin secretions of the Chinese brown frog (Rana chensinensis). Wang C,Li HB,Li S,Tian LL Biochimie. 2012 Feb;94(2):434-41. doi: 10.1016/j.biochi.2011.08.011. Epub 2011 Aug 23.'], 'hemolysis': u'100% hemolysis at 200 \xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1999']}, u'kwksflktfksakktvlhtalkaiss': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', u'Stereochemistry: D'], 'references': [u"Rational design of ?-helical antimicrobial peptides to target Gram-negative pathogens, Acinetobacter baumannii and Pseudomonas aeruginosa: utilization of charge, 'specificity determinants,' total hydrophobicity, hydrophobe type and location as design parameters to improve the therapeutic ratio. Jiang Z,Vasil AI,Gera L,Vasil ML Chem Biol Drug Des. 2011 Apr;77(4):225-40. doi: 10.1111/j.1747-0285.2011.01086.x. Epub 2011 Feb 2."], 'hemolysis': u'HC50 = 140.9\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2820']}, u'RRGWALRLVLAY': {'modifications': [], 'references': [u'Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity. Rathinakumar R, Walkenhorst, William ,Walkenhorst WF J Am Chem Soc. 2009 Jun 10;131(22):7609-17. doi: 10.1021/ja8093247.'], 'hemolysis': u'0.18 fractions hemolysis at 15\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1331']}, u'FSPQMLQDIIEKKTKIL': {'modifications': [], 'references': [u'Functional analysis of an alpha-helical antimicrobial peptide derived from a novel mouse defensin-like gene. Kawaguchi A,Suzuki T,Kimura T,Sakai N,Ayabe T,Sawa H Biochem Biophys Res Commun. 2010 Aug 6;398(4):778-84. doi: 10.1016/j.bbrc.2010.07.028. Epub 2010 Jul 14.'], 'hemolysis': u'0% hemolysis at 200\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3087']}, u'KWKLFKKIGKVLKKL': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Lysine-enriched cecropin-mellitin antimicrobial peptides with enhanced selectivity. Sato H Antimicrob Agents Chemother. 2008 Dec;52(12):4463-5. doi: 10.1128/AAC.00810-08. Epub 2008 Oct 13.'], 'hemolysis': u'8% hemolysis at 64\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1264']}, u'NNLLRAIEAQQHLLQLTVWGIKQLQARILAVERYLKDQ': {'modifications': ['C-Terminal'], 'references': [u'Membrane-perturbing domains of HIV type 1 glycoprotein 41. Mobley PW,Pilpa R,Brown C,Waring AJ AIDS Res Hum Retroviruses. 2001 Mar 1;17(4):311-27.'], 'hemolysis': u'20-30% hemolysis at 40 \xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1972']}, u'INPKSVQSLL': {'modifications': ['C-Terminal'], 'references': [u'Venom peptides from solitary hunting wasps induce feeding disorder in lepidopteran larvae. Baek JH,Ji Y,Shin JS,Lee S Peptides. 2011 Mar;32(3):568-72. doi: 10.1016/j.peptides.2010.12.007. Epub 2010 Dec 22.'], 'hemolysis': u'Non-hemolytic', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2063']}, u'RLYRKVYGRLYRKVYGK': {'modifications': ['Cyclic'], 'references': [u'Antimicrobial dendrimeric peptides. Tam JP,Lu YA Eur J Biochem. 2002 Feb;269(3):923-32.'], 'hemolysis': u'EC50 = 1420\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2414']}, u'PAIAQRATATLGTVGSNTSGTTEIEACILL': {'modifications': [], 'references': [u'Potent inhibition of the classical pathway of complement by a novel C1q-binding peptide derived from the human astrovirus coat protein. Gronemus JQ,Hair PS,Crawford KB,Nyalwidhe JO,Cunnion KM Mol Immunol. 2010 Nov-Dec;48(1-3):305-13. doi: 10.1016/j.molimm.2010.07.012. Epub 2010 Aug 21.'], 'hemolysis': u'100% hemolysis at 0.77mM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1533']}, u'HFLLTLVNLAkKIL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Strategies for transformation of naturally-occurring amphibian antimicrobial peptides into therapeutically valuable anti-infective agents. Conlon JM,Al-Ghaferi N,Abraham B Methods. 2007 Aug;42(4):349-57.'], 'hemolysis': u'LD50 = 210\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1808']}, u'MSGIVEAISNAVKSGLDHDWVNMGTSIADVVAKGADFIAGFFS': {'modifications': [], 'references': [u'The amino acid sequences and activities of synergistic hemolysins from Staphylococcus cohnii. Mak P,Maszewska A FEMS Microbiol Lett. 2008 Oct;287(2):230-5. doi: 10.1111/j.1574-6968.2008.01321.x. Epub 2008 Aug 22.'], 'hemolysis': u'HD50  =3.32\xb10.12mM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1232']}, u'kwksflktfkslkktvlhtllkliss': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', u'Stereochemistry: D'], 'references': [u'Anti-tuberculosis activity of ?-helical antimicrobial peptides: de novo designed L- and D-enantiomers versus L- and D-LL-37. Jiang Z,Higgins MP,Whitehurst J,Kisich KO,Voskuil MI Protein Pept Lett. 2011 Mar;18(3):241-52.'], 'hemolysis': u'HC50 = 3.5\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2803']}, u'GFFALIPKIISSPLFKTLLSAVGSAL': {'modifications': [], 'references': [u'Solution conformations of peptides representing the sequence of the toxin pardaxin and analogues in trifluoroethanol-water mixtures: analysis of CD spectra. Thennarasu S Biopolymers. 1997 May;41(6):635-45.'], 'hemolysis': u'Conc. Required for hemolysis =1.1nmols', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3795']}, u'KKLFKKIlkYL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Improvement of the efficacy of linear undecapeptides against plant-pathogenic bacteria by incorporation of D-amino acids. Guell I,Cabrefiga J,Badosa E,Ferre R,Talleda M,Bardaji E,Planas M,Feliu L Appl Environ Microbiol. 2011 Apr;77(8):2667-75. doi: 10.1128/AEM.02759-10. Epub 2011 Feb 18.'], 'hemolysis': u'1\xb10.1% hemolytic at 250\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2860']}, u'RRRRRRAAFAAWAAFAA': {'modifications': ['C-Terminal'], 'references': [u'Cationic hydrophobic peptides with antimicrobial activity. Stark M,Liu LP Antimicrob Agents Chemother. 2002 Nov;46(11):3585-90.'], 'hemolysis': u'14% hemolysis at 50\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2257']}, u'QAKIRVRLSA': {'modifications': [], 'references': [u'Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification. Pini A,Giuliani A,Falciani C,Runci Y,Ricci C,Lelli B,Malossi M,Neri P,Rossolini GM Antimicrob Agents Chemother. 2005 Jul;49(7):2665-72.'], 'hemolysis': u'<1% hemolysis at 120\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1894']}, u'FFHHIFRGIVHVAKTIHRLVTG': {'modifications': [], 'references': [u'Solution structure and cell selectivity of piscidin 1 and its analogues. Lee SA,Kim YK,Lim SS,Zhu WL,Ko H,Shin SY,Hahm KS Biochemistry. 2007 Mar 27;46(12):3653-63. Epub 2007 Mar 1.'], 'hemolysis': u'HC50 =4\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1111']}, u'WLLKW': {'modifications': ['C-Terminal'], 'references': [u'De novo generation of short antimicrobial peptides with simple amino acid composition. Lee SH,Kim SJ,Lee YS,Song MD,Kim IH Regul Pept. 2011 Jan 17;166(1-3):36-41. doi: 10.1016/j.regpep.2010.08.010. Epub 2010 Aug 22.'], 'hemolysis': u'negligible hemolysis at 320\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3093']}, u'GLGSLLGKAFKIGLKTVGKMMGGAPREQ': {'modifications': [], 'references': [u'Antimicrobial peptides with therapeutic potential from skin secretions of the Marsabit clawed frog Xenopus borealis (Pipidae). Mechkarska M,Ahmed E,Coquet L,Leprince J,Jouenne T,Vaudry H,King JD Comp Biochem Physiol C Toxicol Pharmacol. 2010 Nov;152(4):467-72. doi: 10.1016/j.cbpc.2010.07.007. Epub 2010 Jul 23.'], 'hemolysis': u'18% hemolysis at 200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3778']}, u'G\u0394FRK\u0394FHK\u0394FWA': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', 'Non-Natural'], 'references': [u'Synergy with rifampin and kanamycin enhances potency, kill kinetics, and selectivity of de novo-designed antimicrobial peptides. Anantharaman A,Rizvi MS Antimicrob Agents Chemother. 2010 May;54(5):1693-9. doi: 10.1128/AAC.01231-09. Epub 2010 Feb 22.'], 'hemolysis': u'0% hemolysis upto 1358\u03bcg/ml  (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1464']}, u'KLKKLlKKWLKlLKKLLk': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich alpha-helical model antimicrobial peptide and its diastereomeric peptides. Wang P,Nan YH,Yang ST,Kang SW,Kim Y,Park IS,Hahm KS Peptides. 2010 Jul;31(7):1251-61. doi: 10.1016/j.peptides.2010.03.032. Epub 2010 Apr 2.'], 'hemolysis': u'HC50 =150\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3055']}, u'LKLkLyPLKLKLyP': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Optimization of microbial specificity in cyclic peptides by modulation of hydrophobicity within a defined structural framework. Kondejewski LH,Lee DL,Jelokhani-Niaraki M,Farmer SW,Hancock RE J Biol Chem. 2002 Jan 4;277(1):67-74. Epub 2001 Oct 26.'], 'hemolysis': u'100% hemolysis at 25\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2427']}, u'KWKKLPKKLLKLL': {'modifications': ['C-Terminal'], 'references': [u'A short alpha-helical antimicrobial peptide with antibacterial selectivity. Shin SY Biotechnol Lett. 2004 May;26(9):735-9.'], 'hemolysis': u'0% hemolytic at 100\u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2501']}, u'KIGAKIKLCF3BpgGAKIKIGAKI': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Stereochemical effects on the aggregation and biological properties of the fibril-forming peptide [KIGAKI]3 in membranes. Wadhwani P,Reichert J,Strandberg E,Burck J,Misiewicz J,Afonin S,Heidenreich N,Fanghanel S,Mykhailiuk PK,Komarov IV Phys Chem Chem Phys. 2013 Jun 21;15(23):8962-71. doi: 10.1039/c3cp50896j. Epub 2013 May 7.'], 'hemolysis': u'~38% hemolytic at 60\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2680']}, u'GKPRPYSPRPTSHPRPIRV': {'modifications': [], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC >100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3940']}, u'yPVKLKVyPLKVKL': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Modulation of structure and antibacterial and hemolytic activity by ring size in cyclic gramicidin S analogs. Kondejewski LH,Farmer SW,Wishart DS,Kay CM,Hancock RE J Biol Chem. 1996 Oct 11;271(41):25261-8.'], 'hemolysis': u'100% hemolysis at 6\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3668']}, u'WKWKWK': {'modifications': [], 'references': [u'Reversed sequence enhances antimicrobial activity of a synthetic peptide. Gopal R,Kim YJ,Seo CH,Hahm KS J Pept Sci. 2011 May;17(5):329-34. doi: 10.1002/psc.1369. Epub 2011 Apr 1.'], 'hemolysis': u'~10% hemolytic at 600\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3017']}, u'SFFKKAAHVGKHVGKAALTHYL': {'modifications': ['C-Terminal'], 'references': [u'Influence of the hydrophobic amino acids in the N- and C-terminal regions of pleurocidin on antifungal activity. Lee J J Microbiol Biotechnol. 2010 Aug;20(8):1192-5.'], 'hemolysis': u'0% hemolytoc at 100\u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2787']}, u'GGLRSLGRKILRAWKKYGPIIVPIIRIG': {'modifications': [], 'references': [u'Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities. Skerlavaj B,Gennaro R,Bagella L,Merluzzi L,Risso A J Biol Chem. 1996 Nov 8;271(45):28375-81.'], 'hemolysis': u'0% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3991']}, u'GABAFTicOicGABAKTicOicGABAFTicOicGABAKTicKKKKK': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', 'Non-Natural'], 'references': [u'De novo design of selective antibiotic peptides by incorporation of unnatural amino acids. Hicks RP,Bhonsle JB,Venugopal D,Koser BW J Med Chem. 2007 Jun 28;50(13):3026-36. Epub 2007 Jun 5.'], 'hemolysis': u'10.5% hemolysis at 25\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1790']}, u'GFWGKLFKLGLHGIGLLHLHL': {'modifications': ['C-Terminal'], 'references': [u'The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents. Morash MG,Douglas SE,Robotham A,Ridley CM,Gallant JW Dis Model Mech. 2011 Sep;4(5):622-33. doi: 10.1242/dmm.007310. Epub 2011 Jul 4.'], 'hemolysis': u'50% hemolytic at 64\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2930']}, u'AKKVFKRLGIGAVLWVLTTG': {'modifications': [], 'references': [u'Design of novel analogues with potent antibiotic activity based on the antimicrobial peptide, HP(2-9)-ME(1-12). Park Y,Kim HN,Park SN,Jang SH,Choi CH,Lim HT Biotechnol Lett. 2004 Mar;26(6):493-8.'], 'hemolysis': u'0% hemolysis at 6.25\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4171']}, u'GIGAVLKVLTTGLPALISWIKRKRQQ': {'modifications': ['C-Terminal'], 'references': [u'Selective lysis of bacteria but not mammalian cells by diastereomers of melittin: structure-function study. Oren Z Biochemistry. 1997 Feb 18;36(7):1826-35.'], 'hemolysis': u'100% hemolysis at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3581']}, u'LCYCRRFRCVCV': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'12-25% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1194']}, u'INWLKLGKKVSAIL': {'modifications': ['C-Terminal'], 'references': [u'Structural and biological characterization of three novel mastoparan peptides from the venom of the neotropical social wasp Protopolybia exigua (Saussure). Mendes MA,de Souza BM Toxicon. 2005 Jan;45(1):101-6.'], 'hemolysis': u'40% hemolysis at 10\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1620']}, u'WNPFKELERAGQRVRDAIISAAP': {'modifications': [], 'references': [u'Cecropin D-like antibacterial peptides from the sphingid moth, Agrius convolvuli. Lee IH,Chang KY,Choi CS Arch Insect Biochem Physiol. 1999;41(4):178-85.'], 'hemolysis': u'0% hemolysis at 100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3864']}, u'VOLOfPVOLfP': {'modifications': ['Cyclic', u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'Antimicrobially active cycloundecapeptides related to gramicidin S having a novel turn structure with cis D-Phe-Pro peptide bond. Tamaki M,Sasaki I,Kokuno M,Shindo M,Kimura M Org Biomol Chem. 2010 Apr 21;8(8):1791-7. doi: 10.1039/b922159j.'], 'hemolysis': u'10% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1504']}, u'WYLTLTLGYGRR': {'modifications': [], 'references': [u'Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity. Rathinakumar R, Walkenhorst, William ,Walkenhorst WF J Am Chem Soc. 2009 Jun 10;131(22):7609-17. doi: 10.1021/ja8093247.'], 'hemolysis': u'0.45 fractions hemolysis at 15\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1343']}, u'HFLLTLVKLAKKIL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Strategies for transformation of naturally-occurring amphibian antimicrobial peptides into therapeutically valuable anti-infective agents. Conlon JM,Al-Ghaferi N,Abraham B Methods. 2007 Aug;42(4):349-57.'], 'hemolysis': u'LD50 = 385\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1807']}, u'FQWQRNMRKVR': {'modifications': [], 'references': [u"Human antimicrobial peptides' antifungal activity against Aspergillus fumigatus. Lupetti A,van Dissel JT,Brouwer CP Eur J Clin Microbiol Infect Dis. 2008 Nov;27(11):1125-9. doi: 10.1007/s10096-008-0553-z. Epub 2008 Jun 20."], 'hemolysis': u'>2-3% at \u226516\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1222']}, u'GNleAibOrnOrnNleAibOrnOrnNleNleOrnGY': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Amphipathic alpha helical antimicrobial peptides. Giangaspero A,Sandri L Eur J Biochem. 2001 Nov;268(21):5589-600.'], 'hemolysis': u'70% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2146']}, u'GLLKRIKTLL': {'modifications': ['C-Terminal'], 'references': [u'Anoplin, a novel antimicrobial peptide from the venom of the solitary wasp Anoplius samariensis. Konno K,Hisada M,Fontana R,Lorenzi CC,Naoki H,Itagaki Y,Miwa A,Kawai N,Nakata Y,Yasuhara T,Ruggiero Neto J,de Azevedo WF Jr,Palma MS Biochim Biophys Acta. 2001 Nov 26;1550(1):70-80.'], 'hemolysis': u'Low hemolytic activity', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3474']}, u'INWKKIFQKVKNLV': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 =100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3894']}, u'KWKWKW': {'modifications': [], 'references': [u'Reversed sequence enhances antimicrobial activity of a synthetic peptide. Gopal R,Kim YJ,Seo CH,Hahm KS J Pept Sci. 2011 May;17(5):329-34. doi: 10.1002/psc.1369. Epub 2011 Apr 1.'], 'hemolysis': u'~10% hemolytic at 600\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3019']}, u'INWLKLGKKILGAL': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 =45\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3906']}, u'GIWSSIKNLASKAWNSDIGQSLRNKAAGAINKFVADKIGVTPSQAAS': {'modifications': [], 'references': [u'Vejovine, a new antibiotic from the scorpion venom of Vaejovis mexicanus. Hernandez-Aponte CA,Silva-Sanchez J,Quintero-Hernandez V,Rodriguez-Romero A,Balderas C,Possani LD Toxicon. 2011 Jan;57(1):84-92. doi: 10.1016/j.toxicon.2010.10.008. Epub 2010 Oct 20.'], 'hemolysis': u'HC50 =100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1075']}, u'AKKVFKRLEKLFSKIWNWK': {'modifications': [], 'references': [u'Design of novel analogue peptides with potent antibiotic activity based on the antimicrobial peptide, HP (2-20), derived from N-terminus of Helicobacter pylori ribosomal protein L1. Lee DG,Kim HN,Park Y,Kim HK,Choi BH,Choi CH Biochim Biophys Acta. 2002 Jul 29;1598(1-2):185-94.'], 'hemolysis': u'0% hemolysis at 100\u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2384']}, u'RGGRLAYARRRFAVAVGR': {'modifications': ['C-Terminal'], 'references': [u'Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides. Yasin B,Pang M,Turner JS,Cho Y,Dinh NN,Waring AJ,Lehrer RI Eur J Clin Microbiol Infect Dis. 2000 Mar;19(3):187-94.'], 'hemolysis': u'0.8% hemolysis at 80\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2440']}, u'DFKDWMKTAGEWLKKKGPGILKAAMAAAT': {'modifications': [], 'references': [u'Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii. Orivel J,Redeker V,Le Caer JP, Krier, ,Krier F,Revol-Junelles AM,Longeon A,Chaffotte A,Dejean A J Biol Chem. 2001 May 25;276(21):17823-9. Epub 2001 Feb 22.'], 'hemolysis': u'zone of inhibition not detected at 0.4-0.5mM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2126']}, u'rggrlcycrrrfcvcvgr': {'modifications': ['C-Terminal', u'Stereochemistry: D'], 'references': [u'Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides. Yasin B,Pang M,Turner JS,Cho Y,Dinh NN,Waring AJ,Lehrer RI Eur J Clin Microbiol Infect Dis. 2000 Mar;19(3):187-94.'], 'hemolysis': u'90% hemolysis at 80\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2437']}, u'MQFITDLIKKAVDFFKGLFGNK': {'modifications': [], 'references': [u'Detergent-like activity and alpha-helical structure of warnericin RK, an anti-Legionella peptide. Verdon J,Falge M,Maier E,Bruhn H,Steinert M,Faber C,Benz R Biophys J. 2009 Oct 7;97(7):1933-40. doi: 10.1016/j.bpj.2009.06.053.'], 'hemolysis': u'100% hemolysis at 200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1458']}, u'KIGAKIKIGAKIKLCF3BpgGAKI': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Stereochemical effects on the aggregation and biological properties of the fibril-forming peptide [KIGAKI]3 in membranes. Wadhwani P,Reichert J,Strandberg E,Burck J,Misiewicz J,Afonin S,Heidenreich N,Fanghanel S,Mykhailiuk PK,Komarov IV Phys Chem Chem Phys. 2013 Jun 21;15(23):8962-71. doi: 10.1039/c3cp50896j. Epub 2013 May 7.'], 'hemolysis': u'~34% hemolytic at 60\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2688']}, u'GIGKFIHAVKKWGKTFIGEIAKS': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Immobilization reduces the activity of surface-bound cationic antimicrobial peptides with no influence upon the activity spectrum. Bagheri M,Beyermann M Antimicrob Agents Chemother. 2009 Mar;53(3):1132-41. doi: 10.1128/AAC.01254-08. Epub 2008 Dec 22.'], 'hemolysis': u'EC50 >400\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1271']}, u'LKLKSIVSAAKKVL': {'modifications': ['C-Terminal'], 'references': [u'Relationship between the tertiary structures of mastoparan B and its analogs and their lytic activities studied by NMR spectroscopy. Yu K,Kang S,Park N,Shin J J Pept Res. 2000 Jan;55(1):51-62.'], 'hemolysis': u'8.5% hemolysis at 50\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2020']}, u'PVCTRNGLPVCGETCVGGTCNTPGCTCSW': {'modifications': ['Cyclic'], 'references': [u'Cyclic peptides from Oldenlandia affinis DC. Molecular and biological properties. Gran L,Sletten K Chem Biodivers. 2008 Oct;5(10):2014-22. doi: 10.1002/cbdv.200890184.'], 'hemolysis': u'100% hemolysis at >0.5 mg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1266']}, u'KLLKLLLKLWKKLLKLLK': {'modifications': [], 'references': [u'Design and synthesis of amphiphilic alpha-helical model peptides with systematically varied hydrophobic-hydrophilic balance and their interaction with lipid- and bio-membranes. Kiyota T,Lee S Biochemistry. 1996 Oct 8;35(40):13196-204.'], 'hemolysis': u'100% hemolysis at 10\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3472']}, u'FLLFPLMCKIQGKC': {'modifications': [], 'references': [u'Novel families of antimicrobial peptides with multiple functions from skin of Xizang plateau frog, Nanorana parkeri. Lu Z,Zhai L,Wang H,Che Q,Wang D,Feng F,Zhao Z Biochimie. 2010 May;92(5):475-81. doi: 10.1016/j.biochi.2010.01.025. Epub 2010 Feb 12.'], 'hemolysis': u'1.92% hemolysis at 80\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1072']}, u'KFTIVFPHNQKGNWKNVPSNYHYCP': {'modifications': [], 'references': [u'A synthetic peptide corresponding to the NH2 terminus of vesicular stomatitis virus glycoprotein is a pH-dependent hemolysin. Schlegel R J Biol Chem. 1984 Apr 25;259(8):4691-4.'], 'hemolysis': u'400\u03bcg of peptide can totally lyse 7x108 erythrocytes in 10 min at pH 5.0', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3291']}, u'FKCRRWQWRMKKLGA': {'modifications': [], 'references': [u'Comparative antimicrobial activity and mechanism of action of bovine lactoferricin-derived synthetic peptides. Liu Y,Han F,Xie Y Biometals. 2011 Dec;24(6):1069-78. doi: 10.1007/s10534-011-9465-y. Epub 2011 May 24.'], 'hemolysis': u'>7% hemolytic at 256mg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2913']}, u'TFRRLKWK': {'modifications': ['Cyclic'], 'references': [u'Cyclic antimicrobial peptides based on Limulus anti-lipopolysaccharide factor for neutralization of lipopolysaccharide. Andra J,Lamata M,Martinez de Tejada G,Bartels R,Koch MH Biochem Pharmacol. 2004 Oct 1;68(7):1297-307.'], 'hemolysis': u'~5% hemolysis at 100\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2391']}, u'GLKkIFKAGLGSLKKGIAAHVAS': {'modifications': [u'Stereochemistry: Mix'], 'references': [u'Potent and rapid bactericidal action of alyteserin-1c and its [E4K] analog against multidrug-resistant strains of Acinetobacter baumannii. Conlon JM,Ahmed E,Pal T Peptides. 2010 Oct;31(10):1806-10. doi: 10.1016/j.peptides.2010.06.032. Epub 2010 Jul 11.'], 'hemolysis': u'LC50 >400\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3081']}, u'GLLSGVLGVGKKVLCGLSGLC': {'modifications': [], 'references': [u'Anti-infection peptidomics of amphibian skin. Li J,Xu X,Xu C,Zhou W,Zhang K,Yu H,Zhang Y,Zheng Y,Rees HH,Lai R,Yang D Mol Cell Proteomics. 2007 May;6(5):882-94. Epub 2007 Jan 31.'], 'hemolysis': u'100% hemolysis at 50\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3653']}, u'LLKELWTKIKGAGKAVLGKIKGLL': {'modifications': ['C-Terminal'], 'references': [u'Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii. Orivel J,Redeker V,Le Caer JP, Krier, ,Krier F,Revol-Junelles AM,Longeon A,Chaffotte A,Dejean A J Biol Chem. 2001 May 25;276(21):17823-9. Epub 2001 Feb 22.'], 'hemolysis': u'zone of inhibition not detected at 0.4-0.5mM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2130']}, u'KKKKKKAAFAAFAAFAA': {'modifications': ['C-Terminal'], 'references': [u'Cationic hydrophobic peptides with antimicrobial activity. Stark M,Liu LP Antimicrob Agents Chemother. 2002 Nov;46(11):3585-90.'], 'hemolysis': u'0% hemolysis at 50\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2265']}, u'PAICQRAEIEACILL': {'modifications': [], 'references': [u'Potent inhibition of the classical pathway of complement by a novel C1q-binding peptide derived from the human astrovirus coat protein. Gronemus JQ,Hair PS,Crawford KB,Nyalwidhe JO,Cunnion KM Mol Immunol. 2010 Nov-Dec;48(1-3):305-13. doi: 10.1016/j.molimm.2010.07.012. Epub 2010 Aug 21.'], 'hemolysis': u'100% hemolysis at 0.77mM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1537']}, u'KKAAAAFAAFAAWFAAFAAAAKKKK': {'modifications': ['C-Terminal'], 'references': [u'Cationic hydrophobic peptides with antimicrobial activity. Stark M,Liu LP Antimicrob Agents Chemother. 2002 Nov;46(11):3585-90.'], 'hemolysis': u'17% hemolysis at 50\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2233']}, u'LMAAKAESRK': {'modifications': [], 'references': [u'Antimicrobial activity and mechanism of action of a novel cationic ?-helical dodecapeptide, a partial sequence of cyanate lyase from rice. Takei N,Takahashi N,Takayanagi T,Ikeda A,Hashimoto K,Takagi M,Hamada T,Saitoh E,Ochiai A,Tanaka T Peptides. 2013 Apr;42:55-62. doi: 10.1016/j.peptides.2012.12.015. Epub 2012 Dec 25.'], 'hemolysis': u'No or little hemolysis upto 800\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3249']}, u'LKLFKKILKYL': {'modifications': ['C-Terminal'], 'references': [u'A library of linear undecapeptides with bactericidal activity against phytopathogenic bacteria. Badosa E,Ferre R,Planas M,Feliu L,Besalu E,Cabrefiga J,Bardaji E Peptides. 2007 Dec;28(12):2276-85. Epub 2007 Sep 25.'], 'hemolysis': u'91\xb16.2% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1853']}, u'DYDWSLRGPPKCATYGQKCRTWSPPNCCWNLRCKAFRCRPR': {'modifications': [], 'references': [u'Horseshoe crab hemocyte-derived antimicrobial polypeptides, tachystatins, with sequence similarity to spider neurotoxins. Osaki T,Omotezako M,Nagayama R,Hirata M,Iwanaga S,Kasahara J,Hattori J,Ito I,Sugiyama H J Biol Chem. 1999 Sep 10;274(37):26172-8.'], 'hemolysis': u'~14% hemolysis at 20\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3403']}, u'LNWGKILKHIIK': {'modifications': ['C-Terminal'], 'references': [u'Panurgines, novel antimicrobial peptides from the venom of communal bee Panurgus calcaratus (Hymenoptera: Andrenidae). Cujova S,Slaninova J,Monincova L,Fucik V,Bednarova L,Stokrova J,Hovorka O,Voburka Z,Straka J Amino Acids. 2013 Jul;45(1):143-57. doi: 10.1007/s00726-013-1482-4. Epub 2013 Mar 13.'], 'hemolysis': u'LC50 >140\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3723']}, u'NWCKRGRKQCKTHPHFVIPY': {'modifications': ['Cyclic'], 'references': [u'Antimicrobial activity of peptides derived from human \xdf-amyloid precursor protein. Papareddy P,Morgelin M,Walse B,Schmidtchen A J Pept Sci. 2012 Mar;18(3):183-91. doi: 10.1002/psc.1439. Epub 2012 Jan 16.'], 'hemolysis': u'~3% hemolytic at 60\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2698']}, u'GIINTLQKYYFRVRGGRFAVLSFLPKEEQIGKFSTRGRKFFRRKK': {'modifications': [], 'references': [u'Linear analogues of human beta-defensin 3: concepts for design of antimicrobial peptides with reduced cytotoxicity to mammalian cells. Liu S,Zhou L,Li J,Suresh A,Verma C,Foo YH,Yap EP,Tan DT Chembiochem. 2008 Apr 14;9(6):964-73. doi: 10.1002/cbic.200700560.'], 'hemolysis': u'<1% hemolysis at 3-100 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1161']}, u'IIGAIAAALPHVINAIKNTF': {'modifications': ['C-Terminal'], 'references': [u'A family of kassinatuerin-2 related peptides from the skin secretion of the African hyperoliid frog, Kassina maculata. Wang L,Zhou M,McGrath S,Chen T,Gorman SP,Walker B Peptides. 2009 Aug;30(8):1428-33. doi: 10.1016/j.peptides.2009.04.021. Epub 2009 May 7.'], 'hemolysis': u'45-50% hemolysis at 120\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3487']}, u'GLGSVFGRLARILGRVIPKVAKKLGPKVAKVLPKVMKEAIPMAVEMAKSQEEQQPQ': {'modifications': [], 'references': [u'Cytotoxicity of pilosulin 1, a peptide from the venom of the jumper ant Myrmecia pilosula. Wu QX,King MA,Donovan GR,Alewood D,Alewood P,Sawyer WH Biochim Biophys Acta. 1998 Sep 16;1425(1):74-80.'], 'hemolysis': u'100% hemolysis at 40\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3528']}, u'GFFOicGKFOicGFFOicGKFKKKK': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', 'Non-Natural'], 'references': [u'De novo design of selective antibiotic peptides by incorporation of unnatural amino acids. Hicks RP,Bhonsle JB,Venugopal D,Koser BW J Med Chem. 2007 Jun 28;50(13):3026-36. Epub 2007 Jun 5.'], 'hemolysis': u'8.9% hemolysis at 25\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1780']}, u'KWFKKIPKFLHLLKKF': {'modifications': ['C-Terminal'], 'references': [u'Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs. Shin SY,Lee SH,Yang ST,Park EJ,Lee DG,Lee MK,Eom SH,Song WK,Kim Y,Hahm KS J Pept Res. 2001 Dec;58(6):504-14.'], 'hemolysis': u'27.3% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2163']}, u'FFRRFFRRFFRR': {'modifications': ['C-Terminal'], 'references': [u'Synthetic cationic amphiphilic ?-helical peptides as antimicrobial agents. Wiradharma N,Khoe U,Hauser CA,Seow SV,Zhang S Biomaterials. 2011 Mar;32(8):2204-12. doi: 10.1016/j.biomaterials.2010.11.054. Epub 2010 Dec 18.'], 'hemolysis': u'HC50 > 500', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2048']}, u'RRWCFRVCYRGRFCYRKCR': {'modifications': ['C-Terminal'], 'references': [u'Interaction of polyphemusin I and structural analogs with bacterial membranes, lipopolysaccharide, and lipid monolayers. Zhang L,Scott MG,Yan H,Mayer LD Biochemistry. 2000 Nov 28;39(47):14504-14.'], 'hemolysis': u'100% hemolysis at 42.6\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1043']}, u'YKQCHKKGGHCFPKEKICLPPSSDFGKMDCRWRWKCCKKGSG': {'modifications': [], 'references': [u'Unraveling the antifungal activity of a South American rattlesnake toxin crotamine. Yamane ES,Bizerra FC,Oliveira EB,Moreira JT,Rajabi M,Nunes GL,de Souza AO,da Silva ID,Yamane T,Karpel RL,Silva PI Jr, Hayashi, Mirian A Biochimie. 2013 Feb;95(2):231-40. doi: 10.1016/j.biochi.2012.09.019. Epub 2012 Sep 26.'], 'hemolysis': u'0% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3236']}, u'RLYRRLYRRLYRRLYR': {'modifications': [], 'references': [u'Antimicrobial dendrimeric peptides. Tam JP,Lu YA Eur J Biochem. 2002 Feb;269(3):923-32.'], 'hemolysis': u'EC50 = 338\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2408']}, u'FWGALAKGALKLIVSLFSSFSKKD': {'modifications': [], 'references': [u'Amino acid substitutions in an alpha-helical antimicrobial arachnid peptide affect its chemical properties and biological activity towards pathogenic bacteria but improves its therapeutic index. Rodriguez A,Villegas E,Satake H,Possani LD Amino Acids. 2011 Jan;40(1):61-8. doi: 10.1007/s00726-009-0449-y. Epub 2009 Dec 24.'], 'hemolysis': u'IC50 =6.4\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1276']}, u'DSHAKRHHGYKIKFHENHHSHRGY': {'modifications': ['C-Terminal'], 'references': [u'In vitro assessment of antifungal therapeutic potential of salivary histatin-5, two variants of histatin-5, and salivary mucin (MUC7) domain 1. Situ H Antimicrob Agents Chemother. 2000 Jun;44(6):1485-93.'], 'hemolysis': u'<10% hemolysis at 200\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2028']}, u'LKLkLfPLKLKLfP': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Optimization of microbial specificity in cyclic peptides by modulation of hydrophobicity within a defined structural framework. Kondejewski LH,Lee DL,Jelokhani-Niaraki M,Farmer SW,Hancock RE J Biol Chem. 2002 Jan 4;277(1):67-74. Epub 2001 Oct 26.'], 'hemolysis': u'100% hemolysis at 12.5\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2426']}, u'KWKSFIKKLTSKFLHSAKKN': {'modifications': ['C-Terminal'], 'references': [u'The Design and Construction of K11: A Novel ?-Helical Antimicrobial Peptide. Jin-Jiang H,Jin-Chun L,Min L,Qing-Shan H Int J Microbiol. 2012;2012:764834. doi: 10.1155/2012/764834. Epub 2012 Feb 16.'], 'hemolysis': u'MHC >500\u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2731']}, u'FWGHIWNAVKRVGANALHGAVTGALS': {'modifications': [], 'references': [u'Halocyntin and papillosin, two new antimicrobial peptides isolated from hemocytes of the solitary tunicate, Halocynthia papillosa. Galinier R,Roger E,Sautiere PE,Aumelas A,Banaigs B J Pept Sci. 2009 Jan;15(1):48-55. doi: 10.1002/psc.1101.'], 'hemolysis': u'22% hemolysis at 50\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3619']}, u'kklfKKILKYL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Improvement of the efficacy of linear undecapeptides against plant-pathogenic bacteria by incorporation of D-amino acids. Guell I,Cabrefiga J,Badosa E,Ferre R,Talleda M,Bardaji E,Planas M,Feliu L Appl Environ Microbiol. 2011 Apr;77(8):2667-75. doi: 10.1128/AEM.02759-10. Epub 2011 Feb 18.'], 'hemolysis': u'17\xb10.7% hemolytic at 250\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2871']}, u'KKLFkkilkyl': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Improvement of the efficacy of linear undecapeptides against plant-pathogenic bacteria by incorporation of D-amino acids. Guell I,Cabrefiga J,Badosa E,Ferre R,Talleda M,Bardaji E,Planas M,Feliu L Appl Environ Microbiol. 2011 Apr;77(8):2667-75. doi: 10.1128/AEM.02759-10. Epub 2011 Feb 18.'], 'hemolysis': u'28\xb12.1% hemolytic at 250\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2867']}, u'KWKSFIKKLTSKFLHSAKKF': {'modifications': ['C-Terminal'], 'references': [u'The Design and Construction of K11: A Novel ?-Helical Antimicrobial Peptide. Jin-Jiang H,Jin-Chun L,Min L,Qing-Shan H Int J Microbiol. 2012;2012:764834. doi: 10.1155/2012/764834. Epub 2012 Feb 16.'], 'hemolysis': u'MHC  >500\u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2718']}, u'KLLKLLLKLLKLLLKLLLKLLK': {'modifications': ['C-Terminal', u'N-Terminal Modification: Dansylation'], 'references': [u'The amphipathic helix concept: length effects on ideally amphipathic LiKj(i=2j) peptides to acquire optimal hemolytic activity. Castano S,Cornut I,Buttner K,Dasseux JL Biochim Biophys Acta. 1999 Jan 12;1416(1-2):161-75.'], 'hemolysis': u'LD50 =0.1 \u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3829']}, u'KlKlKlK': {'modifications': [u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'Antiplasmodial activity of lauryl-lysine oligomers. Radzishevsky I,Krugliak M,Ginsburg H Antimicrob Agents Chemother. 2007 May;51(5):1753-9. Epub 2007 Feb 16.'], 'hemolysis': u'2.3\xb11.5% hemolysis at 100 \u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1102']}, u'GFLSILKKVLKVMAHMK': {'modifications': ['C-Terminal'], 'references': [u'Melectin: a novel antimicrobial peptide from the venom of the cleptoparasitic bee Melecta albifrons. Cerovsky V,Hovorka O,Cvacka J,Voburka Z,Bednarova L,Borovickova L,Slaninova J Chembiochem. 2008 Nov 24;9(17):2815-21. doi: 10.1002/cbic.200800476.'], 'hemolysis': u'LC50 = 22.9\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3623']}, u'LLKWLLKWLKK': {'modifications': ['C-Terminal'], 'references': [u'De novo generation of short antimicrobial peptides with simple amino acid composition. Lee SH,Kim SJ,Lee YS,Song MD,Kim IH Regul Pept. 2011 Jan 17;166(1-3):36-41. doi: 10.1016/j.regpep.2010.08.010. Epub 2010 Aug 22.'], 'hemolysis': u'60-65% hemolysis at 160\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3113']}, u'RLYRKVYG': {'modifications': ['Cyclic'], 'references': [u'Antimicrobial dendrimeric peptides. Tam JP,Lu YA Eur J Biochem. 2002 Feb;269(3):923-32.'], 'hemolysis': u'EC50 = 3950\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2413']}, u'SVSNAATRVARTGRSRWRDVARNFMR': {'modifications': [], 'references': [u'Bactericidal and hemolytic activities of synthetic peptides derived from granulysin. Siano A,Tonarelli G,Imaz MS,Perin JC,Ruggeri N,Lopez M,Santi MN Protein Pept Lett. 2010 Apr;17(4):517-21.'], 'hemolysis': u'90% hemolysis at 200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3052']}, u'HFLLTLkNLAKKIL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Strategies for transformation of naturally-occurring amphibian antimicrobial peptides into therapeutically valuable anti-infective agents. Conlon JM,Al-Ghaferi N,Abraham B Methods. 2007 Aug;42(4):349-57.'], 'hemolysis': u'LD50 = 500\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1806']}, u'GIGAVLIVLTTGLPALISWIKRKRQQ': {'modifications': [], 'references': [u'Studies on the mode of action of the antifungal hexapeptide PAF26. Munoz A,Lopez-Garcia B, Marcos, Jose ,Marcos J Antimicrob Agents Chemother. 2006 Nov;50(11):3847-55.'], 'hemolysis': u'30.2\xb12.8% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1723']}, u'VKRALSALKPKNKRFIGGIISFFKRLFG': {'modifications': [], 'references': [u'Molecular cloning of grammistins, peptide toxins from the soapfish Pogonoperca punctata, by hemolytic screening of a cDNA library. Kaji T,Sugiyama N,Ishizaki S,Nagashima Y Peptides. 2006 Dec;27(12):3069-76. Epub 2006 Oct 25.'], 'hemolysis': u'63 HU/mg', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1727']}, u'VKLKVyPLKvKLyP': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Dissociation of antimicrobial and hemolytic activities in cyclic peptide diastereomers by systematic alterations in amphipathicity. Kondejewski LH,Jelokhani-Niaraki M,Farmer SW,Lix B,Kay CM,Sykes BD,Hancock RE J Biol Chem. 1999 May 7;274(19):13181-92.'], 'hemolysis': u'100% hemolytic at 6.2 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2553']}, u'VNWKKSLGKSIKVVK': {'modifications': ['C-Terminal'], 'references': [u'Effect of hydrocarbon stapling on the properties of ?-helical antimicrobial peptides isolated from the venom of hymenoptera. Chapuis H,Slaninova J,Bednarova L,Monincova L,Budesinsky M Amino Acids. 2012 Nov;43(5):2047-58. doi: 10.1007/s00726-012-1283-1. Epub 2012 Apr 17.'], 'hemolysis': u'LC50  = 31.3\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2756']}, u'KlkKLlKKwLKlLKkLLk': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich alpha-helical model antimicrobial peptide and its diastereomeric peptides. Wang P,Nan YH,Yang ST,Kang SW,Kim Y,Park IS,Hahm KS Peptides. 2010 Jul;31(7):1251-61. doi: 10.1016/j.peptides.2010.03.032. Epub 2010 Apr 2.'], 'hemolysis': u'HC50 =800\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3058']}, u'FLGWLFKWASK': {'modifications': ['C-Terminal'], 'references': [u'Activity optimization of an undecapeptide analogue derived from a frog-skin antimicrobial peptide. Won HS,Kang SJ,Choi WS Mol Cells. 2011 Jan;31(1):49-54. doi: 10.1007/s10059-011-0005-y. Epub 2010 Nov 23.'], 'hemolysis': u'MHC =25\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1553']}, u'KSLRPRCWIKIKFRCKSLKF': {'modifications': [], 'references': [u'Two antimicrobial and nematicidal peptides derived from sequences encoded Picea sitchensis. Liu R,Mu L,Liu H,Wei L,Yan T,Chen M,Zhang K,Li J,You D J Pept Sci. 2011 Sep;17(9):627-31. doi: 10.1002/psc.1380. Epub 2011 Jun 6.'], 'hemolysis': u'57.1% hemolysis at 1mg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4038']}, u'LNWGAFLKHFFK': {'modifications': ['C-Terminal'], 'references': [u'Panurgines, novel antimicrobial peptides from the venom of communal bee Panurgus calcaratus (Hymenoptera: Andrenidae). Cujova S,Slaninova J,Monincova L,Fucik V,Bednarova L,Stokrova J,Hovorka O,Voburka Z,Straka J Amino Acids. 2013 Jul;45(1):143-57. doi: 10.1007/s00726-013-1482-4. Epub 2013 Mar 13.'], 'hemolysis': u'LC50 =81\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3734']}, u'GMATKAGTALGKVAKAVIGAAL': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae). Ali, M ,Ali MF,Soto A,Knoop FC Biochim Biophys Acta. 2001 Nov 26;1550(1):81-9.'], 'hemolysis': u'HC50 >150\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3478']}, u'FIFPKKNIINSLFGR': {'modifications': [], 'references': [u'Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs. Yang X,Lee WH J Proteome Res. 2012 Jan 1;11(1):306-19. doi: 10.1021/pr200782u. Epub 2011 Nov 18.'], 'hemolysis': u'Non-hemolytic upto 50 \u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3020']}, u'GLPRKILCAIAKKKGKAKGPLKLVCKA': {'modifications': ['Cyclic'], 'references': [u'Lasiocepsin, a novel cyclic antimicrobial peptide from the venom of eusocial bee Lasioglossum laticeps (Hymenoptera: Halictidae). Monincova L,Slaninova J,Fucik V,Hovorka O,Voburka Z,Bednarova L,Malon P,Stokrova J Amino Acids. 2012 Aug;43(2):751-61. doi: 10.1007/s00726-011-1125-6. Epub 2011 Oct 29.'], 'hemolysis': u'<1% hemolytic at 200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2740']}, u'GSKKPVPIIYCNRRGKCQRM': {'modifications': [], 'references': [u'Role of amino acid residues within the disulfide loop of thanatin, a potent antibiotic peptide. Lee MK,Cha L,Lee SH J Biochem Mol Biol. 2002 May 31;35(3):291-6.'], 'hemolysis': u'0% hemolysis at 20.8\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2214']}, u'LKLKLKLQ': {'modifications': ['Cyclic'], 'references': [u'De novo designed cyclic cationic peptides as inhibitors of plant pathogenic bacteria. Monroc S,Badosa E,Feliu L,Planas M,Montesinos E Peptides. 2006 Nov;27(11):2567-74. Epub 2006 May 30.'], 'hemolysis': u'5\xb10.1% hemolysis at 360\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1690']}, u'KIGAKLCF3BpgKIGAKIKIGAKI': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Stereochemical effects on the aggregation and biological properties of the fibril-forming peptide [KIGAKI]3 in membranes. Wadhwani P,Reichert J,Strandberg E,Burck J,Misiewicz J,Afonin S,Heidenreich N,Fanghanel S,Mykhailiuk PK,Komarov IV Phys Chem Chem Phys. 2013 Jun 21;15(23):8962-71. doi: 10.1039/c3cp50896j. Epub 2013 May 7.'], 'hemolysis': u'~50% hemolytic at 60\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2676']}, u'VCGETCVGGTCNTPGCTCSWPVCTRDGLP': {'modifications': ['Cyclic'], 'references': [u'Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif. Craik DJ,Daly NL,Bond T J Mol Biol. 1999 Dec 17;294(5):1327-36.'], 'hemolysis': u'50% hemolysis at ~20\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4017']}, u'KLllKLKlKlWK': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Structure and organization of hemolytic and nonhemolytic diastereomers of antimicrobial peptides in membranes. Hong J,Oren Z Biochemistry. 1999 Dec 21;38(51):16963-73.'], 'hemolysis': u'0% hemolysis at 50\u03bcM (Non hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3763']}, u'ALLHHGLNCAKGVLA': {'modifications': [], 'references': [u'Halocidin: a new antimicrobial peptide from hemocytes of the solitary tunicate, Halocynthia aurantium. Jang WS,Kim KN,Lee YS,Nam MH FEBS Lett. 2002 Jun 19;521(1-3):81-6.'], 'hemolysis': u'0% hemolysis at 100\u03bcg/ml (non hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3541']}, u'LNWGAILKHIKK': {'modifications': ['C-Terminal'], 'references': [u'Panurgines, novel antimicrobial peptides from the venom of communal bee Panurgus calcaratus (Hymenoptera: Andrenidae). Cujova S,Slaninova J,Monincova L,Fucik V,Bednarova L,Stokrova J,Hovorka O,Voburka Z,Straka J Amino Acids. 2013 Jul;45(1):143-57. doi: 10.1007/s00726-013-1482-4. Epub 2013 Mar 13.'], 'hemolysis': u'LC50 >200\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3728']}, u'LKlLKkLlkKLLkLL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'The consequence of sequence alteration of an amphipathic alpha-helical antimicrobial peptide and its diastereomers. Papo N,Oren Z,Pag U,Sahl HG J Biol Chem. 2002 Sep 13;277(37):33913-21. Epub 2002 Jul 10.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2201']}, u'LNWGAILKKIIK': {'modifications': ['C-Terminal'], 'references': [u'Panurgines, novel antimicrobial peptides from the venom of communal bee Panurgus calcaratus (Hymenoptera: Andrenidae). Cujova S,Slaninova J,Monincova L,Fucik V,Bednarova L,Stokrova J,Hovorka O,Voburka Z,Straka J Amino Acids. 2013 Jul;45(1):143-57. doi: 10.1007/s00726-013-1482-4. Epub 2013 Mar 13.'], 'hemolysis': u'LC50 >200\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3726']}, u'GLPALSSWIKRKRQQ': {'modifications': ['C-Terminal'], 'references': [u"Individual substitution analogs of Mel(12-26), melittin's C-terminal 15-residue peptide: their antimicrobial and hemolytic actions. Yan H,Li S,Sun X,Mi H FEBS Lett. 2003 Nov 6;554(1-2):100-4."], 'hemolysis': u'HC10 = 650 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2362']}, u'SWLRDIWDWICEVLSDFK': {'modifications': [], 'references': [u'Rational design of peptides with anti-HCV/HIV activities and enhanced specificity. Li GR,He LY,Liu XY,Liu AP,Huang YB,Qiu C,Zhang XY,Xu JQ,Yang W Chem Biol Drug Des. 2011 Nov;78(5):835-43. doi: 10.1111/j.1747-0285.2011.01201.x. Epub 2011 Sep 26.'], 'hemolysis': u'MHC= 3.46\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2945']}, u'ILGPVLSMVGSALGGLIKKI': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima. Lai R,Zheng YT,Shen JH,Liu GJ,Liu H,Lee WH,Tang SZ Peptides. 2002 Mar;23(3):427-35.'], 'hemolysis': u'90-100% hemolysis at 50\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3429']}, u'RGLRRLGRKIAHGVKKYGATVLRIIRIA': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity analysis of SMAP-29, a sheep leukocytes-derived antimicrobial peptide. Shin SY,Park EJ,Yang ST,Jung HJ,Eom SH,Song WK,Kim Y,Hahm KS Biochem Biophys Res Commun. 2001 Jul 27;285(4):1046-51.'], 'hemolysis': u'50.40% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1048']}, u'ELMNSTicOicGKLGKTicOicELMS': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'De novo design of selective antibiotic peptides by incorporation of unnatural amino acids. Hicks RP,Bhonsle JB,Venugopal D,Koser BW J Med Chem. 2007 Jun 28;50(13):3026-36. Epub 2007 Jun 5.'], 'hemolysis': u'23% hemolysis at 25\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1750']}, u'AKKVFKRLRKLFKKI': {'modifications': [], 'references': [u'Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions. Park SC,Kim MH,Hossain MA,Shin SY,Kim Y,Stella L,Wade JD,Park Y Biochim Biophys Acta. 2008 Jan;1778(1):229-41. Epub 2007 Oct 2.'], 'hemolysis': u'4.5% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1822']}, u'GLGKFLHSAKRFGKAFVGEAMNS': {'modifications': ['C-Terminal'], 'references': [u'Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes. Wieprecht T,Dathe M,Beyermann M,Krause E,Maloy WL,MacDonald DL Biochemistry. 1997 May 20;36(20):6124-32.'], 'hemolysis': u'12% hemolysis at 150\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3520']}, u'KLKKLLKKWLKLLKKLLK': {'modifications': ['C-Terminal'], 'references': [u'Candidacidal mechanism of a Leu/Lys-rich ?-helical amphipathic model antimicrobial peptide and its diastereomer composed of D,L-amino acids. Wang P,Nan YH J Pept Sci. 2010 Nov;16(11):601-6. doi: 10.1002/psc.1268.'], 'hemolysis': u'HC50 =14\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1528']}, u'AVDLAKIANKVLSSLF': {'modifications': ['C-Terminal'], 'references': [u'Molecular cloning and sequence analyses of preprotemporin mRNAs containing premature stop codons from extradermal tissues of Rana tagoi. Iwamuro S,Nakamura M,Ohnuma A Peptides. 2006 Sep;27(9):2124-8. Epub 2006 May 3.'], 'hemolysis': u'LD50 =250\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4049']}, u'GIGAILKVLATGLPTLISWI': {'modifications': [], 'references': [u'Truncated peptides from melittin and its analog with high lytic activity at endosomal pH enhance branched polyethylenimine-mediated gene transfection. Tan YX,Chen C,Wang YL,Lin S,Wang Y,Li SB,Jin XP,Gao HW,Du FS,Gong F J Gene Med. 2012 Apr;14(4):241-50. doi: 10.1002/jgm.2609.'], 'hemolysis': u'~80% hemolytic at 25\u03bcM at pH 8', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2707']}, u'FKLGSFLKKAWKSKLAKKLRAKGKEMLKDYAKGLLEGGSEEVPGQ': {'modifications': [], 'references': [u'Antibacterial and antifungal properties of alpha-helical, cationic peptides in the venom of scorpions from southern Africa. Moerman L,Bosteels S,Noppe W,Willems J,Clynen E,Schoofs L,Thevissen K,Tytgat J,Van Eldere J,Van Der Walt J,Verdonck Eur J Biochem. 2002 Oct;269(19):4799-810.'], 'hemolysis': u'50% hemolysis at 38\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3752']}, u'TSRCIFYRRKKCS': {'modifications': [], 'references': [u'Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs. Yang X,Lee WH J Proteome Res. 2012 Jan 1;11(1):306-19. doi: 10.1021/pr200782u. Epub 2011 Nov 18.'], 'hemolysis': u'15.2 \xb1 2.1% hemolytic at 50 \u03bcg/mL.', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2691']}, u'GLPALILWIKRKRQQ': {'modifications': ['C-Terminal'], 'references': [u"Individual substitution analogs of Mel(12-26), melittin's C-terminal 15-residue peptide: their antimicrobial and hemolytic actions. Yan H,Li S,Sun X,Mi H FEBS Lett. 2003 Nov 6;554(1-2):100-4."], 'hemolysis': u'HC10  = 15.4 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2363']}, u'AAGLAMLFLGILSAAGSTMGARA': {'modifications': ['C-Terminal'], 'references': [u'Membrane-perturbing domains of HIV type 1 glycoprotein 41. Mobley PW,Pilpa R,Brown C,Waring AJ AIDS Res Hum Retroviruses. 2001 Mar 1;17(4):311-27.'], 'hemolysis': u'55-60% hemolysis at 80 \xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1970']}, u'KAKLFKKIPKFLHLWKKF': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial and anti-inflammatory activities of designed antimicrobial peptide P18 analogues. Nan YH Protein Pept Lett. 2008;15(8):861-5.'], 'hemolysis': u'MHC =200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3983']}, u'FSGGNCRGFRRRCFCTK': {'modifications': ['C-Terminal'], 'references': [u"A novel synthetic peptide from a tomato defensin exhibits antibacterial activities against Helicobacter pylori. Rigano MM,Romanelli A,Fulgione A,Nocerino N,D'Agostino N,Avitabile C,Frusciante L,Barone A, Capuano, ,Capuano F J Pept Sci. 2012 Nov 4. doi: 10.1002/psc.2462."], 'hemolysis': u'<5% hemolytic at 50mg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2613']}, u'RGGRLCYTRpRFTVCVGR': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Roles of salt and conformation in the biological and physicochemical behavior of protegrin-1 and designed analogues: correlation of antimicrobial, hemolytic, and lipid bilayer-perturbing activities. Lai JR, Epand, Raquel ,Epand RF,Weisblum B,Epand RM Biochemistry. 2006 Dec 26;45(51):15718-30. Epub 2006 Dec 1.'], 'hemolysis': u'~60% hemolysis at above 100\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1736']}, u'LKWLLKWLL': {'modifications': ['C-Terminal'], 'references': [u'De novo generation of short antimicrobial peptides with simple amino acid composition. Lee SH,Kim SJ,Lee YS,Song MD,Kim IH Regul Pept. 2011 Jan 17;166(1-3):36-41. doi: 10.1016/j.regpep.2010.08.010. Epub 2010 Aug 22.'], 'hemolysis': u'70% hemolysis at 160\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3109']}, u'ILPWKWPW*WPWRR': {'modifications': ['C-Terminal', 'Cyclic', 'Non-Natural'], 'references': [u'Indolicidin-derived antimicrobial peptide analogs with greater bacterial selectivity and requirements for antibacterial and hemolytic activities. Kim SM,Kim JM,Joshi BP,Cho H Biochim Biophys Acta. 2009 Feb;1794(2):185-92. doi: 10.1016/j.bbapap.2008.10.009. Epub 2008 Nov 6.'], 'hemolysis': u'30% hemolysis at 200\u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3040']}, u'LKWLLKWLK': {'modifications': ['C-Terminal'], 'references': [u'De novo generation of short antimicrobial peptides with simple amino acid composition. Lee SH,Kim SJ,Lee YS,Song MD,Kim IH Regul Pept. 2011 Jan 17;166(1-3):36-41. doi: 10.1016/j.regpep.2010.08.010. Epub 2010 Aug 22.'], 'hemolysis': u'40-50% hemolysis at 160\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3107']}, u'GLLDTFKNLALALNAAKSAGVLNSLSCKLSKTC': {'modifications': [], 'references': [u'Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami. Conlon JM,Al-Ghaferi N,Abraham B,Jiansheng H,Cosette P,Leprince J,Jouenne T Peptides. 2006 Sep;27(9):2111-7. Epub 2006 Apr 18.'], 'hemolysis': u'LC50 =140\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1681']}, u'VCGETCFGGTCNTPGCSCTWPICTRDGLP': {'modifications': ['Cyclic'], 'references': [u'Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif. Craik DJ,Daly NL,Bond T J Mol Biol. 1999 Dec 17;294(5):1327-36.'], 'hemolysis': u'50% hemolysis at ~20\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4015']}, u'AGYLLGKINLKALAALAKKIL': {'modifications': ['C-Terminal'], 'references': [u'Cell-penetrating peptide TP10 shows broad-spectrum activity against both Plasmodium falciparum and Trypanosoma brucei brucei. Arrighi RB,Ebikeme C,Jiang Y,Ranford-Cartwright L,Barrett MP,Langel U Antimicrob Agents Chemother. 2008 Sep;52(9):3414-7. doi: 10.1128/AAC.01450-07. Epub 2008 Jun 2.'], 'hemolysis': u'5% hemolysis at 30\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3569']}, u'FLPLAGRVLSGIL': {'modifications': ['C-Terminal'], 'references': [u'Alanine scanning analysis and structure-function relationships of the frog-skin antimicrobial peptide temporin-1Ta. Grieco P,Luca V,Auriemma L,Carotenuto A,Saviello MR,Campiglia P,Barra D,Novellino E J Pept Sci. 2011 May;17(5):358-65. doi: 10.1002/psc.1350. Epub 2011 Feb 18.'], 'hemolysis': u'0% hemolytic at 1.25\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2890']}, u'GrfKRfRKKfKKLfKKLS': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Cell selectivity, mechanism of action and LPS-neutralizing activity of bovine myeloid antimicrobial peptide-18 (BMAP-18) and its analogs. Lee EK,Kim YC,Nan YH Peptides. 2011 Jun;32(6):1123-30. doi: 10.1016/j.peptides.2011.03.024. Epub 2011 Apr 8.'], 'hemolysis': u'10% hemolysis at >400\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3132']}, u'VGKVLKQLKKVSAVAKVAMKKGAALLK': {'modifications': [], 'references': [u'Lytic activity and structural differences of amphipathic peptides derived from trialysin. Martins RM,Sforca ML,Amino R,Juliano MA,Oyama S Jr,Juliano L,Pertinhez TA,Spisni A Biochemistry. 2006 Feb 14;45(6):1765-74.'], 'hemolysis': u'50% hemolysis at >900\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1670']}, u'RLYRRLYRRLYRRLYRRLYRRLYRRLYRKKKKK': {'modifications': [], 'references': [u'Antimicrobial dendrimeric peptides. Tam JP,Lu YA Eur J Biochem. 2002 Feb;269(3):923-32.'], 'hemolysis': u'EC50 = 1514\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2412']}, u'KWLKKLLKKLL': {'modifications': ['C-Terminal'], 'references': [u'Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities. Kim SJ,Kim JS,Lee YS,Sim DW,Lee SH,Bahk YY,Lee KH,Kim EH,Park SJ,Lee BJ Molecules. 2013 Jan 11;18(1):859-76. doi: 10.3390/molecules18010859.'], 'hemolysis': u'MHC = 16\u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2593']}, u'ILGKIWEGIKSLF': {'modifications': ['C-Terminal'], 'references': [u'Antibiotic activity and structural analysis of the scorpion-derived antimicrobial peptide IsCT and its analogs. Lee K,Shin SY,Kim K,Lim SS,Hahm KS Biochem Biophys Res Commun. 2004 Oct 15;323(2):712-9.'], 'hemolysis': u'80% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2395']}, u'KWKSFLKTFKSAKKTVLHTALKAISS': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Effects of net charge and the number of positively charged residues on the biological activity of amphipathic alpha-helical cationic antimicrobial peptides. Jiang Z,Vasil AI,Hale JD,Hancock RE,Vasil ML Biopolymers. 2008;90(3):369-83.'], 'hemolysis': u'MHC =250.0\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1141']}, u'yPyP': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Modulation of structure and antibacterial and hemolytic activity by ring size in cyclic gramicidin S analogs. Kondejewski LH,Farmer SW,Wishart DS,Kay CM,Hancock RE J Biol Chem. 1996 Oct 11;271(41):25261-8.'], 'hemolysis': u'100% hemolysis at >800\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3663']}, u'FFHLHFHdc\u0394DOPA': {'modifications': ['Cyclic', 'Non-Natural'], 'references': [u'Plicatamide, an antimicrobial octapeptide from Styela plicata hemocytes. Tincu JA,Menzel LP,Azimov R,Sands J,Hong T,Waring AJ,Taylor SW J Biol Chem. 2003 Apr 11;278(15):13546-53. Epub 2003 Feb 4.'], 'hemolysis': u'~10% hemolysis at 80\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2282']}, u'GLPVCGETCTLGTVYTQGCTCSWPICKRN': {'modifications': ['Cyclic'], 'references': [u'Structural and biochemical characteristics of the cyclotide kalata B5 from Oldenlandia affinis. Plan MR,Rosengren KJ,Sando L,Daly NL Biopolymers. 2010;94(5):647-58. doi: 10.1002/bip.21409.'], 'hemolysis': u'HD50 = 55.2\xb11.3\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4159']}, u'VGKTWIKVIRGIGKSKIKWQ': {'modifications': [], 'references': [u'Bactrocerin-1: a novel inducible antimicrobial peptide from pupae of oriental fruit fly Bactrocera dorsalis Hendel. Dang XL,Tian JH,Yang WY,Wang WX,Ishibashi J,Asaoka A,Yi HY,Li YF,Cao Y,Yamakawa M Arch Insect Biochem Physiol. 2009 Jul;71(3):117-29. doi: 10.1002/arch.20308.'], 'hemolysis': u'0% hemolysis at 1-50\u03bcM  (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1364']}, u'ILGKLLSTAAkLLSNL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent. Conlon JM,Mechkarska M,Prajeep M,Arafat K,Zaric M,Lukic ML Amino Acids. 2013 Feb;44(2):715-23. doi: 10.1007/s00726-012-1395-7. Epub 2012 Sep 11.'], 'hemolysis': u'LC50 =42\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3173']}, u'WFKKIPKFLHLLKKF': {'modifications': ['C-Terminal'], 'references': [u'Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs. Shin SY,Lee SH,Yang ST,Park EJ,Lee DG,Lee MK,Eom SH,Song WK,Kim Y,Hahm KS J Pept Res. 2001 Dec;58(6):504-14.'], 'hemolysis': u'28.8% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2164']}, u'SLWETIKNAGKGFILNILDKIRCKVAGGCKT': {'modifications': [], 'references': [u'Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata. Ma Y,Liu C,Liu X,Wu J,Yang H,Wang Y,Li J,Yu H Genomics. 2010 Jan;95(1):66-71. doi: 10.1016/j.ygeno.2009.09.004. Epub 2009 Sep 22.'], 'hemolysis': u'85.52\xb13.26% hemolysis at 100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4025']}, u'WKSYVRRWR': {'modifications': [], 'references': [u'Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide. Wu YS,Liao ZJ,Wang KS Bioorg Med Chem Lett. 2013 May 15;23(10):2929-32. doi: 10.1016/j.bmcl.2013.03.053. Epub 2013 Mar 25.'], 'hemolysis': u'1.1 \xb11.3% hemolytic at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2583']}, u'KAACAAHCLWR': {'modifications': ['C-Terminal'], 'references': [u'Design and synthesis of novel antimicrobial peptides on the basis of alpha helical domain of Tenecin 1, an insect defensin protein, and structure-activity relationship study. Ahn HS,Cho W,Kang SH,Ko SS,Park MS,Cho H Peptides. 2006 Apr;27(4):640-8. Epub 2005 Oct 13.'], 'hemolysis': u'0% hemolysis at 200\u03bcg/ml (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1899']}, u'ILPWKWPWLPWRR': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship of indolicidin, a Trp-rich antibacterial peptide. Ando S,Mitsuyasu K,Soeda Y,Hidaka M,Ito Y,Matsubara K,Shindo M,Uchida Y J Pept Sci. 2010 Apr;16(4):171-7. doi: 10.1002/psc.1217.'], 'hemolysis': u'6% hemolysis at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1474']}, u'CVKVQVKVGSGVKVQVKVC': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', 'Cyclic'], 'references': [u'De novo design of potent antimicrobial peptides. Frecer V,Ho B Antimicrob Agents Chemother. 2004 Sep;48(9):3349-57.'], 'hemolysis': u'EC50 = 3226000 nM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2376']}, u'GWKKWLRKGAKHLGQAAIK': {'modifications': ['C-Terminal'], 'references': [u'The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents. Morash MG,Douglas SE,Robotham A,Ridley CM,Gallant JW Dis Model Mech. 2011 Sep;4(5):622-33. doi: 10.1242/dmm.007310. Epub 2011 Jul 4.'], 'hemolysis': u'50% hemolytic at >256 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2931']}, u'KLKKLLKKWlkllkkllk': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich alpha-helical model antimicrobial peptide and its diastereomeric peptides. Wang P,Nan YH,Yang ST,Kang SW,Kim Y,Park IS,Hahm KS Peptides. 2010 Jul;31(7):1251-61. doi: 10.1016/j.peptides.2010.03.032. Epub 2010 Apr 2.'], 'hemolysis': u'HC50 =154\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3060']}, u'CH3SCKLLLKWLLKLLKCSCH3': {'modifications': [], 'references': [u'Cyclization of a cytolytic amphipathic alpha-helical peptide and its diastereomer: effect on structure, interaction with model membranes, and biological function. Oren Z Biochemistry. 2000 May 23;39(20):6103-14.'], 'hemolysis': u'100% hemolytic at 5\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2533']}, u'GRRRRSVQWCA': {'modifications': [], 'references': [u"Human antimicrobial peptides' antifungal activity against Aspergillus fumigatus. Lupetti A,van Dissel JT,Brouwer CP Eur J Clin Microbiol Infect Dis. 2008 Nov;27(11):1125-9. doi: 10.1007/s10096-008-0553-z. Epub 2008 Jun 20."], 'hemolysis': u'0% hemolysis at \u2265200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1221']}, u'CGESCVWIPCISAVVGCSCKSKVCYKNGTLP': {'modifications': ['Cyclic'], 'references': [u'Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif. Craik DJ,Daly NL,Bond T J Mol Biol. 1999 Dec 17;294(5):1327-36.'], 'hemolysis': u'50% hemolysis at ~20\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4007']}, u'ILPILGNLLNGLL': {'modifications': ['C-Terminal'], 'references': [u'A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica. Conlon JM,Sonnevend A,Patel M,Al-Dhaheri K, Nielsen, Per ,Nielsen PF,Kolodziejek J,Nowotny N,Iwamuro S Regul Pept. 2004 May 15;118(3):135-41.'], 'hemolysis': u'HC50 >300\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1996']}, u'FLPWFSKFLGRIL': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship, conformational and biological studies of temporin L analogues. Mangoni ML,Carotenuto A,Auriemma L,Saviello MR,Campiglia P,Gomez-Monterrey I,Malfi S,Marcellini L,Barra D,Novellino E J Med Chem. 2011 Mar 10;54(5):1298-307. doi: 10.1021/jm1012853. Epub 2011 Feb 14.'], 'hemolysis': u'19% hemolytic at 6\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2836']}, u'ILGKLLSTAAGLLSKL': {'modifications': ['C-Terminal'], 'references': [u'Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent. Conlon JM,Mechkarska M,Prajeep M,Arafat K,Zaric M,Lukic ML Amino Acids. 2013 Feb;44(2):715-23. doi: 10.1007/s00726-012-1395-7. Epub 2012 Sep 11.'], 'hemolysis': u'LC50 =50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3175']}, u'AWASFFKKAAHVAKHVAKAALTHYL': {'modifications': [], 'references': [u'Interaction of pleurocidin and its analogs with phospholipid membrane and their antibacterial activity. Yoshida K,Mukai Y,Niidome T,Takashi C,Tokunaga Y,Hatakeyama T J Pept Res. 2001 Feb;57(2):119-26.'], 'hemolysis': u'90% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2107']}, u'CGESCVWIPCLTSAIGCSCKSKVCYRNGIP': {'modifications': ['Cyclic'], 'references': [u'Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif. Craik DJ,Daly NL,Bond T J Mol Biol. 1999 Dec 17;294(5):1327-36.'], 'hemolysis': u'50% hemolysis at ~20\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3999']}, u'RGGRLTYTRpRFTVTVGR': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Roles of salt and conformation in the biological and physicochemical behavior of protegrin-1 and designed analogues: correlation of antimicrobial, hemolytic, and lipid bilayer-perturbing activities. Lai JR, Epand, Raquel ,Epand RF,Weisblum B,Epand RM Biochemistry. 2006 Dec 26;45(51):15718-30. Epub 2006 Dec 1.'], 'hemolysis': u'~10% hemolysis at above 100\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1734']}, u'GFLSILKKVLPKVMet(O2)AHMet(O2)K': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Melectin MAPs: the influence of dendrimerization on antimicrobial and hemolytic activity. Niederhafner P,Bednarova L,Budesinsky M,Safarik M,Ehala S,Jezek J,Borovickova L,Fucik V,Cerovsky V Amino Acids. 2010 Nov;39(5):1553-61. doi: 10.1007/s00726-010-0626-z. Epub 2010 May 25.'], 'hemolysis': u'LC50 >200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1509']}, u'VOLticPVOLticP': {'modifications': ['Cyclic', u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'Therapeutic index of gramicidin S is strongly modulated by D-phenylalanine analogues at the beta-turn. Solanas C,de la Torre BG,Fernandez-Reyes M,Santiveri CM,Jimenez MA,Rivas L,Jimenez AI,Andreu D J Med Chem. 2009 Feb 12;52(3):664-74. doi: 10.1021/jm800886n.'], 'hemolysis': u'HC50 >50 \u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1289']}, u'FLSLIPHAINAVSAIAKHN': {'modifications': ['C-Terminal'], 'references': [u'Phylloseptins: a novel class of anti-bacterial and anti-protozoan peptides from the Phyllomedusa genus. Leite JR,Silva LP,Rodrigues MI,Prates MV,Brand GD,Lacava BM,Azevedo RB,Bocca AL,Albuquerque S Peptides. 2005 Apr;26(4):565-73. Epub 2004 Dec 25.'], 'hemolysis': u'1.98% hemolysis at 64\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2367']}, u'TSKYR': {'modifications': [], 'references': [u'Isolation and characterization of four antibacterial peptides from bovine hemoglobin. Nedjar-Arroume N,Dubois-Delval V,Miloudi K,Daoud R,Krier F,Kouach M,Briand G Peptides. 2006 Sep;27(9):2082-9. Epub 2006 May 30.'], 'hemolysis': u'Non-hemolytic', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1911']}, u'KKVVFKVKFKK': {'modifications': ['C-Terminal'], 'references': [u'The comparison of characteristics between membrane-active antifungal peptide and its pseudopeptides. Oh JE,Hong SY Bioorg Med Chem. 1999 Nov;7(11):2509-15.'], 'hemolysis': u'0% hemolysis upto 500 \u03bcg/mL (Non hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3767']}, u'FLSLIPHAINAVSAIAKHF': {'modifications': ['C-Terminal'], 'references': [u'Isolation and biochemical characterization of peptides presenting antimicrobial activity from the skin of Phyllomedusa hypochondrialis. Conceicao K,Konno K,Richardson M,Antoniazzi MM,Jared C,Daffre S,Camargo AC Peptides. 2006 Dec;27(12):3092-9. Epub 2006 Sep 11.'], 'hemolysis': u'No hemolysis at 6\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1916']}, u'KGRGKQGGKVRAKAKTRSS': {'modifications': [], 'references': [u'Parasin I, an antimicrobial peptide derived from histone H2A in the catfish, Parasilurus asotus. Park IY,Park CB,Kim MS FEBS Lett. 1998 Oct 23;437(3):258-62.'], 'hemolysis': u'0.2% hemolysis at 200\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3824']}, u'DLLGTLGNLPLPFI': {'modifications': ['C-Terminal'], 'references': [u'An immunomodulatory peptide related to frenatin 2 from skin secretions of the Tyrrhenian painted frog Discoglossus sardus (Alytidae). Conlon JM,Mechkarska M,Pantic JM,Lukic ML,Coquet L,Leprince J, Nielsen, Per ,Nielsen PF Peptides. 2013 Feb;40:65-71. doi: 10.1016/j.peptides.2012.12.012. Epub 2012 Dec 20.'], 'hemolysis': u'No hemolysis upto 500\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3246']}, u'LNWGAILKHKIK': {'modifications': ['C-Terminal'], 'references': [u'Panurgines, novel antimicrobial peptides from the venom of communal bee Panurgus calcaratus (Hymenoptera: Andrenidae). Cujova S,Slaninova J,Monincova L,Fucik V,Bednarova L,Stokrova J,Hovorka O,Voburka Z,Straka J Amino Acids. 2013 Jul;45(1):143-57. doi: 10.1007/s00726-013-1482-4. Epub 2013 Mar 13.'], 'hemolysis': u'LC50 >200\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3727']}, u'GLMSLFKGVLKTAGKHIFKNVGGSLLDQAKCKITGEC': {'modifications': [], 'references': [u'A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica. Conlon JM,Sonnevend A,Patel M,Al-Dhaheri K, Nielsen, Per ,Nielsen PF,Kolodziejek J,Nowotny N,Iwamuro S Regul Pept. 2004 May 15;118(3):135-41.'], 'hemolysis': u'HC50 = 55\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1989']}, u'GLPVCGDTCVGGTCNTPGCTCSWPVCTRN': {'modifications': ['Cyclic'], 'references': [u'Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities. Henriques ST,Huang YH,Rosengren KJ,Franquelim HG,Carvalho FA,Johnson A,Sonza S,Tachedjian G,Castanho MA,Daly NL J Biol Chem. 2011 Jul 8;286(27):24231-41. doi: 10.1074/jbc.M111.253393. Epub 2011 May 16.'], 'hemolysis': u'3.8\xb10.4% hemolytic at 25\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3004']}, u'RLRLRIGRR': {'modifications': ['C-Terminal', 'Cyclic'], 'references': [u'In vitro and in vivo activity of antimicrobial peptides synthesized based on the insect defensin. Saido-Sakanaka H,Ishibashi J,Momotani E,Amano F Peptides. 2004 Jan;25(1):19-27.'], 'hemolysis': u'0% hemolysis at 100\xb5g/ml (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1866']}, u'GLPVCGETCKGGTCNTPGCTCSWPVCTRN': {'modifications': ['Cyclic'], 'references': [u'Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities. Henriques ST,Huang YH,Rosengren KJ,Franquelim HG,Carvalho FA,Johnson A,Sonza S,Tachedjian G,Castanho MA,Daly NL J Biol Chem. 2011 Jul 8;286(27):24231-41. doi: 10.1074/jbc.M111.253393. Epub 2011 May 16.'], 'hemolysis': u'0\xb11.7% hemolytic at 25\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3006']}, u'MLQDLLSSLGDLLKSWLDTLNKFTKK': {'modifications': [], 'references': [u'Interaction of staphylococcal delta-toxin and synthetic analogues with erythrocytes and phospholipid vesicles. Biological and physical properties of the amphipathic peptides. Alouf JE,Dufourcq J,Siffert O,Thiaudiere E Eur J Biochem. 1989 Aug 1;183(2):381-90.'], 'hemolysis': u'13% hemolysis at 75\u03bcg', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3364']}, u'KWKKLLKKPLKLLKKLLK': {'modifications': ['C-Terminal'], 'references': [u'Effects of L- or D-Pro incorporation into hydrophobic or hydrophilic helix face of amphipathic alpha-helical model peptide on structure and cell selectivity. Song YM,Yang ST,Lim SS,Kim Y,Hahm KS,Kim JI Biochem Biophys Res Commun. 2004 Feb 6;314(2):615-21.'], 'hemolysis': u'~10% hemolysis  at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1571']}, u'KLALKLALKALKAAlkLA': {'modifications': [u'Stereochemistry: Mix'], 'references': [u'Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes. Dathe M,Schumann M,Wieprecht T,Winkler A,Beyermann M,Krause E,Matsuzaki K,Murase O Biochemistry. 1996 Sep 24;35(38):12612-22.'], 'hemolysis': u'EC50 = 210\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3465']}, u'RCYARRRFAVCR': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'0-3% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1177']}, u'KKKKKKKKKKKKKKKKKKKKGIGKFLHSAKKFGKAFVGEIMNS': {'modifications': [], 'references': [u'Augmentation of the antibacterial activity of magainin by positive-charge chain extension. Bessalle R,Haas H,Goria A,Shalit I Antimicrob Agents Chemother. 1992 Feb;36(2):313-7.'], 'hemolysis': u'14% hemolysis at 200\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3444']}, u'kklfkkILKYL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Improvement of the efficacy of linear undecapeptides against plant-pathogenic bacteria by incorporation of D-amino acids. Guell I,Cabrefiga J,Badosa E,Ferre R,Talleda M,Bardaji E,Planas M,Feliu L Appl Environ Microbiol. 2011 Apr;77(8):2667-75. doi: 10.1128/AEM.02759-10. Epub 2011 Feb 18.'], 'hemolysis': u'0\xb10% hemolytic at 250\u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2873']}, u'GLPALISSIKRKRQQ': {'modifications': ['C-Terminal'], 'references': [u"Individual substitution analogs of Mel(12-26), melittin's C-terminal 15-residue peptide: their antimicrobial and hemolytic actions. Yan H,Li S,Sun X,Mi H FEBS Lett. 2003 Nov 6;554(1-2):100-4."], 'hemolysis': u'HC10  = 13800 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2365']}, u'FLGPIIKIATGILPTAICKILKKC': {'modifications': [], 'references': [u'Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata. Ma Y,Liu C,Liu X,Wu J,Yang H,Wang Y,Li J,Yu H Genomics. 2010 Jan;95(1):66-71. doi: 10.1016/j.ygeno.2009.09.004. Epub 2009 Sep 22.'], 'hemolysis': u'0% hemolysis at 100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4027']}, u'ZSRRLCYKQRCVTYSRGR': {'modifications': ['C-Terminal', 'Cyclic', 'Non-Natural'], 'references': [u'Structure-activity relationship studies of gomesin: importance of the disulfide bridges for conformation, bioactivities, and serum stability. Fazio MA,Oliveira VX Jr,Bulet P,Miranda MT,Daffre S Biopolymers. 2006;84(2):205-18.'], 'hemolysis': u'<10% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4196']}, u'FLGALIKGAIHGGRFIHGMIQNHH': {'modifications': ['C-Terminal'], 'references': [u'The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents. Morash MG,Douglas SE,Robotham A,Ridley CM,Gallant JW Dis Model Mech. 2011 Sep;4(5):622-33. doi: 10.1242/dmm.007310. Epub 2011 Jul 4.'], 'hemolysis': u'50% hemolytic at >256 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2920']}, u'KGFFALIpKIISSPLFKTllSAV': {'modifications': [u'C-Terminal Non-Amidation: NH(CH2)2NH2', u'Stereochemistry: Mix'], 'references': [u'A comparative study on the structure and function of a cytolytic alpha-helical peptide and its antimicrobial beta-sheet diastereomer. Oren Z,Hong J Eur J Biochem. 1999 Jan;259(1-2):360-9.'], 'hemolysis': u'0% hemolysis at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3835']}, u'kwksflktfkslkktklhtllkliss': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', u'Stereochemistry: D'], 'references': [u'Anti-tuberculosis activity of ?-helical antimicrobial peptides: de novo designed L- and D-enantiomers versus L- and D-LL-37. Jiang Z,Higgins MP,Whitehurst J,Kisich KO,Voskuil MI Protein Pept Lett. 2011 Mar;18(3):241-52.'], 'hemolysis': u'HC50 = 47\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2804']}, u'KNLRRIIRKIIHIIKKYG': {'modifications': [], 'references': [u'Impact of single-residue mutations on the structure and function of ovispirin/novispirin antimicrobial peptides. Sawai MV,Waring AJ,Kearney WR,McCray PB Jr,Forsyth WR,Lehrer RI, Tack, Brian ,Tack B Protein Eng. 2002 Mar;15(3):225-32.'], 'hemolysis': u'55.0% hemolysis at 40 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2177']}, u'ILGKLLSTAWGLLSNL': {'modifications': ['C-Terminal'], 'references': [u'Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent. Conlon JM,Mechkarska M,Prajeep M,Arafat K,Zaric M,Lukic ML Amino Acids. 2013 Feb;44(2):715-23. doi: 10.1007/s00726-012-1395-7. Epub 2012 Sep 11.'], 'hemolysis': u'LC50 =11\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3183']}, u'GFLSLLKKVLPKVMetAHNleK': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Melectin MAPs: the influence of dendrimerization on antimicrobial and hemolytic activity. Niederhafner P,Bednarova L,Budesinsky M,Safarik M,Ehala S,Jezek J,Borovickova L,Fucik V,Cerovsky V Amino Acids. 2010 Nov;39(5):1553-61. doi: 10.1007/s00726-010-0626-z. Epub 2010 May 25.'], 'hemolysis': u'LC50 =80\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1511']}, u'FFRHLFRGAKAIFRGARQGXRAHKVVSRYRNRDVPETDNNQEEP': {'modifications': [], 'references': [u'Structure-activity relationships of piscidin 4, a piscine antimicrobial peptide. Park NG,Silphaduang U,Moon HS,Seo JK,Corrales J Biochemistry. 2011 Apr 26;50(16):3288-99. doi: 10.1021/bi101395j. Epub 2011 Mar 31.'], 'hemolysis': u'~1.4% hemolytic at 100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2910']}, u'GWLDVAKKIGKAAFNVAKNFLspacerLFNKAVNFAAKGIKKAVDLWG': {'modifications': ['Non-Natural'], 'references': [u'Effects of dimerization on the structure and biological activity of antimicrobial peptide Ctx-Ha. Lorenzon EN, Cespedes, G ,Cespedes GF, Vicente, E ,Vicente EF,Nogueira LG,Bauab TM,Castro MS Antimicrob Agents Chemother. 2012 Jun;56(6):3004-10. doi: 10.1128/AAC.06262-11. Epub 2012 Mar 5.'], 'hemolysis': u'HC50 = 0.8\xb1 0.1 \u03bcmol/L', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2715']}, u'KLTicOicKTicOicFTicOicKTicOicFTicOicKTicOicKR': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'De novo design of selective antibiotic peptides by incorporation of unnatural amino acids. Hicks RP,Bhonsle JB,Venugopal D,Koser BW J Med Chem. 2007 Jun 28;50(13):3026-36. Epub 2007 Jun 5.'], 'hemolysis': u'63% hemolysis at 25\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1758']}, u'XALWMTLLKKVLKAAAKAALNAVLVGANA': {'modifications': ['Non-Natural'], 'references': [u'Selective cytotoxicity of dermaseptin S3 toward intraerythrocytic Plasmodium falciparum and the underlying molecular basis. Ghosh JK,Shaool D,Guillaud P,Ciceron L,Mazier D,Kustanovich I,Shai Y J Biol Chem. 1997 Dec 12;272(50):31609-16.'], 'hemolysis': u'Hemolysis observed at >8.5\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3566']}, u'FRPKVTITIQGSARF': {'modifications': ['C-Terminal'], 'references': [u'Identification of chicken cathelicidin-2 core elements involved in antibacterial and immunomodulatory activities. van Dijk A,Molhoek EM,Veldhuizen EJ,Bokhoven JL,Wagendorp E,Bikker F Mol Immunol. 2009 Aug;46(13):2465-73. doi: 10.1016/j.molimm.2009.05.019. Epub 2009 Jun 12.'], 'hemolysis': u'0% hemolysis at 40\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1369']}, u'GVIIDTLKGAAKTVAAELLRKAHCKLTNSC': {'modifications': ['C-Terminal'], 'references': [u'A potent, non-toxic insulin-releasing peptide isolated from an extract of the skin of the Asian frog, Hylarana guntheri (Anura:Ranidae). Conlon JM,Power GJ,Abdel-Wahab YH,Flatt PR,Jiansheng H,Coquet L,Leprince J,Jouenne T Regul Pept. 2008 Nov 29;151(1-3):153-9. doi: 10.1016/j.regpep.2008.04.002. Epub 2008 Apr 13.'], 'hemolysis': u'LC50 = 700\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2541']}, u'RLYRKVYGRLYRKVYGRLYRKVYGRLYRKVYGRLYRKVYGRLYRKVYGRLYRKVYGKKKKK': {'modifications': ['Cyclic'], 'references': [u'Antimicrobial dendrimeric peptides. Tam JP,Lu YA Eur J Biochem. 2002 Feb;269(3):923-32.'], 'hemolysis': u'EC50 = 112\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2416']}, u'NWCKRGRKQCKTHPH': {'modifications': ['Cyclic'], 'references': [u'Antimicrobial activity of peptides derived from human \xdf-amyloid precursor protein. Papareddy P,Morgelin M,Walse B,Schmidtchen A J Pept Sci. 2012 Mar;18(3):183-91. doi: 10.1002/psc.1439. Epub 2012 Jan 16.'], 'hemolysis': u'~3% hemolytic at 60\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2696']}, u'GLPALISWSKRKRQQ': {'modifications': ['C-Terminal'], 'references': [u"Individual substitution analogs of Mel(12-26), melittin's C-terminal 15-residue peptide: their antimicrobial and hemolytic actions. Yan H,Li S,Sun X,Mi H FEBS Lett. 2003 Nov 6;554(1-2):100-4."], 'hemolysis': u'HC10  = 6140 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2366']}, u'LLIILKKKWKKQAKAKSK': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial activity, bactericidal mechanism and LPS-neutralizing activity of the cell-penetrating peptide pVEC and its analogs. Nan YH,Park IS,Hahm KS J Pept Sci. 2011 Dec;17(12):812-7. doi: 10.1002/psc.1408. Epub 2011 Sep 29.'], 'hemolysis': u'>10% hemolytic at 200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2972']}, u'GWGSFFKKAAHVGKHVGKAALT': {'modifications': ['C-Terminal'], 'references': [u'Influence of the hydrophobic amino acids in the N- and C-terminal regions of pleurocidin on antifungal activity. Lee J J Microbiol Biotechnol. 2010 Aug;20(8):1192-5.'], 'hemolysis': u'0% hemolysis at 100\u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2789']}, u'INWSSIFEKVKNLV': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 >100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3899']}, u'QSRVIQGLVAGETAQQICED': {'modifications': [], 'references': [u'Hemolysis of erythrocytes by granulysin-derived peptides but not by granulysin. Li Q,Dong C,Deng A,Katsumata M,Nakadai A,Kawada T,Okada S,Clayberger C Antimicrob Agents Chemother. 2005 Jan;49(1):388-97.'], 'hemolysis': u'No hemolysis at 10\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1889']}, u'RWRWRWRW': {'modifications': ['C-Terminal'], 'references': [u'Length effects in antimicrobial peptides of the (RW)n series. Liu Z,Brady A,Young A,Rasimick B,Chen K,Zhou C Antimicrob Agents Chemother. 2007 Feb;51(2):597-603. Epub 2006 Dec 4.'], 'hemolysis': u'HD50  =1.0x102\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1080']}, u'GWKDWFRKAKKVGKTVGGLALNHYL': {'modifications': ['C-Terminal'], 'references': [u'The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents. Morash MG,Douglas SE,Robotham A,Ridley CM,Gallant JW Dis Model Mech. 2011 Sep;4(5):622-33. doi: 10.1242/dmm.007310. Epub 2011 Jul 4.'], 'hemolysis': u'50% hemolytic at >256 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2936']}, u'GFFALIPKIIS': {'modifications': [u'C-Terminal Non-Amidation: [NH(CH2)2NH2]2'], 'references': [u'A class of highly potent antibacterial peptides derived from pardaxin, a pore-forming peptide isolated from Moses sole fish Pardachirus marmoratus. Oren Z Eur J Biochem. 1996 Apr 1;237(1):303-10.'], 'hemolysis': u'No hemolysis (Non hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3682']}, u'FFHHIFRGIVHVGKTIHRLVTG': {'modifications': [], 'references': [u'Peptide antibiotics in mast cells of fish. Silphaduang U Nature. 2001 Nov 15;414(6861):268-9.'], 'hemolysis': u'~90% hemolysis at 100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3410']}, u'WNPFKELERAGQRIRDSIISAAP': {'modifications': [], 'references': [u'Cecropin D-like antibacterial peptides from the sphingid moth, Agrius convolvuli. Lee IH,Chang KY,Choi CS Arch Insect Biochem Physiol. 1999;41(4):178-85.'], 'hemolysis': u'0% hemolysis at 100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3863']}, u'VKLKyPKVKLyP': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Conformation and other biophysical properties of cyclic antimicrobial peptides in aqueous solutions. Jelokhani-Niaraki M,Prenner EJ,Kondejewski LH,Kay CM,McElhaney RN J Pept Res. 2001 Oct;58(4):293-306.'], 'hemolysis': u'Weak hemolysis', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2422']}, u'AWASFFKKAAHVGKHVGKAALTHYL': {'modifications': [], 'references': [u'Interaction of pleurocidin and its analogs with phospholipid membrane and their antibacterial activity. Yoshida K,Mukai Y,Niidome T,Takashi C,Tokunaga Y,Hatakeyama T J Pept Res. 2001 Feb;57(2):119-26.'], 'hemolysis': u'8% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2103']}, u'GIGKFLHSAKKFGKAFVGEIMNSKKKKKKKKKK': {'modifications': [], 'references': [u'Augmentation of the antibacterial activity of magainin by positive-charge chain extension. Bessalle R,Haas H,Goria A,Shalit I Antimicrob Agents Chemother. 1992 Feb;36(2):313-7.'], 'hemolysis': u'1% hemolysis at 200\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3446']}, u'LLGMIPLAISAISALSKL': {'modifications': ['C-Terminal'], 'references': [u'Peptides with differential cytolytic activity from skin secretions of the lemur leaf frog Hylomantis lemur (Hylidae: Phyllomedusinae). Conlon JM,Woodhams DC,Raza H,Coquet L,Leprince J,Jouenne T,Vaudry H Toxicon. 2007 Sep 15;50(4):498-506. Epub 2007 May 3.'], 'hemolysis': u'LC50 =40\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4020']}, u'RKKWFW': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Studies on the mode of action of the antifungal hexapeptide PAF26. Munoz A,Lopez-Garcia B, Marcos, Jose ,Marcos J Antimicrob Agents Chemother. 2006 Nov;50(11):3847-55.'], 'hemolysis': u'<0.3% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1721']}, u'FLPLIGRVLAGIL': {'modifications': ['C-Terminal'], 'references': [u'Alanine scanning analysis and structure-function relationships of the frog-skin antimicrobial peptide temporin-1Ta. Grieco P,Luca V,Auriemma L,Carotenuto A,Saviello MR,Campiglia P,Barra D,Novellino E J Pept Sci. 2011 May;17(5):358-65. doi: 10.1002/psc.1350. Epub 2011 Feb 18.'], 'hemolysis': u'0% hemolytic at 1.25\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2900']}, u'pslvslvVqLv\u0394ButallothrIHsedabK': {'modifications': [u'N-Terminal Modification: \u03b2-hydroxyoctanoyl-\u0394-But', u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'Temperature-dependent hemolytic activity of membrane pore-forming peptide toxin, tolaasin. Cho KH,Wang HS J Pept Sci. 2010 Feb;16(2):85-90. doi: 10.1002/psc.1199.'], 'hemolysis': u'100% hemolysis at 0.53 \u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2775']}, u'FFHHIFRAIVHVPKTIHRLVTG': {'modifications': [], 'references': [u'Solution structure and cell selectivity of piscidin 1 and its analogues. Lee SA,Kim YK,Lim SS,Zhu WL,Ko H,Shin SY,Hahm KS Biochemistry. 2007 Mar 27;46(12):3653-63. Epub 2007 Mar 1.'], 'hemolysis': u'HC50 =75\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1116']}, u'WFKKIPKFLHLAKKF': {'modifications': ['C-Terminal'], 'references': [u'Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs. Shin SY,Lee SH,Yang ST,Park EJ,Lee DG,Lee MK,Eom SH,Song WK,Kim Y,Hahm KS J Pept Res. 2001 Dec;58(6):504-14.'], 'hemolysis': u'1.5% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2161']}, u'ILGKLLkTAAkLLSNL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent. Conlon JM,Mechkarska M,Prajeep M,Arafat K,Zaric M,Lukic ML Amino Acids. 2013 Feb;44(2):715-23. doi: 10.1007/s00726-012-1395-7. Epub 2012 Sep 11.'], 'hemolysis': u'LC50 =185\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3178']}, u'SWLSKTAKKLENSAKKRISEGIAIAIQGGPR': {'modifications': [], 'references': [u'Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides. Yasin B,Pang M,Turner JS,Cho Y,Dinh NN,Waring AJ,Lehrer RI Eur J Clin Microbiol Infect Dis. 2000 Mar;19(3):187-94.'], 'hemolysis': u'0.3% hemolysis at 80\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2444']}, u'AibGGLAibGIL': {'modifications': [u'C-Terminal Non-Amidation: Methoxy (Ome)', u'N-Terminal Modification: Acetylated by lipol (n-octanoyl)', 'Non-Natural'], 'references': [u'Trichogin GA IV: an antibacterial and protease-resistant peptide. De Zotti M,Biondi B,Formaggio F,Toniolo C,Stella L,Park Y J Pept Sci. 2009 Sep;15(9):615-9. doi: 10.1002/psc.1135.'], 'hemolysis': u'0% hemolysis at 15 \u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1294']}, u'GLLSKFGRLARKLARVIPKV': {'modifications': ['C-Terminal'], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC <10\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3960']}, u'ILPFKFPFFPFRR': {'modifications': ['C-Terminal'], 'references': [u'Requirements for antibacterial and hemolytic activities in the bovine neutrophil derived 13-residue peptide indolicidin. Subbalakshmi C,Krishnakumari V,Nagaraj R FEBS Lett. 1996 Oct 14;395(1):48-52.'], 'hemolysis': u'~20% hemolysis upto 80\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3660']}, u'KNWKGIAGMAKKLLGENWKLM': {'modifications': [], 'references': [u'Design of a novel membrane-destabilizing peptide selectively acting on acidic liposomes. Machida S,Niimi S,Shi X,Ando Y Biosci Biotechnol Biochem. 2000 May;64(5):985-94.'], 'hemolysis': u'7.1% hemolytic at 10\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2524']}, u'GVAKFGKAAAHFGKGWIKEMLNS': {'modifications': ['C-Terminal'], 'references': [u'Influence of the angle subtended by the positively charged helix face on the membrane activity of amphipathic, antibacterial peptides. Wieprecht T,Dathe M,Epand RM,Beyermann M,Krause E,Maloy WL,MacDonald DL Biochemistry. 1997 Oct 21;36(42):12869-80.'], 'hemolysis': u'EC25=307\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3584']}, u'KKWLKKWLK': {'modifications': ['C-Terminal'], 'references': [u'De novo generation of short antimicrobial peptides with simple amino acid composition. Lee SH,Kim SJ,Lee YS,Song MD,Kim IH Regul Pept. 2011 Jan 17;166(1-3):36-41. doi: 10.1016/j.regpep.2010.08.010. Epub 2010 Aug 22.'], 'hemolysis': u'negligible hemolysis at 320\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3096']}, u'KIASIGKEVLKAL': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 >>100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3927']}, u'fvqwfskflGril': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Structure-activity relationship, conformational and biological studies of temporin L analogues. Mangoni ML,Carotenuto A,Auriemma L,Saviello MR,Campiglia P,Gomez-Monterrey I,Malfi S,Marcellini L,Barra D,Novellino E J Med Chem. 2011 Mar 10;54(5):1298-307. doi: 10.1021/jm1012853. Epub 2011 Feb 14.'], 'hemolysis': u'46% hemolytic at 6\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2845']}, u'RFGRFLRKIRRFRPK': {'modifications': [], 'references': [u'Identification of chicken cathelicidin-2 core elements involved in antibacterial and immunomodulatory activities. van Dijk A,Molhoek EM,Veldhuizen EJ,Bokhoven JL,Wagendorp E,Bikker F Mol Immunol. 2009 Aug;46(13):2465-73. doi: 10.1016/j.molimm.2009.05.019. Epub 2009 Jun 12.'], 'hemolysis': u'0% hemolysis at 40\u03bcM  (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1368']}, u'KNWKKIAGMAKKLLKKNWKLM': {'modifications': [], 'references': [u'Design of a novel membrane-destabilizing peptide selectively acting on acidic liposomes. Machida S,Niimi S,Shi X,Ando Y Biosci Biotechnol Biochem. 2000 May;64(5):985-94.'], 'hemolysis': u'6.3% hemolytic at 10\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2525']}, u'KWKLFKKIPLKKF': {'modifications': ['C-Terminal'], 'references': [u'Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs. Shin SY,Lee SH,Yang ST,Park EJ,Lee DG,Lee MK,Eom SH,Song WK,Kim Y,Hahm KS J Pept Res. 2001 Dec;58(6):504-14.'], 'hemolysis': u'6.2% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2174']}, u'ILPKKWPKLPWRR': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship of indolicidin, a Trp-rich antibacterial peptide. Ando S,Mitsuyasu K,Soeda Y,Hidaka M,Ito Y,Matsubara K,Shindo M,Uchida Y J Pept Sci. 2010 Apr;16(4):171-7. doi: 10.1002/psc.1217.'], 'hemolysis': u'7% hemolysis at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1487']}, u'KLLGPLLKIAAKVGSNLL': {'modifications': ['C-Terminal'], 'references': [u'Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7. Conlon JM,Galadari S,Raza H Chem Biol Drug Des. 2008 Jul;72(1):58-64. doi: 10.1111/j.1747-0285.2008.00671.x. Epub 2008 Jun 12.'], 'hemolysis': u'LD50 = 400\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1958']}, u'GLSALISWIKRKRQQ': {'modifications': ['C-Terminal'], 'references': [u"Individual substitution analogs of Mel(12-26), melittin's C-terminal 15-residue peptide: their antimicrobial and hemolytic actions. Yan H,Li S,Sun X,Mi H FEBS Lett. 2003 Nov 6;554(1-2):100-4."], 'hemolysis': u'HC10  = 44 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2359']}, u'QADFQKVVAGVANALAHRYH': {'modifications': [], 'references': [u'Isolation and characterization of four antibacterial peptides from bovine hemoglobin. Nedjar-Arroume N,Dubois-Delval V,Miloudi K,Daoud R,Krier F,Kouach M,Briand G Peptides. 2006 Sep;27(9):2082-9. Epub 2006 May 30.'], 'hemolysis': u'Non-hemolytic', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1914']}, u'VKLKVyPLKVkLyP': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Dissociation of antimicrobial and hemolytic activities in cyclic peptide diastereomers by systematic alterations in amphipathicity. Kondejewski LH,Jelokhani-Niaraki M,Farmer SW,Lix B,Kay CM,Sykes BD,Hancock RE J Biol Chem. 1999 May 7;274(19):13181-92.'], 'hemolysis': u'100% hemolytic at 150 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2566']}, u'LALKSGGWLRLFGLKDKKH': {'modifications': [], 'references': [u'Molecular cloning and functional characterization of novel antimicrobial peptides from the skin of brown frog, Rana zhenhaiensis. Xu B,Che H,Kang L,Zheng S,Mu S,Wan Zoolog Sci. 2012 Sep;29(9):553-8. doi: 10.2108/zsj.29.553.'], 'hemolysis': u'HC50 >92\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3165']}, u'GIGKFLHSAKKFGKAWVGEIMNS': {'modifications': ['C-Terminal'], 'references': [u'Influence of the angle subtended by the positively charged helix face on the membrane activity of amphipathic, antibacterial peptides. Wieprecht T,Dathe M,Epand RM,Beyermann M,Krause E,Maloy WL,MacDonald DL Biochemistry. 1997 Oct 21;36(42):12869-80.'], 'hemolysis': u'EC25=271\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3586']}, u'FTicOicKTicOicFTicOicKTicKKKKKK': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', 'Non-Natural'], 'references': [u'De novo design of selective antibiotic peptides by incorporation of unnatural amino acids. Hicks RP,Bhonsle JB,Venugopal D,Koser BW J Med Chem. 2007 Jun 28;50(13):3026-36. Epub 2007 Jun 5.'], 'hemolysis': u'33.5% hemolysis at 25\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1786']}, u'RRLMAAKAESRK': {'modifications': [], 'references': [u'Antimicrobial activity and mechanism of action of a novel cationic ?-helical dodecapeptide, a partial sequence of cyanate lyase from rice. Takei N,Takahashi N,Takayanagi T,Ikeda A,Hashimoto K,Takagi M,Hamada T,Saitoh E,Ochiai A,Tanaka T Peptides. 2013 Apr;42:55-62. doi: 10.1016/j.peptides.2012.12.015. Epub 2012 Dec 25.'], 'hemolysis': u'No or little hemolysis upto 800\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3247']}, u'KWKKLLKKLLKLLKKLL': {'modifications': ['C-Terminal'], 'references': [u'Contribution of a central proline in model amphipathic alpha-helical peptides to self-association, interaction with phospholipids, and antimicrobial mode of action. Yang ST,Lee JY,Kim HJ,Eu YJ,Shin SY,Hahm KS FEBS J. 2006 Sep;273(17):4040-54. Epub 2006 Aug 2.'], 'hemolysis': u'~63%  hemolysis at 50\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1707']}, u'KFFKFFKFF': {'modifications': [], 'references': [u'Group of peptides that act synergistically with hydrophobic antibiotics against gram-negative enteric bacteria. Vaara M Antimicrob Agents Chemother. 1996 Aug;40(8):1801-5.'], 'hemolysis': u'Strongly hemolytic at 40\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3661']}, u'GLKKLISWIKRAAQQG': {'modifications': ['C-Terminal'], 'references': [u'Biological activities of C-terminal 15-residue synthetic fragment of melittin: design of an analog with improved antibacterial activity. Subbalakshmi C,Nagaraj R FEBS Lett. 1999 Apr 1;448(1):62-6.'], 'hemolysis': u'100% hemolysis at 110\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3844']}, u'IKIPAVVKDTLKKVAKGVLSAVAGALTQ': {'modifications': [], 'references': [u'The hymenochirins: a family of host-defense peptides from the Congo dwarf clawed frog Hymenochirus boettgeri (Pipidae). Mechkarska M,Prajeep M,Coquet L,Leprince J,Jouenne T,Vaudry H,King JD Peptides. 2012 Jun;35(2):269-75. doi: 10.1016/j.peptides.2012.03.029. Epub 2012 Apr 3.'], 'hemolysis': u'LC50 > 300\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2092']}, u'ALWMTLLKKVLKAAAK': {'modifications': [], 'references': [u'Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity. Feder R,Dagan A J Biol Chem. 2000 Feb 11;275(6):4230-8.'], 'hemolysis': u'LC50 =23\xb11\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1009']}, u'KWKLFKKIPKFLHLAKK': {'modifications': ['C-Terminal'], 'references': [u'Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs. Shin SY,Lee SH,Yang ST,Park EJ,Lee DG,Lee MK,Eom SH,Song WK,Kim Y,Hahm KS J Pept Res. 2001 Dec;58(6):504-14.'], 'hemolysis': u'19.8% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2167']}, u'NGVQPKY': {'modifications': [], 'references': [u'Characterization of the novel antibacterial peptide Leucrocin from crocodile (Crocodylus siamensis) white blood cell extracts. Pata S,Yaraksa N,Daduang S,Temsiripong Y,Svasti J,Araki T Dev Comp Immunol. 2011 May;35(5):545-53. doi: 10.1016/j.dci.2010.12.011. Epub 2010 Dec 22.'], 'hemolysis': u'15.88% hemolysis upto 48.0\u03bcg', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1561']}, u'FRKLFRVYSNFLRGKLKL': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Amphipathic alpha-helices in proteins: results from analysis of protein structures. Sharadadevi A,Sivakamasundari C Proteins. 2005 Jun 1;59(4):791-801.'], 'hemolysis': u'62% hemolysis at 10\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1639']}, u'VRRFAWWWAFLRR': {'modifications': [], 'references': [u'Conformation-dependent antibiotic activity of tritrpticin, a cathelicidin-derived antimicrobial peptide. Yang ST,Yub Shin SY,Kim YC,Kim Y,Hahm KS Biochem Biophys Res Commun. 2002 Sep 6;296(5):1044-50.'], 'hemolysis': u'~ 90% hemolysis at 200\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2209']}, u'LRLEYRRFEYRV': {'modifications': ['Cyclic'], 'references': [u'Macrocyclic hairpin mimetics of the cationic antimicrobial peptide protegrin I: a new family of broad-spectrum antibiotics. Shankaramma SC,Athanassiou Z,Zerbe O,Moehle K,Mouton C,Bernardini F,Vrijbloed JW,Obrecht D Chembiochem. 2002 Nov 4;3(11):1126-33.'], 'hemolysis': u'14% hemolysis at 100\xb5g ml-1', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2273']}, u'yPVKyPKL': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Modulation of structure and antibacterial and hemolytic activity by ring size in cyclic gramicidin S analogs. Kondejewski LH,Farmer SW,Wishart DS,Kay CM,Hancock RE J Biol Chem. 1996 Oct 11;271(41):25261-8.'], 'hemolysis': u'100% hemolysis at >1600\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3665']}, u'KAYSTPRCKYLFRAVLCWL': {'modifications': ['C-Terminal'], 'references': [u'Three novel antimicrobial peptides from the skin of Rana shuchinae. Pei J,Zhao G,Wang B Gene. 2013 Jun 1;521(2):234-7. doi: 10.1016/j.gene.2013.03.054. Epub 2013 Apr 2.'], 'hemolysis': u'1.5% hemolysis at 200\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3749']}, u'LNWGAALKHAAK': {'modifications': ['C-Terminal'], 'references': [u'Panurgines, novel antimicrobial peptides from the venom of communal bee Panurgus calcaratus (Hymenoptera: Andrenidae). Cujova S,Slaninova J,Monincova L,Fucik V,Bednarova L,Stokrova J,Hovorka O,Voburka Z,Straka J Amino Acids. 2013 Jul;45(1):143-57. doi: 10.1007/s00726-013-1482-4. Epub 2013 Mar 13.'], 'hemolysis': u'LC50 >200\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3733']}, u'KWKLFKKIGIGAVLKVLTTG': {'modifications': ['C-Terminal'], 'references': [u'NMR structural characterization of cecropin A(1-8) - magainin 2(1-12) and cecropin A (1-8) - melittin (1-12) hybrid peptides. Oh D,Shin SY,Kang JH,Hahm KS,Kim KL J Pept Res. 1999 May;53(5):578-89.'], 'hemolysis': u'15.5% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3868']}, u'KKLFKKILKyL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Improvement of the efficacy of linear undecapeptides against plant-pathogenic bacteria by incorporation of D-amino acids. Guell I,Cabrefiga J,Badosa E,Ferre R,Talleda M,Bardaji E,Planas M,Feliu L Appl Environ Microbiol. 2011 Apr;77(8):2667-75. doi: 10.1128/AEM.02759-10. Epub 2011 Feb 18.'], 'hemolysis': u'7 \xb10.1% hemolytic at 250\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2848']}, u'FLPIVGRLISGLL': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial peptides and protease inhibitors in the skin secretions of the crawfish frog, Rana areolata. Ali, Mohamed ,Ali MF,Lips KR,Knoop FC,Fritzsch B,Miller C Biochim Biophys Acta. 2002 Nov 19;1601(1):55-63.'], 'hemolysis': u'HC50 = 210\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2483']}, u'FLPLILRKIVTAL': {'modifications': ['C-Terminal'], 'references': [u'Anoplin, a novel antimicrobial peptide from the venom of the solitary wasp Anoplius samariensis. Konno K,Hisada M,Fontana R,Lorenzi CC,Naoki H,Itagaki Y,Miwa A,Kawai N,Nakata Y,Yasuhara T,Ruggiero Neto J,de Azevedo WF Jr,Palma MS Biochim Biophys Acta. 2001 Nov 26;1550(1):70-80.'], 'hemolysis': u'No hemolysis (non hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3475']}, u'FLPILAGLAAKIVPKLFCLATKKC': {'modifications': [], 'references': [u'Peptide defenses of the Cascades frog Rana cascadae: implications for the evolutionary history of frogs of the Amerana species group. Conlon JM,Al-Dhaheri A,Al-Mutawa E,Al-Kharrge R,Ahmed E,Kolodziejek J,Nowotny N, Nielsen, Per ,Nielsen PF Peptides. 2007 Jun;28(6):1268-74. Epub 2007 Mar 27.'], 'hemolysis': u'LD50 =5\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1129']}, u'AibGLAibGGLAibGILOL': {'modifications': [u'C-Terminal Non-Amidation: 1,2-aminoalcohol, Lol (leucinol)', u'N-Terminal Modification: Acetylated by lipol (n-octanoyl)', 'Non-Natural'], 'references': [u'Trichogin GA IV: an antibacterial and protease-resistant peptide. De Zotti M,Biondi B,Formaggio F,Toniolo C,Stella L,Park Y J Pept Sci. 2009 Sep;15(9):615-9. doi: 10.1002/psc.1135.'], 'hemolysis': u'2% hemolysis at 15 \u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1292']}, u'WW': {'modifications': ['C-Terminal', u'N-Terminal Modification: pHCA= Hydroxy cinnamic acid', 'Non-Natural'], 'references': [u'Antimicrobial activity of rationally designed amino terminal modified peptides. Bisht GS,Rawat DS,Kumar A,Kumar R Bioorg Med Chem Lett. 2007 Aug 1;17(15):4343-6. Epub 2007 May 13.'], 'hemolysis': u'No hemolysis at 1000\xb5g/ml (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1924']}, u'LLKWLLKWLLK': {'modifications': ['C-Terminal'], 'references': [u'De novo generation of short antimicrobial peptides with simple amino acid composition. Lee SH,Kim SJ,Lee YS,Song MD,Kim IH Regul Pept. 2011 Jan 17;166(1-3):36-41. doi: 10.1016/j.regpep.2010.08.010. Epub 2010 Aug 22.'], 'hemolysis': u'70-75% hemolysis at 160\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3115']}, u'LLKWLKK': {'modifications': ['C-Terminal'], 'references': [u'De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface. Kang SJ,Won HS,Choi WS J Pept Sci. 2009 Sep;15(9):583-8. doi: 10.1002/psc.1149.'], 'hemolysis': u'4.78% Hmolysis at 6.3\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1387']}, u'KWKSFLKTFKSlKKTVLHTLLKAISS': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', u'Stereochemistry: Mix'], 'references': [u'Role of helicity on the anticancer mechanism of action of cationic-helical peptides. Huang YB,He LY,Jiang HY Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849. Epub 2012 Jun 5.'], 'hemolysis': u'MHC =20.81 \xb1 0.03\u03bcmol/L', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2645']}, u'NIWKKIASIAKEVLKAL': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 =32\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3934']}, u'HFLLTLVNLKKKIL': {'modifications': ['C-Terminal'], 'references': [u'Strategies for transformation of naturally-occurring amphibian antimicrobial peptides into therapeutically valuable anti-infective agents. Conlon JM,Al-Ghaferi N,Abraham B Methods. 2007 Aug;42(4):349-57.'], 'hemolysis': u'LD50 = 500\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1801']}, u'KLLKWLLK': {'modifications': ['C-Terminal'], 'references': [u'De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface. Kang SJ,Won HS,Choi WS J Pept Sci. 2009 Sep;15(9):583-8. doi: 10.1002/psc.1149.'], 'hemolysis': u'5.47% hemolysis at 63\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1405']}, u'FLPKMSTKLRVPYRRGTKDYH': {'modifications': [], 'references': [u'Two novel antimicrobial peptides from centipede venoms. Peng K,Kong Y,Zhai L,Wu X,Jia P,Liu J Toxicon. 2010 Feb-Mar;55(2-3):274-9. doi: 10.1016/j.toxicon.2009.07.040. Epub 2009 Aug 28.'], 'hemolysis': u'21\xb15% hemolysis at 50\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3709']}, u'KFLGTLVNLAKKIL': {'modifications': ['C-Terminal'], 'references': [u'Strategies for transformation of naturally-occurring amphibian antimicrobial peptides into therapeutically valuable anti-infective agents. Conlon JM,Al-Ghaferi N,Abraham B Methods. 2007 Aug;42(4):349-57.'], 'hemolysis': u'LD50 = 500\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1792']}, u'MFTSKKSMLLLFFLGMISMSLCQDERGADEDDGGEMTEEEKRGAFGDLLKGVAKEAGMKLLNMAQCKLSGKC': {'modifications': [], 'references': [u'Molecular cloning and characterization of antimicrobial peptides from skin of the broad-folded frog, Hylarana latouchii. Wang H,Yu Z,Hu Y,Yu H,Ran R,Xia J,Wang D,Yang S,Yang X Biochimie. 2012 Jun;94(6):1317-26. doi: 10.1016/j.biochi.2012.02.032. Epub 2012 Mar 8.'], 'hemolysis': u'LD50 = 520\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2076']}, u'KWKSFLKTFKSLKKTVLHTALKLISS': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides. Chen Y,Guarnieri MT,Vasil AI,Vasil ML,Mant CT Antimicrob Agents Chemother. 2007 Apr;51(4):1398-406. Epub 2006 Dec 11.'], 'hemolysis': u'MHC =15.6\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1088']}, u'SIITMTKEAKLPQSWKQIACRLYNTC': {'modifications': ['Cyclic'], 'references': [u'A new family of antimicrobial peptides from skin secretions of Rana pleuraden. Wang X,Song Y,Li J,Liu H,Xu X,Lai R Peptides. 2007 Oct;28(10):2069-74. Epub 2007 Jul 22.'], 'hemolysis': u'Little hemolysis at 200mg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3639']}, u'GIMSIVKDVAKNAAKEAAKGALSTLSCKLAKTC': {'modifications': [], 'references': [u'Antimicrobial peptides from the skin of a Korean frog, Rana rugosa. Park JM,Jung JE Biochem Biophys Res Commun. 1994 Nov 30;205(1):948-54.'], 'hemolysis': u'0.82% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3700']}, u'KWKSFINKLTSKFLHSAKKF': {'modifications': ['C-Terminal'], 'references': [u'The Design and Construction of K11: A Novel ?-Helical Antimicrobial Peptide. Jin-Jiang H,Jin-Chun L,Min L,Qing-Shan H Int J Microbiol. 2012;2012:764834. doi: 10.1155/2012/764834. Epub 2012 Feb 16.'], 'hemolysis': u'MHC  >500\u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2720']}, u'FLHFLHHLF': {'modifications': [], 'references': [u'Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus. Hong W,Zhang R,Di Z,He Y,Zhao Z,Hu J,Wu Y,Li W Biomaterials. 2013 Apr;34(13):3511-22. doi: 10.1016/j.biomaterials.2013.01.075. Epub 2013 Feb 13.'], 'hemolysis': u'HC50 =416.4\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3260']}, u'FALLGDFFRKSKEKIGKEFKRIVQRIKDFFRNLVPRTES': {'modifications': [], 'references': [u'PCR-based site-specific mutagenesis of peptide antibiotics FALL-39 and its biologic activities. Yang YX,Feng Y,Wang BY Acta Pharmacol Sin. 2004 Feb;25(2):239-45.'], 'hemolysis': u'>30% hemolysis at 400g/l', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1579']}, u'LKLKSIVSFAKKVL': {'modifications': ['C-Terminal'], 'references': [u'Structural requirements for the edema-inducing and hemolytic activities of mastoparan B isolated from the hornet (Vespa basalis) venom. Ho CL,Lin YL,Chen WC,Hwang LL,Yu HM Toxicon. 1996 Sep;34(9):1027-35.'], 'hemolysis': u'~3% hemolysis at 20\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3508']}, u'KWKKLLKKLaKLLKKLLK': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues. Song YM,Park Y,Lim SS,Yang ST,Woo ER,Park IS,Lee JS,Kim JI,Hahm KS,Kim Y Biochemistry. 2005 Sep 13;44(36):12094-106.'], 'hemolysis': u'10-15% hemolysis at 50\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1655']}, u'RCYCRRRFCVCVGR': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'12-25% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1170']}, u'KWKSFlKTFKSLKKTVLHTLLKAISS': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', u'Stereochemistry: Mix'], 'references': [u'Role of helicity on the anticancer mechanism of action of cationic-helical peptides. Huang YB,He LY,Jiang HY Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849. Epub 2012 Jun 5.'], 'hemolysis': u'MHC =10.40 \xb1 0.08\u03bcmol/L', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2644']}, u'LCYCRRRFCTCV': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'0-3% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1218']}, u'IIGPVLGLVGSALGGLLKKI': {'modifications': ['C-Terminal'], 'references': [u'Antibacterial and haemolytic peptides containing D-alloisoleucine from the skin of Bombina variegata. Mignogna G,Simmaco M,Kreil G EMBO J. 1993 Dec;12(12):4829-32.'], 'hemolysis': u'Lethal concentration =17.0\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3559']}, u'FGVLAKVAAHVVPAIAEHF': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship of an antibacterial peptide, maculatin 1.1, from the skin glands of the tree frog, Litoria genimaculata. Niidome T,Kobayashi K,Arakawa H,Hatakeyama T J Pept Sci. 2004 Jul;10(7):414-22.'], 'hemolysis': u'0% hemolysis upto 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4191']}, u'ACPCLAPCKAPCLACPCKAPCLACPCLACPCLACPC': {'modifications': ['C-Terminal', 'Cyclic', 'Non-Natural'], 'references': [u'Interplay among folding, sequence, and lipophilicity in the antibacterial and hemolytic activities of alpha/beta-peptides. Schmitt MA,Weisblum B J Am Chem Soc. 2007 Jan 17;129(2):417-28.'], 'hemolysis': u'>10% hemolysis at 100 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1093']}, u'KKKKKKALFALWLAFAA': {'modifications': ['C-Terminal', 'Cyclic'], 'references': [u'Membrane interactions of designed cationic antimicrobial peptides: the two thresholds. Glukhov E,Burrows LL Biopolymers. 2008 May;89(5):360-71. doi: 10.1002/bip.20917.'], 'hemolysis': u'MHC  <<81\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1153']}, u'CYCRRRFCVC': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'0-3% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1189']}, u'INWLKLGKMVIDAL': {'modifications': ['C-Terminal'], 'references': [u'Mass spectrometric characterization of two novel inflammatory peptides from the venom of the social wasp Polybia paulista. de Souza BM,Marques MR,Tomazela DM,Eberlin MN,Mendes MA Rapid Commun Mass Spectrom. 2004;18(10):1095-102.'], 'hemolysis': u'100% hemolysis at 6.2x10-5 M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1596']}, u'RRWPLLPWKWPLI': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship of indolicidin, a Trp-rich antibacterial peptide. Ando S,Mitsuyasu K,Soeda Y,Hidaka M,Ito Y,Matsubara K,Shindo M,Uchida Y J Pept Sci. 2010 Apr;16(4):171-7. doi: 10.1002/psc.1217.'], 'hemolysis': u'11% hemolysis at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1491']}, u'LRLKYRRFKYRV': {'modifications': ['Cyclic'], 'references': [u'Macrocyclic hairpin mimetics of the cationic antimicrobial peptide protegrin I: a new family of broad-spectrum antibiotics. Shankaramma SC,Athanassiou Z,Zerbe O,Moehle K,Mouton C,Bernardini F,Vrijbloed JW,Obrecht D Chembiochem. 2002 Nov 4;3(11):1126-33.'], 'hemolysis': u'27% hemolysis at 100\xb5g ml-1', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2271']}, u'SWLRDIWDWLCELLSDFK': {'modifications': [], 'references': [u'Rational design of peptides with anti-HCV/HIV activities and enhanced specificity. Li GR,He LY,Liu XY,Liu AP,Huang YB,Qiu C,Zhang XY,Xu JQ,Yang W Chem Biol Drug Des. 2011 Nov;78(5):835-43. doi: 10.1111/j.1747-0285.2011.01201.x. Epub 2011 Sep 26.'], 'hemolysis': u'MHC = 3.44\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2951']}, u'GIGKFLHTLKTFGKKWVGEIMNS': {'modifications': ['C-Terminal'], 'references': [u'Influence of the angle subtended by the positively charged helix face on the membrane activity of amphipathic, antibacterial peptides. Wieprecht T,Dathe M,Epand RM,Beyermann M,Krause E,Maloy WL,MacDonald DL Biochemistry. 1997 Oct 21;36(42):12869-80.'], 'hemolysis': u'EC25=15\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3587']}, u'VKLVyPLKVKLyP': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Effects of single D-amino acid substitutions on disruption of beta-sheet structure and hydrophobicity in cyclic 14-residue antimicrobial peptide analogs related to gramicidin S. Lee DL,Powers JP,Pflegerl K,Vasil ML,Hancock RE J Pept Res. 2004 Feb;63(2):69-84.'], 'hemolysis': u'MHC =3 \xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4162']}, u'GWKSVFRKAKKVGKTVGGLALDHYL': {'modifications': ['C-Terminal'], 'references': [u'The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents. Morash MG,Douglas SE,Robotham A,Ridley CM,Gallant JW Dis Model Mech. 2011 Sep;4(5):622-33. doi: 10.1242/dmm.007310. Epub 2011 Jul 4.'], 'hemolysis': u'50% hemolytic at >256 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2926']}, u'ALALLOHALHOLALLAOHLAHOLALA': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Structural determinants of antimicrobial and antiplasmodial activity and selectivity in histidine-rich amphipathic cationic peptides. Mason AJ,Moussaoui W,Abdelrahman T,Boukhari A,Bertani P,Marquette A,Shooshtarizaheh P,Moulay G,Boehm N,Guerold B,Sawers RJ,Kichler A,Metz-Boutigue MH,Candolfi E,Prevost G J Biol Chem. 2009 Jan 2;284(1):119-33. doi: 10.1074/jbc.M806201200. Epub 2008 Nov 4.'], 'hemolysis': u'HC50 <5.6\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3571']}, u'KWKLFKKIEKVGQGIGAVLKVLTTGL': {'modifications': ['C-Terminal'], 'references': [u'Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids. Boman HG,Wade D,Boman IA,Wahlin B FEBS Lett. 1989 Dec 18;259(1):103-6.'], 'hemolysis': u'Lethal concentration calculated from zone of inhibition  >200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3561']}, u'QKKIRVRLSA': {'modifications': [], 'references': [u'Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification. Pini A,Giuliani A,Falciani C,Runci Y,Ricci C,Lelli B,Malossi M,Neri P,Rossolini GM Antimicrob Agents Chemother. 2005 Jul;49(7):2665-72.'], 'hemolysis': u'<1% hemolysis at 120\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1896']}, u'KLKKlLKKWlKLLKkLLK': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich alpha-helical model antimicrobial peptide and its diastereomeric peptides. Wang P,Nan YH,Yang ST,Kang SW,Kim Y,Park IS,Hahm KS Peptides. 2010 Jul;31(7):1251-61. doi: 10.1016/j.peptides.2010.03.032. Epub 2010 Apr 2.'], 'hemolysis': u'HC50 =116\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3056']}, u'KNIGNSVSCLRNKGVCMPGKCAPKMKQIGTCGMPQVKCCKRK': {'modifications': [], 'references': [u'Cloning, expression and characterization of antimicrobial porcine ? defensin 1 in Escherichia coli. Li CL,Xu TT,Chen RB,Huang XX,Zhao YC,Bao YY,Zhao WD Protein Expr Purif. 2013 Mar;88(1):47-53. doi: 10.1016/j.pep.2012.11.015. Epub 2012 Dec 7.'], 'hemolysis': u'<11% hemolytic from 0\u2013100\u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2612']}, u'GFFALIAQIISSPLFQTL': {'modifications': ['C-Terminal'], 'references': [u'Specific antimicrobial and hemolytic activities of 18-residue peptides derived from the amino terminal region of the toxin pardaxin. Thennarasu S Protein Eng. 1996 Dec;9(12):1219-24.'], 'hemolysis': u'100% hemolysis at 56\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3792']}, u'RLKELITTGGQKIGEKIRRIGQRIKDFFKNLQPREEKS': {'modifications': [], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC >100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3949']}, u'KKllKKLkKlLK': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation (CH3(CH2)6CO)', u'Stereochemistry: Mix'], 'references': [u'Effect of the hydrophobicity to net positive charge ratio on antibacterial and anti-endotoxin activities of structurally similar antimicrobial peptides. Rosenfeld Y,Lev N Biochemistry. 2010 Feb 9;49(5):853-61. doi: 10.1021/bi900724x.'], 'hemolysis': u'0% hemolytic at 100\u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2782']}, u'FKIKASKVLDKFGKIVGKVLKQLKKVSAVAKV': {'modifications': [], 'references': [u'Lytic activity and structural differences of amphipathic peptides derived from trialysin. Martins RM,Sforca ML,Amino R,Juliano MA,Oyama S Jr,Juliano L,Pertinhez TA,Spisni A Biochemistry. 2006 Feb 14;45(6):1765-74.'], 'hemolysis': u'LD50=12.6\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4192']}, u'MIRIAMKALNCFKVSGLKCWSFNSPRGQESPCPG': {'modifications': [], 'references': [u'Correlation of charge, hydrophobicity, and structure with antimicrobial activity of S1 and MIRIAM peptides. Leptihn S,Har JY,Wohland T Biochemistry. 2010 Nov 2;49(43):9161-70. doi: 10.1021/bi1011578.'], 'hemolysis': u'25% hemolysis at 100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1538']}, u'GFKDLLKGAAKALVKTVLF': {'modifications': ['C-Terminal'], 'references': [u'Activities of the frog skin peptide, ascaphin-8 and its lysine-substituted analogs against clinical isolates of extended-spectrum beta-lactamase (ESBL) producing bacteria. Eley A,Ibrahim M,Kurdi SE Peptides. 2008 Jan;29(1):25-30. Epub 2007 Nov 9.'], 'hemolysis': u'LC50 =55\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2548']}, u'LNWKAILKHIIK': {'modifications': ['C-Terminal'], 'references': [u'Panurgines, novel antimicrobial peptides from the venom of communal bee Panurgus calcaratus (Hymenoptera: Andrenidae). Cujova S,Slaninova J,Monincova L,Fucik V,Bednarova L,Stokrova J,Hovorka O,Voburka Z,Straka J Amino Acids. 2013 Jul;45(1):143-57. doi: 10.1007/s00726-013-1482-4. Epub 2013 Mar 13.'], 'hemolysis': u'LC50 ~110\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3722']}, u'KLLLKLLKLLLKLLLKLLK': {'modifications': [u'C-Terminal Non-Amidation: Dansylation'], 'references': [u'The amphipathic alpha-helix concept. Application to the de novo design of ideally amphipathic Leu, Lys peptides with hemolytic activity higher than that of melittin. Cornut I,Buttner K,Dasseux JL FEBS Lett. 1994 Jul 25;349(1):29-33.'], 'hemolysis': u'LD50 ~2.1\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3687']}, u'LNWGALLKHLLK': {'modifications': ['C-Terminal'], 'references': [u'Panurgines, novel antimicrobial peptides from the venom of communal bee Panurgus calcaratus (Hymenoptera: Andrenidae). Cujova S,Slaninova J,Monincova L,Fucik V,Bednarova L,Stokrova J,Hovorka O,Voburka Z,Straka J Amino Acids. 2013 Jul;45(1):143-57. doi: 10.1007/s00726-013-1482-4. Epub 2013 Mar 13.'], 'hemolysis': u'LC50 =63\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3736']}, u'INLKALAALAKALL': {'modifications': ['C-Terminal'], 'references': [u'Cell-penetrating peptides: a comparative membrane toxicity study. Saar K,Lindgren M,Hansen M,Eiriksdottir E,Jiang Y,Rosenthal-Aizman K,Sassian M Anal Biochem. 2005 Oct 1;345(1):55-65.'], 'hemolysis': u'100 % hemolysis at 25 \xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4149']}, u'GRILSFIKGLAEHL': {'modifications': ['C-Terminal'], 'references': [u'Venom peptides from solitary hunting wasps induce feeding disorder in lepidopteran larvae. Baek JH,Ji Y,Shin JS,Lee S Peptides. 2011 Mar;32(3):568-72. doi: 10.1016/j.peptides.2010.12.007. Epub 2010 Dec 22.'], 'hemolysis': u'Non-hemolytic', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2055']}, u'IFGAIWNGIKSLF': {'modifications': ['C-Terminal'], 'references': [u'Three new antimicrobial peptides from the scorpion Pandinus imperator. Zeng XC,Zhou L,Shi W,Luo X,Zhang L,Nie Y,Wang J,Wu S,Cao B Peptides. 2013 Jul;45:28-34. doi: 10.1016/j.peptides.2013.03.026. Epub 2013 Apr 23.'], 'hemolysis': u'100% hemolysis at 64\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3273']}, u'KVFKRLEKLFSKIQNDK': {'modifications': [], 'references': [u'Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions. Park SC,Kim MH,Hossain MA,Shin SY,Kim Y,Stella L,Wade JD,Park Y Biochim Biophys Acta. 2008 Jan;1778(1):229-41. Epub 2007 Oct 2.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1926']}, u'HFLLTLVNLAKKKL': {'modifications': ['C-Terminal'], 'references': [u'Strategies for transformation of naturally-occurring amphibian antimicrobial peptides into therapeutically valuable anti-infective agents. Conlon JM,Al-Ghaferi N,Abraham B Methods. 2007 Aug;42(4):349-57.'], 'hemolysis': u'LD50 = 500\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1802']}, u'ILPLKWPWWPWRR': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship of indolicidin, a Trp-rich antibacterial peptide. Ando S,Mitsuyasu K,Soeda Y,Hidaka M,Ito Y,Matsubara K,Shindo M,Uchida Y J Pept Sci. 2010 Apr;16(4):171-7. doi: 10.1002/psc.1217.'], 'hemolysis': u'73% hemolysis at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1471']}, u'HFLLTLVNKAKKIL': {'modifications': ['C-Terminal'], 'references': [u'Strategies for transformation of naturally-occurring amphibian antimicrobial peptides into therapeutically valuable anti-infective agents. Conlon JM,Al-Ghaferi N,Abraham B Methods. 2007 Aug;42(4):349-57.'], 'hemolysis': u'LD50 = 500\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1800']}, u'GWKDWAKKAGGWLKKKGPGMAKAALKAAMQ': {'modifications': [], 'references': [u'Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii. Orivel J,Redeker V,Le Caer JP, Krier, ,Krier F,Revol-Junelles AM,Longeon A,Chaffotte A,Dejean A J Biol Chem. 2001 May 25;276(21):17823-9. Epub 2001 Feb 22.'], 'hemolysis': u'zone of inhibition not detected at 0.4-0.5mM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2122']}, u'KfKQ': {'modifications': ['Cyclic', u'Stereochemistry: D'], 'references': [u'De novo designed cyclic cationic peptides as inhibitors of plant pathogenic bacteria. Monroc S,Badosa E,Feliu L,Planas M,Montesinos E Peptides. 2006 Nov;27(11):2567-74. Epub 2006 May 30.'], 'hemolysis': u'0% hemolysis at 360\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1907']}, u'QKAVLDCLKAAGSSLSKAAITAI': {'modifications': [], 'references': [u'Dicynthaurin: an antimicrobial peptide from hemocytes of the solitary tunicate, Halocynthia aurantium. Lee IH,Lee YS,Kim CH,Kim CR,Hong T,Menzel L,Boo LM,Pohl J,Sherman MA,Waring A Biochim Biophys Acta. 2001 Aug 15;1527(3):141-8.'], 'hemolysis': u'0% hemolysis at 100\u03bcg/ml (non hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3532']}, u'FVPWFSkFLGRIL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'The effect of d-amino acid substitution on the selectivity of temporin L towards target cells: identification of a potent anti-Candida peptide. Grieco P,Carotenuto A,Auriemma L,Saviello MR,Campiglia P,Gomez-Monterrey IM,Marcellini L,Luca V,Barra D,Novellino E Biochim Biophys Acta. 2013 Feb;1828(2):652-60. doi: 10.1016/j.bbamem.2012.08.027. Epub 2012 Sep 10.'], 'hemolysis': u'2% hemolysis at 1.5\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3205']}, u'FKRLKKLFKKIWNWK': {'modifications': [], 'references': [u'Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions. Park SC,Kim MH,Hossain MA,Shin SY,Kim Y,Stella L,Wade JD,Park Y Biochim Biophys Acta. 2008 Jan;1778(1):229-41. Epub 2007 Oct 2.'], 'hemolysis': u'11.62% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1823']}, u'GFMKYIKPLIPHAVKAISKLI': {'modifications': [], 'references': [u'Antimicrobial and cytolytic properties of the frog skin peptide, kassinatuerin-1 and its L- and D-lysine-substituted derivatives. Conlon JM,Abraham B,Galadari S,Knoop FC,Sonnevend A Peptides. 2005 Nov;26(11):2104-10.'], 'hemolysis': u'LD50 =135\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4080']}, u'MAFKKLEKVGRNIRDGIIKAGPAVAVIGQATSIARPTGK': {'modifications': [], 'references': [u'cDNA cloning and characterization of the antibacterial peptide cecropin 1 from the diamondback moth, Plutella xylostella L. Jin F,Sun Q,Xu X,Li L,Gao G,Xu Y,Yu X Protein Expr Purif. 2012 Oct;85(2):230-8. doi: 10.1016/j.pep.2012.08.006. Epub 2012 Aug 17.'], 'hemolysis': u'Non-hemolytic', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2620']}, u'LRRLWLRANRL': {'modifications': [], 'references': [u'Rational design of cationic antimicrobial peptides by the tandem of leucine-rich repeat. Ma QQ, Lv, Y ,Lv YF,Gu Y,Dong N,Li DS Amino Acids. 2013 Apr;44(4):1215-24. doi: 10.1007/s00726-012-1457-x. Epub 2013 Feb 22.'], 'hemolysis': u'0% hemolysis at 128\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2068']}, u'CTCSWPVCTRNGLPVCGETCVGGTCNTPG': {'modifications': ['Cyclic'], 'references': [u'An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides. Tam JP,Lu YA,Yang JL Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):8913-8.'], 'hemolysis': u'50% hemolysis at >400\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3396']}, u'KKKKKKALFALWLAFLA': {'modifications': ['C-Terminal', 'Cyclic'], 'references': [u'Membrane interactions of designed cationic antimicrobial peptides: the two thresholds. Glukhov E,Burrows LL Biopolymers. 2008 May;89(5):360-71. doi: 10.1002/bip.20917.'], 'hemolysis': u'MHC <<81\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1155']}, u'ZSRRLOYKQRDVTYSRGR': {'modifications': ['C-Terminal', 'Cyclic', 'Non-Natural'], 'references': [u'Structure-activity relationship studies of gomesin: importance of the disulfide bridges for conformation, bioactivities, and serum stability. Fazio MA,Oliveira VX Jr,Bulet P,Miranda MT,Daffre S Biopolymers. 2006;84(2):205-18.'], 'hemolysis': u'<10% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4199']}, u'KKKKKKKKKKGIGKFLHSAKKFGKAFVGEIMNS': {'modifications': [], 'references': [u'Augmentation of the antibacterial activity of magainin by positive-charge chain extension. Bessalle R,Haas H,Goria A,Shalit I Antimicrob Agents Chemother. 1992 Feb;36(2):313-7.'], 'hemolysis': u'0% hemolysis upto 200\u03bcg/ml (non hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3434']}, u'KWKSFLKTFKSPARTVLYTALKPISS': {'modifications': [], 'references': [u'Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides. Zhang L,Benz R Biochemistry. 1999 Jun 22;38(25):8102-11.'], 'hemolysis': u'MHC >128\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3597']}, u'RWRSFFKKAAHRGKHVGKRARTHYL': {'modifications': ['C-Terminal'], 'references': [u'Pleurocidin-derived antifungal peptides with selective membrane-disruption effect. Sung WS Biochem Biophys Res Commun. 2008 May 9;369(3):858-61. doi: 10.1016/j.bbrc.2008.02.109. Epub 2008 Mar 4.'], 'hemolysis': u'0% hemolytic at 100\u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2546']}, u'VDIHVWaGV': {'modifications': [u'Stereochemistry: Mix'], 'references': [u'Therapeutic potential of peptides with neutralizing ability towards the venom and toxin (CaTx-I) of crotalus adamanteus. Samy RP,Thwin MM,Stiles BG,Bow H,Chow VT Curr Top Med Chem. 2011;11(20):2540-55.'], 'hemolysis': u'7.5% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3146']}, u'GKGALKKFLAKKVAKTVAKQAAKQGAKYVVNKQME': {'modifications': ['C-Terminal'], 'references': [u'N-terminal aromatic residues closely impact the cytolytic activity of cupiennin 1a, a major spider venom peptide. Kuhn-Nentwig L,Sheynis T,Kolusheva S,Nentwig W Toxicon. 2013 Mar 21. pii: S0041-0101(13)00089-5. doi: 10.1016/j.toxicon.2013.03.003.'], 'hemolysis': u'EC50 >40\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3263']}, u'LKLKSIVSWAkkVL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Enhancing the hypotensive effect and diminishing the cytolytic activity of hornet mastoparan B by D-amino acid substitution. Ho CL,Shih YP,Wang KT Toxicon. 2001 Oct;39(10):1561-6.'], 'hemolysis': u'89-85% hemolysis at 15 \xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1982']}, u'KWKLFKKIPLHLAKKF': {'modifications': ['C-Terminal'], 'references': [u'Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs. Shin SY,Lee SH,Yang ST,Park EJ,Lee DG,Lee MK,Eom SH,Song WK,Kim Y,Hahm KS J Pept Res. 2001 Dec;58(6):504-14.'], 'hemolysis': u'4.7% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2168']}, u'KWKKLLKKPLKLLKKLL': {'modifications': ['C-Terminal'], 'references': [u'Contribution of a central proline in model amphipathic alpha-helical peptides to self-association, interaction with phospholipids, and antimicrobial mode of action. Yang ST,Lee JY,Kim HJ,Eu YJ,Shin SY,Hahm KS FEBS J. 2006 Sep;273(17):4040-54. Epub 2006 Aug 2.'], 'hemolysis': u'4% hemolysis at 50\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1708']}, u'KNWKGIAGMAKKLLGKNWELMKK': {'modifications': [], 'references': [u'Design of a novel membrane-destabilizing peptide selectively acting on acidic liposomes. Machida S,Niimi S,Shi X,Ando Y Biosci Biotechnol Biochem. 2000 May;64(5):985-94.'], 'hemolysis': u'7.2% hemolytic at 10\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2529']}, u'KLLKLLLKLWLKLLKLLL': {'modifications': [], 'references': [u'Design and synthesis of amphiphilic alpha-helical model peptides with systematically varied hydrophobic-hydrophilic balance and their interaction with lipid- and bio-membranes. Kiyota T,Lee S Biochemistry. 1996 Oct 8;35(40):13196-204.'], 'hemolysis': u'100% hemolysis at 1\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3473']}, u'ALWKTLLKKVLKAAA': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity. Feder R,Dagan A J Biol Chem. 2000 Feb 11;275(6):4230-8.'], 'hemolysis': u'LC50 =20\xb11\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1017']}, u'FLSTIWNGIKSLL': {'modifications': ['C-Terminal'], 'references': [u'Three new antimicrobial peptides from the scorpion Pandinus imperator. Zeng XC,Zhou L,Shi W,Luo X,Zhang L,Nie Y,Wang J,Wu S,Cao B Peptides. 2013 Jul;45:28-34. doi: 10.1016/j.peptides.2013.03.026. Epub 2013 Apr 23.'], 'hemolysis': u'100% hemolysis at 32\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3272']}, u'GIWGTALKWGVKLLPKLVGMAQTKKQ': {'modifications': [], 'references': [u'Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii. Orivel J,Redeker V,Le Caer JP, Krier, ,Krier F,Revol-Junelles AM,Longeon A,Chaffotte A,Dejean A J Biol Chem. 2001 May 25;276(21):17823-9. Epub 2001 Feb 22.'], 'hemolysis': u'zone of inhibition not detected at 0.4-0.5mM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2116']}, u'RGGRLCYCRRRFCVC': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'3-6% hemolysis at 80\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1181']}, u'GRFKRFRKKFKKLFKKLSPVIPLLHLG': {'modifications': [], 'references': [u'Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities. Skerlavaj B,Gennaro R,Bagella L,Merluzzi L,Risso A J Biol Chem. 1996 Nov 8;271(45):28375-81.'], 'hemolysis': u'22% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3990']}, u'KKKKKKAAFLAWALFAA': {'modifications': ['C-Terminal', 'Cyclic'], 'references': [u'Membrane interactions of designed cationic antimicrobial peptides: the two thresholds. Glukhov E,Burrows LL Biopolymers. 2008 May;89(5):360-71. doi: 10.1002/bip.20917.'], 'hemolysis': u'MHC <81\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1149']}, u'GLLSGILGAGKQKVCGLSGLC': {'modifications': [], 'references': [u'Anti-infection peptidomics of amphibian skin. Li J,Xu X,Xu C,Zhou W,Zhang K,Yu H,Zhang Y,Zheng Y,Rees HH,Lai R,Yang D Mol Cell Proteomics. 2007 May;6(5):882-94. Epub 2007 Jan 31.'], 'hemolysis': u'87.2\xb12.6% hemolysis at 50\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3652']}, u'IAWLKLGKGILGAL': {'modifications': ['C-Terminal'], 'references': [u'Novel biologically active peptides from the venom of Polistes rothneyi iwatai. Murata K,Shinada T,Ohfune Y,Hisada M,Yasuda A,Naoki H Biol Pharm Bull. 2006 Dec;29(12):2493-7.'], 'hemolysis': u'36 % of hemolysis at 50mM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1730']}, u'GVPCGESCVFIPCITGVIGCSCSSNVCYLN': {'modifications': ['Cyclic'], 'references': [u'Anti-HIV cyclotides from the Chinese medicinal herb Viola yedoensis. Wang CK,Colgrave ML,Gustafson KR,Ireland DC,Goransson U J Nat Prod. 2008 Jan;71(1):47-52. Epub 2007 Dec 15.'], 'hemolysis': u'HD50 =9.3\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1028']}, u'FTicOicKTicOicFTicOicKTicKKKK': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', 'Non-Natural'], 'references': [u'De novo design of selective antibiotic peptides by incorporation of unnatural amino acids. Hicks RP,Bhonsle JB,Venugopal D,Koser BW J Med Chem. 2007 Jun 28;50(13):3026-36. Epub 2007 Jun 5.'], 'hemolysis': u'50% hemolysis at 25\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1766']}, u'ILPWKWPWWPWRR': {'modifications': ['C-Terminal'], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC =25\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3947']}, u'AQDIISTIGDLVKWIIDTVNKFTKK': {'modifications': [], 'references': [u'Conformation and activity of delta-lysin and its analogs. Dhople VM Peptides. 2005 Feb;26(2):217-25.'], 'hemolysis': u'>75% hemolysis at 30\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1628']}, u'LKKLLKWLLKLLK': {'modifications': ['C-Terminal'], 'references': [u'De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface. Kang SJ,Won HS,Choi WS J Pept Sci. 2009 Sep;15(9):583-8. doi: 10.1002/psc.1149.'], 'hemolysis': u'5.07% hemolysis at 6.3\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1435']}, u'XNHGVATQLLAAYILLFDEYNEKKASAQKDILIKVL': {'modifications': ['C-Terminal', u'N-Terminal Modification: X=H, NBD, Rhodamine'], 'references': [u'A peptide derived from the putative transmembrane domain in the tail region of E. coli toxin hemolysin E assembles in phospholipid membrane and exhibits lytic activity to human red blood cells: plausible implications in the toxic activity of the protein. Yadav SP,Ahmad A,Pandey BK,Singh D,Asthana N,Verma R,Tripathi RK Biochim Biophys Acta. 2009 Feb;1788(2):538-50. doi: 10.1016/j.bbamem.2008.11.013. Epub 2008 Nov 28.'], 'hemolysis': u'50% hemolysis at ~0.72\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4166']}, u'KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK': {'modifications': [], 'references': [u'Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides. Yasin B,Pang M,Turner JS,Cho Y,Dinh NN,Waring AJ,Lehrer RI Eur J Clin Microbiol Infect Dis. 2000 Mar;19(3):187-94.'], 'hemolysis': u'0.6% hemolysis at 80\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2445']}, u'KFAKKFKWFAKAAFKFFKK': {'modifications': ['C-Terminal'], 'references': [u'Design of a novel tryptophan-rich membrane-active antimicrobial peptide from the membrane-proximal region of the HIV glycoprotein, gp41. Haney, Evan ,Haney EF,Nguyen LT,Schibli DJ Beilstein J Org Chem. 2012;8:1172-84. Epub 2012 Jul 24.'], 'hemolysis': u'EC50 = 195\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2619']}, u'GLLALISWIKRKRQQ': {'modifications': ['C-Terminal'], 'references': [u"Individual substitution analogs of Mel(12-26), melittin's C-terminal 15-residue peptide: their antimicrobial and hemolytic actions. Yan H,Li S,Sun X,Mi H FEBS Lett. 2003 Nov 6;554(1-2):100-4."], 'hemolysis': u'HC10  = 35.2 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2358']}, u'GLPVCGETCVGGTCNTPGCNCSWPVCTRK': {'modifications': ['Cyclic'], 'references': [u'Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities. Henriques ST,Huang YH,Rosengren KJ,Franquelim HG,Carvalho FA,Johnson A,Sonza S,Tachedjian G,Castanho MA,Daly NL J Biol Chem. 2011 Jul 8;286(27):24231-41. doi: 10.1074/jbc.M111.253393. Epub 2011 May 16.'], 'hemolysis': u'64.4\xb12.2% hemolytic at 25\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3013']}, u'FVPWFSKFLGOIL': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship, conformational and biological studies of temporin L analogues. Mangoni ML,Carotenuto A,Auriemma L,Saviello MR,Campiglia P,Gomez-Monterrey I,Malfi S,Marcellini L,Barra D,Novellino E J Med Chem. 2011 Mar 10;54(5):1298-307. doi: 10.1021/jm1012853. Epub 2011 Feb 14.'], 'hemolysis': u'2% hemolytic at 6\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2844']}, u'LCYCRRRFCYCV': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'6-12% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1216']}, u'GILKTIKSIASKVANTVQKLKRKAKNAVA': {'modifications': [], 'references': [u'Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin. Sanchez-Vasquez L,Silva-Sanchez J,Jimenez-Vargas JM,Rodriguez-Romero A,Munoz-Garay C,Rodriguez MC,Gurrola GB Biochim Biophys Acta. 2013 Jun;1830(6):3427-36. doi: 10.1016/j.bbagen.2013.01.028. Epub 2013 Feb 9.'], 'hemolysis': u'EC50 =46\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3253']}, u'frlkfh': {'modifications': [u'Stereochemistry: D'], 'references': [u'Synthetic peptide combinatorial libraries: a method for the identification of bioactive peptides against phytopathogenic fungi. Reed JD,Edwards DL, Gonzalez, C ,Gonzalez C Mol Plant Microbe Interact. 1997 Jul;10(5):537-49.'], 'hemolysis': u'0% hemolysis at 312 to 0\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3800']}, u'GVVTDLLNTAGGLLGNLVGSLSG': {'modifications': ['C-Terminal'], 'references': [u'Membrane association, electrostatic sequestration, and cytotoxicity of Gly-Leu-rich peptide orthologs with differing functions. Vanhoye D,Bruston F,El Amri S,Ladram A,Amiche M Biochemistry. 2004 Jul 6;43(26):8391-409.'], 'hemolysis': u'65% hemolytic at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2495']}, u'KKLFKKILKFL': {'modifications': ['C-Terminal', u'N-Terminal Modification: Tosylation'], 'references': [u'A library of linear undecapeptides with bactericidal activity against phytopathogenic bacteria. Badosa E,Ferre R,Planas M,Feliu L,Besalu E,Cabrefiga J,Bardaji E Peptides. 2007 Dec;28(12):2276-85. Epub 2007 Sep 25.'], 'hemolysis': u'85\xb17.4% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1848']}, u'CGESCVYIPCISGVIGCSCTDKVCYLNGTP': {'modifications': ['Cyclic'], 'references': [u'Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif. Craik DJ,Daly NL,Bond T J Mol Biol. 1999 Dec 17;294(5):1327-36.'], 'hemolysis': u'50% hemolysis at ~20\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4009']}, u'WKLFKKIPKFLHLAKKF': {'modifications': ['C-Terminal'], 'references': [u'Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs. Shin SY,Lee SH,Yang ST,Park EJ,Lee DG,Lee MK,Eom SH,Song WK,Kim Y,Hahm KS J Pept Res. 2001 Dec;58(6):504-14.'], 'hemolysis': u'10.1% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2158']}, u'GFLSILKKVLPKVNleAHMetK': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Melectin MAPs: the influence of dendrimerization on antimicrobial and hemolytic activity. Niederhafner P,Bednarova L,Budesinsky M,Safarik M,Ehala S,Jezek J,Borovickova L,Fucik V,Cerovsky V Amino Acids. 2010 Nov;39(5):1553-61. doi: 10.1007/s00726-010-0626-z. Epub 2010 May 25.'], 'hemolysis': u'LC50 =56.3\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1513']}, u'GKGLTicOicGKTicOicGLTicOicGKTicOicGLTicOicGKTicOicGKR': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'De novo design of selective antibiotic peptides by incorporation of unnatural amino acids. Hicks RP,Bhonsle JB,Venugopal D,Koser BW J Med Chem. 2007 Jun 28;50(13):3026-36. Epub 2007 Jun 5.'], 'hemolysis': u'100% hemolysis at 25\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1742']}, u'KWKSFlKTFKSlKKTVLHTllKAISS': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', u'Stereochemistry: Mix'], 'references': [u'Role of helicity on the anticancer mechanism of action of cationic-helical peptides. Huang YB,He LY,Jiang HY Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849. Epub 2012 Jun 5.'], 'hemolysis': u'MHC >325.20\u03bcmol/L', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2651']}, u'GFFALIPKIISSPLFKTLLSAVGSALSSSGEQE': {'modifications': [], 'references': [u'Solution conformations of peptides representing the sequence of the toxin pardaxin and analogues in trifluoroethanol-water mixtures: analysis of CD spectra. Thennarasu S Biopolymers. 1997 May;41(6):635-45.'], 'hemolysis': u'Conc. Required for hemolysis =1.75nmols', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3793']}, u'ELLKAVRLIK': {'modifications': [], 'references': [u'Effects of positively charged arginine residues on membrane pore forming activity of Rev-NIS peptide in bacterial cells. Lee J,Choi H,Cho J Biochim Biophys Acta. 2011 Oct;1808(10):2421-7. doi: 10.1016/j.bbamem.2011.06.024. Epub 2011 Jul 6.'], 'hemolysis': u'0% hemolytic upto 100\u03bcM  (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2999']}, u'LCYCRRRFCVCV': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'>50% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1175']}, u'RW': {'modifications': ['C-Terminal'], 'references': [u'Length effects in antimicrobial peptides of the (RW)n series. Liu Z,Brady A,Young A,Rasimick B,Chen K,Zhou C Antimicrob Agents Chemother. 2007 Feb;51(2):597-603. Epub 2006 Dec 4.'], 'hemolysis': u'HD50  =8.9x103\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1077']}, u'LLIILRRRWRRQARARSR': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial activity, bactericidal mechanism and LPS-neutralizing activity of the cell-penetrating peptide pVEC and its analogs. Nan YH,Park IS,Hahm KS J Pept Sci. 2011 Dec;17(12):812-7. doi: 10.1002/psc.1408. Epub 2011 Sep 29.'], 'hemolysis': u'>10% hemolytic at 94\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2971']}, u'kwksflktfskakkkklktllkaisk': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', u'Stereochemistry: D'], 'references': [u"Rational design of ?-helical antimicrobial peptides to target Gram-negative pathogens, Acinetobacter baumannii and Pseudomonas aeruginosa: utilization of charge, 'specificity determinants,' total hydrophobicity, hydrophobe type and location as design parameters to improve the therapeutic ratio. Jiang Z,Vasil AI,Gera L,Vasil ML Chem Biol Drug Des. 2011 Apr;77(4):225-40. doi: 10.1111/j.1747-0285.2011.01086.x. Epub 2011 Feb 2."], 'hemolysis': u'HC50 =351.5\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2823']}, u'SIGSALKKALPVAKKIGKIALPIAKAALPVAAGLVG': {'modifications': [], 'references': [u'Antibacterial activity and pore-forming properties of ceratotoxins: a mechanism of action based on the barrel stave model. Bessin Y,Saint N,Marri L,Marchini D Biochim Biophys Acta. 2004 Dec 15;1667(2):148-56.'], 'hemolysis': u'Hemolytic at 110 \xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2369']}, u'TDTNVIGECFDEWSRCHRQTRWWTKILFQSCENRCKCKVQLMGNCIKVPFKCFLWKQKRFMCECYGPISGTKPWYCGWEL': {'modifications': [], 'references': [u'A novel cysteine-rich antimicrobial peptide from the mucus of the snail of Achatina fulica. Zhong J,Wang W,Yang X,Yan X Peptides. 2013 Jan;39:1-5. doi: 10.1016/j.peptides.2012.09.001. Epub 2012 Oct 24.'], 'hemolysis': u'3.9% hemolysis at 320\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3244']}, u'GFLGPLLKLGLKGVAKVIPHLIPSRQQ': {'modifications': [], 'references': [u'Host-defense peptides in skin secretions of the tetraploid frog Silurana epitropicalis with potent activity against methicillin-resistant Staphylococcus aureus (MRSA). Conlon JM,Mechkarska M,Prajeep M,Sonnevend A,Coquet L,Leprince J,Jouenne T,Vaudry H Peptides. 2012 Sep;37(1):113-9. doi: 10.1016/j.peptides.2012.07.005. Epub 2012 Jul 16.'], 'hemolysis': u'LC50 =50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3157']}, u'SLKDKVKSMGEKLKQYIQTWKAKF': {'modifications': ['C-Terminal'], 'references': [u'Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity. Kozlov SA,Vassilevski AA,Feofanov AV,Surovoy AY,Karpunin DV J Biol Chem. 2006 Jul 28;281(30):20983-92. Epub 2006 May 30.'], 'hemolysis': u'20% hemolysis at >120\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4056']}, u'KWKSFLKTFKSAKKTVLHTLLKAISS': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides. Chen Y,Guarnieri MT,Vasil AI,Vasil ML,Mant CT Antimicrob Agents Chemother. 2007 Apr;51(4):1398-406. Epub 2006 Dec 11.'], 'hemolysis': u'MHC =31.3\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1087']}, u'KWKKLLKKPLLKKLLKKL': {'modifications': ['C-Terminal'], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC >100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3955']}, u'kwklfkkipkflhlakkf': {'modifications': ['C-Terminal', u'Stereochemistry: D'], 'references': [u'CT and MRI features of ileostomies. El Mouhadi S,Tourabi C,Cazejust J,Azizi L,Menu Y AJR Am J Roentgenol. 2011 Mar;196(3):577-84. doi: 10.2214/AJR.10.4894.'], 'hemolysis': u'~10% hemolytic at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2908']}, u'GW*LR**K**AAK**SVGK**FY*Y*K**HK*Y*Y*IK*AAWQIGKHAL': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Styelin D, an extensively modified antimicrobial peptide from ascidian hemocytes. Taylor SW,Craig AG,Fischer WH,Park M J Biol Chem. 2000 Dec 8;275(49):38417-26.'], 'hemolysis': u'EC50 =40 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1021']}, u'KVAKQEKKKKKTGRAKRR': {'modifications': [], 'references': [u"Human antimicrobial peptides' antifungal activity against Aspergillus fumigatus. Lupetti A,van Dissel JT,Brouwer CP Eur J Clin Microbiol Infect Dis. 2008 Nov;27(11):1125-9. doi: 10.1007/s10096-008-0553-z. Epub 2008 Jun 20."], 'hemolysis': u'>2-3% at \u226520\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1223']}, u'FFRLLFHGVHHGGGYLNAA': {'modifications': ['C-Terminal'], 'references': [u'The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents. Morash MG,Douglas SE,Robotham A,Ridley CM,Gallant JW Dis Model Mech. 2011 Sep;4(5):622-33. doi: 10.1242/dmm.007310. Epub 2011 Jul 4.'], 'hemolysis': u'50% hemolytic at >256 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2924']}, u'RGRCYTVCRQLYCLRRCQ': {'modifications': [], 'references': [u'Synthesis and properties of cyclic gomesin and analogues. Machado A,Fazio MA,Miranda A,Daffre S J Pept Sci. 2012 Sep;18(9):588-98. doi: 10.1002/psc.2439. Epub 2012 Aug 2.'], 'hemolysis': u'17% hemolytic at 100mM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2623']}, u'FVPWFSKFlGRIL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'The effect of d-amino acid substitution on the selectivity of temporin L towards target cells: identification of a potent anti-Candida peptide. Grieco P,Carotenuto A,Auriemma L,Saviello MR,Campiglia P,Gomez-Monterrey IM,Marcellini L,Luca V,Barra D,Novellino E Biochim Biophys Acta. 2013 Feb;1828(2):652-60. doi: 10.1016/j.bbamem.2012.08.027. Epub 2012 Sep 10.'], 'hemolysis': u'2% hemolysis at 1.5\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3217']}, u'RRGWVLALVLYYGRR': {'modifications': [], 'references': [u'Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity. Rathinakumar R, Walkenhorst, William ,Walkenhorst WF J Am Chem Soc. 2009 Jun 10;131(22):7609-17. doi: 10.1021/ja8093247.'], 'hemolysis': u'0.4 fractions hemolysis at 15\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1307']}, u'NIWKKIFEKVKNLV': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 >100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3905']}, u'SWLRDLWDWLCELLSDFK': {'modifications': [], 'references': [u'Rational design of peptides with anti-HCV/HIV activities and enhanced specificity. Li GR,He LY,Liu XY,Liu AP,Huang YB,Qiu C,Zhang XY,Xu JQ,Yang W Chem Biol Drug Des. 2011 Nov;78(5):835-43. doi: 10.1111/j.1747-0285.2011.01201.x. Epub 2011 Sep 26.'], 'hemolysis': u'MHC = 107.50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2952']}, u'GFMKYIGPLIPHKVKAISDLI': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial and cytolytic properties of the frog skin peptide, kassinatuerin-1 and its L- and D-lysine-substituted derivatives. Conlon JM,Abraham B,Galadari S,Knoop FC,Sonnevend A Peptides. 2005 Nov;26(11):2104-10.'], 'hemolysis': u'32% hemolysis at 400\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4073']}, u'KRFKKFFKKPK': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial and antibiofilm activity of cathelicidins and short, synthetic peptides against Francisella. Amer LS,Bishop BM Biochem Biophys Res Commun. 2010 May 28;396(2):246-51. doi: 10.1016/j.bbrc.2010.04.073. Epub 2010 Apr 23.'], 'hemolysis': u'EC50 =95.92\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3065']}, u'FFRLLFHGVHHVGKIKPRA': {'modifications': ['C-Terminal'], 'references': [u'The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents. Morash MG,Douglas SE,Robotham A,Ridley CM,Gallant JW Dis Model Mech. 2011 Sep;4(5):622-33. doi: 10.1242/dmm.007310. Epub 2011 Jul 4.'], 'hemolysis': u'50% hemolytic at >256 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2925']}, u'LKKLLKWLKKL': {'modifications': ['C-Terminal'], 'references': [u'Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities. Kim SJ,Kim JS,Lee YS,Sim DW,Lee SH,Bahk YY,Lee KH,Kim EH,Park SJ,Lee BJ Molecules. 2013 Jan 11;18(1):859-76. doi: 10.3390/molecules18010859.'], 'hemolysis': u'MHC = 128\u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2598']}, u'FVPWFSKFlGRIl': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'The effect of d-amino acid substitution on the selectivity of temporin L towards target cells: identification of a potent anti-Candida peptide. Grieco P,Carotenuto A,Auriemma L,Saviello MR,Campiglia P,Gomez-Monterrey IM,Marcellini L,Luca V,Barra D,Novellino E Biochim Biophys Acta. 2013 Feb;1828(2):652-60. doi: 10.1016/j.bbamem.2012.08.027. Epub 2012 Sep 10.'], 'hemolysis': u'3% hemolysis at 1.5\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3235']}, u'I/LLGTILGLLKGI/L': {'modifications': ['C-Terminal'], 'references': [u'Structural characterization of novel chemotactic and mastoparan peptides from the venom of the social wasp Agelaiapallipes pallipes by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry. Mendes MA,Monson de Souza B,Delazari dos Santos L Rapid Commun Mass Spectrom. 2004;18(6):636-42.'], 'hemolysis': u'0% hemolysis at 1x10-5 M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1867']}, u'GIGKFLHSAGKFGKAFLGEVMKS': {'modifications': [], 'references': [u'Peptidomic analysis of skin secretions demonstrates that the allopatric populations of Xenopus muelleri (Pipidae) are not conspecific. Mechkarska M,Ahmed E,Coquet L,Leprince J,Jouenne T,Vaudry H,King JD Peptides. 2011 Jul;32(7):1502-8. doi: 10.1016/j.peptides.2011.05.025. Epub 2011 Jun 1.'], 'hemolysis': u'LC50 >200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3135']}, u'KWKKLLKKLLKLPKKLLKKLKKLLK': {'modifications': ['C-Terminal'], 'references': [u'Contribution of a central proline in model amphipathic alpha-helical peptides to self-association, interaction with phospholipids, and antimicrobial mode of action. Yang ST,Lee JY,Kim HJ,Eu YJ,Shin SY,Hahm KS FEBS J. 2006 Sep;273(17):4040-54. Epub 2006 Aug 2.'], 'hemolysis': u'11%  hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1704']}, u'FFGAIAAALPHVISAIKNAL': {'modifications': ['C-Terminal'], 'references': [u'A family of kassinatuerin-2 related peptides from the skin secretion of the African hyperoliid frog, Kassina maculata. Wang L,Zhou M,McGrath S,Chen T,Gorman SP,Walker B Peptides. 2009 Aug;30(8):1428-33. doi: 10.1016/j.peptides.2009.04.021. Epub 2009 May 7.'], 'hemolysis': u'45-50% hemolysis at 120\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3485']}, u'VNSKKISPKSIKVSK': {'modifications': ['C-Terminal'], 'references': [u'Effect of hydrocarbon stapling on the properties of ?-helical antimicrobial peptides isolated from the venom of hymenoptera. Chapuis H,Slaninova J,Bednarova L,Monincova L,Budesinsky M Amino Acids. 2012 Nov;43(5):2047-58. doi: 10.1007/s00726-012-1283-1. Epub 2012 Apr 17.'], 'hemolysis': u'LC50  = 82\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2763']}, u'ZCRRLEYKQRKVTYCRGR': {'modifications': ['C-Terminal', 'Cyclic', 'Non-Natural'], 'references': [u'Structure-activity relationship studies of gomesin: importance of the disulfide bridges for conformation, bioactivities, and serum stability. Fazio MA,Oliveira VX Jr,Bulet P,Miranda MT,Daffre S Biopolymers. 2006;84(2):205-18.'], 'hemolysis': u'<10% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4200']}, u'KyPKyP': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Structure-activity relationships of de novo designed cyclic antimicrobial peptides based on gramicidin S. Lee DL Biopolymers. 2003;71(1):28-48.'], 'hemolysis': u'100% hemolysis at >150\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2288']}, u'RPRCWIKIKFRCKSLKF': {'modifications': [], 'references': [u'Two antimicrobial and nematicidal peptides derived from sequences encoded Picea sitchensis. Liu R,Mu L,Liu H,Wei L,Yan T,Chen M,Zhang K,Li J,You D J Pept Sci. 2011 Sep;17(9):627-31. doi: 10.1002/psc.1380. Epub 2011 Jun 6.'], 'hemolysis': u'66.3% hemolysis at 1mg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4048']}, u'gwgsffkkaahvgkhvgkaalthyl': {'modifications': ['C-Terminal', u'Stereochemistry: D'], 'references': [u'Structure-antimicrobial activity relationship between pleurocidin and its enantiomer. Lee J Exp Mol Med. 2008 Aug 31;40(4):370-6.'], 'hemolysis': u'0% hemolysis at 3.13-50 \u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1247']}, u'IPPFIKKVLTTVF': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial peptides from the skin secretions of the New World frogs Lithobates capito and Lithobates warszewitschii (Ranidae). Conlon JM,Meetani MA,Coquet L,Jouenne T,Leprince J,Vaudry H,Kolodziejek J,Nowotny N Peptides. 2009 Oct;30(10):1775-81. doi: 10.1016/j.peptides.2009.07.011. Epub 2009 Jul 25.'], 'hemolysis': u'LC50 =220\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4146']}, u'RRGWVLALYLRYGRR': {'modifications': [], 'references': [u'Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity. Rathinakumar R, Walkenhorst, William ,Walkenhorst WF J Am Chem Soc. 2009 Jun 10;131(22):7609-17. doi: 10.1021/ja8093247.'], 'hemolysis': u'0.25 fractions hemolyis at 15\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1319']}, u'VkLkVyPLkVkLyP': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Dissociation of antimicrobial and hemolytic activities in cyclic peptide diastereomers by systematic alterations in amphipathicity. Kondejewski LH,Jelokhani-Niaraki M,Farmer SW,Lix B,Kay CM,Sykes BD,Hancock RE J Biol Chem. 1999 May 7;274(19):13181-92.'], 'hemolysis': u'100% hemolytic at >200 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2568']}, u'QRSVSNAATRVCRTGRSRW': {'modifications': [], 'references': [u'Hemolysis of erythrocytes by granulysin-derived peptides but not by granulysin. Li Q,Dong C,Deng A,Katsumata M,Nakadai A,Kawada T,Okada S,Clayberger C Antimicrob Agents Chemother. 2005 Jan;49(1):388-97.'], 'hemolysis': u'20% hemolysis 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1622']}, u'GFKDLLKGAkKALVKTVLF': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7. Conlon JM,Galadari S,Raza H Chem Biol Drug Des. 2008 Jul;72(1):58-64. doi: 10.1111/j.1747-0285.2008.00671.x. Epub 2008 Jun 12.'], 'hemolysis': u'LD50 >500 \xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1953']}, u'ALWDTLLKKVLKAAAKAALNAVLVGANA': {'modifications': [], 'references': [u'Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity. Feder R,Dagan A J Biol Chem. 2000 Feb 11;275(6):4230-8.'], 'hemolysis': u'LC50 =2.3\xb10.3\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1003']}, u'FPFSLIPHAIGGLISAIK': {'modifications': [], 'references': [u'Antimicrobial/cytolytic peptides from the venom of the North African scorpion, Androctonus amoreuxi: biochemical and functional characterization of natural peptides and a single site-substituted analog. Almaaytah A,Zhou M,Wang L,Chen T,Walker B Peptides. 2012 Jun;35(2):291-9. doi: 10.1016/j.peptides.2012.03.016. Epub 2012 Mar 28.'], 'hemolysis': u'75%  hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2087']}, u'GLWSTIKQKGKEAAIAAAKAAGQAALGAL': {'modifications': ['C-Terminal'], 'references': [u'Dermaseptins from Phyllomedusa oreades and Phyllomedusa distincta. Anti-Trypanosoma cruzi activity without cytotoxicity to mammalian cells. Brand GD,Leite JR,Silva LP,Albuquerque S,Prates MV,Azevedo RB,Carregaro V,Silva JS,Sa VC,Brandao RA J Biol Chem. 2002 Dec 20;277(51):49332-40. Epub 2002 Oct 11.'], 'hemolysis': u'2.17% hemolysis at 128\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4109']}, u'AMNSQLTLIVTIVLIFSSSRCERILDLRKTKKSCKNGEVLGCVSGHGPPGCSENECGGPRPKACFFDCHYGCCMCTGKLYRRKRDRKCVPKHECLL': {'modifications': [], 'references': [u'Identification of a cysteine-rich antimicrobial peptide from salivary glands of the tick Rhipicephalus haemaphysaloides. Zhang H,Zhang W,Wang X,Zhou Y,Wang N Peptides. 2011 Mar;32(3):441-6. doi: 10.1016/j.peptides.2010.12.004. Epub 2010 Dec 17.'], 'hemolysis': u'Very little hemolysis at 10\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2073']}, u'KLLLKLLLKLLK': {'modifications': ['C-Terminal'], 'references': [u'Design and synthesis of novel antimicrobial pseudopeptides with selective membrane-perturbation activity. Lee KH Bioorg Med Chem. 2000 Apr;8(4):833-9.'], 'hemolysis': u'100% hemolysis at 200\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2031']}, u'GIGKFLHAAKKFAKAFVAEIMNS': {'modifications': [], 'references': [u'Lycotoxins, antimicrobial peptides from venom of the wolf spider Lycosa carolinensis. Yan L J Biol Chem. 1998 Jan 23;273(4):2059-66.'], 'hemolysis': u'35% hemolysis at 200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3385']}, u'ILPWKWPWWPLRR': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship of indolicidin, a Trp-rich antibacterial peptide. Ando S,Mitsuyasu K,Soeda Y,Hidaka M,Ito Y,Matsubara K,Shindo M,Uchida Y J Pept Sci. 2010 Apr;16(4):171-7. doi: 10.1002/psc.1217.'], 'hemolysis': u'13% hemolysis at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1475']}, u'VKlKVyPLKVKLyP': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Dissociation of antimicrobial and hemolytic activities in cyclic peptide diastereomers by systematic alterations in amphipathicity. Kondejewski LH,Jelokhani-Niaraki M,Farmer SW,Lix B,Kay CM,Sykes BD,Hancock RE J Biol Chem. 1999 May 7;274(19):13181-92.'], 'hemolysis': u'100% hemolytic at 12.5 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2554']}, u'ZCRRLCYKQRCVTYCRGR': {'modifications': ['C-Terminal', 'Cyclic', 'Non-Natural'], 'references': [u'Structure-activity relationship studies of gomesin: importance of the disulfide bridges for conformation, bioactivities, and serum stability. Fazio MA,Oliveira VX Jr,Bulet P,Miranda MT,Daffre S Biopolymers. 2006;84(2):205-18.'], 'hemolysis': u'~ 40% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4194']}, u'INWKKGKEVLKAL': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 >>100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3933']}, u'LNFKALAALAKKIL': {'modifications': ['C-Terminal'], 'references': [u'Novel biologically active peptides from the venom of Polistes rothneyi iwatai. Murata K,Shinada T,Ohfune Y,Hisada M,Yasuda A,Naoki H Biol Pharm Bull. 2006 Dec;29(12):2493-7.'], 'hemolysis': u'23 % of hemolysis at 50mM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1729']}, u'KWKKPLLKKLLKKL': {'modifications': ['C-Terminal'], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC >100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3957']}, u'kklalalakkwlalakklalalakk': {'modifications': ['C-Terminal', u'Stereochemistry: D'], 'references': [u'Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic ?-helical peptides. Vermeer LS,Lan Y,Abbate V,Ruh E,Bui TT,Wilkinson LJ,Kanno T,Jumagulova E,Kozlowska J,Patel J,McIntyre CA,Yam WC,Siu G,Atkinson RA,Lam JK,Bansal SS, Drake, Alex ,Drake AF,Mitchell GH J Biol Chem. 2012 Oct 5;287(41):34120-33. doi: 10.1074/jbc.M112.359067. Epub 2012 Aug 6.'], 'hemolysis': u'HC50 = 17.42\xb12.17\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2626']}, u'LVRGCWTKSYPPKPCFVR': {'modifications': ['Cyclic'], 'references': [u'Ranacyclins, a new family of short cyclic antimicrobial peptides: biological function, mode of action, and parameters involved in target specificity. Mangoni ML,Papo N,Mignogna G,Andreu D,Shai Y,Barra D Biochemistry. 2003 Dec 2;42(47):14023-35.'], 'hemolysis': u'85% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3772']}, u'GFGOicGKGOicGFGOicGKGKKKK': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', 'Non-Natural'], 'references': [u'De novo design of selective antibiotic peptides by incorporation of unnatural amino acids. Hicks RP,Bhonsle JB,Venugopal D,Koser BW J Med Chem. 2007 Jun 28;50(13):3026-36. Epub 2007 Jun 5.'], 'hemolysis': u'3.3% hemolysis at 25\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1778']}, u'FWGALAKGALKLIGVSLFSSFSKKD': {'modifications': [], 'references': [u'Amino acid substitutions in an alpha-helical antimicrobial arachnid peptide affect its chemical properties and biological activity towards pathogenic bacteria but improves its therapeutic index. Rodriguez A,Villegas E,Satake H,Possani LD Amino Acids. 2011 Jan;40(1):61-8. doi: 10.1007/s00726-009-0449-y. Epub 2009 Dec 24.'], 'hemolysis': u'IC50 =9.3\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1277']}, u'INWKSIFEKVKNLV': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 >100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3904']}, u'RQIKIWFQNRRMKWKK': {'modifications': ['C-Terminal'], 'references': [u'Cell-penetrating peptides: a comparative membrane toxicity study. Saar K,Lindgren M,Hansen M,Eiriksdottir E,Jiang Y,Rosenthal-Aizman K,Sassian M Anal Biochem. 2005 Oct 1;345(1):55-65.'], 'hemolysis': u'20.0\xb11.8% hemolysis at 50\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1643']}, u'SWLRDIWDWLCEVLSDFK': {'modifications': [], 'references': [u'Rational design of peptides with anti-HCV/HIV activities and enhanced specificity. Li GR,He LY,Liu XY,Liu AP,Huang YB,Qiu C,Zhang XY,Xu JQ,Yang W Chem Biol Drug Des. 2011 Nov;78(5):835-43. doi: 10.1111/j.1747-0285.2011.01201.x. Epub 2011 Sep 26.'], 'hemolysis': u'MHC =6.92\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2947']}, u'KKAAAAfAAfAAwfAAfAAAAKKKK': {'modifications': ['C-Terminal'], 'references': [u'Cationic hydrophobic peptides with antimicrobial activity. Stark M,Liu LP Antimicrob Agents Chemother. 2002 Nov;46(11):3585-90.'], 'hemolysis': u'34% hemolysis at 200\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2230']}, u'CKLLLKWLLKLLKC': {'modifications': ['Cyclic'], 'references': [u'Cyclization of a cytolytic amphipathic alpha-helical peptide and its diastereomer: effect on structure, interaction with model membranes, and biological function. Oren Z Biochemistry. 2000 May 23;39(20):6103-14.'], 'hemolysis': u'50% hemolytic at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2532']}, u'GKPRPYSPRPT*SHPRPIRV': {'modifications': ['Non-Natural'], 'references': [u'Glycosylated analogs of formaecin I and drosocin exhibit differential pattern of antibacterial activity. Talat S,Thiruvikraman M,Kumari S Glycoconj J. 2011 Dec;28(8-9):537-55. doi: 10.1007/s10719-011-9353-2. Epub 2011 Oct 4.'], 'hemolysis': u'<5% hemolytic at 100 \u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2975']}, u'NPVLVKDATGSTQFGPVQALGAQYSMWKLK': {'modifications': [], 'references': [u'Potent inhibition of the classical pathway of complement by a novel C1q-binding peptide derived from the human astrovirus coat protein. Gronemus JQ,Hair PS,Crawford KB,Nyalwidhe JO,Cunnion KM Mol Immunol. 2010 Nov-Dec;48(1-3):305-13. doi: 10.1016/j.molimm.2010.07.012. Epub 2010 Aug 21.'], 'hemolysis': u'100% hemolysis at 0.77mM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1531']}, u'GIIKVIKSLIEQFTGK': {'modifications': [], 'references': [u'Novel phenol-soluble modulin derivatives in community-associated methicillin-resistant Staphylococcus aureus identified through imaging mass spectrometry. Gonzalez DJ,Okumura CY,Hollands A,Kersten R,Akong-Moore K,Pence MA,Malone CL,Derieux J,Moore BS,Horswill AR,Dixon JE,Dorrestein PC J Biol Chem. 2012 Apr 20;287(17):13889-98. doi: 10.1074/jbc.M112.349860. Epub 2012 Feb 27.'], 'hemolysis': u'Non-hemolytic at 10 \u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2709']}, u'WEAKLAKALAKALAKHLAKALAKALKACEA': {'modifications': [], 'references': [u'A new gene delivery formulation of polyethylenimine/DNA complexes coated with PEG conjugated fusogenic peptide. Lee H,Jeong JH J Control Release. 2001 Sep 11;76(1-2):183-92.'], 'hemolysis': u'90-95% hemolysis at 100 \xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1988']}, u'VOLAfPVOLfP': {'modifications': ['Cyclic', u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'Antimicrobially active cycloundecapeptides related to gramicidin S having a novel turn structure with cis D-Phe-Pro peptide bond. Tamaki M,Sasaki I,Kokuno M,Shindo M,Kimura M Org Biomol Chem. 2010 Apr 21;8(8):1791-7. doi: 10.1039/b922159j.'], 'hemolysis': u'50% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1503']}, u'GLPVCGETCVGGTCNTPGCTCSWPVCTKN': {'modifications': ['Cyclic'], 'references': [u'Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities. Henriques ST,Huang YH,Rosengren KJ,Franquelim HG,Carvalho FA,Johnson A,Sonza S,Tachedjian G,Castanho MA,Daly NL J Biol Chem. 2011 Jul 8;286(27):24231-41. doi: 10.1074/jbc.M111.253393. Epub 2011 May 16.'], 'hemolysis': u'12.0\xb11.8% hemolytic at 25\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3014']}, u'EEEEAAAkwklfkkipkflhlakkf': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', u'Stereochemistry: Mix'], 'references': [u'CT and MRI features of ileostomies. El Mouhadi S,Tourabi C,Cazejust J,Azizi L,Menu Y AJR Am J Roentgenol. 2011 Mar;196(3):577-84. doi: 10.2214/AJR.10.4894.'], 'hemolysis': u'~3.5% hemolytic upto 500\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2909']}, u'GVLGTVKNLLIGAGKSAAQSVLKTLSCKLSNDC': {'modifications': [], 'references': [u'Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami. Conlon JM,Al-Ghaferi N,Abraham B,Jiansheng H,Cosette P,Leprince J,Jouenne T Peptides. 2006 Sep;27(9):2111-7. Epub 2006 Apr 18.'], 'hemolysis': u'LC50 = 180\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1682']}, u'RWKIFKKIEKMGRNIRDGIVKAGPAIEVLGSAKAIGK': {'modifications': [], 'references': [u'Expression, purification and characterization of cecropin antibacterial peptide from Bombyx mori in Saccharomyces cerevisiae. Xia L,Liu Z,Ma J,Sun S,Yang J,Zhang Protein Expr Purif. 2013 Jul;90(1):47-54. doi: 10.1016/j.pep.2013.02.013. Epub 2013 Mar 14.'], 'hemolysis': u'~2% hemolytic at 200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2585']}, u'cgetcvggtcntpgctcswpvctrnglnpv': {'modifications': ['Cyclic', u'Stereochemistry: D'], 'references': [u'A Synthetic mirror image of kalata B1 reveals that cyclotide activity is independent of a protein receptor. Sando L,Henriques ST,Foley F,Simonsen SM,Daly NL,Hall KN,Gustafson KR,Aguilar MI Chembiochem. 2011 Nov 4;12(16):2456-62. doi: 10.1002/cbic.201100450. Epub 2011 Sep 16.'], 'hemolysis': u'IC50 = 77 \xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2005']}, u'AKKVFKRLEKLFSKIWNDK': {'modifications': [], 'references': [u'Design of novel analogue peptides with potent antibiotic activity based on the antimicrobial peptide, HP (2-20), derived from N-terminus of Helicobacter pylori ribosomal protein L1. Lee DG,Kim HN,Park Y,Kim HK,Choi BH,Choi CH Biochim Biophys Acta. 2002 Jul 29;1598(1-2):185-94.'], 'hemolysis': u'0% hemolysis at 100\u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2383']}, u'GRFKRFRKKFKKLFKKLSPVIPLLHL': {'modifications': ['C-Terminal'], 'references': [u'Cell selectivity, mechanism of action and LPS-neutralizing activity of bovine myeloid antimicrobial peptide-18 (BMAP-18) and its analogs. Lee EK,Kim YC,Nan YH Peptides. 2011 Jun;32(6):1123-30. doi: 10.1016/j.peptides.2011.03.024. Epub 2011 Apr 8.'], 'hemolysis': u'10% hemolysis at 6.2\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3127']}, u'VTLASHLPSDFTPAVHASLDKFLANVSTVLTSKYR': {'modifications': [], 'references': [u'Isolation and characterization of four antibacterial peptides from bovine hemoglobin. Nedjar-Arroume N,Dubois-Delval V,Miloudi K,Daoud R,Krier F,Kouach M,Briand G Peptides. 2006 Sep;27(9):2082-9. Epub 2006 May 30.'], 'hemolysis': u'Non-hemolytic', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1910']}, u'GIINTLQKYYYRVRGGRYAVLSYLPKEEQIGKYSTRGRKYYRRKK': {'modifications': [], 'references': [u'Linear analogues of human beta-defensin 3: concepts for design of antimicrobial peptides with reduced cytotoxicity to mammalian cells. Liu S,Zhou L,Li J,Suresh A,Verma C,Foo YH,Yap EP,Tan DT Chembiochem. 2008 Apr 14;9(6):964-73. doi: 10.1002/cbic.200700560.'], 'hemolysis': u'<1% hemolysis at 3-100 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1160']}, u'KWKSFIKKLTSAAKKVVTTAKPLISS': {'modifications': [], 'references': [u'Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides. Zhang L,Benz R Biochemistry. 1999 Jun 22;38(25):8102-11.'], 'hemolysis': u'MHC=8\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3590']}, u'RGGRLCYCRGWICFCVGR': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'>50% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1165']}, u'MFTMKKSLLLLFFLGIVSLSLCEQERGADEDEGEDVEEVKRSLWENFKNAGKQFILNILDKIRCRVAGGCRT': {'modifications': [], 'references': [u'Molecular cloning and characterization of antimicrobial peptides from skin of the broad-folded frog, Hylarana latouchii. Wang H,Yu Z,Hu Y,Yu H,Ran R,Xia J,Wang D,Yang S,Yang X Biochimie. 2012 Jun;94(6):1317-26. doi: 10.1016/j.biochi.2012.02.032. Epub 2012 Mar 8.'], 'hemolysis': u'LD50 = 220\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2081']}, u'GLPKCGETCVGGTCNTPGCTCSWPVCTRN': {'modifications': ['Cyclic'], 'references': [u'Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities. Henriques ST,Huang YH,Rosengren KJ,Franquelim HG,Carvalho FA,Johnson A,Sonza S,Tachedjian G,Castanho MA,Daly NL J Biol Chem. 2011 Jul 8;286(27):24231-41. doi: 10.1074/jbc.M111.253393. Epub 2011 May 16.'], 'hemolysis': u'2.9\xb10.5% hemolytic at 25\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3003']}, u'PKLLKTFLSKWKKIG': {'modifications': [], 'references': [u'Addition and omission analogs of the 13-residue antibacterial and hemolytic peptide PKLLKTFLSKWIG: structural preferences, model membrane binding and biological activities. Bikshapathy E,Sitaram N J Pept Res. 1999 Jan;53(1):47-55.'], 'hemolysis': u'100% hemolysis at 85\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3838']}, u'KKIASIGKEVLKAL': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 >>100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3926']}, u'RLMAAKAESRK': {'modifications': [], 'references': [u'Antimicrobial activity and mechanism of action of a novel cationic ?-helical dodecapeptide, a partial sequence of cyanate lyase from rice. Takei N,Takahashi N,Takayanagi T,Ikeda A,Hashimoto K,Takagi M,Hamada T,Saitoh E,Ochiai A,Tanaka T Peptides. 2013 Apr;42:55-62. doi: 10.1016/j.peptides.2012.12.015. Epub 2012 Dec 25.'], 'hemolysis': u'No or little hemolysis upto 800\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3248']}, u'GLFGVLAKVAAHVVPAIAEHF': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship of an antibacterial peptide, maculatin 1.1, from the skin glands of the tree frog, Litoria genimaculata. Niidome T,Kobayashi K,Arakawa H,Hatakeyama T J Pept Sci. 2004 Jul;10(7):414-22.'], 'hemolysis': u'100% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1608']}, u'ILGKLLSTAAGLLKNL': {'modifications': ['C-Terminal'], 'references': [u'Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent. Conlon JM,Mechkarska M,Prajeep M,Arafat K,Zaric M,Lukic ML Amino Acids. 2013 Feb;44(2):715-23. doi: 10.1007/s00726-012-1395-7. Epub 2012 Sep 11.'], 'hemolysis': u'LC50 =55\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3174']}, u'QPTRRPRPGTGPGRRPRPRPRP': {'modifications': [], 'references': [u'Bacterial killing by heparin-binding peptides from PRELP and thrombospondin. Malmsten M,Davoudi M Matrix Biol. 2006 Jul;25(5):294-300. Epub 2006 Apr 25.'], 'hemolysis': u'~4% hemolysis at 60\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2074']}, u'LFGFLIPLLPHIIGAIPQVIGAIR': {'modifications': [], 'references': [u'Isolation and structures of grammistins, peptide toxins from the skin secretion of the soapfish Grammistes sexlineatus. Shiomi K,Igarashi T,Yokota H,Nagashima Y Toxicon. 2000 Jan;38(1):91-103.'], 'hemolysis': u'LC50 = 0.19\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2540']}, u'ILGKLLSWAAGLLSNL': {'modifications': ['C-Terminal'], 'references': [u'Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent. Conlon JM,Mechkarska M,Prajeep M,Arafat K,Zaric M,Lukic ML Amino Acids. 2013 Feb;44(2):715-23. doi: 10.1007/s00726-012-1395-7. Epub 2012 Sep 11.'], 'hemolysis': u'LC50 =13\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3181']}, u'GIGAvLKvLTTGLPALiSWIkRKRQQ': {'modifications': [u'Stereochemistry: Mix'], 'references': [u'Selective lysis of bacteria but not mammalian cells by diastereomers of melittin: structure-function study. Oren Z Biochemistry. 1997 Feb 18;36(7):1826-35.'], 'hemolysis': u'~1-2% hemolysis at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3583']}, u'GFGALFKFLAKKVAKTVAKQAAKQGAKYVVNKQME': {'modifications': [], 'references': [u'Cupiennin 1, a new family of highly basic antimicrobial peptides in the venom of the spider Cupiennius salei (Ctenidae). Kuhn-Nentwig L,Muller J,Schaller J,Walz A,Dathe M J Biol Chem. 2002 Mar 29;277(13):11208-16. Epub 2002 Jan 15.'], 'hemolysis': u'EC50 = 20.5\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3426']}, u'RRLMAAKAES': {'modifications': [], 'references': [u'Antimicrobial activity and mechanism of action of a novel cationic ?-helical dodecapeptide, a partial sequence of cyanate lyase from rice. Takei N,Takahashi N,Takayanagi T,Ikeda A,Hashimoto K,Takagi M,Hamada T,Saitoh E,Ochiai A,Tanaka T Peptides. 2013 Apr;42:55-62. doi: 10.1016/j.peptides.2012.12.015. Epub 2012 Dec 25.'], 'hemolysis': u'No or little hemolysis upto 800\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3251']}, u'KKKKKKAAFAAWAAFDA': {'modifications': ['C-Terminal', 'Cyclic'], 'references': [u'Membrane interactions of designed cationic antimicrobial peptides: the two thresholds. Glukhov E,Burrows LL Biopolymers. 2008 May;89(5):360-71. doi: 10.1002/bip.20917.'], 'hemolysis': u'MHC =650\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1145']}, u'KLKkLLKkWLKlLKKlLK': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich alpha-helical model antimicrobial peptide and its diastereomeric peptides. Wang P,Nan YH,Yang ST,Kang SW,Kim Y,Park IS,Hahm KS Peptides. 2010 Jul;31(7):1251-61. doi: 10.1016/j.peptides.2010.03.032. Epub 2010 Apr 2.'], 'hemolysis': u'HC50 =800\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3057']}, u'KWKL\u0394FKK\u0394FGAV\u0394FKVL': {'modifications': ['Non-Natural'], 'references': [u'Alpha,beta-dehydrophenylalanine containing cecropin-melittin hybrid peptides: conformation and activity. Mathur P,Jagannathan NR J Pept Sci. 2007 Apr;13(4):253-62.'], 'hemolysis': u'>60% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1127']}, u'GYGCPFNQYQCHSHCSGIRGYKGGYCKGTFKQTCKCY': {'modifications': [], 'references': [u'Antibacterial activity and mechanism of action of tick defensin against Gram-positive bacteria. Nakajima Y,Ishibashi J,Yukuhiro F,Asaoka A,Taylor D Biochim Biophys Acta. 2003 Dec 5;1624(1-3):125-30.'], 'hemolysis': u'EC50   >100 (\xb5g/ml)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2331']}, u'KWKLFKKIGAVLKVL': {'modifications': ['C-Terminal'], 'references': [u'Lysine N(epsilon)-trimethylation, a tool for improving the selectivity of antimicrobial peptides. Fernandez-Reyes M,Diaz D,de la Torre BG,Cabrales-Rico A,Valles-Miret M,Jimenez-Barbero J,Andreu D J Med Chem. 2010 Aug 12;53(15):5587-96. doi: 10.1021/jm100261r.'], 'hemolysis': u'HD50  >200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1527']}, u'FLGLLFHGVHHVGKWIHGLIHGHH': {'modifications': ['C-Terminal'], 'references': [u'The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents. Morash MG,Douglas SE,Robotham A,Ridley CM,Gallant JW Dis Model Mech. 2011 Sep;4(5):622-33. doi: 10.1242/dmm.007310. Epub 2011 Jul 4.'], 'hemolysis': u'50% hemolytic at 16\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2934']}, u'GLPLLISWIKRKRQQ': {'modifications': ['C-Terminal'], 'references': [u"Individual substitution analogs of Mel(12-26), melittin's C-terminal 15-residue peptide: their antimicrobial and hemolytic actions. Yan H,Li S,Sun X,Mi H FEBS Lett. 2003 Nov 6;554(1-2):100-4."], 'hemolysis': u'HC10  = 203 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2360']}, u'GLPRKILAAIAKKKGKCKGPLKLVAKC': {'modifications': ['Cyclic'], 'references': [u'Lasiocepsin, a novel cyclic antimicrobial peptide from the venom of eusocial bee Lasioglossum laticeps (Hymenoptera: Halictidae). Monincova L,Slaninova J,Fucik V,Hovorka O,Voburka Z,Bednarova L,Malon P,Stokrova J Amino Acids. 2012 Aug;43(2):751-61. doi: 10.1007/s00726-011-1125-6. Epub 2011 Oct 29.'], 'hemolysis': u'<1% hemolytic at 200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2741']}, u'INWKKIASIGKEVL': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 >>100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3930']}, u'APCLACPCKACPCAAPCAACPCKACPCAAPCLACPC': {'modifications': ['C-Terminal', 'Cyclic', 'Non-Natural'], 'references': [u'Interplay among folding, sequence, and lipophilicity in the antibacterial and hemolytic activities of alpha/beta-peptides. Schmitt MA,Weisblum B J Am Chem Soc. 2007 Jan 17;129(2):417-28.'], 'hemolysis': u'>10% hemolysis at >400 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1097']}, u'ILGKLLSTAAKLLSKL': {'modifications': ['C-Terminal'], 'references': [u'Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent. Conlon JM,Mechkarska M,Prajeep M,Arafat K,Zaric M,Lukic ML Amino Acids. 2013 Feb;44(2):715-23. doi: 10.1007/s00726-012-1395-7. Epub 2012 Sep 11.'], 'hemolysis': u'LC50 =16\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3179']}, u'GIMDSVKGLAKNLAGKLLDSLKCKITGC': {'modifications': [], 'references': [u'Isolation of peptides of the brevinin-1 family with potent candidacidal activity from the skin secretions of the frog Rana boylii. Conlon JM,Sonnevend A,Patel M,Davidson C, Nielsen, P ,Nielsen PF,Pal T J Pept Res. 2003 Nov;62(5):207-13.'], 'hemolysis': u'HC50   >200\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2327']}, u'GWRTLLKKAEVKTVGKLALKHYL': {'modifications': ['C-Terminal'], 'references': [u'The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents. Morash MG,Douglas SE,Robotham A,Ridley CM,Gallant JW Dis Model Mech. 2011 Sep;4(5):622-33. doi: 10.1242/dmm.007310. Epub 2011 Jul 4.'], 'hemolysis': u'50% hemolytic at >256 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2928']}, u'CGESCVWIPCISSAIGCSCKNKVCYRNGIP': {'modifications': ['Cyclic'], 'references': [u'Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif. Craik DJ,Daly NL,Bond T J Mol Biol. 1999 Dec 17;294(5):1327-36.'], 'hemolysis': u'50% hemolysis at ~20\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4000']}, u'GFTicOicGKTicOicGFTicOicGKTicKKKK': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'De novo design of selective antibiotic peptides by incorporation of unnatural amino acids. Hicks RP,Bhonsle JB,Venugopal D,Koser BW J Med Chem. 2007 Jun 28;50(13):3026-36. Epub 2007 Jun 5.'], 'hemolysis': u'14.3% hemolysis at 25\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1762']}, u'FLPILGKLLSGIL': {'modifications': ['C-Terminal'], 'references': [u'A melittin-related peptide from the skin of the Japanese frog, Rana tagoi, with antimicrobial and cytolytic properties. Conlon JM,Sonnevend A,Patel M,Camasamudram V,Nowotny N,Zilahi E,Iwamuro S, Nielsen, Per ,Nielsen PF Biochem Biophys Res Commun. 2003 Jun 27;306(2):496-500.'], 'hemolysis': u'LC50 = 8\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4058']}, u'ILPWKWPWAPARR': {'modifications': ['C-Terminal'], 'references': [u'The effects of tryptophan and hydrophobicity on the structure and bioactivity of novel indolicidin derivatives with promising pharmaceutical potential. Podorieszach AP Org Biomol Chem. 2010 Apr 7;8(7):1679-87. doi: 10.1039/b921248e. Epub 2010 Feb 11.'], 'hemolysis': u'MHC = >2.6 x 10-3 g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1497']}, u'SFPFFPPGICKRLKRC': {'modifications': [], 'references': [u'Limnonectins: a new class of antimicrobial peptides from the skin secretion of the Fujian large-headed frog (Limnonectes fujianensis). Wu Y,Wang L,Zhou M,Ma C,Chen X,Bai B,Chen T Biochimie. 2011 Jun;93(6):981-7. doi: 10.1016/j.biochi.2011.03.003. Epub 2011 Mar 17.'], 'hemolysis': u'0% hemolysis upto 160\u03bcM (Non hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3780']}, u'HALWMTLLKKVLKAAAKAALNAVLVGANA': {'modifications': [], 'references': [u'Selective cytotoxicity of dermaseptin S3 toward intraerythrocytic Plasmodium falciparum and the underlying molecular basis. Ghosh JK,Shaool D,Guillaud P,Ciceron L,Mazier D,Kustanovich I,Shai Y J Biol Chem. 1997 Dec 12;272(50):31609-16.'], 'hemolysis': u'2.6% hemolysis at 10\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3807']}, u'FDLLGLVKKVASAL': {'modifications': ['C-Terminal'], 'references': [u'Venom peptides from solitary hunting wasps induce feeding disorder in lepidopteran larvae. Baek JH,Ji Y,Shin JS,Lee S Peptides. 2011 Mar;32(3):568-72. doi: 10.1016/j.peptides.2010.12.007. Epub 2010 Dec 22.'], 'hemolysis': u'Non-hemolytic', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2060']}, u'ILPWKWPWWPARR': {'modifications': ['C-Terminal'], 'references': [u'The effects of tryptophan and hydrophobicity on the structure and bioactivity of novel indolicidin derivatives with promising pharmaceutical potential. Podorieszach AP Org Biomol Chem. 2010 Apr 7;8(7):1679-87. doi: 10.1039/b921248e. Epub 2010 Feb 11.'], 'hemolysis': u'MHC = 2.8x10-3 g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1496']}, u'INWKKMAAATALKMI': {'modifications': ['C-Terminal'], 'references': [u'Structural and biological characterization of three novel mastoparan peptides from the venom of the neotropical social wasp Protopolybia exigua (Saussure). Mendes MA,de Souza BM Toxicon. 2005 Jan;45(1):101-6.'], 'hemolysis': u'40% hemolysis at 10\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1619']}, u'GFTicGGKTicGGFTicGGKTicKKKK': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', 'Non-Natural'], 'references': [u'De novo design of selective antibiotic peptides by incorporation of unnatural amino acids. Hicks RP,Bhonsle JB,Venugopal D,Koser BW J Med Chem. 2007 Jun 28;50(13):3026-36. Epub 2007 Jun 5.'], 'hemolysis': u'3.80% hemolysis at 25\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1776']}, u'GIWKSLFTKLLKG': {'modifications': ['C-Terminal'], 'references': [u'Biological activities of retro and diastereo analogs of a 13-residue peptide with antimicrobial and hemolytic activities. Subbalakshmi C,Nagaraj R J Pept Res. 2001 Jan;57(1):59-67.'], 'hemolysis': u'95-100% hemolysis at 60 \xb5g/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2097']}, u'LCYCRRRRCVCV': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'3-6% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1191']}, u'GKVLDKFGKIVGKVLKQLKKVSAVAKV': {'modifications': [], 'references': [u'Lytic activity and structural differences of amphipathic peptides derived from trialysin. Martins RM,Sforca ML,Amino R,Juliano MA,Oyama S Jr,Juliano L,Pertinhez TA,Spisni A Biochemistry. 2006 Feb 14;45(6):1765-74.'], 'hemolysis': u'50% hemolysis at 117\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1672']}, u'QQRKRKGIGAVLKVLTTGLPALISWI': {'modifications': [u'N-Terminal Modification: Acetylation'], 'references': [u'Structure-immunogenicity relationship of melittin, its transposed analogues, and D-melittin. King TP,Wade D,Coscia MR,Mitchell S,Kochoumian L J Immunol. 1994 Aug 1;153(3):1124-31.'], 'hemolysis': u'15% hemolysis at 120\u03bcM compared with melittin', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3301']}, u'MKLGLLVVLAVAVLVPSLSEQDFPSCQLKEPNQTPVEAGNMRNKREADESSEEFDLAEM': {'modifications': [], 'references': [u'Molecular cloning of grammistins, peptide toxins from the soapfish Pogonoperca punctata, by hemolytic screening of a cDNA library. Kaji T,Sugiyama N,Ishizaki S,Nagashima Y Peptides. 2006 Dec;27(12):3069-76. Epub 2006 Oct 25.'], 'hemolysis': u'79 HU/mg', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1726']}, u'alKlKlKlK': {'modifications': [u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'Antiplasmodial activity of lauryl-lysine oligomers. Radzishevsky I,Krugliak M,Ginsburg H Antimicrob Agents Chemother. 2007 May;51(5):1753-9. Epub 2007 Feb 16.'], 'hemolysis': u'24.6\xb1 1.2% hemolysis at 100 \u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1100']}, u'kklfkkiLKYL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Improvement of the efficacy of linear undecapeptides against plant-pathogenic bacteria by incorporation of D-amino acids. Guell I,Cabrefiga J,Badosa E,Ferre R,Talleda M,Bardaji E,Planas M,Feliu L Appl Environ Microbiol. 2011 Apr;77(8):2667-75. doi: 10.1128/AEM.02759-10. Epub 2011 Feb 18.'], 'hemolysis': u'6 \xb10.2% hemolytic at 250\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2874']}, u'FLSLALAALPKLFCLIFKKC': {'modifications': [], 'references': [u'Cytolytic peptides belonging to the brevinin-1 and brevinin-2 families isolated from the skin of the Japanese brown frog, Rana dybowskii. Conlon JM,Kolodziejek J,Nowotny N,Leprince J,Vaudry H,Coquet L,Jouenne T Toxicon. 2007 Nov;50(6):746-56. Epub 2007 Jul 4.'], 'hemolysis': u'LC50 <5\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3644']}, u'ILGKLLSTAWGLLSKL': {'modifications': ['C-Terminal'], 'references': [u'Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent. Conlon JM,Mechkarska M,Prajeep M,Arafat K,Zaric M,Lukic ML Amino Acids. 2013 Feb;44(2):715-23. doi: 10.1007/s00726-012-1395-7. Epub 2012 Sep 11.'], 'hemolysis': u'LC50 =6\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3185']}, u'KWKEFLKEFKEAKKEVLHEALKAISE': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Effects of net charge and the number of positively charged residues on the biological activity of amphipathic alpha-helical cationic antimicrobial peptides. Jiang Z,Vasil AI,Hale JD,Hancock RE,Vasil ML Biopolymers. 2008;90(3):369-83.'], 'hemolysis': u'MHC  >1000.0\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1138']}, u'MAQDIISTIGD': {'modifications': [u'N-Terminal Modification: Formylation'], 'references': [u'Interaction of staphylococcal delta-toxin and synthetic analogues with erythrocytes and phospholipid vesicles. Biological and physical properties of the amphipathic peptides. Alouf JE,Dufourcq J,Siffert O,Thiaudiere E Eur J Biochem. 1989 Aug 1;183(2):381-90.'], 'hemolysis': u'0% hemolysis at 1000\u03bcg (non hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3354']}, u'FKRLEKLFSKIWNWK': {'modifications': ['C-Terminal'], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC >100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3937']}, u'kkalahalkkwlpalkklahalakk': {'modifications': ['C-Terminal', u'Stereochemistry: D'], 'references': [u'Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic ?-helical peptides. Vermeer LS,Lan Y,Abbate V,Ruh E,Bui TT,Wilkinson LJ,Kanno T,Jumagulova E,Kozlowska J,Patel J,McIntyre CA,Yam WC,Siu G,Atkinson RA,Lam JK,Bansal SS, Drake, Alex ,Drake AF,Mitchell GH J Biol Chem. 2012 Oct 5;287(41):34120-33. doi: 10.1074/jbc.M112.359067. Epub 2012 Aug 6.'], 'hemolysis': u'HC50 = 79.61\xb12.80\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2629']}, u'KLLKWLKKLLK': {'modifications': ['C-Terminal'], 'references': [u'Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities. Kim SJ,Kim JS,Lee YS,Sim DW,Lee SH,Bahk YY,Lee KH,Kim EH,Park SJ,Lee BJ Molecules. 2013 Jan 11;18(1):859-76. doi: 10.3390/molecules18010859.'], 'hemolysis': u'MHC = 64\u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2596']}, u'klALKLALKALKAALKLA': {'modifications': [u'Stereochemistry: Mix'], 'references': [u'Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes. Dathe M,Schumann M,Wieprecht T,Winkler A,Beyermann M,Krause E,Matsuzaki K,Murase O Biochemistry. 1996 Sep 24;35(38):12612-22.'], 'hemolysis': u'EC50 = 7\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3458']}, u'GMASKAGAIAGKIAKVALKAL': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial properties of peptides from Xenopus granular gland secretions. Soravia E,Martini G FEBS Lett. 1988 Feb 15;228(2):337-40.'], 'hemolysis': u'7% hemolysis at 1000\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4096']}, u'IIPLPLGYFAKKT': {'modifications': [], 'references': [u'Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii. Jin LL,Li Q,Song SS,Feng K,Zhang DB,Wang QY Comp Biochem Physiol B Biochem Mol Biol. 2009 Oct;154(2):174-8. doi: 10.1016/j.cbpb.2009.05.015. Epub 2009 Jun 17.'], 'hemolysis': u'HC50 >300\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3493']}, u'KWKWKWKWKW': {'modifications': ['C-Terminal'], 'references': [u'Effect of repetitive lysine-tryptophan motifs on the bactericidal activity of antimicrobial peptides. Gopal R,Seo CH,Song PI Amino Acids. 2013 Feb;44(2):645-60. doi: 10.1007/s00726-012-1388-6. Epub 2012 Aug 23.'], 'hemolysis': u'71% hemolytic at 200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2606']}, u'FLGALFKVASKVLPSVKCAITKKC': {'modifications': [], 'references': [u'Antimicrobial peptides from the skin of a Korean frog, Rana rugosa. Park JM,Jung JE Biochem Biophys Res Commun. 1994 Nov 30;205(1):948-54.'], 'hemolysis': u'1.01% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3703']}, u'GFWKKVGSAAWGGVKAAAKGAAVGGLNALAKHIQ': {'modifications': [], 'references': [u'Halocyntin and papillosin, two new antimicrobial peptides isolated from hemocytes of the solitary tunicate, Halocynthia papillosa. Galinier R,Roger E,Sautiere PE,Aumelas A,Banaigs B J Pept Sci. 2009 Jan;15(1):48-55. doi: 10.1002/psc.1101.'], 'hemolysis': u'0% hemolysis upto 50\xb5M (Non hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3620']}, u'ILGKLLkTAAGLLSNL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent. Conlon JM,Mechkarska M,Prajeep M,Arafat K,Zaric M,Lukic ML Amino Acids. 2013 Feb;44(2):715-23. doi: 10.1007/s00726-012-1395-7. Epub 2012 Sep 11.'], 'hemolysis': u'LC50 =105\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3171']}, u'KKLFKkILKYL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Improvement of the efficacy of linear undecapeptides against plant-pathogenic bacteria by incorporation of D-amino acids. Guell I,Cabrefiga J,Badosa E,Ferre R,Talleda M,Bardaji E,Planas M,Feliu L Appl Environ Microbiol. 2011 Apr;77(8):2667-75. doi: 10.1128/AEM.02759-10. Epub 2011 Feb 18.'], 'hemolysis': u'53 \xb11.1% hemolytic at 250\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2856']}, u'alKlKlK': {'modifications': [u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'Antiplasmodial activity of lauryl-lysine oligomers. Radzishevsky I,Krugliak M,Ginsburg H Antimicrob Agents Chemother. 2007 May;51(5):1753-9. Epub 2007 Feb 16.'], 'hemolysis': u'3.4\xb10.8% hemolysis at 100 \u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1103']}, u'KLLLKLWLKLLK': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Synthesis of antibacterial pseudopeptides with less hemolytic activity from a cytotoxic peptide and their pH-dependent activity. Kim SM,Kim JM,Cho H Bioorg Med Chem Lett. 2009 Oct 1;19(19):5627-31. doi: 10.1016/j.bmcl.2009.08.031. Epub 2009 Aug 12.'], 'hemolysis': u'100% hemolysis at >50\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1455']}, u'FLFSLIPHAIGGLISAFK': {'modifications': [], 'references': [u'Antimicrobial/cytolytic peptides from the venom of the North African scorpion, Androctonus amoreuxi: biochemical and functional characterization of natural peptides and a single site-substituted analog. Almaaytah A,Zhou M,Wang L,Chen T,Walker B Peptides. 2012 Jun;35(2):291-9. doi: 10.1016/j.peptides.2012.03.016. Epub 2012 Mar 28.'], 'hemolysis': u'100%  hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2085']}, u'GSKKPVPIIYCNRRTGKCQRM': {'modifications': [], 'references': [u'Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides. Fehlbaum P,Bulet P,Chernysh S,Briand JP,Roussel JP,Letellier L,Hetru C Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1221-5.'], 'hemolysis': u'0% hemolysis at 40\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3987']}, u'MVSVSVAVQLMLGFGTFVLMLLGLVVELIKNSNKK': {'modifications': [], 'references': [u'Functional characterization of a new holin-like antibacterial protein coding gene tmp1 from goat skin surface metagenome. Rajesh T,Anthony T,Saranya S,Pushpam PL Appl Microbiol Biotechnol. 2011 Feb;89(4):1061-73. doi: 10.1007/s00253-010-2907-6. Epub 2010 Oct 7.'], 'hemolysis': u'0% hemolysis at 50\u03bcM  (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1543']}, u'klksllktlskakkkllktalkalsk': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', u'Stereochemistry: D'], 'references': [u"Rational design of ?-helical antimicrobial peptides to target Gram-negative pathogens, Acinetobacter baumannii and Pseudomonas aeruginosa: utilization of charge, 'specificity determinants,' total hydrophobicity, hydrophobe type and location as design parameters to improve the therapeutic ratio. Jiang Z,Vasil AI,Gera L,Vasil ML Chem Biol Drug Des. 2011 Apr;77(4):225-40. doi: 10.1111/j.1747-0285.2011.01086.x. Epub 2011 Feb 2."], 'hemolysis': u'HC50 =169.6\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2824']}, u'GIGKFLHSAGKFGKAFVGEIMKS': {'modifications': [], 'references': [u'Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides. Yasin B,Pang M,Turner JS,Cho Y,Dinh NN,Waring AJ,Lehrer RI Eur J Clin Microbiol Infect Dis. 2000 Mar;19(3):187-94.'], 'hemolysis': u'0% hemolysis at 80\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2442']}, u'APCLACPCAAPCAACPCKACPCLACPCKACPCAAPC': {'modifications': ['C-Terminal', 'Cyclic', 'Non-Natural'], 'references': [u'Interplay among folding, sequence, and lipophilicity in the antibacterial and hemolytic activities of alpha/beta-peptides. Schmitt MA,Weisblum B J Am Chem Soc. 2007 Jan 17;129(2):417-28.'], 'hemolysis': u'>10% hemolysis at 100 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1098']}, u'LCYTFRPRFVCV': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'0-3% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1185']}, u'KWKSFlKTFKSlKKTVLHTlLKAISS': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', u'Stereochemistry: Mix'], 'references': [u'Role of helicity on the anticancer mechanism of action of cationic-helical peptides. Huang YB,He LY,Jiang HY Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849. Epub 2012 Jun 5.'], 'hemolysis': u'MHC =81.31 \xb1 1.05\u03bcmol/L', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2650']}, u'kklfkkilKYL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Improvement of the efficacy of linear undecapeptides against plant-pathogenic bacteria by incorporation of D-amino acids. Guell I,Cabrefiga J,Badosa E,Ferre R,Talleda M,Bardaji E,Planas M,Feliu L Appl Environ Microbiol. 2011 Apr;77(8):2667-75. doi: 10.1128/AEM.02759-10. Epub 2011 Feb 18.'], 'hemolysis': u'1\xb10.2% hemolytic at 250\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2875']}, u'GIIKKIIKKIIKKIIKKI': {'modifications': ['C-Terminal'], 'references': [u'Designed antimicrobial and antitumor peptides with high selectivity. Hu J,Chen C,Zhang S,Zhao X,Xu H,Zhao X Biomacromolecules. 2011 Nov 14;12(11):3839-43. doi: 10.1021/bm201098j. Epub 2011 Oct 3.'], 'hemolysis': u'EC50 = 41\xb12\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2967']}, u'KWKKLLKKLLKLL': {'modifications': ['C-Terminal'], 'references': [u'A short alpha-helical antimicrobial peptide with antibacterial selectivity. Shin SY Biotechnol Lett. 2004 May;26(9):735-9.'], 'hemolysis': u'75% hemolytic at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2500']}, u'LNWGAILKHIIK': {'modifications': ['C-Terminal'], 'references': [u'Panurgines, novel antimicrobial peptides from the venom of communal bee Panurgus calcaratus (Hymenoptera: Andrenidae). Cujova S,Slaninova J,Monincova L,Fucik V,Bednarova L,Stokrova J,Hovorka O,Voburka Z,Straka J Amino Acids. 2013 Jul;45(1):143-57. doi: 10.1007/s00726-013-1482-4. Epub 2013 Mar 13.'], 'hemolysis': u'LC50 =119\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3717']}, u'PAICQRATATLGTVGSNTSGTTEIEACILL': {'modifications': [], 'references': [u'Potent inhibition of the classical pathway of complement by a novel C1q-binding peptide derived from the human astrovirus coat protein. Gronemus JQ,Hair PS,Crawford KB,Nyalwidhe JO,Cunnion KM Mol Immunol. 2010 Nov-Dec;48(1-3):305-13. doi: 10.1016/j.molimm.2010.07.012. Epub 2010 Aug 21.'], 'hemolysis': u'100% hemolysis at 0.77mM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1532']}, u'INWKKIFEKVKDLV': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 =100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3895']}, u'VDIHVWDGV': {'modifications': [], 'references': [u'Therapeutic potential of peptides with neutralizing ability towards the venom and toxin (CaTx-I) of crotalus adamanteus. Samy RP,Thwin MM,Stiles BG,Bow H,Chow VT Curr Top Med Chem. 2011;11(20):2540-55.'], 'hemolysis': u'3.2% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3142']}, u'GIFGKILGVGKKVLCGLSGVC': {'modifications': [], 'references': [u'Anti-infection peptidomics of amphibian skin. Li J,Xu X,Xu C,Zhou W,Zhang K,Yu H,Zhang Y,Zheng Y,Rees HH,Lai R,Yang D Mol Cell Proteomics. 2007 May;6(5):882-94. Epub 2007 Jan 31.'], 'hemolysis': u'21.6\xb17.3% hemolysis at 50\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3649']}, u'LCYTFRGRFVCV': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'0-3% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1186']}, u'HALWKNMLKGIGKLAGKAALGAVKKLVGAES': {'modifications': [], 'references': [u'Selective cytotoxicity of dermaseptin S3 toward intraerythrocytic Plasmodium falciparum and the underlying molecular basis. Ghosh JK,Shaool D,Guillaud P,Ciceron L,Mazier D,Kustanovich I,Shai Y J Biol Chem. 1997 Dec 12;272(50):31609-16.'], 'hemolysis': u'50% hemolysis at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3806']}, u'WVLVLRLGY': {'modifications': [], 'references': [u'Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity. Rathinakumar R, Walkenhorst, William ,Walkenhorst WF J Am Chem Soc. 2009 Jun 10;131(22):7609-17. doi: 10.1021/ja8093247.'], 'hemolysis': u'0.26 fractions hemolysis at 15\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1355']}, u'RDVCRNFMRR': {'modifications': [], 'references': [u'Hemolysis of erythrocytes by granulysin-derived peptides but not by granulysin. Li Q,Dong C,Deng A,Katsumata M,Nakadai A,Kawada T,Okada S,Clayberger C Antimicrob Agents Chemother. 2005 Jan;49(1):388-97.'], 'hemolysis': u'No hemolysis at 10\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1886']}, u'FLPLIGRVLSGAL': {'modifications': ['C-Terminal'], 'references': [u'Alanine scanning analysis and structure-function relationships of the frog-skin antimicrobial peptide temporin-1Ta. Grieco P,Luca V,Auriemma L,Carotenuto A,Saviello MR,Campiglia P,Barra D,Novellino E J Pept Sci. 2011 May;17(5):358-65. doi: 10.1002/psc.1350. Epub 2011 Feb 18.'], 'hemolysis': u'0% hemolytic at 1.25\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2904']}, u'INWKKIFEKVKNLV': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 >100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3893']}, u'RGGRLAYCRRRFCVAVGR': {'modifications': ['C-Terminal'], 'references': [u'Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides. Yasin B,Pang M,Turner JS,Cho Y,Dinh NN,Waring AJ,Lehrer RI Eur J Clin Microbiol Infect Dis. 2000 Mar;19(3):187-94.'], 'hemolysis': u'0% hemolysis at 80\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2439']}, u'ILPWKLPWWPWRR': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship of indolicidin, a Trp-rich antibacterial peptide. Ando S,Mitsuyasu K,Soeda Y,Hidaka M,Ito Y,Matsubara K,Shindo M,Uchida Y J Pept Sci. 2010 Apr;16(4):171-7. doi: 10.1002/psc.1217.'], 'hemolysis': u'88% hemolysis at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1472']}, u'GKFSVFGKILRSIAKVFKGVGKVRKQFKTASDLDKNQ': {'modifications': [], 'references': [u'Oxyopinins, large amphipathic peptides isolated from the venom of the wolf spider Oxyopes kitabensis with cytolytic properties and positive insecticidal cooperativity with spider neurotoxins. Corzo G,Villegas E,Gomez-Lagunas F,Possani LD,Belokoneva OS J Biol Chem. 2002 Jun 28;277(26):23627-37. Epub 2002 Apr 25.'], 'hemolysis': u'~10% hemolysis at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2187']}, u'KQLIRFLKRLDRNLWGLA': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Amphipathic alpha-helices in proteins: results from analysis of protein structures. Sharadadevi A,Sivakamasundari C Proteins. 2005 Jun 1;59(4):791-801.'], 'hemolysis': u'48% hemolysis at 10\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1642']}, u'SIRDKIKTIAIDLAKSAGTGVLKTLICKLDKSC': {'modifications': [], 'references': [u'Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata. Ma Y,Liu C,Liu X,Wu J,Yang H,Wang Y,Li J,Yu H Genomics. 2010 Jan;95(1):66-71. doi: 10.1016/j.ygeno.2009.09.004. Epub 2009 Sep 22.'], 'hemolysis': u'6.69\xb11.51% hemolysis at 100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4026']}, u'GILKKFMLHRGTKVYKMRTLSKRSH': {'modifications': [], 'references': [u'Two novel antimicrobial peptides from centipede venoms. Peng K,Kong Y,Zhai L,Wu X,Jia P,Liu J Toxicon. 2010 Feb-Mar;55(2-3):274-9. doi: 10.1016/j.toxicon.2009.07.040. Epub 2009 Aug 28.'], 'hemolysis': u'37\xb16% hemolysis at 50\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3711']}, u'IFGAIWNGIKS': {'modifications': [], 'references': [u'Purification, structure-function analysis, and molecular characterization of novel linear peptides from scorpion Opisthacanthus madagascariensis. Dai L,Corzo G,Naoki H,Andriantsiferana M Biochem Biophys Res Commun. 2002 May 24;293(5):1514-22.'], 'hemolysis': u'~0% hemolysis at 200\u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2197']}, u'AKKVFKRLGIGAVLKVLTWG': {'modifications': [], 'references': [u'Design of novel analogues with potent antibiotic activity based on the antimicrobial peptide, HP(2-9)-ME(1-12). Park Y,Kim HN,Park SN,Jang SH,Choi CH,Lim HT Biotechnol Lett. 2004 Mar;26(6):493-8.'], 'hemolysis': u'0% hemolysis upto 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4172']}, u'GFLSIVKKVLPKVNleAHMet(O)K': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Melectin MAPs: the influence of dendrimerization on antimicrobial and hemolytic activity. Niederhafner P,Bednarova L,Budesinsky M,Safarik M,Ehala S,Jezek J,Borovickova L,Fucik V,Cerovsky V Amino Acids. 2010 Nov;39(5):1553-61. doi: 10.1007/s00726-010-0626-z. Epub 2010 May 25.'], 'hemolysis': u'LC50 >200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1515']}, u'GRWKRWRKKWKKLWKKLS': {'modifications': ['C-Terminal'], 'references': [u'Cell selectivity, mechanism of action and LPS-neutralizing activity of bovine myeloid antimicrobial peptide-18 (BMAP-18) and its analogs. Lee EK,Kim YC,Nan YH Peptides. 2011 Jun;32(6):1123-30. doi: 10.1016/j.peptides.2011.03.024. Epub 2011 Apr 8.'], 'hemolysis': u'10% hemolysis at 38\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3129']}, u'LGFGTFVLMLLGLVVELIK': {'modifications': [], 'references': [u'Functional characterization of a new holin-like antibacterial protein coding gene tmp1 from goat skin surface metagenome. Rajesh T,Anthony T,Saranya S,Pushpam PL Appl Microbiol Biotechnol. 2011 Feb;89(4):1061-73. doi: 10.1007/s00253-010-2907-6. Epub 2010 Oct 7.'], 'hemolysis': u'Mild hemolytic activity at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1541']}, u'LKKWLK': {'modifications': ['C-Terminal'], 'references': [u'De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface. Kang SJ,Won HS,Choi WS J Pept Sci. 2009 Sep;15(9):583-8. doi: 10.1002/psc.1149.'], 'hemolysis': u'5.07% hemolysis at 6.3\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1375']}, u'GIRKWFKKAAHVGKKVGKVALNAYL': {'modifications': ['C-Terminal'], 'references': [u'The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents. Morash MG,Douglas SE,Robotham A,Ridley CM,Gallant JW Dis Model Mech. 2011 Sep;4(5):622-33. doi: 10.1242/dmm.007310. Epub 2011 Jul 4.'], 'hemolysis': u'50% hemolytic at >256 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2941']}, u'PICKRNGLPVCGETCTLGTCYTQGCTCSW': {'modifications': ['Cyclic'], 'references': [u'Cyclic peptides from Oldenlandia affinis DC. Molecular and biological properties. Gran L,Sletten K Chem Biodivers. 2008 Oct;5(10):2014-22. doi: 10.1002/cbdv.200890184.'], 'hemolysis': u'100% hemolysis at >0.5 mg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1267']}, u'LCYTRGRFTVCVR': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'0-3% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1212']}, u'GFWTTAAEGLKKFAKAGLASILNPK': {'modifications': [], 'references': [u'Host-defense peptides in skin secretions of the tetraploid frog Silurana epitropicalis with potent activity against methicillin-resistant Staphylococcus aureus (MRSA). Conlon JM,Mechkarska M,Prajeep M,Sonnevend A,Coquet L,Leprince J,Jouenne T,Vaudry H Peptides. 2012 Sep;37(1):113-9. doi: 10.1016/j.peptides.2012.07.005. Epub 2012 Jul 16.'], 'hemolysis': u'LC50 =105\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3155']}, u'ILGPVLGLVGNALGGLIKKI': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima. Lai R,Zheng YT,Shen JH,Liu GJ,Liu H,Lee WH,Tang SZ Peptides. 2002 Mar;23(3):427-35.'], 'hemolysis': u'90-100% hemolysis at 50\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3430']}, u'SAVGRHGRRFGLRKHRKH': {'modifications': [], 'references': [u'Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii. Jin LL,Li Q,Song SS,Feng K,Zhang DB,Wang QY Comp Biochem Physiol B Biochem Mol Biol. 2009 Oct;154(2):174-8. doi: 10.1016/j.cbpb.2009.05.015. Epub 2009 Jun 17.'], 'hemolysis': u'HC50 >300\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3494']}, u'LNWGAGLKHGGK': {'modifications': ['C-Terminal'], 'references': [u'Panurgines, novel antimicrobial peptides from the venom of communal bee Panurgus calcaratus (Hymenoptera: Andrenidae). Cujova S,Slaninova J,Monincova L,Fucik V,Bednarova L,Stokrova J,Hovorka O,Voburka Z,Straka J Amino Acids. 2013 Jul;45(1):143-57. doi: 10.1007/s00726-013-1482-4. Epub 2013 Mar 13.'], 'hemolysis': u'LC50 >200\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3735']}, u'INFLKLGKKILGAL': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 >140\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3909']}, u'GKKLLKKLKKLWKKW': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Bioactivity and the first transmission electron microscopy immunogold studies of short de novo-designed antimicrobial peptides. Azad MA,Huttunen-Hennelly HE Antimicrob Agents Chemother. 2011 May;55(5):2137-45. doi: 10.1128/AAC.01148-10. Epub 2011 Feb 7.'], 'hemolysis': u'18% hemolytic at 3.4mg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2829']}, u'GLPALISWIKRKRQQG': {'modifications': ['C-Terminal'], 'references': [u'Biological activities of C-terminal 15-residue synthetic fragment of melittin: design of an analog with improved antibacterial activity. Subbalakshmi C,Nagaraj R FEBS Lett. 1999 Apr 1;448(1):62-6.'], 'hemolysis': u'100% hemolysis at 100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3843']}, u'GLMSVLKGVLKTAGKHIFKNVGGSLLDQAKCKITGQC': {'modifications': [], 'references': [u'A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica. Conlon JM,Sonnevend A,Patel M,Al-Dhaheri K, Nielsen, Per ,Nielsen PF,Kolodziejek J,Nowotny N,Iwamuro S Regul Pept. 2004 May 15;118(3):135-41.'], 'hemolysis': u'HC50 = 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1992']}, u'LFGFLIKLIPSLFGALSNIGRNRNQ': {'modifications': [], 'references': [u'Isolation and structures of grammistins, peptide toxins from the skin secretion of the soapfish Grammistes sexlineatus. Shiomi K,Igarashi T,Yokota H,Nagashima Y Toxicon. 2000 Jan;38(1):91-103.'], 'hemolysis': u'LC50 =1.9\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2539']}, u'GKGLTicOicGRTicOicGFTicOicGRTicOicGFTicOicGRTicOicGKR': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'De novo design of selective antibiotic peptides by incorporation of unnatural amino acids. Hicks RP,Bhonsle JB,Venugopal D,Koser BW J Med Chem. 2007 Jun 28;50(13):3026-36. Epub 2007 Jun 5.'], 'hemolysis': u'100% hemolysis at 25\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1738']}, u'ILPAKAPAAPARR': {'modifications': ['C-Terminal'], 'references': [u'The effects of tryptophan and hydrophobicity on the structure and bioactivity of novel indolicidin derivatives with promising pharmaceutical potential. Podorieszach AP Org Biomol Chem. 2010 Apr 7;8(7):1679-87. doi: 10.1039/b921248e. Epub 2010 Feb 11.'], 'hemolysis': u'MHC = >6.8x10-3 g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1500']}, u'ILGKLLSTAAGLLSNL': {'modifications': ['C-Terminal'], 'references': [u'Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent. Conlon JM,Mechkarska M,Prajeep M,Arafat K,Zaric M,Lukic ML Amino Acids. 2013 Feb;44(2):715-23. doi: 10.1007/s00726-012-1395-7. Epub 2012 Sep 11.'], 'hemolysis': u'LC50 =140\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3168']}, u'GMASKAGSVLGKITKIALGAL': {'modifications': ['C-Terminal'], 'references': [u'Peptidomic analysis of skin secretions demonstrates that the allopatric populations of Xenopus muelleri (Pipidae) are not conspecific. Mechkarska M,Ahmed E,Coquet L,Leprince J,Jouenne T,Vaudry H,King JD Peptides. 2011 Jul;32(7):1502-8. doi: 10.1016/j.peptides.2011.05.025. Epub 2011 Jun 1.'], 'hemolysis': u'LC50 >200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3136']}, u'GLFSKFAGKGIKNLIFKGVKHIGKEVGMDVIRTGIDVAGCKIKGEC': {'modifications': [], 'references': [u'Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami. Conlon JM,Al-Ghaferi N,Abraham B,Jiansheng H,Cosette P,Leprince J,Jouenne T Peptides. 2006 Sep;27(9):2111-7. Epub 2006 Apr 18.'], 'hemolysis': u'LC50 = 210\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1680']}, u'GFLSSLKKSLPKSXAHSK': {'modifications': ['C-Terminal'], 'references': [u'Effect of hydrocarbon stapling on the properties of ?-helical antimicrobial peptides isolated from the venom of hymenoptera. Chapuis H,Slaninova J,Bednarova L,Monincova L,Budesinsky M Amino Acids. 2012 Nov;43(5):2047-58. doi: 10.1007/s00726-012-1283-1. Epub 2012 Apr 17.'], 'hemolysis': u'LC50  = 13.9\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2750']}, u'INWKAIIEAAKQAL': {'modifications': ['C-Terminal'], 'references': [u'Structural and biological characterization of three novel mastoparan peptides from the venom of the neotropical social wasp Protopolybia exigua (Saussure). Mendes MA,de Souza BM Toxicon. 2005 Jan;45(1):101-6.'], 'hemolysis': u'No hemolysis at 10\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1883']}, u'GIGAVLKVLTTGLPALISWI': {'modifications': [], 'references': [u'Truncated peptides from melittin and its analog with high lytic activity at endosomal pH enhance branched polyethylenimine-mediated gene transfection. Tan YX,Chen C,Wang YL,Lin S,Wang Y,Li SB,Jin XP,Gao HW,Du FS,Gong F J Gene Med. 2012 Apr;14(4):241-50. doi: 10.1002/jgm.2609.'], 'hemolysis': u'40% hemolytic at 25\u03bcM at pH 5', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2703']}, u'RRLMAAKAESR': {'modifications': [], 'references': [u'Antimicrobial activity and mechanism of action of a novel cationic ?-helical dodecapeptide, a partial sequence of cyanate lyase from rice. Takei N,Takahashi N,Takayanagi T,Ikeda A,Hashimoto K,Takagi M,Hamada T,Saitoh E,Ochiai A,Tanaka T Peptides. 2013 Apr;42:55-62. doi: 10.1016/j.peptides.2012.12.015. Epub 2012 Dec 25.'], 'hemolysis': u'No or little hemolysis upto 800\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3250']}, u'KLKFKLKQ': {'modifications': ['Cyclic'], 'references': [u'De novo designed cyclic cationic peptides as inhibitors of plant pathogenic bacteria. Monroc S,Badosa E,Feliu L,Planas M,Montesinos E Peptides. 2006 Nov;27(11):2567-74. Epub 2006 May 30.'], 'hemolysis': u'68\xb17.5% hemolysis at 360\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1685']}, u'VKKLVyPLKVKLyP': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Development of the structural basis for antimicrobial and hemolytic activities of peptides based on gramicidin S and design of novel analogs using NMR spectroscopy. McInnes C,Kondejewski LH,Hodges RS J Biol Chem. 2000 May 12;275(19):14287-94.'], 'hemolysis': u'37% hemolytic at 100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2491']}, u'RRWPLKPWKKPLI': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship of indolicidin, a Trp-rich antibacterial peptide. Ando S,Mitsuyasu K,Soeda Y,Hidaka M,Ito Y,Matsubara K,Shindo M,Uchida Y J Pept Sci. 2010 Apr;16(4):171-7. doi: 10.1002/psc.1217.'], 'hemolysis': u'9% hemolysis at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1492']}, u'AKKVFKRLEKLFS': {'modifications': [], 'references': [u'Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions. Park SC,Kim MH,Hossain MA,Shin SY,Kim Y,Stella L,Wade JD,Park Y Biochim Biophys Acta. 2008 Jan;1778(1):229-41. Epub 2007 Oct 2.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1931']}, u'KlKlK': {'modifications': [u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'Antiplasmodial activity of lauryl-lysine oligomers. Radzishevsky I,Krugliak M,Ginsburg H Antimicrob Agents Chemother. 2007 May;51(5):1753-9. Epub 2007 Feb 16.'], 'hemolysis': u'<0.1% hemolysis at 100 \u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1105']}, u'vKLKVyPLKVKLyP': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Structure-activity relationships of de novo designed cyclic antimicrobial peptides based on gramicidin S. Lee DL Biopolymers. 2003;71(1):28-48.'], 'hemolysis': u'100% hemolysis at 15-50\xb5g/m', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2293']}, u'KWKLFKKIPKFLHLAK': {'modifications': ['C-Terminal'], 'references': [u'Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs. Shin SY,Lee SH,Yang ST,Park EJ,Lee DG,Lee MK,Eom SH,Song WK,Kim Y,Hahm KS J Pept Res. 2001 Dec;58(6):504-14.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2169']}, u'SWLRDIWDWKCEVLSDFK': {'modifications': [], 'references': [u'Rational design of peptides with anti-HCV/HIV activities and enhanced specificity. Li GR,He LY,Liu XY,Liu AP,Huang YB,Qiu C,Zhang XY,Xu JQ,Yang W Chem Biol Drug Des. 2011 Nov;78(5):835-43. doi: 10.1111/j.1747-0285.2011.01201.x. Epub 2011 Sep 26.'], 'hemolysis': u'MHC =214.81\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2959']}, u'KWKSFLKTFKSAVKTVLHTALKAISS': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC =7.8\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3974']}, u'LRLKKRRWKYRV': {'modifications': ['Cyclic'], 'references': [u'Macrocyclic hairpin mimetics of the cationic antimicrobial peptide protegrin I: a new family of broad-spectrum antibiotics. Shankaramma SC,Athanassiou Z,Zerbe O,Moehle K,Mouton C,Bernardini F,Vrijbloed JW,Obrecht D Chembiochem. 2002 Nov 4;3(11):1126-33.'], 'hemolysis': u'13% hemolysis at 100\xb5g ml-1', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2275']}, u'DANVENGEDAEDLTDKFIGLMG': {'modifications': [], 'references': [u'Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs. Yang X,Lee WH J Proteome Res. 2012 Jan 1;11(1):306-19. doi: 10.1021/pr200782u. Epub 2011 Nov 18.'], 'hemolysis': u'Non-hemolytic upto 50 \u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3025']}, u'INWKKIFEKVSNLV': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 >100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3902']}, u'KKTWWKTWWTKWSQPKKKRKV': {'modifications': [], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC >200\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3958']}, u'GKVWDWIKSTAKKLWNSEPVKELKNTALNAAKNLVAEKIGATPS': {'modifications': [], 'references': [u'Antibacterial and antifungal properties of alpha-helical, cationic peptides in the venom of scorpions from southern Africa. Moerman L,Bosteels S,Noppe W,Willems J,Clynen E,Schoofs L,Thevissen K,Tytgat J,Van Eldere J,Van Der Walt J,Verdonck Eur J Biochem. 2002 Oct;269(19):4799-810.'], 'hemolysis': u'30% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3750']}, u'CYCRKGHCKRGERVRGTCGIRFLYCCPRRGLL': {'modifications': ['Cyclic'], 'references': [u'Biosynthesis and antimicrobial evaluation of backbone-cyclized ?-defensins. Garcia AE,Tai KP,Puttamadappa SS,Shekhtman A,Ouellette AJ Biochemistry. 2011 Dec 6;50(48):10508-19. doi: 10.1021/bi201430f. Epub 2011 Nov 9.'], 'hemolysis': u'4.9% hemolytic at 100 \u03bc g/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2986']}, u'HNKQEGRDHDKSKGHFHRVVIHHKGGKAH': {'modifications': [], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC >200\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3961']}, u'SWLRDIWDWACEVLSDFK': {'modifications': [], 'references': [u'Rational design of peptides with anti-HCV/HIV activities and enhanced specificity. Li GR,He LY,Liu XY,Liu AP,Huang YB,Qiu C,Zhang XY,Xu JQ,Yang W Chem Biol Drug Des. 2011 Nov;78(5):835-43. doi: 10.1111/j.1747-0285.2011.01201.x. Epub 2011 Sep 26.'], 'hemolysis': u'MHC = 14.10\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2955']}, u'KKllKLKlKwKK': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Structure and organization of hemolytic and nonhemolytic diastereomers of antimicrobial peptides in membranes. Hong J,Oren Z Biochemistry. 1999 Dec 21;38(51):16963-73.'], 'hemolysis': u'0% hemolysis at 50\u03bcM (Non hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3766']}, u'KWKLFKKIPHLAKKF': {'modifications': ['C-Terminal'], 'references': [u'Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs. Shin SY,Lee SH,Yang ST,Park EJ,Lee DG,Lee MK,Eom SH,Song WK,Kim Y,Hahm KS J Pept Res. 2001 Dec;58(6):504-14.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2170']}, u'FFHHIFRAIVHVAKTIHRLVTG': {'modifications': [], 'references': [u'Solution structure and cell selectivity of piscidin 1 and its analogues. Lee SA,Kim YK,Lim SS,Zhu WL,Ko H,Shin SY,Hahm KS Biochemistry. 2007 Mar 27;46(12):3653-63. Epub 2007 Mar 1.'], 'hemolysis': u'HC50 =6\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1112']}, u'FKCRRWQWRMKKLGAPSITCVRRAF': {'modifications': [], 'references': [u'Comparative antimicrobial activity and mechanism of action of bovine lactoferricin-derived synthetic peptides. Liu Y,Han F,Xie Y Biometals. 2011 Dec;24(6):1069-78. doi: 10.1007/s10534-011-9465-y. Epub 2011 May 24.'], 'hemolysis': u'<10% hemolytic at 256mg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2912']}, u'LNWGAKLKHIIK': {'modifications': ['C-Terminal'], 'references': [u'Panurgines, novel antimicrobial peptides from the venom of communal bee Panurgus calcaratus (Hymenoptera: Andrenidae). Cujova S,Slaninova J,Monincova L,Fucik V,Bednarova L,Stokrova J,Hovorka O,Voburka Z,Straka J Amino Acids. 2013 Jul;45(1):143-57. doi: 10.1007/s00726-013-1482-4. Epub 2013 Mar 13.'], 'hemolysis': u'LC50 >200\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3724']}, u'VRRF(Nphe)WWW(Nphe)FLRR': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC >1\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3967']}, u'KWKL\u0394FKKIGAV\u0394FKVL': {'modifications': ['Non-Natural'], 'references': [u'Alpha,beta-dehydrophenylalanine containing cecropin-melittin hybrid peptides: conformation and activity. Mathur P,Jagannathan NR J Pept Sci. 2007 Apr;13(4):253-62.'], 'hemolysis': u'~90% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1126']}, u'FALLGDFFRKSKEKIGKEFKRIVQRIKDFFRKLVPRTES': {'modifications': [], 'references': [u'PCR-based site-specific mutagenesis of peptide antibiotics FALL-39 and its biologic activities. Yang YX,Feng Y,Wang BY Acta Pharmacol Sin. 2004 Feb;25(2):239-45.'], 'hemolysis': u'40% hemolysis at 400g/l', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1581']}, u'GWKDWLNKGKEWLKKKGPGIMKAALKAATQ': {'modifications': [], 'references': [u'Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii. Orivel J,Redeker V,Le Caer JP, Krier, ,Krier F,Revol-Junelles AM,Longeon A,Chaffotte A,Dejean A J Biol Chem. 2001 May 25;276(21):17823-9. Epub 2001 Feb 22.'], 'hemolysis': u'zone of inhibition not detected at 0.4-0.5mM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2124']}, u'GIGKFLHKVGSFIKSWKGEIMNS': {'modifications': ['C-Terminal'], 'references': [u'Influence of the angle subtended by the positively charged helix face on the membrane activity of amphipathic, antibacterial peptides. Wieprecht T,Dathe M,Epand RM,Beyermann M,Krause E,Maloy WL,MacDonald DL Biochemistry. 1997 Oct 21;36(42):12869-80.'], 'hemolysis': u'EC25=24\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3589']}, u'ENAEEDIVLMENLFCSYIVGSADSFWT': {'modifications': [], 'references': [u'Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs. Yang X,Lee WH J Proteome Res. 2012 Jan 1;11(1):306-19. doi: 10.1021/pr200782u. Epub 2011 Nov 18.'], 'hemolysis': u'Non-hemolytic upto 50 \u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3024']}, u'GWLDVAKKIGKAAFNVAKNFLFNKAVNFAAKGIKKAVDLWG': {'modifications': [], 'references': [u'Effects of dimerization on the structure and biological activity of antimicrobial peptide Ctx-Ha. Lorenzon EN, Cespedes, G ,Cespedes GF, Vicente, E ,Vicente EF,Nogueira LG,Bauab TM,Castro MS Antimicrob Agents Chemother. 2012 Jun;56(6):3004-10. doi: 10.1128/AAC.06262-11. Epub 2012 Mar 5.'], 'hemolysis': u'HC50 = 0.6\xb1 0.1 \u03bcmol/L', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2713']}, u'GFTicGKTicGFTicGKTicKKKK': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', 'Non-Natural'], 'references': [u'De novo design of selective antibiotic peptides by incorporation of unnatural amino acids. Hicks RP,Bhonsle JB,Venugopal D,Koser BW J Med Chem. 2007 Jun 28;50(13):3026-36. Epub 2007 Jun 5.'], 'hemolysis': u'4.9% hemolysis at 25\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1774']}, u'FIGLLISAGKAIHDLIRRRH': {'modifications': ['C-Terminal'], 'references': [u'Purification and characterization of three isoforms of chrysophsin, a novel antimicrobial peptide in the gills of the red sea bream, Chrysophrys major. Iijima N,Tanimoto N,Emoto Y,Morita Y,Uematsu K,Murakami T Eur J Biochem. 2003 Feb;270(4):675-86.'], 'hemolysis': u'100% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3548']}, u'GFLSILKKVL': {'modifications': ['C-Terminal'], 'references': [u'Melectin: a novel antimicrobial peptide from the venom of the cleptoparasitic bee Melecta albifrons. Cerovsky V,Hovorka O,Cvacka J,Voburka Z,Bednarova L,Borovickova L,Slaninova J Chembiochem. 2008 Nov 24;9(17):2815-21. doi: 10.1002/cbic.200800476.'], 'hemolysis': u'LC50 >100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3631']}, u'KWKLKPLLKKLLKKL': {'modifications': ['C-Terminal'], 'references': [u'Antibiotic activity of Leu-Lys rich model peptides. Park Y,Lee DG Biotechnol Lett. 2003 Aug;25(16):1305-10.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2319']}, u'KKLFKKILKVL': {'modifications': ['C-Terminal', u'N-Terminal Modification: Benzoylation'], 'references': [u'A library of linear undecapeptides with bactericidal activity against phytopathogenic bacteria. Badosa E,Ferre R,Planas M,Feliu L,Besalu E,Cabrefiga J,Bardaji E Peptides. 2007 Dec;28(12):2276-85. Epub 2007 Sep 25.'], 'hemolysis': u'71\xb12.3% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1844']}, u'FSPQMLQDIIEAATAIL': {'modifications': [], 'references': [u'Functional analysis of an alpha-helical antimicrobial peptide derived from a novel mouse defensin-like gene. Kawaguchi A,Suzuki T,Kimura T,Sakai N,Ayabe T,Sawa H Biochem Biophys Res Commun. 2010 Aug 6;398(4):778-84. doi: 10.1016/j.bbrc.2010.07.028. Epub 2010 Jul 14.'], 'hemolysis': u'0% hemolysis at 200\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3086']}, u'VNWKKILGKIIKVVK': {'modifications': ['C-Terminal'], 'references': [u'Effect of hydrocarbon stapling on the properties of ?-helical antimicrobial peptides isolated from the venom of hymenoptera. Chapuis H,Slaninova J,Bednarova L,Monincova L,Budesinsky M Amino Acids. 2012 Nov;43(5):2047-58. doi: 10.1007/s00726-012-1283-1. Epub 2012 Apr 17.'], 'hemolysis': u'LC50   >200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2755']}, u'IWNKIAKSIGKVLEKAL': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 >100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3932']}, u'LGRVDIHVWDGVYI': {'modifications': [], 'references': [u'Therapeutic potential of peptides with neutralizing ability towards the venom and toxin (CaTx-I) of crotalus adamanteus. Samy RP,Thwin MM,Stiles BG,Bow H,Chow VT Curr Top Med Chem. 2011;11(20):2540-55.'], 'hemolysis': u'2.48% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3140']}, u'FLPLLAGLAANFLPKIFCAcmKITRKCAcm': {'modifications': ['Non-Natural'], 'references': [u'Structure-function studies on the amphibian peptide brevinin 1E: translocating the cationic segment from the C-terminal end to a central position favors selective antibacterial activity. Kumari VK J Pept Res. 2001 Nov;58(5):433-41.'], 'hemolysis': u'100% hemolysis  at 5\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2148']}, u'GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE': {'modifications': [u'C-Terminal Non-Amidation: [NH(CH2)2NH2]2'], 'references': [u'A class of highly potent antibacterial peptides derived from pardaxin, a pore-forming peptide isolated from Moses sole fish Pardachirus marmoratus. Oren Z Eur J Biochem. 1996 Apr 1;237(1):303-10.'], 'hemolysis': u'>100% hemolysis at 12\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3675']}, u'HFLLTLVNLAKKIK': {'modifications': ['C-Terminal'], 'references': [u'Strategies for transformation of naturally-occurring amphibian antimicrobial peptides into therapeutically valuable anti-infective agents. Conlon JM,Al-Ghaferi N,Abraham B Methods. 2007 Aug;42(4):349-57.'], 'hemolysis': u'LD50 = 500\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1803']}, u'HFLLTLVNLAKKIL': {'modifications': ['C-Terminal'], 'references': [u'Strategies for transformation of naturally-occurring amphibian antimicrobial peptides into therapeutically valuable anti-infective agents. Conlon JM,Al-Ghaferi N,Abraham B Methods. 2007 Aug;42(4):349-57.'], 'hemolysis': u'LD50 = 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1812']}, u'KLKLKLKQ': {'modifications': ['Cyclic'], 'references': [u'De novo designed cyclic cationic peptides as inhibitors of plant pathogenic bacteria. Monroc S,Badosa E,Feliu L,Planas M,Montesinos E Peptides. 2006 Nov;27(11):2567-74. Epub 2006 May 30.'], 'hemolysis': u'1\xb10.1% hemolysis at 360\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1689']}, u'KWKSFLKKLTSAAKKVLTTALKPISS': {'modifications': [], 'references': [u'Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides. Zhang L,Benz R Biochemistry. 1999 Jun 22;38(25):8102-11.'], 'hemolysis': u'MHC=64\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3593']}, u'SWSSFFKKAAHSGKHVGKSASTHYL': {'modifications': ['C-Terminal'], 'references': [u'Pleurocidin-derived antifungal peptides with selective membrane-disruption effect. Sung WS Biochem Biophys Res Commun. 2008 May 9;369(3):858-61. doi: 10.1016/j.bbrc.2008.02.109. Epub 2008 Mar 4.'], 'hemolysis': u'0% hemolytic at 100\u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2547']}, u'KLKLKLKE': {'modifications': ['Cyclic'], 'references': [u'De novo designed cyclic cationic peptides as inhibitors of plant pathogenic bacteria. Monroc S,Badosa E,Feliu L,Planas M,Montesinos E Peptides. 2006 Nov;27(11):2567-74. Epub 2006 May 30.'], 'hemolysis': u'0% hemolysis at 360\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1909']}, u'fPVOAdaAfPVOAdaA': {'modifications': ['Cyclic', u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'An adamantyl amino acid containing gramicidin S analogue with broad spectrum antibacterial activity and reduced hemolytic activity. Kapoerchan VV,Knijnenburg AD,Niamat M,Spalburg E,de Neeling AJ,Nibbering PH,Mars-Groenendijk RH,Noort D,Otero JM,Llamas-Saiz AL,van Raaij MJ,van der Marel GA,Overkleeft HS Chemistry. 2010 Oct 25;16(40):12174-81. doi: 10.1002/chem.201001686.'], 'hemolysis': u'HC50 =10.3\xb11.07\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2794']}, u'GVWTTILGGLKKFAKGGLEALTNPK': {'modifications': [], 'references': [u'Host-defense peptides in skin secretions of the tetraploid frog Silurana epitropicalis with potent activity against methicillin-resistant Staphylococcus aureus (MRSA). Conlon JM,Mechkarska M,Prajeep M,Sonnevend A,Coquet L,Leprince J,Jouenne T,Vaudry H Peptides. 2012 Sep;37(1):113-9. doi: 10.1016/j.peptides.2012.07.005. Epub 2012 Jul 16.'], 'hemolysis': u'LC50 =60\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3156']}, u'INWKKLLDAAKQIL': {'modifications': ['C-Terminal'], 'references': [u'The effect of acidic residues and amphipathicity on the lytic activities of mastoparan peptides studied by fluorescence and CD spectroscopy. Leite NB,da Costa LC,Dos Santos Alvares D,Dos Santos Cabrera MP,de Souza BM,Palma MS Amino Acids. 2011 Jan;40(1):91-100. doi: 10.1007/s00726-010-0511-9. Epub 2010 Mar 1.'], 'hemolysis': u'EC50 =26 \u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1469']}, u'GIGAVLKVLTTGLpALISWIKRKRQQ': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', u'Stereochemistry: Mix'], 'references': [u'Structure and activity of D-Pro14 melittin. Hewish DR,Barnham KJ,Werkmeister JA,Kirkpatrick A,Bartone N,Liu ST,Norton RS,Curtain C J Protein Chem. 2002 May;21(4):243-53.'], 'hemolysis': u'50% hemolysis at >200\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2476']}, u'AibGLAibGGLAibGIL': {'modifications': [u'C-Terminal Non-Amidation: Methoxy (Ome)', u'N-Terminal Modification: Acetylated by lipol (n-octanoyl)', 'Non-Natural'], 'references': [u'Trichogin GA IV: an antibacterial and protease-resistant peptide. De Zotti M,Biondi B,Formaggio F,Toniolo C,Stella L,Park Y J Pept Sci. 2009 Sep;15(9):615-9. doi: 10.1002/psc.1135.'], 'hemolysis': u'2% hemolysis at 15 \u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1293']}, u'HFKGTLVNLAKKIL': {'modifications': ['C-Terminal'], 'references': [u'Strategies for transformation of naturally-occurring amphibian antimicrobial peptides into therapeutically valuable anti-infective agents. Conlon JM,Al-Ghaferi N,Abraham B Methods. 2007 Aug;42(4):349-57.'], 'hemolysis': u'LD50 = 500\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1794']}, u'FWGALAKGALKLIPSLFSSFSKKD': {'modifications': [], 'references': [u"Pore formation of phospholipid membranes by the action of two hemolytic arachnid peptides of different size. Belokoneva OS,Satake H,Mal'tseva EL,Pal'mina NP,Villegas E,Nakajima T Biochim Biophys Acta. 2004 Aug 30;1664(2):182-8."], 'hemolysis': u'100% hemolysis at 25\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4066']}, u'KLllKWKlKlLK': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Structure and organization of hemolytic and nonhemolytic diastereomers of antimicrobial peptides in membranes. Hong J,Oren Z Biochemistry. 1999 Dec 21;38(51):16963-73.'], 'hemolysis': u'0% hemolysis at 50\u03bcM (Non hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3762']}, u'KLLKKLLKWLK': {'modifications': ['C-Terminal'], 'references': [u'Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities. Kim SJ,Kim JS,Lee YS,Sim DW,Lee SH,Bahk YY,Lee KH,Kim EH,Park SJ,Lee BJ Molecules. 2013 Jan 11;18(1):859-76. doi: 10.3390/molecules18010859.'], 'hemolysis': u'MHC = 64\u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2600']}, u'VRRFPWWWPFLRR': {'modifications': ['C-Terminal'], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC =50\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3966']}, u'GLFGKSSVWGRKYYVDLAGCAKA': {'modifications': [], 'references': [u'Anti-infection peptidomics of amphibian skin. Li J,Xu X,Xu C,Zhou W,Zhang K,Yu H,Zhang Y,Zheng Y,Rees HH,Lai R,Yang D Mol Cell Proteomics. 2007 May;6(5):882-94. Epub 2007 Jan 31.'], 'hemolysis': u'17.6\xb12.2% hemolysis at 50\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3648']}, u'ILPWKWKFFPWRR': {'modifications': ['C-Terminal'], 'references': [u'Coupling molecular dynamics simulations with experiments for the rational design of indolicidin-analogous antimicrobial peptides. Tsai CW,Hsu NY,Wang CH,Lu CY,Chang Y,Tsai HH J Mol Biol. 2009 Sep 25;392(3):837-54. doi: 10.1016/j.jmb.2009.06.071. Epub 2009 Jul 2.'], 'hemolysis': u'10% hemolysis at 64\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1453']}, u'LKWGAILKHIIK': {'modifications': ['C-Terminal'], 'references': [u'Panurgines, novel antimicrobial peptides from the venom of communal bee Panurgus calcaratus (Hymenoptera: Andrenidae). Cujova S,Slaninova J,Monincova L,Fucik V,Bednarova L,Stokrova J,Hovorka O,Voburka Z,Straka J Amino Acids. 2013 Jul;45(1):143-57. doi: 10.1007/s00726-013-1482-4. Epub 2013 Mar 13.'], 'hemolysis': u'LC50 >200\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3720']}, u'ZCRRLSYKQRSVTYCRGR': {'modifications': ['C-Terminal', 'Cyclic', 'Non-Natural'], 'references': [u'Structure-activity relationship studies of gomesin: importance of the disulfide bridges for conformation, bioactivities, and serum stability. Fazio MA,Oliveira VX Jr,Bulet P,Miranda MT,Daffre S Biopolymers. 2006;84(2):205-18.'], 'hemolysis': u'<10% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4197']}, u'KWKSFAKTFKSAKKTVLHTAAKAISS': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides. Chen Y,Guarnieri MT,Vasil AI,Vasil ML,Mant CT Antimicrob Agents Chemother. 2007 Apr;51(4):1398-406. Epub 2006 Dec 11.'], 'hemolysis': u'MHC =1000 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1083']}, u'MESQSDAVQLMLGFGTFVLMLLGLVVELIKNSNKK': {'modifications': [], 'references': [u'Functional characterization of a new holin-like antibacterial protein coding gene tmp1 from goat skin surface metagenome. Rajesh T,Anthony T,Saranya S,Pushpam PL Appl Microbiol Biotechnol. 2011 Feb;89(4):1061-73. doi: 10.1007/s00253-010-2907-6. Epub 2010 Oct 7.'], 'hemolysis': u'0% hemolysis at 50\u03bcM  (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1547']}, u'k\u03a8[CH2NH]KVVFKVKFKk': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'The comparison of characteristics between membrane-active antifungal peptide and its pseudopeptides. Oh JE,Hong SY Bioorg Med Chem. 1999 Nov;7(11):2509-15.'], 'hemolysis': u'0% hemolysis upto 500 \u03bcg/mL (Non hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3768']}, u'SMWSGMWRRKLKKLRNALKKKLKGE': {'modifications': [], 'references': [u'Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity. Kozlov SA,Vassilevski AA,Feofanov AV,Surovoy AY,Karpunin DV J Biol Chem. 2006 Jul 28;281(30):20983-92. Epub 2006 May 30.'], 'hemolysis': u'20% hemolysis at 80\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4051']}, u'KVFKRLEKLFS': {'modifications': [], 'references': [u'Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions. Park SC,Kim MH,Hossain MA,Shin SY,Kim Y,Stella L,Wade JD,Park Y Biochim Biophys Acta. 2008 Jan;1778(1):229-41. Epub 2007 Oct 2.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1933']}, u'GRDYRTSLTIVQKLKKMVD': {'modifications': [], 'references': [u'Hemolysis of erythrocytes by granulysin-derived peptides but not by granulysin. Li Q,Dong C,Deng A,Katsumata M,Nakadai A,Kawada T,Okada S,Clayberger C Antimicrob Agents Chemother. 2005 Jan;49(1):388-97.'], 'hemolysis': u'No hemolysis at 10\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1885']}, u'KWKLFKKIGIGKFLHSAKKF': {'modifications': ['C-Terminal'], 'references': [u'NMR structural characterization of cecropin A(1-8) - magainin 2(1-12) and cecropin A (1-8) - melittin (1-12) hybrid peptides. Oh D,Shin SY,Kang JH,Hahm KS,Kim KL J Pept Res. 1999 May;53(5):578-89.'], 'hemolysis': u'0% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3866']}, u'KWKKFKKIGAVLKVL': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Lysine-enriched cecropin-mellitin antimicrobial peptides with enhanced selectivity. Sato H Antimicrob Agents Chemother. 2008 Dec;52(12):4463-5. doi: 10.1128/AAC.00810-08. Epub 2008 Oct 13.'], 'hemolysis': u'21% hemolysis at 64\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1259']}, u'GKFSGFAKILKSIAKFFKGVGKVRKQFKEASDLDKNQ': {'modifications': [], 'references': [u'The hemolytic activity of six arachnid cationic peptides is affected by the phosphatidylcholine-to-sphingomyelin ratio in lipid bilayers. Belokoneva OS,Villegas E,Corzo G,Dai L Biochim Biophys Acta. 2003 Oct 31;1617(1-2):22-30.'], 'hemolysis': u'100% hemolysis at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2347']}, u'GWANTLKNVAGGLCKITGAA': {'modifications': [], 'references': [u'Novel families of antimicrobial peptides with multiple functions from skin of Xizang plateau frog, Nanorana parkeri. Lu Z,Zhai L,Wang H,Che Q,Wang D,Feng F,Zhao Z Biochimie. 2010 May;92(5):475-81. doi: 10.1016/j.biochi.2010.01.025. Epub 2010 Feb 12.'], 'hemolysis': u'2.36% hemolysis at 80\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1074']}, u'KKKKKKAAAFAAAAAFAAWAAFAAA': {'modifications': ['C-Terminal'], 'references': [u'Cationic hydrophobic peptides with antimicrobial activity. Stark M,Liu LP Antimicrob Agents Chemother. 2002 Nov;46(11):3585-90.'], 'hemolysis': u'11% hemolysis at 50\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2229']}, u'FLSIIAKVLGSLF': {'modifications': ['C-Terminal'], 'references': [u'Purification and characterization of antimicrobial peptides from the skin secretions of the carpenter frog Rana virgatipes (Ranidae, Aquarana). Conlon JM,Abraham B,Sonnevend A,Jouenne T,Cosette P,Leprince J,Vaudry H Regul Pept. 2005 Nov;131(1-3):38-45.'], 'hemolysis': u'LD50 =30\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3891']}, u'GRIKRIRKKIKKLIKKLS': {'modifications': ['C-Terminal'], 'references': [u'Cell selectivity, mechanism of action and LPS-neutralizing activity of bovine myeloid antimicrobial peptide-18 (BMAP-18) and its analogs. Lee EK,Kim YC,Nan YH Peptides. 2011 Jun;32(6):1123-30. doi: 10.1016/j.peptides.2011.03.024. Epub 2011 Apr 8.'], 'hemolysis': u'10% hemolysis at 265\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3131']}, u'SRWRDVARNFMRRYQSRVIQGLVA': {'modifications': [], 'references': [u'Bactericidal and hemolytic activities of synthetic peptides derived from granulysin. Siano A,Tonarelli G,Imaz MS,Perin JC,Ruggeri N,Lopez M,Santi MN Protein Pept Lett. 2010 Apr;17(4):517-21.'], 'hemolysis': u'100% hemolysis at 200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3053']}, u'GFLGPLLKLAAKGVAKVIPHLIPSRQQ': {'modifications': [], 'references': [u'Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae). Ali, M ,Ali MF,Soto A,Knoop FC Biochim Biophys Acta. 2001 Nov 26;1550(1):81-9.'], 'hemolysis': u'HC50 =90\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3476']}, u'GLWSKIKTAGKSVAKAAAKAAVKAVTNAV': {'modifications': [], 'references': [u'The vertebrate peptide antibiotics dermaseptins have overlapping structural features but target specific microorganisms. Mor A,Hani K J Biol Chem. 1994 Dec 16;269(50):31635-41.'], 'hemolysis': u'100% hemolysis at >90\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3694']}, u'RGGRLCYCRRRFCVCVGR': {'modifications': ['C-Terminal', 'Cyclic'], 'references': [u'A family of macrocyclic antibiotics with a mixed peptide-peptoid beta-hairpin backbone conformation. Shankaramma SC,Moehle K,James S,Vrijbloed JW,Obrecht D Chem Commun (Camb). 2003 Aug 7;(15):1842-3.'], 'hemolysis': u'37% hemolytic at 100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2506']}, u'GFRSILKKVSPKVXAHXK': {'modifications': ['C-Terminal'], 'references': [u'Effect of hydrocarbon stapling on the properties of ?-helical antimicrobial peptides isolated from the venom of hymenoptera. Chapuis H,Slaninova J,Bednarova L,Monincova L,Budesinsky M Amino Acids. 2012 Nov;43(5):2047-58. doi: 10.1007/s00726-012-1283-1. Epub 2012 Apr 17.'], 'hemolysis': u'LC50  = 20\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2752']}, u'GFFALIPKIISSPLFKTLLSAV': {'modifications': [u'C-Terminal Non-Amidation: NH(CH2)2NH2'], 'references': [u'A comparative study on the structure and function of a cytolytic alpha-helical peptide and its antimicrobial beta-sheet diastereomer. Oren Z,Hong J Eur J Biochem. 1999 Jan;259(1-2):360-9.'], 'hemolysis': u'22% hemolysis at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3833']}, u'SADVAGAVIDGASLSFKILKTVLEALGNVKRK': {'modifications': [], 'references': [u'Structure and activity of the N-terminal region of the eukaryotic cytolysin equinatoxin II. Drechsler A,Potrich C,Sabo JK,Frisanco M,Guella G,Dalla Serra M,Anderluh G,Separovic F Biochemistry. 2006 Feb 14;45(6):1818-28.'], 'hemolysis': u'Non-hemolytic', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1903']}, u'MLSLSDAVQLMLGFGTFVLMLLGLVVELIKNSNKK': {'modifications': [], 'references': [u'Functional characterization of a new holin-like antibacterial protein coding gene tmp1 from goat skin surface metagenome. Rajesh T,Anthony T,Saranya S,Pushpam PL Appl Microbiol Biotechnol. 2011 Feb;89(4):1061-73. doi: 10.1007/s00253-010-2907-6. Epub 2010 Oct 7.'], 'hemolysis': u'0% hemolysis at 50\u03bcM  (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1545']}, u'KWASLWNWFNITNWLWYIK': {'modifications': ['C-Terminal'], 'references': [u'Design of a novel tryptophan-rich membrane-active antimicrobial peptide from the membrane-proximal region of the HIV glycoprotein, gp41. Haney, Evan ,Haney EF,Nguyen LT,Schibli DJ Beilstein J Org Chem. 2012;8:1172-84. Epub 2012 Jul 24.'], 'hemolysis': u'EC50 =550\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2616']}, u'LSPAVMASLA': {'modifications': ['C-Terminal'], 'references': [u'Venom peptides from solitary hunting wasps induce feeding disorder in lepidopteran larvae. Baek JH,Ji Y,Shin JS,Lee S Peptides. 2011 Mar;32(3):568-72. doi: 10.1016/j.peptides.2010.12.007. Epub 2010 Dec 22.'], 'hemolysis': u'Non-hemolytic', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2064']}, u'WLNALLHHGLNCAKGVLAWLNALLHHGLNCAKGVLA': {'modifications': [], 'references': [u'Halocidin: a new antimicrobial peptide from hemocytes of the solitary tunicate, Halocynthia aurantium. Jang WS,Kim KN,Lee YS,Nam MH FEBS Lett. 2002 Jun 19;521(1-3):81-6.'], 'hemolysis': u'>10% hemolysis at 100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3540']}, u'RKCNFLCKLKEKLRTVITSHIDKVLRPQG': {'modifications': [], 'references': [u'Structure and function of a potent lipopolysaccharide-binding antimicrobial and anti-inflammatory peptide. Wei L,Yang J,He X,Mo G,Hong J,Yan X,Lin D J Med Chem. 2013 May 9;56(9):3546-56. doi: 10.1021/jm4004158. Epub 2013 Apr 29.'], 'hemolysis': u'5.5% hemolysis at 50\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2072']}, u'fPOVO': {'modifications': ['Cyclic', u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'An adamantyl amino acid containing gramicidin S analogue with broad spectrum antibacterial activity and reduced hemolytic activity. Kapoerchan VV,Knijnenburg AD,Niamat M,Spalburg E,de Neeling AJ,Nibbering PH,Mars-Groenendijk RH,Noort D,Otero JM,Llamas-Saiz AL,van Raaij MJ,van der Marel GA,Overkleeft HS Chemistry. 2010 Oct 25;16(40):12174-81. doi: 10.1002/chem.201001686.'], 'hemolysis': u'Non-hemolytic', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2798']}, u'LLRRLLRR': {'modifications': ['C-Terminal'], 'references': [u'Synthetic cationic amphiphilic ?-helical peptides as antimicrobial agents. Wiradharma N,Khoe U,Hauser CA,Seow SV,Zhang S Biomaterials. 2011 Mar;32(8):2204-12. doi: 10.1016/j.biomaterials.2010.11.054. Epub 2010 Dec 18.'], 'hemolysis': u'HC50 > 500', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2046']}, u'FLKPLFNAALKLLP': {'modifications': [], 'references': [u'Identification and characterization of two novel antimicrobial peptides, temporin-Ra and temporin-Rb, from skin secretions of the marsh frog (Rana ridibunda). Asoodeh A,Zardini HZ J Pept Sci. 2012 Jan;18(1):10-6. doi: 10.1002/psc.1409. Epub 2011 Sep 29.'], 'hemolysis': u'1.3% hemolysis at 60\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3609']}, u'GTicOicKTicOicGTicOicKTicKKKK': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', 'Non-Natural'], 'references': [u'De novo design of selective antibiotic peptides by incorporation of unnatural amino acids. Hicks RP,Bhonsle JB,Venugopal D,Koser BW J Med Chem. 2007 Jun 28;50(13):3026-36. Epub 2007 Jun 5.'], 'hemolysis': u'9.2% hemolysis at 25\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1770']}, u'KRLFKKLLFSLRKY': {'modifications': [], 'references': [u'Fungicidal effect of three new synthetic cationic peptides against Candida albicans. Nikawa H,Fukushima H,Makihira S,Hamada T Oral Dis. 2004 Jul;10(4):221-8.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1874']}, u'PKLLETFLSKWIG': {'modifications': [], 'references': [u'Change of glutamic acid to lysine in a 13-residue antibacterial and hemolytic peptide results in enhanced antibacterial activity without increase in hemolytic activity. Sitaram N,Chandy M,Pillai VN Antimicrob Agents Chemother. 1992 Nov;36(11):2468-72.'], 'hemolysis': u'10% hemolysis at 9\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3305']}, u'FLGFLKNLF': {'modifications': [], 'references': [u'Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus. Hong W,Zhang R,Di Z,He Y,Zhao Z,Hu J,Wu Y,Li W Biomaterials. 2013 Apr;34(13):3511-22. doi: 10.1016/j.biomaterials.2013.01.075. Epub 2013 Feb 13.'], 'hemolysis': u'HC50 =137.9\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3258']}, u'GFLSILKKVLAKVMAHMK': {'modifications': ['C-Terminal'], 'references': [u'Melectin: a novel antimicrobial peptide from the venom of the cleptoparasitic bee Melecta albifrons. Cerovsky V,Hovorka O,Cvacka J,Voburka Z,Bednarova L,Borovickova L,Slaninova J Chembiochem. 2008 Nov 24;9(17):2815-21. doi: 10.1002/cbic.200800476.'], 'hemolysis': u'LC50 = 29.7\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3624']}, u'GWMSEKKVQGILDKKLPEGIIRNAAKAIVHKMAKMQFGCFANVDVKGDCKRHCKAEDKEGICHGTKCKCGVPISYL': {'modifications': [], 'references': [u'Cytolytic and K+ channel blocking activities of beta-KTx and scorpine-like peptides purified from scorpion venoms. Diego-Garcia E,Abdel-Mottaleb Y, Schwartz, E ,Schwartz EF,de la Vega RC,Tytgat J Cell Mol Life Sci. 2008 Jan;65(1):187-200.'], 'hemolysis': u'No hemolysis at 200nM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3632']}, u'LLkLLkKllKKLlKL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'The consequence of sequence alteration of an amphipathic alpha-helical antimicrobial peptide and its diastereomers. Papo N,Oren Z,Pag U,Sahl HG J Biol Chem. 2002 Sep 13;277(37):33913-21. Epub 2002 Jul 10.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2203']}, u'CAESCVWIPCTVTALLGCSCSNNVCYNGIP': {'modifications': ['Cyclic'], 'references': [u'Cycloviolacin H4, a hydrophobic cyclotide from Viola hederaceae. Chen B,Colgrave ML,Wang C J Nat Prod. 2006 Jan;69(1):23-8.'], 'hemolysis': u'HD50 =5.5\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3995']}, u'FVRWFSRFLGRIL': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship, conformational and biological studies of temporin L analogues. Mangoni ML,Carotenuto A,Auriemma L,Saviello MR,Campiglia P,Gomez-Monterrey I,Malfi S,Marcellini L,Barra D,Novellino E J Med Chem. 2011 Mar 10;54(5):1298-307. doi: 10.1021/jm1012853. Epub 2011 Feb 14.'], 'hemolysis': u'43% hemolytic at 6\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2843']}, u'KWKSFLKTFKSLKkTVLHTLLKAISS': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', u'Stereochemistry: Mix'], 'references': [u'Role of helicity on the anticancer mechanism of action of cationic-helical peptides. Huang YB,He LY,Jiang HY Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849. Epub 2012 Jun 5.'], 'hemolysis': u'MHC = 5.20 \xb1 0.02\u03bcmol/L', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2636']}, u'LLkKLlKllLKLlKK': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'The consequence of sequence alteration of an amphipathic alpha-helical antimicrobial peptide and its diastereomers. Papo N,Oren Z,Pag U,Sahl HG J Biol Chem. 2002 Sep 13;277(37):33913-21. Epub 2002 Jul 10.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2202']}, u'KAaaKWAaKaAK': {'modifications': ['C-Terminal', u'N-Terminal Modification: Palmitoylation', u'Stereochemistry: Mix'], 'references': [u'A new group of antifungal and antibacterial lipopeptides derived from non-membrane active peptides conjugated to palmitic acid. Avrahami D J Biol Chem. 2004 Mar 26;279(13):12277-85. Epub 2004 Jan 6.'], 'hemolysis': u'<25% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1565']}, u'VRRYPWWWPYLRR': {'modifications': ['C-Terminal'], 'references': [u'Structure-function analysis of tritrpticin analogs: potential relationships between antimicrobial activities, model membrane interactions, and their micelle-bound NMR structures. Schibli DJ,Nguyen LT,Kernaghan SD,Rekdal O Biophys J. 2006 Dec 15;91(12):4413-26. Epub 2006 Sep 22.'], 'hemolysis': u'EC50 = 220\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1715']}, u'LNWGAWLKHWWK': {'modifications': ['C-Terminal'], 'references': [u'Panurgines, novel antimicrobial peptides from the venom of communal bee Panurgus calcaratus (Hymenoptera: Andrenidae). Cujova S,Slaninova J,Monincova L,Fucik V,Bednarova L,Stokrova J,Hovorka O,Voburka Z,Straka J Amino Acids. 2013 Jul;45(1):143-57. doi: 10.1007/s00726-013-1482-4. Epub 2013 Mar 13.'], 'hemolysis': u'LC50 =132\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3739']}, u'ILGKLLSTAAGLLSkL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent. Conlon JM,Mechkarska M,Prajeep M,Arafat K,Zaric M,Lukic ML Amino Acids. 2013 Feb;44(2):715-23. doi: 10.1007/s00726-012-1395-7. Epub 2012 Sep 11.'], 'hemolysis': u'LC50 =310\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3176']}, u'LRRLWLRANRLLRRLWLRANRL': {'modifications': [], 'references': [u'Rational design of cationic antimicrobial peptides by the tandem of leucine-rich repeat. Ma QQ, Lv, Y ,Lv YF,Gu Y,Dong N,Li DS Amino Acids. 2013 Apr;44(4):1215-24. doi: 10.1007/s00726-012-1457-x. Epub 2013 Feb 22.'], 'hemolysis': u'~70% hemolysis at 128\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2069']}, u'GFGSFLGKALKAGLKLGANLLGGAPQQ': {'modifications': [], 'references': [u'Host-defense peptides from skin secretions of the tetraploid frogs Xenopus petersii and Xenopus pygmaeus, and the octoploid frog Xenopus lenduensis (Pipidae). King JD,Mechkarska M,Coquet L,Leprince J,Jouenne T,Vaudry H,Takada K Peptides. 2012 Jan;33(1):35-43. doi: 10.1016/j.peptides.2011.11.015. Epub 2011 Nov 22.'], 'hemolysis': u'LC50 = 145 \xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2008']}, u'LNWGAAcaLKHAcaAcaK': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Panurgines, novel antimicrobial peptides from the venom of communal bee Panurgus calcaratus (Hymenoptera: Andrenidae). Cujova S,Slaninova J,Monincova L,Fucik V,Bednarova L,Stokrova J,Hovorka O,Voburka Z,Straka J Amino Acids. 2013 Jul;45(1):143-57. doi: 10.1007/s00726-013-1482-4. Epub 2013 Mar 13.'], 'hemolysis': u'LC50 =43\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3738']}, u'INSLKLGKKILGAL': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 >100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3911']}, u'KKLLKKLLKWL': {'modifications': ['C-Terminal'], 'references': [u'Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities. Kim SJ,Kim JS,Lee YS,Sim DW,Lee SH,Bahk YY,Lee KH,Kim EH,Park SJ,Lee BJ Molecules. 2013 Jan 11;18(1):859-76. doi: 10.3390/molecules18010859.'], 'hemolysis': u'MHC = 32\u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2601']}, u'KWKLFKKIPKFLHLAKKF': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial and anti-inflammatory activities of designed antimicrobial peptide P18 analogues. Nan YH Protein Pept Lett. 2008;15(8):861-5.'], 'hemolysis': u'MHC =50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3980']}, u'FLGWLFKWAWK': {'modifications': ['C-Terminal'], 'references': [u'Activity optimization of an undecapeptide analogue derived from a frog-skin antimicrobial peptide. Won HS,Kang SJ,Choi WS Mol Cells. 2011 Jan;31(1):49-54. doi: 10.1007/s10059-011-0005-y. Epub 2010 Nov 23.'], 'hemolysis': u'MHC =50\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1554']}, u'LSPAAMASLA': {'modifications': ['C-Terminal'], 'references': [u'Venom peptides from solitary hunting wasps induce feeding disorder in lepidopteran larvae. Baek JH,Ji Y,Shin JS,Lee S Peptides. 2011 Mar;32(3):568-72. doi: 10.1016/j.peptides.2010.12.007. Epub 2010 Dec 22.'], 'hemolysis': u'Non-hemolytic', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2065']}, u'RLYRKVYGRLYRKVYGRLYRKVYGRLYRKVYGKKK': {'modifications': ['Cyclic'], 'references': [u'Antimicrobial dendrimeric peptides. Tam JP,Lu YA Eur J Biochem. 2002 Feb;269(3):923-32.'], 'hemolysis': u'EC50 = 610\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2415']}, u'FLPLIGRVLSGIA': {'modifications': ['C-Terminal'], 'references': [u'Alanine scanning analysis and structure-function relationships of the frog-skin antimicrobial peptide temporin-1Ta. Grieco P,Luca V,Auriemma L,Carotenuto A,Saviello MR,Campiglia P,Barra D,Novellino E J Pept Sci. 2011 May;17(5):358-65. doi: 10.1002/psc.1350. Epub 2011 Feb 18.'], 'hemolysis': u'0% hemolytic at 1.25\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2906']}, u'FLPLIGRVLSGIL': {'modifications': ['C-Terminal'], 'references': [u'Temporins, small antimicrobial peptides with leishmanicidal activity. Mangoni ML,Saugar JM,Dellisanti M,Barra D,Simmaco M J Biol Chem. 2005 Jan 14;280(2):984-90. Epub 2004 Oct 28.'], 'hemolysis': u'LC50 >120\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4110']}, u'MFTMKKSMLLIVLLGIISLSLCEQERNADEDEQSEMKRISFKKGKGSWIKNGLIKGIKGLGKEISLDVIRTGIDIAGCKIKGEC': {'modifications': [], 'references': [u'Molecular cloning and characterization of antimicrobial peptides from skin of the broad-folded frog, Hylarana latouchii. Wang H,Yu Z,Hu Y,Yu H,Ran R,Xia J,Wang D,Yang S,Yang X Biochimie. 2012 Jun;94(6):1317-26. doi: 10.1016/j.biochi.2012.02.032. Epub 2012 Mar 8.'], 'hemolysis': u'LD50 > 480\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2079']}, u'AVAVVGQATQIAKKWKLFKKIEKVGQ': {'modifications': ['C-Terminal'], 'references': [u'Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids. Boman HG,Wade D,Boman IA,Wahlin B FEBS Lett. 1989 Dec 18;259(1):103-6.'], 'hemolysis': u'Lethal concentration calculated from zone of inhibition  >300\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3562']}, u'FDLLGLVKSVVSAL': {'modifications': ['C-Terminal'], 'references': [u'Venom peptides from solitary hunting wasps induce feeding disorder in lepidopteran larvae. Baek JH,Ji Y,Shin JS,Lee S Peptides. 2011 Mar;32(3):568-72. doi: 10.1016/j.peptides.2010.12.007. Epub 2010 Dec 22.'], 'hemolysis': u'EC50 = 64 (68\u201370)\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2061']}, u'KVFKRLEKLFSKI': {'modifications': [], 'references': [u'Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions. Park SC,Kim MH,Hossain MA,Shin SY,Kim Y,Stella L,Wade JD,Park Y Biochim Biophys Acta. 2008 Jan;1778(1):229-41. Epub 2007 Oct 2.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1932']}, u'KKAAHVGKHVGKAALTHYL': {'modifications': ['C-Terminal'], 'references': [u'Influence of the hydrophobic amino acids in the N- and C-terminal regions of pleurocidin on antifungal activity. Lee J J Microbiol Biotechnol. 2010 Aug;20(8):1192-5.'], 'hemolysis': u'0% hemolytic at 100\u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2788']}, u'IDWSKIFEKVKNLV': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 >100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3898']}, u'NAGSLLSGWG': {'modifications': [], 'references': [u'Characterization of the novel antibacterial peptide Leucrocin from crocodile (Crocodylus siamensis) white blood cell extracts. Pata S,Yaraksa N,Daduang S,Temsiripong Y,Svasti J,Araki T Dev Comp Immunol. 2011 May;35(5):545-53. doi: 10.1016/j.dci.2010.12.011. Epub 2010 Dec 22.'], 'hemolysis': u'11.63% hemolysis at 6.0\u03bcg', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1563']}, u'HAEHKVKIGVEQKYGQFPQGTEVTYTCSGNYFLM': {'modifications': [], 'references': [u'High therapeutic index of factor C Sushi peptides: potent antimicrobials against Pseudomonas aeruginosa. Yau YH,Ho B,Tan NS,Ng ML Antimicrob Agents Chemother. 2001 Oct;45(10):2820-5.'], 'hemolysis': u'8% hemolysis at 100 \xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2133']}, u'KWKLFKKISKFLHLAKKF': {'modifications': ['C-Terminal'], 'references': [u'Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs. Shin SY,Lee SH,Yang ST,Park EJ,Lee DG,Lee MK,Eom SH,Song WK,Kim Y,Hahm KS J Pept Res. 2001 Dec;58(6):504-14.'], 'hemolysis': u'50.4% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2157']}, u'WKKIASIGKEVLKAL': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 >>100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3925']}, u'VKLyVyPLKVKLyP': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Effects of single D-amino acid substitutions on disruption of beta-sheet structure and hydrophobicity in cyclic 14-residue antimicrobial peptide analogs related to gramicidin S. Lee DL,Powers JP,Pflegerl K,Vasil ML,Hancock RE J Pept Res. 2004 Feb;63(2):69-84.'], 'hemolysis': u'MHC =5 \xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1587']}, u'yPVKLyPVKL': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Modulation of structure and antibacterial and hemolytic activity by ring size in cyclic gramicidin S analogs. Kondejewski LH,Farmer SW,Wishart DS,Kay CM,Hancock RE J Biol Chem. 1996 Oct 11;271(41):25261-8.'], 'hemolysis': u'100% hemolysis at 67\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3666']}, u'RRWQWRMKK': {'modifications': [], 'references': [u'Comparative antimicrobial activity and mechanism of action of bovine lactoferricin-derived synthetic peptides. Liu Y,Han F,Xie Y Biometals. 2011 Dec;24(6):1069-78. doi: 10.1007/s10534-011-9465-y. Epub 2011 May 24.'], 'hemolysis': u'<5% hemolytic at 256mg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2915']}, u'FFGSLLSLGSKLLPSVFKLFQRKKE': {'modifications': [], 'references': [u'Antimicrobial peptides from arachnid venoms and their microbicidal activity in the presence of commercial antibiotics. Garcia F,Villegas E,Espino-Solis GP,Rodriguez A, Paniagua-Solis, Jorge ,Paniagua-Solis JF,Sandoval-Lopez G,Possani LD J Antibiot (Tokyo). 2013 Jan;66(1):3-10. doi: 10.1038/ja.2012.87. Epub 2012 Oct 24.'], 'hemolysis': u'83% hemolytic at 25mM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2615']}, u'SLSRYAKLANRLANPKLLETFLSKWIG': {'modifications': [], 'references': [u'Identification of the region that plays an important role in determining antibacterial activity of bovine seminalplasmin. Sitaram N,Subbalakshmi C,Krishnakumari V FEBS Lett. 1997 Jan 6;400(3):289-92.'], 'hemolysis': u'100% hemolysis at 180\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3788']}, u'ILGPVISKIGGVLGGLLKNL': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima. Lai R,Zheng YT,Shen JH,Liu GJ,Liu H,Lee WH,Tang SZ Peptides. 2002 Mar;23(3):427-35.'], 'hemolysis': u'90-100% hemolysis at 50\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3431']}, u'LRQSQFVGSR': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial effect and membrane-active mechanism of Urechistachykinins, neuropeptides derived from Urechis unicinctus. Sung WS,Park SH FEBS Lett. 2008 Jul 9;582(16):2463-6. doi: 10.1016/j.febslet.2008.06.015. Epub 2008 Jun 18.'], 'hemolysis': u'0% hemolysis at 3-100 \u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1226']}, u'GLFTLIKGAAKLIGKTVAKEAGKTGLELMACKITNQC': {'modifications': [], 'references': [u'Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami. Conlon JM,Al-Ghaferi N,Abraham B,Jiansheng H,Cosette P,Leprince J,Jouenne T Peptides. 2006 Sep;27(9):2111-7. Epub 2006 Apr 18.'], 'hemolysis': u'LC50 = 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1683']}, u'kwksflktfskakkkvlktalkaisk': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', u'Stereochemistry: D'], 'references': [u"Rational design of ?-helical antimicrobial peptides to target Gram-negative pathogens, Acinetobacter baumannii and Pseudomonas aeruginosa: utilization of charge, 'specificity determinants,' total hydrophobicity, hydrophobe type and location as design parameters to improve the therapeutic ratio. Jiang Z,Vasil AI,Gera L,Vasil ML Chem Biol Drug Des. 2011 Apr;77(4):225-40. doi: 10.1111/j.1747-0285.2011.01086.x. Epub 2011 Feb 2."], 'hemolysis': u'HC50 = 254.1\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2821']}, u'CYCRRRFCVCVGR': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'3-6% hemolysis at 80\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1180']}, u'RLYRRLYRRLYRRLYRKKK': {'modifications': [], 'references': [u'Antimicrobial dendrimeric peptides. Tam JP,Lu YA Eur J Biochem. 2002 Feb;269(3):923-32.'], 'hemolysis': u'EC50 = 1510\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2411']}, u'LPKVMAHMK': {'modifications': ['C-Terminal'], 'references': [u'Melectin: a novel antimicrobial peptide from the venom of the cleptoparasitic bee Melecta albifrons. Cerovsky V,Hovorka O,Cvacka J,Voburka Z,Bednarova L,Borovickova L,Slaninova J Chembiochem. 2008 Nov 24;9(17):2815-21. doi: 10.1002/cbic.200800476.'], 'hemolysis': u'LC50 >100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3628']}, u'DFGCGQGMIFMCQRRCMRLYPGSTGFCRGFRCMCDTHIPLRPPFMVG': {'modifications': [], 'references': [u'A novel defensin-like peptide from salivary glands of the hard tick, Haemaphysalis longicornis. Lu X,Che Q,Lv Y,Wang M,Lu Z,Feng F,Liu J Protein Sci. 2010 Mar;19(3):392-7. doi: 10.1002/pro.317.'], 'hemolysis': u'1.2% hemolysis at 200\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3611']}, u'CLRIGMRGRELMGGIGKTM': {'modifications': [], 'references': [u'Antibacterial potential of hGlyrichin encoded by a human gene. Sha J,Zhao G,Chen X,Guan W,He Y J Pept Sci. 2012 Feb;18(2):97-104. doi: 10.1002/psc.1421. Epub 2011 Nov 14.'], 'hemolysis': u'0.119% hemolytic at 3000 \u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2693']}, u'LLQWLSKLLGRLL': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship, conformational and biological studies of temporin L analogues. Mangoni ML,Carotenuto A,Auriemma L,Saviello MR,Campiglia P,Gomez-Monterrey I,Malfi S,Marcellini L,Barra D,Novellino E J Med Chem. 2011 Mar 10;54(5):1298-307. doi: 10.1021/jm1012853. Epub 2011 Feb 14.'], 'hemolysis': u'25% hemolytic at 6\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2832']}, u'QlLVDlI': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Lichenysin: a more efficient cation chelator than surfactin. Grangemard I,Wallach J,Maget-Dana R, Peypoux, ,Peypoux Appl Biochem Biotechnol. 2001 Mar;90(3):199-210.'], 'hemolysis': u'100% hemolysis at 15\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3889']}, u'AKKVFKRLGIGAVLWVLTWG': {'modifications': [], 'references': [u'Design of novel analogues with potent antibiotic activity based on the antimicrobial peptide, HP(2-9)-ME(1-12). Park Y,Kim HN,Park SN,Jang SH,Choi CH,Lim HT Biotechnol Lett. 2004 Mar;26(6):493-8.'], 'hemolysis': u'0% hemolysis at 1.5\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4177']}, u'kkLfKKILKYL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Improvement of the efficacy of linear undecapeptides against plant-pathogenic bacteria by incorporation of D-amino acids. Guell I,Cabrefiga J,Badosa E,Ferre R,Talleda M,Bardaji E,Planas M,Feliu L Appl Environ Microbiol. 2011 Apr;77(8):2667-75. doi: 10.1128/AEM.02759-10. Epub 2011 Feb 18.'], 'hemolysis': u'41\xb16.2% hemolytic at 250\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2863']}, u'KLL\u03a8[CH2OCONH]LKLLL\u03a8[CH2OCONH]KLLK': {'modifications': ['C-Terminal'], 'references': [u'Design and synthesis of novel antimicrobial pseudopeptides with selective membrane-perturbation activity. Lee KH Bioorg Med Chem. 2000 Apr;8(4):833-9.'], 'hemolysis': u'~90% hemolysis at 200\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2033']}, u'I*LPWKWPW*WPWRR': {'modifications': ['C-Terminal', 'Cyclic', 'Non-Natural'], 'references': [u'Indolicidin-derived antimicrobial peptide analogs with greater bacterial selectivity and requirements for antibacterial and hemolytic activities. Kim SM,Kim JM,Joshi BP,Cho H Biochim Biophys Acta. 2009 Feb;1794(2):185-92. doi: 10.1016/j.bbapap.2008.10.009. Epub 2008 Nov 6.'], 'hemolysis': u'~10% hemolysis at 200\u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3041']}, u'FLPAIGRVLSGIL': {'modifications': ['C-Terminal'], 'references': [u'Alanine scanning analysis and structure-function relationships of the frog-skin antimicrobial peptide temporin-1Ta. Grieco P,Luca V,Auriemma L,Carotenuto A,Saviello MR,Campiglia P,Barra D,Novellino E J Pept Sci. 2011 May;17(5):358-65. doi: 10.1002/psc.1350. Epub 2011 Feb 18.'], 'hemolysis': u'2% hemolytic at 1.25\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2888']}, u'FKCRRWQWRWKKLGAKPVPIIYCNRRTGKCQRM': {'modifications': [], 'references': [u'Recombinant expression, purification, and antimicrobial activity of a novel hybrid antimicrobial peptide LFT33. Feng X,Liu C,Guo J,Song X,Li J,Xu W Appl Microbiol Biotechnol. 2012 Sep;95(5):1191-8. doi: 10.1007/s00253-011-3816-z. Epub 2011 Dec 22.'], 'hemolysis': u'Non-hemolytic upto 256 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2989']}, u'CGESCVFIPCITSLAGCSCKNKVCYYDGGSVP': {'modifications': ['Cyclic'], 'references': [u'Identification and structural characterization of novel cyclotide with activity against an insect pest of sugar cane. Pinto MF,Fensterseifer IC,Migliolo L,Sousa DA,de Capdville G,Arboleda-Valencia JW,Colgrave ML,Craik DJ,Magalhaes BS,Dias SC J Biol Chem. 2012 Jan 2;287(1):134-47. doi: 10.1074/jbc.M111.294009. Epub 2011 Nov 10.'], 'hemolysis': u'28% hemolysis at 20\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3608']}, u'RGLRRLGRKIAHGVKKYGPTVKRIKRKA': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity analysis of SMAP-29, a sheep leukocytes-derived antimicrobial peptide. Shin SY,Park EJ,Yang ST,Jung HJ,Eom SH,Song WK,Kim Y,Hahm KS Biochem Biophys Res Commun. 2001 Jul 27;285(4):1046-51.'], 'hemolysis': u'0% hemolysis at 100\u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1047']}, u'VKLyPVKLyP': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Conformation and other biophysical properties of cyclic antimicrobial peptides in aqueous solutions. Jelokhani-Niaraki M,Prenner EJ,Kondejewski LH,Kay CM,McElhaney RN J Pept Res. 2001 Oct;58(4):293-306.'], 'hemolysis': u'Strong hemolysis', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2421']}, u'IKLSPETKDNLKKVLKGAIKGAIAVAKMV': {'modifications': ['C-Terminal'], 'references': [u'The hymenochirins: a family of host-defense peptides from the Congo dwarf clawed frog Hymenochirus boettgeri (Pipidae). Mechkarska M,Prajeep M,Coquet L,Leprince J,Jouenne T,Vaudry H,King JD Peptides. 2012 Jun;35(2):269-75. doi: 10.1016/j.peptides.2012.03.029. Epub 2012 Apr 3.'], 'hemolysis': u'LC50 = 225\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2090']}, u'LKLLKWLLKLL': {'modifications': ['C-Terminal'], 'references': [u'De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface. Kang SJ,Won HS,Choi WS J Pept Sci. 2009 Sep;15(9):583-8. doi: 10.1002/psc.1149.'], 'hemolysis': u'5.13% hemolysis at 6.3\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1429']}, u'KWKW': {'modifications': ['C-Terminal'], 'references': [u'Effect of repetitive lysine-tryptophan motifs on the bactericidal activity of antimicrobial peptides. Gopal R,Seo CH,Song PI Amino Acids. 2013 Feb;44(2):645-60. doi: 10.1007/s00726-012-1388-6. Epub 2012 Aug 23.'], 'hemolysis': u'0% hemolytic at 200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2603']}, u'GKKLLKKLKKLLKKW': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Bioactivity and the first transmission electron microscopy immunogold studies of short de novo-designed antimicrobial peptides. Azad MA,Huttunen-Hennelly HE Antimicrob Agents Chemother. 2011 May;55(5):2137-45. doi: 10.1128/AAC.01148-10. Epub 2011 Feb 7.'], 'hemolysis': u'17% hemolytic at 3.4mg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2828']}, u'KRLRRVWRRWR': {'modifications': ['C-Terminal'], 'references': [u'Discovery of potent antimicrobial peptide analogs of Ixosin-B. Lung FD,Wang KS,Liao ZJ,Hsu SK,Song FY,Liou CC Bioorg Med Chem Lett. 2012 Jun 15;22(12):4185-8. doi: 10.1016/j.bmcl.2012.04.018. Epub 2012 Apr 20.'], 'hemolysis': u'3% hemolytic at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2768']}, u'KIKLFKKWPKFLHLAKKF': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial and anti-inflammatory activities of designed antimicrobial peptide P18 analogues. Nan YH Protein Pept Lett. 2008;15(8):861-5.'], 'hemolysis': u'MHC =200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3982']}, u'SLGGVISGAKKVAKVAIPIGKAVLPVVAKLVG': {'modifications': [], 'references': [u'Antibacterial activity and pore-forming properties of ceratotoxins: a mechanism of action based on the barrel stave model. Bessin Y,Saint N,Marri L,Marchini D Biochim Biophys Acta. 2004 Dec 15;1667(2):148-56.'], 'hemolysis': u'Hemolytic 645\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2370']}, u'GKKLLKKLKKLLKKG': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Bioactivity and the first transmission electron microscopy immunogold studies of short de novo-designed antimicrobial peptides. Azad MA,Huttunen-Hennelly HE Antimicrob Agents Chemother. 2011 May;55(5):2137-45. doi: 10.1128/AAC.01148-10. Epub 2011 Feb 7.'], 'hemolysis': u'0.3% hemolytic at 3.4mg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2826']}, u'KWKSFIKKLTSKFLHSADKF': {'modifications': ['C-Terminal'], 'references': [u'The Design and Construction of K11: A Novel ?-Helical Antimicrobial Peptide. Jin-Jiang H,Jin-Chun L,Min L,Qing-Shan H Int J Microbiol. 2012;2012:764834. doi: 10.1155/2012/764834. Epub 2012 Feb 16.'], 'hemolysis': u'MHC >500\u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2729']}, u'VOLKfPVOLfP': {'modifications': ['Cyclic', u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'Antimicrobially active cycloundecapeptides related to gramicidin S having a novel turn structure with cis D-Phe-Pro peptide bond. Tamaki M,Sasaki I,Kokuno M,Shindo M,Kimura M Org Biomol Chem. 2010 Apr 21;8(8):1791-7. doi: 10.1039/b922159j.'], 'hemolysis': u'10% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1505']}, u'kkkkkkaafaawaafll': {'modifications': ['C-Terminal', 'Cyclic', u'Stereochemistry: D'], 'references': [u'Membrane interactions of designed cationic antimicrobial peptides: the two thresholds. Glukhov E,Burrows LL Biopolymers. 2008 May;89(5):360-71. doi: 10.1002/bip.20917.'], 'hemolysis': u'MHC <81\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1150']}, u'FVQWFSKFLGKIL': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship, conformational and biological studies of temporin L analogues. Mangoni ML,Carotenuto A,Auriemma L,Saviello MR,Campiglia P,Gomez-Monterrey I,Malfi S,Marcellini L,Barra D,Novellino E J Med Chem. 2011 Mar 10;54(5):1298-307. doi: 10.1021/jm1012853. Epub 2011 Feb 14.'], 'hemolysis': u'14% hemolytic at 6\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2839']}, u'FKLFKKILKFL': {'modifications': ['C-Terminal'], 'references': [u'A library of linear undecapeptides with bactericidal activity against phytopathogenic bacteria. Badosa E,Ferre R,Planas M,Feliu L,Besalu E,Cabrefiga J,Bardaji E Peptides. 2007 Dec;28(12):2276-85. Epub 2007 Sep 25.'], 'hemolysis': u'63\xb15.9% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1846']}, u'PAICQRATATLGTVGSNTSGTTEIAACILL': {'modifications': [], 'references': [u'Potent inhibition of the classical pathway of complement by a novel C1q-binding peptide derived from the human astrovirus coat protein. Gronemus JQ,Hair PS,Crawford KB,Nyalwidhe JO,Cunnion KM Mol Immunol. 2010 Nov-Dec;48(1-3):305-13. doi: 10.1016/j.molimm.2010.07.012. Epub 2010 Aug 21.'], 'hemolysis': u'95% hemolysis at 0.77mM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1536']}, u'CGESCVWIPCISAAVGCSCKSKVCYKNGTLP': {'modifications': ['Cyclic'], 'references': [u'Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif. Craik DJ,Daly NL,Bond T J Mol Biol. 1999 Dec 17;294(5):1327-36.'], 'hemolysis': u'50% hemolysis at ~20\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4002']}, u'KWKSFLKTLKSPVKTVFYTALKPISS': {'modifications': [], 'references': [u'Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides. Zhang L,Benz R Biochemistry. 1999 Jun 22;38(25):8102-11.'], 'hemolysis': u'MHC >128\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3594']}, u'INWKKIASIGKEVLKAI': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 >100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3923']}, u'GECIWDAIFHGAKHFLHRLVNP': {'modifications': [], 'references': [u'Five different piscidins from Nile tilapia, Oreochromis niloticus: analysis of their expressions and biological functions. Peng KC,Lee SH,Hour AL,Pan CY,Lee LH PLoS One. 2012;7(11):e50263. doi: 10.1371/journal.pone.0050263. Epub 2012 Nov 30.'], 'hemolysis': u'60% hemolytic at 40\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2608']}, u'FLSLIPHAINAVSTLVHHF': {'modifications': ['C-Terminal'], 'references': [u'Phylloseptins: a novel class of anti-bacterial and anti-protozoan peptides from the Phyllomedusa genus. Leite JR,Silva LP,Rodrigues MI,Prates MV,Brand GD,Lacava BM,Azevedo RB,Bocca AL,Albuquerque S Peptides. 2005 Apr;26(4):565-73. Epub 2004 Dec 25.'], 'hemolysis': u'2.05% hemolysis at 64\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2368']}, u'LKLLSIVSWAKKVL': {'modifications': ['C-Terminal'], 'references': [u'Structural requirements for the edema-inducing and hemolytic activities of mastoparan B isolated from the hornet (Vespa basalis) venom. Ho CL,Lin YL,Chen WC,Hwang LL,Yu HM Toxicon. 1996 Sep;34(9):1027-35.'], 'hemolysis': u'>75% hemolysis at 20\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3504']}, u'INWKKIASIGKEVLKAL': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 =80\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3922']}, u'GLLSGILGAGKNIVCGLSGLC': {'modifications': [], 'references': [u'Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami. Conlon JM,Al-Ghaferi N,Abraham B,Jiansheng H,Cosette P,Leprince J,Jouenne T Peptides. 2006 Sep;27(9):2111-7. Epub 2006 Apr 18.'], 'hemolysis': u'LC50 = 500\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1679']}, u'GVIKSVLKGVAKTVALGML': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial peptides from the skin secretions of the South-East Asian frog Hylarana erythraea (Ranidae). Al-Ghaferi N,Kolodziejek J,Nowotny N,Coquet L,Jouenne T,Leprince J,Vaudry H,King JD Peptides. 2010 Apr;31(4):548-54. doi: 10.1016/j.peptides.2009.12.013. Epub 2009 Dec 14.'], 'hemolysis': u'LC50 = 280 \xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1939']}, u'GLFPKFNKKKVKTGIFDIIKTVGKEAGMDVLRTGIDVIGCKIKGEC': {'modifications': [], 'references': [u'Antimicrobial peptides and protease inhibitors in the skin secretions of the crawfish frog, Rana areolata. Ali, Mohamed ,Ali MF,Lips KR,Knoop FC,Fritzsch B,Miller C Biochim Biophys Acta. 2002 Nov 19;1601(1):55-63.'], 'hemolysis': u'HC50 = 120\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2479']}, u'VIPFVASVAAEMMQHVYCAASRKC': {'modifications': [], 'references': [u'Structure-activity relationships of antimicrobial peptides from the skin of Rana esculenta inhabiting in Korea. Won HS,Kim SS,Jung SJ,Son WS,Lee B Mol Cells. 2004 Jun 30;17(3):469-76.'], 'hemolysis': u'0.08% hemolysis at 100\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1607']}, u'FVQWFSRFLGRIL': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship, conformational and biological studies of temporin L analogues. Mangoni ML,Carotenuto A,Auriemma L,Saviello MR,Campiglia P,Gomez-Monterrey I,Malfi S,Marcellini L,Barra D,Novellino E J Med Chem. 2011 Mar 10;54(5):1298-307. doi: 10.1021/jm1012853. Epub 2011 Feb 14.'], 'hemolysis': u'29% hemolytic at 6\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2841']}, u'ACPCAAPCKAPCLACPCKAPCAACPCAACPCLACPC': {'modifications': ['C-Terminal', 'Cyclic', 'Non-Natural'], 'references': [u'Interplay among folding, sequence, and lipophilicity in the antibacterial and hemolytic activities of alpha/beta-peptides. Schmitt MA,Weisblum B J Am Chem Soc. 2007 Jan 17;129(2):417-28.'], 'hemolysis': u'>10% hemolysis at >400 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1099']}, u'CGESCVYIPCLTSAVGCSCKSKVCYRNGIP': {'modifications': ['Cyclic'], 'references': [u'Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif. Craik DJ,Daly NL,Bond T J Mol Biol. 1999 Dec 17;294(5):1327-36.'], 'hemolysis': u'50% hemolysis at ~20\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4006']}, u'KRAKKFFKKLK': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial and antibiofilm activity of cathelicidins and short, synthetic peptides against Francisella. Amer LS,Bishop BM Biochem Biophys Res Commun. 2010 May 28;396(2):246-51. doi: 10.1016/j.bbrc.2010.04.073. Epub 2010 Apr 23.'], 'hemolysis': u'EC50 =7.98\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3064']}, u'MKLSCLLLTLTIIFVLTIVHAPNVEAKDLADPESEAVGFADAVGEADPNAGLGS': {'modifications': [], 'references': [u'Molecular cloning and biological characterization of novel antimicrobial peptides, pilosulin 3 and pilosulin 4, from a species of the Australian ant genus Myrmecia. Inagaki H,Akagi M,Imai HT,Taylor RW Arch Biochem Biophys. 2004 Aug 15;428(2):170-8.'], 'hemolysis': u'No hemolysis at 50\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1878']}, u'GTPCGESCVYIPCISGVIGCSCTDKVCYLN': {'modifications': ['Cyclic'], 'references': [u'Structural and biochemical characteristics of the cyclotide kalata B5 from Oldenlandia affinis. Plan MR,Rosengren KJ,Sando L,Daly NL Biopolymers. 2010;94(5):647-58. doi: 10.1002/bip.21409.'], 'hemolysis': u'HD50 =27.4\xb11.2\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1516']}, u'GLGSVFGRLARILGRVIPKV': {'modifications': ['C-Terminal'], 'references': [u'Identification and optimization of an antimicrobial peptide from the ant venom toxin pilosulin. Zelezetsky I,Pag U,Antcheva N,Sahl HG Arch Biochem Biophys. 2005 Feb 15;434(2):358-64.'], 'hemolysis': u'100% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1635']}, u'MFTLKKSLLLLFFLGTINLSLCEEERDAEEERRDGDDEMDVEVKKRFLAGLIGGLAKMLGK': {'modifications': [], 'references': [u'Molecular cloning and characterization of antimicrobial peptides from skin of the broad-folded frog, Hylarana latouchii. Wang H,Yu Z,Hu Y,Yu H,Ran R,Xia J,Wang D,Yang S,Yang X Biochimie. 2012 Jun;94(6):1317-26. doi: 10.1016/j.biochi.2012.02.032. Epub 2012 Mar 8.'], 'hemolysis': u'LD50 = 40\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2082']}, u'FVPWFSKFLGRIL': {'modifications': ['C-Terminal'], 'references': [u'The effect of d-amino acid substitution on the selectivity of temporin L towards target cells: identification of a potent anti-Candida peptide. Grieco P,Carotenuto A,Auriemma L,Saviello MR,Campiglia P,Gomez-Monterrey IM,Marcellini L,Luca V,Barra D,Novellino E Biochim Biophys Acta. 2013 Feb;1828(2):652-60. doi: 10.1016/j.bbamem.2012.08.027. Epub 2012 Sep 10.'], 'hemolysis': u'4.5% hemolysis at 1.5\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3199']}, u'SSLLEKGLDGAKKAVGGLGKLGK': {'modifications': [], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC >100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3962']}, u'GKLEVLHSTKKFAKGFITGLTGQ': {'modifications': [], 'references': [u'Host-defense peptides in skin secretions of the tetraploid frog Silurana epitropicalis with potent activity against methicillin-resistant Staphylococcus aureus (MRSA). Conlon JM,Mechkarska M,Prajeep M,Sonnevend A,Coquet L,Leprince J,Jouenne T,Vaudry H Peptides. 2012 Sep;37(1):113-9. doi: 10.1016/j.peptides.2012.07.005. Epub 2012 Jul 16.'], 'hemolysis': u'LC50 >160\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3151']}, u'QRLFQVKGRR': {'modifications': [], 'references': [u'Interaction of the gelsolin-derived antibacterial PBP 10 peptide with lipid bilayers and cell membranes. Bucki R Antimicrob Agents Chemother. 2006 Sep;50(9):2932-40.'], 'hemolysis': u'>40% hemolysis at 40 \xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1709']}, u'KVLKAAAKAALNAVLVGANA': {'modifications': [], 'references': [u'Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity. Feder R,Dagan A J Biol Chem. 2000 Feb 11;275(6):4230-8.'], 'hemolysis': u'LC50 =24\xb11\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1013']}, u'CYCRRRFCVCV': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'0-3% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1187']}, u'KWKSFLkTFKSLKkTVLHTLLKAISS': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', u'Stereochemistry: Mix'], 'references': [u'Role of helicity on the anticancer mechanism of action of cationic-helical peptides. Huang YB,He LY,Jiang HY Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849. Epub 2012 Jun 5.'], 'hemolysis': u'MHC = 20.81 \xb1 0.15\u03bcmol/L', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2638']}, u'KIKIPWGKVKDFLVGGMKAV': {'modifications': ['C-Terminal'], 'references': [u'Identification and characterization of a novel antimicrobial peptide from the venom of the ant Tetramorium bicarinatum. Rifflet A,Gavalda S,Tene N,Orivel J,Leprince J,Guilhaudis L,Genin E,Vetillard A Peptides. 2012 Dec;38(2):363-70. doi: 10.1016/j.peptides.2012.08.018. Epub 2012 Sep 7.'], 'hemolysis': u'50% hemolysis at 0.72mg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3166']}, u'kklalalakkwlplakklalalakk': {'modifications': ['C-Terminal', u'Stereochemistry: D'], 'references': [u'Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic ?-helical peptides. Vermeer LS,Lan Y,Abbate V,Ruh E,Bui TT,Wilkinson LJ,Kanno T,Jumagulova E,Kozlowska J,Patel J,McIntyre CA,Yam WC,Siu G,Atkinson RA,Lam JK,Bansal SS, Drake, Alex ,Drake AF,Mitchell GH J Biol Chem. 2012 Oct 5;287(41):34120-33. doi: 10.1074/jbc.M112.359067. Epub 2012 Aug 6.'], 'hemolysis': u'HC50 = 58.61\xb110.41\u03bcMc', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2627']}, u'LKDVEEAQQKIINIIRRL': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Amphipathic alpha-helices in proteins: results from analysis of protein structures. Sharadadevi A,Sivakamasundari C Proteins. 2005 Jun 1;59(4):791-801.'], 'hemolysis': u'Non-hemolytic', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1891']}, u'GLLGKLLKIAAKVGKKLL': {'modifications': ['C-Terminal'], 'references': [u'Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7. Conlon JM,Galadari S,Raza H Chem Biol Drug Des. 2008 Jul;72(1):58-64. doi: 10.1111/j.1747-0285.2008.00671.x. Epub 2008 Jun 12.'], 'hemolysis': u'LD50 = 25\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1965']}, u'VGTIIKIIKAIIDIFAK': {'modifications': [], 'references': [u'Novel phenol-soluble modulin derivatives in community-associated methicillin-resistant Staphylococcus aureus identified through imaging mass spectrometry. Gonzalez DJ,Okumura CY,Hollands A,Kersten R,Akong-Moore K,Pence MA,Malone CL,Derieux J,Moore BS,Horswill AR,Dixon JE,Dorrestein PC J Biol Chem. 2012 Apr 20;287(17):13889-98. doi: 10.1074/jbc.M112.349860. Epub 2012 Feb 27.'], 'hemolysis': u'52% hemolytic at 10 \u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2711']}, u'VLPLVGNLLNDLL': {'modifications': ['C-Terminal'], 'references': [u'Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii. Jin LL,Li Q,Song SS,Feng K,Zhang DB,Wang QY Comp Biochem Physiol B Biochem Mol Biol. 2009 Oct;154(2):174-8. doi: 10.1016/j.cbpb.2009.05.015. Epub 2009 Jun 17.'], 'hemolysis': u'HC50 =180\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3492']}, u'KWKLFKKIPLAKKF': {'modifications': ['C-Terminal'], 'references': [u'Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs. Shin SY,Lee SH,Yang ST,Park EJ,Lee DG,Lee MK,Eom SH,Song WK,Kim Y,Hahm KS J Pept Res. 2001 Dec;58(6):504-14.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2172']}, u'KLFKRHLKWKII': {'modifications': ['C-Terminal', u'N-Terminal Modification: Conjugated with lauric acid'], 'references': [u'Promotion of peptide antimicrobial activity by fatty acid conjugation. Chu-Kung, Alexander ,Chu-Kung AF,Bozzelli KN,Lockwood NA,Haseman JR,Mayo KH Bioconjug Chem. 2004 May-Jun;15(3):530-5.'], 'hemolysis': u'<15% hemolysis at 500\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1024']}, u'kGGGkWGGkGGk': {'modifications': ['C-Terminal', u'N-Terminal Modification: Palmitoylation', u'Stereochemistry: Mix'], 'references': [u'A new group of antifungal and antibacterial lipopeptides derived from non-membrane active peptides conjugated to palmitic acid. Avrahami D J Biol Chem. 2004 Mar 26;279(13):12277-85. Epub 2004 Jan 6.'], 'hemolysis': u'>75% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1564']}, u'KWKSFLKTFKSLKKTVLHTlLKAISS': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', u'Stereochemistry: Mix'], 'references': [u'Role of helicity on the anticancer mechanism of action of cationic-helical peptides. Huang YB,He LY,Jiang HY Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849. Epub 2012 Jun 5.'], 'hemolysis': u'MHC =20.81 \xb1 0.13\u03bcmol/L', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2646']}, u'DHYICAKKGGTCNFSPCPLFNRIEGTCYSGKAKCCIR': {'modifications': [], 'references': [u'Molecular cloning, expression and characterization of the porcine ? defensin 2 in E. coli. Li CL,Zhao YC,Song XY,Huang XX Protein Pept Lett. 2013 Jun;20(6):715-23.'], 'hemolysis': u'12% hemolysis at 80\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3187']}, u'GIGKFLKKAKKFGKAFVKILKK': {'modifications': [], 'references': [u'Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides. Yasin B,Pang M,Turner JS,Cho Y,Dinh NN,Waring AJ,Lehrer RI Eur J Clin Microbiol Infect Dis. 2000 Mar;19(3):187-94.'], 'hemolysis': u'11.4% hemolysis at 80\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2443']}, u'GIGAVLKVLTTGLKWKLFKKIEKVGQ': {'modifications': ['C-Terminal'], 'references': [u'Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids. Boman HG,Wade D,Boman IA,Wahlin B FEBS Lett. 1989 Dec 18;259(1):103-6.'], 'hemolysis': u'Lethal concentration calculated from zone of inhibition  80\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3563']}, u'ALWMTLLKKVLKAAAKAALKAVLVGANA': {'modifications': [], 'references': [u'Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity. Feder R,Dagan A J Biol Chem. 2000 Feb 11;275(6):4230-8.'], 'hemolysis': u'LC50 =1.2\xb10.4\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1005']}, u'MFTMKKSLLFLFFFLGTISLSLCEQERGADEDDGGEEVKRGIFSLFKAGAKFFGKHLLKQAGKAGAEHLACKATNQC': {'modifications': [], 'references': [u'Molecular cloning and characterization of antimicrobial peptides from skin of the broad-folded frog, Hylarana latouchii. Wang H,Yu Z,Hu Y,Yu H,Ran R,Xia J,Wang D,Yang S,Yang X Biochimie. 2012 Jun;94(6):1317-26. doi: 10.1016/j.biochi.2012.02.032. Epub 2012 Mar 8.'], 'hemolysis': u'LD50 > 600\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2080']}, u'GILNTIKSIASKLKRKAK': {'modifications': [], 'references': [u'Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin. Sanchez-Vasquez L,Silva-Sanchez J,Jimenez-Vargas JM,Rodriguez-Romero A,Munoz-Garay C,Rodriguez MC,Gurrola GB Biochim Biophys Acta. 2013 Jun;1830(6):3427-36. doi: 10.1016/j.bbagen.2013.01.028. Epub 2013 Feb 9.'], 'hemolysis': u'EC50 =139\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3256']}, u'CKLLKTFLSKWIC': {'modifications': ['C-Terminal', 'Cyclic'], 'references': [u'Consequences of introducing a disulfide bond into an antibacterial and hemolytic peptide. Krishnakumari V,Sharadadevi A,Sitaram N J Pept Res. 1999 Dec;54(6):528-35.'], 'hemolysis': u'100% hemolysis at 5\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3456']}, u'GFLSILKKVLGKVMAHMK': {'modifications': ['C-Terminal'], 'references': [u'Melectin: a novel antimicrobial peptide from the venom of the cleptoparasitic bee Melecta albifrons. Cerovsky V,Hovorka O,Cvacka J,Voburka Z,Bednarova L,Borovickova L,Slaninova J Chembiochem. 2008 Nov 24;9(17):2815-21. doi: 10.1002/cbic.200800476.'], 'hemolysis': u'LC50 = 41.4\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3625']}, u'GLLGKILGVEKKVLCGLSGMC': {'modifications': [], 'references': [u'Anti-infection peptidomics of amphibian skin. Li J,Xu X,Xu C,Zhou W,Zhang K,Yu H,Zhang Y,Zheng Y,Rees HH,Lai R,Yang D Mol Cell Proteomics. 2007 May;6(5):882-94. Epub 2007 Jan 31.'], 'hemolysis': u'60\xb17.1% hemolysis at 50\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3650']}, u'CAKAKAKAGSGAKAKAKAC': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', 'Cyclic'], 'references': [u'De novo design of potent antimicrobial peptides. Frecer V,Ho B Antimicrob Agents Chemother. 2004 Sep;48(9):3349-57.'], 'hemolysis': u'EC50 = 1055000 nM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2377']}, u'KRLFRRLLFSMKKY': {'modifications': [], 'references': [u'Fungicidal effect of three new synthetic cationic peptides against Candida albicans. Nikawa H,Fukushima H,Makihira S,Hamada T Oral Dis. 2004 Jul;10(4):221-8.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1876']}, u'KKLFKKILKWL': {'modifications': ['C-Terminal'], 'references': [u'A library of linear undecapeptides with bactericidal activity against phytopathogenic bacteria. Badosa E,Ferre R,Planas M,Feliu L,Besalu E,Cabrefiga J,Bardaji E Peptides. 2007 Dec;28(12):2276-85. Epub 2007 Sep 25.'], 'hemolysis': u'84\xb16.5% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1845']}, u'ILPWKWPFFPWRR': {'modifications': ['C-Terminal'], 'references': [u'Coupling molecular dynamics simulations with experiments for the rational design of indolicidin-analogous antimicrobial peptides. Tsai CW,Hsu NY,Wang CH,Lu CY,Chang Y,Tsai HH J Mol Biol. 2009 Sep 25;392(3):837-54. doi: 10.1016/j.jmb.2009.06.071. Epub 2009 Jul 2.'], 'hemolysis': u'21.4% hemolysis at 64\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1452']}, u'AKLkAyPLKAKLyP': {'modifications': [u'Stereochemistry: Mix'], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC >800\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3946']}, u'FLPLLAGLCKITRKCAANFLPKIF': {'modifications': ['Cyclic'], 'references': [u'Structure-function studies on the amphibian peptide brevinin 1E: translocating the cationic segment from the C-terminal end to a central position favors selective antibacterial activity. Kumari VK J Pept Res. 2001 Nov;58(5):433-41.'], 'hemolysis': u'100% hemolysis at 7\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2149']}, u'akklohalhoallalohlpholkkff': {'modifications': ['C-Terminal', u'Stereochemistry: D', 'Non-Natural'], 'references': [u'Structural determinants of antimicrobial and antiplasmodial activity and selectivity in histidine-rich amphipathic cationic peptides. Mason AJ,Moussaoui W,Abdelrahman T,Boukhari A,Bertani P,Marquette A,Shooshtarizaheh P,Moulay G,Boehm N,Guerold B,Sawers RJ,Kichler A,Metz-Boutigue MH,Candolfi E,Prevost G J Biol Chem. 2009 Jan 2;284(1):119-33. doi: 10.1074/jbc.M806201200. Epub 2008 Nov 4.'], 'hemolysis': u'HC50 >65.2\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3575']}, u'RLYR': {'modifications': [], 'references': [u'Antimicrobial dendrimeric peptides. Tam JP,Lu YA Eur J Biochem. 2002 Feb;269(3):923-32.'], 'hemolysis': u'EC50 = 5200\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2406']}, u'GIGKFIHAAKKFGKLFIGEIMNS': {'modifications': ['C-Terminal'], 'references': [u'Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes. Wieprecht T,Dathe M,Beyermann M,Krause E,Maloy WL,MacDonald DL Biochemistry. 1997 May 20;36(20):6124-32.'], 'hemolysis': u'98% hemolysis at 150\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3526']}, u'VKAkVyPAKVKAyP': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Optimization of microbial specificity in cyclic peptides by modulation of hydrophobicity within a defined structural framework. Kondejewski LH,Lee DL,Jelokhani-Niaraki M,Farmer SW,Hancock RE J Biol Chem. 2002 Jan 4;277(1):67-74. Epub 2001 Oct 26.'], 'hemolysis': u'100% hemolysis at >800\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2431']}, u'VKLKVyPlKVKLyP': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Dissociation of antimicrobial and hemolytic activities in cyclic peptide diastereomers by systematic alterations in amphipathicity. Kondejewski LH,Jelokhani-Niaraki M,Farmer SW,Lix B,Kay CM,Sykes BD,Hancock RE J Biol Chem. 1999 May 7;274(19):13181-92.'], 'hemolysis': u'100% hemolytic at 50 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2561']}, u'KKF(Nlys)WWW(Nlys)FKK': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC >200\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3972']}, u'KWKLFKKIpKFLHLAKKF': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial and anti-inflammatory activities of designed antimicrobial peptide P18 analogues. Nan YH Protein Pept Lett. 2008;15(8):861-5.'], 'hemolysis': u'MHC <200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3985']}, u'GNleNleOrnOrnNleAibOrnOrnAibOrnOrnAibNleOrnOrnNleGY': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Amphipathic alpha helical antimicrobial peptides. Giangaspero A,Sandri L Eur J Biochem. 2001 Nov;268(21):5589-600.'], 'hemolysis': u'70% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2136']}, u'WWSYVRRWRSR': {'modifications': [], 'references': [u'Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide. Wu YS,Liao ZJ,Wang KS Bioorg Med Chem Lett. 2013 May 15;23(10):2929-32. doi: 10.1016/j.bmcl.2013.03.053. Epub 2013 Mar 25.'], 'hemolysis': u'3.4 \xb11.3% hemolytic at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2580']}, u'FVDLKKIANIINSIFGK': {'modifications': [], 'references': [u'Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEa. Yang QZ,Wang C,Lang L,Zhou Y,Wang H Arch Pharm Res. 2013 Apr 23.'], 'hemolysis': u'LC50 =95.7\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2570']}, u'lKlK': {'modifications': [u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'Antiplasmodial activity of lauryl-lysine oligomers. Radzishevsky I,Krugliak M,Ginsburg H Antimicrob Agents Chemother. 2007 May;51(5):1753-9. Epub 2007 Feb 16.'], 'hemolysis': u'4.9\xb11.7% hemolysis at 100 \u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1107']}, u'lKlKlK': {'modifications': [u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'Antiplasmodial activity of lauryl-lysine oligomers. Radzishevsky I,Krugliak M,Ginsburg H Antimicrob Agents Chemother. 2007 May;51(5):1753-9. Epub 2007 Feb 16.'], 'hemolysis': u'13.3\xb14.3% hemolysis at 100 \u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1104']}, u'KAVAAKKSPKKAKKPAT': {'modifications': [], 'references': [u'Isolation and characterisation of oncorhyncin II, a histone H1-derived antimicrobial peptide from skin secretions of rainbow trout, Oncorhynchus mykiss. Fernandes JM,Molle G,Kemp GD Dev Comp Immunol. 2004 Feb;28(2):127-38.'], 'hemolysis': u'No hemolysis at 0.8\u03bcM(non hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3580']}, u'GEKLKKIGQKIKNFFQKL': {'modifications': [], 'references': [u'CRAMP analogues having potent antibiotic activity against bacterial, fungal, and tumor cells without hemolytic activity. Shin SY,Kang SW,Lee DG,Eom SH,Song WK Biochem Biophys Res Commun. 2000 Sep 7;275(3):904-9.'], 'hemolysis': u'0% hemolytic at 100\u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2515']}, u'KWkSFLkTFkSLKkTVLHTLLkAISS': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', u'Stereochemistry: Mix'], 'references': [u'Role of helicity on the anticancer mechanism of action of cationic-helical peptides. Huang YB,He LY,Jiang HY Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849. Epub 2012 Jun 5.'], 'hemolysis': u'MHC >325.20\u03bcmol/L', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2642']}, u'MASRAARLAARLARLALRAL': {'modifications': [], 'references': [u'Modification of a synthetic antimicrobial peptide (ESF1) for improved inhibitory activity. Dykes GA,Aimoto S Biochem Biophys Res Commun. 1998 Jul 20;248(2):268-72.'], 'hemolysis': u'0.9% hemolysis at 200\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3283']}, u'SIITMTKEAKLPQLWKQIACRLYNTC': {'modifications': ['Cyclic'], 'references': [u'A new family of antimicrobial peptides from skin secretions of Rana pleuraden. Wang X,Song Y,Li J,Liu H,Xu X,Lai R Peptides. 2007 Oct;28(10):2069-74. Epub 2007 Jul 22.'], 'hemolysis': u'Little hemolysis at 200mg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3638']}, u'GILSTFKGLAKGVAKDLAGNLLDKFKCKITGC': {'modifications': [], 'references': [u'Isolation of peptides of the brevinin-1 family with potent candidacidal activity from the skin secretions of the frog Rana boylii. Conlon JM,Sonnevend A,Patel M,Davidson C, Nielsen, P ,Nielsen PF,Pal T J Pept Res. 2003 Nov;62(5):207-13.'], 'hemolysis': u'HC50  = 120\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2326']}, u'TCGETCFGGTCNTPGCTCDPWPICTDRGLP': {'modifications': ['Cyclic'], 'references': [u'Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif. Craik DJ,Daly NL,Bond T J Mol Biol. 1999 Dec 17;294(5):1327-36.'], 'hemolysis': u'50% hemolysis at ~20\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4016']}, u'KQLKKVSAVAKVAMKKGAALLKKMGVK': {'modifications': [], 'references': [u'Lytic activity and structural differences of amphipathic peptides derived from trialysin. Martins RM,Sforca ML,Amino R,Juliano MA,Oyama S Jr,Juliano L,Pertinhez TA,Spisni A Biochemistry. 2006 Feb 14;45(6):1765-74.'], 'hemolysis': u'50% hemolysis at 450\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1669']}, u'SWLRDIWDWICELLSDFK': {'modifications': [], 'references': [u'Rational design of peptides with anti-HCV/HIV activities and enhanced specificity. Li GR,He LY,Liu XY,Liu AP,Huang YB,Qiu C,Zhang XY,Xu JQ,Yang W Chem Biol Drug Des. 2011 Nov;78(5):835-43. doi: 10.1111/j.1747-0285.2011.01201.x. Epub 2011 Sep 26.'], 'hemolysis': u'MHC = 3.44\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2948']}, u'GWKKWLRKGAKHLGQAAIKGLAS': {'modifications': [], 'references': [u'The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents. Morash MG,Douglas SE,Robotham A,Ridley CM,Gallant JW Dis Model Mech. 2011 Sep;4(5):622-33. doi: 10.1242/dmm.007310. Epub 2011 Jul 4.'], 'hemolysis': u'50% hemolytic at >256 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2932']}, u'KKVADKVLLLKQLRIMRL': {'modifications': [], 'references': [u'Solution structure of termite-derived antimicrobial peptide, spinigerin, as determined in SDS micelle by NMR spectroscopy. Lee KH,Shin SY,Hong JE,Yang ST,Kim JI,Hahm KS Biochem Biophys Res Commun. 2003 Sep 26;309(3):591-7.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2316']}, u'ILGTILGLLKGL': {'modifications': ['C-Terminal'], 'references': [u'Novel biologically active peptides from the venom of Polistes rothneyi iwatai. Murata K,Shinada T,Ohfune Y,Hisada M,Yasuda A,Naoki H Biol Pharm Bull. 2006 Dec;29(12):2493-7.'], 'hemolysis': u'97 % of hemolysis at 50mM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1731']}, u'WLNALLKKGLNCAKGVLA': {'modifications': ['C-Terminal'], 'references': [u'Biological activities of synthetic analogs of halocidin, an antimicrobial peptide from the tunicate Halocynthia aurantium. Jang WS,Kim CH,Kim KN,Park SY,Lee JH,Son SM Antimicrob Agents Chemother. 2003 Aug;47(8):2481-6.'], 'hemolysis': u'<10% hemolysis at 100\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2402']}, u'GKKllKKlKKllKKG': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', u'Stereochemistry: Mix'], 'references': [u'Bioactivity and the first transmission electron microscopy immunogold studies of short de novo-designed antimicrobial peptides. Azad MA,Huttunen-Hennelly HE Antimicrob Agents Chemother. 2011 May;55(5):2137-45. doi: 10.1128/AAC.01148-10. Epub 2011 Feb 7.'], 'hemolysis': u'1% hemolytic at 3.4mg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2827']}, u'LRLKKRRWKYRVp': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'A family of macrocyclic antibiotics with a mixed peptide-peptoid beta-hairpin backbone conformation. Shankaramma SC,Moehle K,James S,Vrijbloed JW,Obrecht D Chem Commun (Camb). 2003 Aug 7;(15):1842-3.'], 'hemolysis': u'1.4% hemolytic at 100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2507']}, u'ZDRRLSYKQRSVTYORGR': {'modifications': ['C-Terminal', 'Cyclic', 'Non-Natural'], 'references': [u'Structure-activity relationship studies of gomesin: importance of the disulfide bridges for conformation, bioactivities, and serum stability. Fazio MA,Oliveira VX Jr,Bulet P,Miranda MT,Daffre S Biopolymers. 2006;84(2):205-18.'], 'hemolysis': u'<10% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4198']}, u'KklFKkILkYL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Improvement of the efficacy of linear undecapeptides against plant-pathogenic bacteria by incorporation of D-amino acids. Guell I,Cabrefiga J,Badosa E,Ferre R,Talleda M,Bardaji E,Planas M,Feliu L Appl Environ Microbiol. 2011 Apr;77(8):2667-75. doi: 10.1128/AEM.02759-10. Epub 2011 Feb 18.'], 'hemolysis': u'1\xb10.3% hemolytic at 250\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2861']}, u'LKLKSIVSWAKLVL': {'modifications': ['C-Terminal'], 'references': [u'Structural requirements for the edema-inducing and hemolytic activities of mastoparan B isolated from the hornet (Vespa basalis) venom. Ho CL,Lin YL,Chen WC,Hwang LL,Yu HM Toxicon. 1996 Sep;34(9):1027-35.'], 'hemolysis': u'>55% hemolysis at 20\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3514']}, u'KILRGVSKKIMRTFLRRISKDILTGKK': {'modifications': ['C-Terminal'], 'references': [u'Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens. Andra J,Monreal D,Martinez de Tejada G,Olak C,Brezesinski G,Gomez SS,Goldmann T,Bartels R,Brandenburg K J Biol Chem. 2007 May 18;282(20):14719-28. Epub 2007 Mar 27.'], 'hemolysis': u'>20% hemolysis at 100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1120']}, u'GKGLTicOic\u03b2AlaKTicOic\u03b2AlaFTicOic\u03b2AlaKTicOic\u03b2AlaFTicOicELMNS': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'De novo design of selective antibiotic peptides by incorporation of unnatural amino acids. Hicks RP,Bhonsle JB,Venugopal D,Koser BW J Med Chem. 2007 Jun 28;50(13):3026-36. Epub 2007 Jun 5.'], 'hemolysis': u'55% hemolysis at 25\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1754']}, u'LLKWLKKLLKK': {'modifications': ['C-Terminal'], 'references': [u'Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities. Kim SJ,Kim JS,Lee YS,Sim DW,Lee SH,Bahk YY,Lee KH,Kim EH,Park SJ,Lee BJ Molecules. 2013 Jan 11;18(1):859-76. doi: 10.3390/molecules18010859.'], 'hemolysis': u'MHC = 128\u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2595']}, u'GFKDLLKGAAKALVKAVLF': {'modifications': ['C-Terminal'], 'references': [u'Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7. Conlon JM,Galadari S,Raza H Chem Biol Drug Des. 2008 Jul;72(1):58-64. doi: 10.1111/j.1747-0285.2008.00671.x. Epub 2008 Jun 12.'], 'hemolysis': u'LD50 = 22\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1956']}, u'KDRPKKPGLCPPRPQKPCVKECKNDDSCPGQQKCCNYGCKDECRDPIFVG': {'modifications': [], 'references': [u'Antimicrobial activity of omwaprin, a new member of the waprin family of snake venom proteins. Nair DG,Fry BG,Alewood P,Kumar PP Biochem J. 2007 Feb 15;402(1):93-104.'], 'hemolysis': u'0% hemolysis upto 1 mM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3654']}, u'kwksflktfskakkkalktllkaisk': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', u'Stereochemistry: D'], 'references': [u"Rational design of ?-helical antimicrobial peptides to target Gram-negative pathogens, Acinetobacter baumannii and Pseudomonas aeruginosa: utilization of charge, 'specificity determinants,' total hydrophobicity, hydrophobe type and location as design parameters to improve the therapeutic ratio. Jiang Z,Vasil AI,Gera L,Vasil ML Chem Biol Drug Des. 2011 Apr;77(4):225-40. doi: 10.1111/j.1747-0285.2011.01086.x. Epub 2011 Feb 2."], 'hemolysis': u'HC50 =81.3\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2822']}, u'KWKKLLaKLLaLLKKLLK': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues. Song YM,Park Y,Lim SS,Yang ST,Woo ER,Park IS,Lee JS,Kim JI,Hahm KS,Kim Y Biochemistry. 2005 Sep 13;44(36):12094-106.'], 'hemolysis': u'10-15% hemolysis at 50\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1657']}, u'GLLSVLKGVLKTAGKHIFKNVGGSLLDQAKCKISGEC': {'modifications': [], 'references': [u'A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica. Conlon JM,Sonnevend A,Patel M,Al-Dhaheri K, Nielsen, Per ,Nielsen PF,Kolodziejek J,Nowotny N,Iwamuro S Regul Pept. 2004 May 15;118(3):135-41.'], 'hemolysis': u'HC50 = 80\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1993']}, u'CVDIHVWDGVC': {'modifications': ['Cyclic'], 'references': [u'Therapeutic potential of peptides with neutralizing ability towards the venom and toxin (CaTx-I) of crotalus adamanteus. Samy RP,Thwin MM,Stiles BG,Bow H,Chow VT Curr Top Med Chem. 2011;11(20):2540-55.'], 'hemolysis': u'7.2% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3150']}, u'RWRWRW': {'modifications': ['C-Terminal'], 'references': [u'Length effects in antimicrobial peptides of the (RW)n series. Liu Z,Brady A,Young A,Rasimick B,Chen K,Zhou C Antimicrob Agents Chemother. 2007 Feb;51(2):597-603. Epub 2006 Dec 4.'], 'hemolysis': u'HD50  =2.1x102\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1079']}, u'GIGAVLKVLTTGLpALISWIKXXKRQQ': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Structure and activity of D-Pro14 melittin. Hewish DR,Barnham KJ,Werkmeister JA,Kirkpatrick A,Bartone N,Liu ST,Norton RS,Curtain C J Protein Chem. 2002 May;21(4):243-53.'], 'hemolysis': u'50% hemolysis at >18\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2474']}, u'LCYARRRFAVCV': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'3-6% hemolysis at 80\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1176']}, u'FLGFLHHLF': {'modifications': [], 'references': [u'Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus. Hong W,Zhang R,Di Z,He Y,Zhao Z,Hu J,Wu Y,Li W Biomaterials. 2013 Apr;34(13):3511-22. doi: 10.1016/j.biomaterials.2013.01.075. Epub 2013 Feb 13.'], 'hemolysis': u'HC50 =203.3\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3259']}, u'FFKKLOHALHOLALLAOHLAHOLKKA': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Structural determinants of antimicrobial and antiplasmodial activity and selectivity in histidine-rich amphipathic cationic peptides. Mason AJ,Moussaoui W,Abdelrahman T,Boukhari A,Bertani P,Marquette A,Shooshtarizaheh P,Moulay G,Boehm N,Guerold B,Sawers RJ,Kichler A,Metz-Boutigue MH,Candolfi E,Prevost G J Biol Chem. 2009 Jan 2;284(1):119-33. doi: 10.1074/jbc.M806201200. Epub 2008 Nov 4.'], 'hemolysis': u'HC50 <5.6\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3572']}, u'GIINTLQKYYWRVRGGRWAVLSWLPKEEQIGKWSTRGRKWWRRKK': {'modifications': [], 'references': [u'Linear analogues of human beta-defensin 3: concepts for design of antimicrobial peptides with reduced cytotoxicity to mammalian cells. Liu S,Zhou L,Li J,Suresh A,Verma C,Foo YH,Yap EP,Tan DT Chembiochem. 2008 Apr 14;9(6):964-73. doi: 10.1002/cbic.200700560.'], 'hemolysis': u'Increased hemolysis at 3-100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1162']}, u'CVHWQTNPARTSCIGP': {'modifications': [], 'references': [u'Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata. Ma Y,Liu C,Liu X,Wu J,Yang H,Wang Y,Li J,Yu H Genomics. 2010 Jan;95(1):66-71. doi: 10.1016/j.ygeno.2009.09.004. Epub 2009 Sep 22.'], 'hemolysis': u'0% hemolysis at 100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4023']}, u'KWKSFLKTFKSLKKTVLHTLLkAISS': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', u'Stereochemistry: Mix'], 'references': [u'Role of helicity on the anticancer mechanism of action of cationic-helical peptides. Huang YB,He LY,Jiang HY Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849. Epub 2012 Jun 5.'], 'hemolysis': u'MHC = 20.81 \xb1 0.10 \u03bcmol/L', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2637']}, u'KRKRQQGIGAVLKVLTTGLPALISWI': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Structure-immunogenicity relationship of melittin, its transposed analogues, and D-melittin. King TP,Wade D,Coscia MR,Mitchell S,Kochoumian L J Immunol. 1994 Aug 1;153(3):1124-31.'], 'hemolysis': u'20% hemolysis at 120\u03bcM compared with melittin', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3299']}, u'RAGLQFPVGRLLR': {'modifications': [], 'references': [u'A cancer specific cell-penetrating peptide, BR2, for the efficient delivery of an scFv into cancer cells. Lim KJ,Sung BH,Shin JR,Lee YW,Kim da J,Yang KS PLoS One. 2013 Jun 11;8(6):e66084. doi: 10.1371/journal.pone.0066084. Print 2013.'], 'hemolysis': u'Inactive', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3274']}, u'GLKkIFKKGLGSLVKGIAAHVAS': {'modifications': [u'Stereochemistry: Mix'], 'references': [u'Potent and rapid bactericidal action of alyteserin-1c and its [E4K] analog against multidrug-resistant strains of Acinetobacter baumannii. Conlon JM,Ahmed E,Pal T Peptides. 2010 Oct;31(10):1806-10. doi: 10.1016/j.peptides.2010.06.032. Epub 2010 Jul 11.'], 'hemolysis': u'LC50 >400\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3079']}, u'lirGlfksfwqvf': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Structure-activity relationship, conformational and biological studies of temporin L analogues. Mangoni ML,Carotenuto A,Auriemma L,Saviello MR,Campiglia P,Gomez-Monterrey I,Malfi S,Marcellini L,Barra D,Novellino E J Med Chem. 2011 Mar 10;54(5):1298-307. doi: 10.1021/jm1012853. Epub 2011 Feb 14.'], 'hemolysis': u'15% hemolytic at 6\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2846']}, u'QGWEAVAAAVASKIVGLWRNEKTELLGHECKFTVKPYLKRFQVYYKGRMWCPGWTAIRGEASTRSQSGVAGKTAKDFVRKAFQKGLLSQQEANQWLSS': {'modifications': [], 'references': [u'Trypanocidal and leishmanicidal activities of different antimicrobial peptides (AMPs) isolated from aquatic animals. Lofgren SE,Miletti LC,Steindel M,Bachere E Exp Parasitol. 2008 Feb;118(2):197-202. Epub 2007 Aug 15.'], 'hemolysis': u'55% hemolysis 100 \xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1944']}, u'VKyPKLyP': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Structure-activity relationships of de novo designed cyclic antimicrobial peptides based on gramicidin S. Lee DL Biopolymers. 2003;71(1):28-48.'], 'hemolysis': u'100% hemolysis at >150\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2289']}, u'RCLPAGKTCVRGPMRVPCCGSCSQNKCT': {'modifications': [], 'references': [u'Isolation and characterization of Psalmopeotoxin I and II: two novel antimalarial peptides from the venom of the tarantula Psalmopoeus cambridgei. Choi SJ,Parent R,Guillaume C,Deregnaucourt C,Delarbre C,Ojcius DM,Montagne JJ,Celerier ML,Phelipot A,Amiche M,Molgo J,Camadro JM FEBS Lett. 2004 Aug 13;572(1-3):109-17.'], 'hemolysis': u'No hemolysis at 10\u03bcM (non hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3568']}, u'KWCFCVCYRGICYCRCRG': {'modifications': [], 'references': [u'Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework. Tam JP,Lu YA Biochem Biophys Res Commun. 2000 Jan 27;267(3):783-90.'], 'hemolysis': u'EC25 =590\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2537']}, u'DLVKWIIDTVNKFTKK': {'modifications': [], 'references': [u'Interaction of staphylococcal delta-toxin and synthetic analogues with erythrocytes and phospholipid vesicles. Biological and physical properties of the amphipathic peptides. Alouf JE,Dufourcq J,Siffert O,Thiaudiere E Eur J Biochem. 1989 Aug 1;183(2):381-90.'], 'hemolysis': u'17% hemolysis at 500\u03bcg', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3349']}, u'GKGLTicOicFKTicOicKFTicOicFKTicOicKFTicOicFKTicOicFKR': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'De novo design of selective antibiotic peptides by incorporation of unnatural amino acids. Hicks RP,Bhonsle JB,Venugopal D,Koser BW J Med Chem. 2007 Jun 28;50(13):3026-36. Epub 2007 Jun 5.'], 'hemolysis': u'100% hemolysis at 25\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1744']}, u'LLKWLKKL': {'modifications': ['C-Terminal'], 'references': [u'De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface. Kang SJ,Won HS,Choi WS J Pept Sci. 2009 Sep;15(9):583-8. doi: 10.1002/psc.1149.'], 'hemolysis': u'4.78% hemolysis at 6.3\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1399']}, u'CGESCVWIPCTITALAGCKCKSKVCYNSIP': {'modifications': ['Cyclic'], 'references': [u'Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif. Craik DJ,Daly NL,Bond T J Mol Biol. 1999 Dec 17;294(5):1327-36.'], 'hemolysis': u'50% hemolysis at ~20\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4003']}, u'LKKLLKKLLKW': {'modifications': ['C-Terminal'], 'references': [u'Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities. Kim SJ,Kim JS,Lee YS,Sim DW,Lee SH,Bahk YY,Lee KH,Kim EH,Park SJ,Lee BJ Molecules. 2013 Jan 11;18(1):859-76. doi: 10.3390/molecules18010859.'], 'hemolysis': u'MHC = 128\u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2602']}, u'KKKKKKALFAAWAAFLA': {'modifications': ['C-Terminal', 'Cyclic'], 'references': [u'Membrane interactions of designed cationic antimicrobial peptides: the two thresholds. Glukhov E,Burrows LL Biopolymers. 2008 May;89(5):360-71. doi: 10.1002/bip.20917.'], 'hemolysis': u'MHC  <81\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1151']}, u'FLPIVGKLLSGLL': {'modifications': ['C-Terminal'], 'references': [u'Peptide defenses of the Cascades frog Rana cascadae: implications for the evolutionary history of frogs of the Amerana species group. Conlon JM,Al-Dhaheri A,Al-Mutawa E,Al-Kharrge R,Ahmed E,Kolodziejek J,Nowotny N, Nielsen, Per ,Nielsen PF Peptides. 2007 Jun;28(6):1268-74. Epub 2007 Mar 27.'], 'hemolysis': u'LD50 =75\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1130']}, u'MAIVGTIIKIIKAIIDIFAK': {'modifications': [], 'references': [u'Novel phenol-soluble modulin derivatives in community-associated methicillin-resistant Staphylococcus aureus identified through imaging mass spectrometry. Gonzalez DJ,Okumura CY,Hollands A,Kersten R,Akong-Moore K,Pence MA,Malone CL,Derieux J,Moore BS,Horswill AR,Dixon JE,Dorrestein PC J Biol Chem. 2012 Apr 20;287(17):13889-98. doi: 10.1074/jbc.M112.349860. Epub 2012 Feb 27.'], 'hemolysis': u'19% hemolytic at 10 \u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2710']}, u'GLFGVLAKVAAHVVPAIAKHF': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship of an antibacterial peptide, maculatin 1.1, from the skin glands of the tree frog, Litoria genimaculata. Niidome T,Kobayashi K,Arakawa H,Hatakeyama T J Pept Sci. 2004 Jul;10(7):414-22.'], 'hemolysis': u'100% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1609']}, u'GWRKWIKKATHVGKHIGKAALDAYI': {'modifications': ['C-Terminal'], 'references': [u'The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents. Morash MG,Douglas SE,Robotham A,Ridley CM,Gallant JW Dis Model Mech. 2011 Sep;4(5):622-33. doi: 10.1242/dmm.007310. Epub 2011 Jul 4.'], 'hemolysis': u'50% hemolytic at >256 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2939']}, u'SVSNAATRVCRTGRSRWRDVCRNFMR': {'modifications': ['Cyclic'], 'references': [u'Bactericidal and hemolytic activities of synthetic peptides derived from granulysin. Siano A,Tonarelli G,Imaz MS,Perin JC,Ruggeri N,Lopez M,Santi MN Protein Pept Lett. 2010 Apr;17(4):517-21.'], 'hemolysis': u'70% hemolysis at 200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3051']}, u'GVVTDLLKTAGKLLGNLVGSLSG': {'modifications': ['C-Terminal'], 'references': [u'Membrane association, electrostatic sequestration, and cytotoxicity of Gly-Leu-rich peptide orthologs with differing functions. Vanhoye D,Bruston F,El Amri S,Ladram A,Amiche M Biochemistry. 2004 Jul 6;43(26):8391-409.'], 'hemolysis': u'71% hemolytic at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2499']}, u'ALWDTLLKKVLKAAAKAALDAVLVGANA': {'modifications': [], 'references': [u'Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity. Feder R,Dagan A J Biol Chem. 2000 Feb 11;275(6):4230-8.'], 'hemolysis': u'LC50 =5\xb11\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1004']}, u'AibGIL': {'modifications': [u'C-Terminal Non-Amidation: Methoxy (Ome)', u'N-Terminal Modification: Acetylated by lipol (n-octanoyl)', 'Non-Natural'], 'references': [u'Trichogin GA IV: an antibacterial and protease-resistant peptide. De Zotti M,Biondi B,Formaggio F,Toniolo C,Stella L,Park Y J Pept Sci. 2009 Sep;15(9):615-9. doi: 10.1002/psc.1135.'], 'hemolysis': u'0% hemolysis at 15 \u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1295']}, u'FVQWFSKFLGRIL': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial peptides from the skin secretions of the New World frogs Lithobates capito and Lithobates warszewitschii (Ranidae). Conlon JM,Meetani MA,Coquet L,Jouenne T,Leprince J,Vaudry H,Kolodziejek J,Nowotny N Peptides. 2009 Oct;30(10):1775-81. doi: 10.1016/j.peptides.2009.07.011. Epub 2009 Jul 25.'], 'hemolysis': u'LC50 =2\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4148']}, u'KAACAAKCLWR': {'modifications': ['C-Terminal'], 'references': [u'Design and synthesis of novel antimicrobial peptides on the basis of alpha helical domain of Tenecin 1, an insect defensin protein, and structure-activity relationship study. Ahn HS,Cho W,Kang SH,Ko SS,Park MS,Cho H Peptides. 2006 Apr;27(4):640-8. Epub 2005 Oct 13.'], 'hemolysis': u'0% hemolysis at 200\u03bcg/ml (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1900']}, u'RIKRFWPVVIRTVVAGYNLYRAIKKK': {'modifications': [], 'references': [u'Molecular cloning and characterization of novel cathelicidin-derived myeloid antimicrobial peptide from Phasianus colchicus. Wang Y,Lu Z,Feng F,Zhu W,Guang H,Liu J,He W,Chi L,Li Z Dev Comp Immunol. 2011 Mar;35(3):314-22. doi: 10.1016/j.dci.2010.10.004. Epub 2010 Oct 26.'], 'hemolysis': u'3.6% hemolytic at 3.15\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2810']}, u'CGESCVWIPCLTSAVGCSCKSKVCYRNGIP': {'modifications': ['Cyclic'], 'references': [u'Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif. Craik DJ,Daly NL,Bond T J Mol Biol. 1999 Dec 17;294(5):1327-36.'], 'hemolysis': u'50% hemolysis at ~20\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4005']}, u'kklallalkkwlpalkklallalkk': {'modifications': ['C-Terminal', u'Stereochemistry: D'], 'references': [u'Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic ?-helical peptides. Vermeer LS,Lan Y,Abbate V,Ruh E,Bui TT,Wilkinson LJ,Kanno T,Jumagulova E,Kozlowska J,Patel J,McIntyre CA,Yam WC,Siu G,Atkinson RA,Lam JK,Bansal SS, Drake, Alex ,Drake AF,Mitchell GH J Biol Chem. 2012 Oct 5;287(41):34120-33. doi: 10.1074/jbc.M112.359067. Epub 2012 Aug 6.'], 'hemolysis': u'HC50 = 11.66\xb10.03\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2625']}, u'KKLLPIVANLLKSLL': {'modifications': [], 'references': [u"Design, structural and functional characterization of a Temporin-1b analog active against Gram-negative bacteria. Avitabile C,Netti F,Orefice G,Palmieri M,Nocerino N,Malgieri G,D'Andrea LD,Capparelli R,Fattorusso R Biochim Biophys Acta. 2013 Jun;1830(6):3767-75. doi: 10.1016/j.bbagen.2013.01.026. Epub 2013 Feb 9."], 'hemolysis': u'Inactive', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3257']}, u'GILDTLKQFAKGVGKDLVKGAAQGVLSTVSCKLAKTC': {'modifications': [], 'references': [u'Solution structure of the antimicrobial peptide gaegurin 4 by H and 15N nuclear magnetic resonance spectroscopy. Park SH,Kim YK,Park JW,Lee B Eur J Biochem. 2000 May;267(9):2695-704.'], 'hemolysis': u'Non-hemolytic', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2485']}, u'GLFGKLIKKFLRKAISYAVKKARGKH': {'modifications': [], 'references': [u'N-terminal amphipathic helix as a trigger of hemolytic activity in antimicrobial peptides: a case study in latarcins. Polyansky AA,Vassilevski AA,Volynsky PE,Vorontsova OV,Samsonova OV,Egorova NS,Krylov NA,Feofanov AV,Arseniev AS,Grishin EV FEBS Lett. 2009 Jul 21;583(14):2425-8. doi: 10.1016/j.febslet.2009.06.044. Epub 2009 Jun 27.'], 'hemolysis': u'EC50 =3\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1445']}, u'RWGKWFKKATHVGKHVGKAALTAYL': {'modifications': ['C-Terminal'], 'references': [u'The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents. Morash MG,Douglas SE,Robotham A,Ridley CM,Gallant JW Dis Model Mech. 2011 Sep;4(5):622-33. doi: 10.1242/dmm.007310. Epub 2011 Jul 4.'], 'hemolysis': u'50% hemolytic at >256 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2922']}, u'GNleAibOrnOrnAibAibOrnOrnNleNleGY': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Amphipathic alpha helical antimicrobial peptides. Giangaspero A,Sandri L Eur J Biochem. 2001 Nov;268(21):5589-600.'], 'hemolysis': u'12% hemolysis at 10\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2145']}, u'kWkSFLkTFkSLKkTVLHTLLkAISS': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', u'Stereochemistry: Mix'], 'references': [u'Role of helicity on the anticancer mechanism of action of cationic-helical peptides. Huang YB,He LY,Jiang HY Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849. Epub 2012 Jun 5.'], 'hemolysis': u'MHC >325.20\u03bcmol/L', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2643']}, u'RSTEDIIKSISGGGFLNAMNA': {'modifications': ['C-Terminal'], 'references': [u'The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents. Morash MG,Douglas SE,Robotham A,Ridley CM,Gallant JW Dis Model Mech. 2011 Sep;4(5):622-33. doi: 10.1242/dmm.007310. Epub 2011 Jul 4.'], 'hemolysis': u'50% hemolytic at >256 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2923']}, u'RILRGVSRRIMRRILTGRR': {'modifications': ['C-Terminal'], 'references': [u'Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens. Andra J,Monreal D,Martinez de Tejada G,Olak C,Brezesinski G,Gomez SS,Goldmann T,Bartels R,Brandenburg K J Biol Chem. 2007 May 18;282(20):14719-28. Epub 2007 Mar 27.'], 'hemolysis': u'~8% hemolysis at 100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1123']}, u'FFHHIFRaIVHVaKTIHRLVTG': {'modifications': [u'Stereochemistry: Mix'], 'references': [u'Solution structure and cell selectivity of piscidin 1 and its analogues. Lee SA,Kim YK,Lim SS,Zhu WL,Ko H,Shin SY,Hahm KS Biochemistry. 2007 Mar 27;46(12):3653-63. Epub 2007 Mar 1.'], 'hemolysis': u'HC50 =8\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1118']}, u'FHPSLWVLIPQYIQLIRKILKSG': {'modifications': [], 'references': [u'Conolysin-Mt: a conus peptide that disrupts cellular membranes. Biggs JS,Rosenfeld Y,Shai Y Biochemistry. 2007 Nov 6;46(44):12586-93. Epub 2007 Oct 10.'], 'hemolysis': u'~90% hemolysis at 10\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3636']}, u'GLKDKFKSMGEKLKQYIQTWKAKF': {'modifications': ['C-Terminal'], 'references': [u'Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity. Kozlov SA,Vassilevski AA,Feofanov AV,Surovoy AY,Karpunin DV J Biol Chem. 2006 Jul 28;281(30):20983-92. Epub 2006 May 30.'], 'hemolysis': u'20% hemolysis at >120\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4055']}, u'ILGKLLSTWAGLLSNL': {'modifications': ['C-Terminal'], 'references': [u'Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent. Conlon JM,Mechkarska M,Prajeep M,Arafat K,Zaric M,Lukic ML Amino Acids. 2013 Feb;44(2):715-23. doi: 10.1007/s00726-012-1395-7. Epub 2012 Sep 11.'], 'hemolysis': u'LC50 =39\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3182']}, u'KSTVGQKLKKKLNQAVDKVKEVLNKSEYMCPVVSSFCKQHCARLGKSGQCDLLECIC': {'modifications': [], 'references': [u'Cytolytic and K+ channel blocking activities of beta-KTx and scorpine-like peptides purified from scorpion venoms. Diego-Garcia E,Abdel-Mottaleb Y, Schwartz, E ,Schwartz EF,de la Vega RC,Tytgat J Cell Mol Life Sci. 2008 Jan;65(1):187-200.'], 'hemolysis': u'No hemolysis at 200nM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3633']}, u'FLPILAGLAAKLVPKVFCSITKKC': {'modifications': [], 'references': [u'Host-defense peptides isolated from the skin secretions of the Northern red-legged frog Rana aurora aurora. Conlon JM,Sonnevend A,Davidson C,Demandt A Dev Comp Immunol. 2005;29(1):83-90.'], 'hemolysis': u'HC50 =5\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1616']}, u'GIGAVLKVLALISWIKRKR': {'modifications': ['C-Terminal'], 'references': [u'Micelle-bound structures and dynamics of the hinge deleted analog of melittin and its diastereomer: implications in cell selective lysis by D-amino acid containing antimicrobial peptides. Saravanan R,Bhunia A Biochim Biophys Acta. 2010 Feb;1798(2):128-39. doi: 10.1016/j.bbamem.2009.07.014. Epub 2009 Jul 25.'], 'hemolysis': u'42% hemolysis at 23\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1461']}, u'KWKSFLKTFKSLKKTVLHTALKAISS': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides. Chen Y,Guarnieri MT,Vasil AI,Vasil ML,Mant CT Antimicrob Agents Chemother. 2007 Apr;51(4):1398-406. Epub 2006 Dec 11.'], 'hemolysis': u'MHC =31.3\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1086']}, u'FFGWLIRGAIHAGKAIHGLIHRRRH': {'modifications': ['C-Terminal'], 'references': [u'Purification and characterization of three isoforms of chrysophsin, a novel antimicrobial peptide in the gills of the red sea bream, Chrysophrys major. Iijima N,Tanimoto N,Emoto Y,Morita Y,Uematsu K,Murakami T Eur J Biochem. 2003 Feb;270(4):675-86.'], 'hemolysis': u'100% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3546']}, u'CVYAYVRVRGVLVRYRRCW': {'modifications': [], 'references': [u'The characteristic region of arenicin-1 involved with a bacterial membrane targeting mechanism. Cho J Biochem Biophys Res Commun. 2011 Feb 18;405(3):422-7. doi: 10.1016/j.bbrc.2011.01.046. Epub 2011 Jan 15.'], 'hemolysis': u'4% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3122']}, u'KKSYVRRWRS': {'modifications': [], 'references': [u'Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide. Wu YS,Liao ZJ,Wang KS Bioorg Med Chem Lett. 2013 May 15;23(10):2929-32. doi: 10.1016/j.bmcl.2013.03.053. Epub 2013 Mar 25.'], 'hemolysis': u'-0.6 \xb1 1.6% hemolytic at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2582']}, u'VKKFPWWWPFLKK': {'modifications': [], 'references': [u'Selective cytotoxicity following Arg-to-Lys substitution in tritrpticin adopting a unique amphipathic turn structure. Yang ST,Shin SY,Lee CW,Kim YC,Hahm KS FEBS Lett. 2003 Apr 10;540(1-3):229-33.'], 'hemolysis': u'1% hemolysis at 200 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2284']}, u'ILGKLLSTAAkLLSKL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent. Conlon JM,Mechkarska M,Prajeep M,Arafat K,Zaric M,Lukic ML Amino Acids. 2013 Feb;44(2):715-23. doi: 10.1007/s00726-012-1395-7. Epub 2012 Sep 11.'], 'hemolysis': u'LC50 =195\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3180']}, u'GIGAVLKVLTTGLpALISWIKFKRQQ': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Structure and activity of D-Pro14 melittin. Hewish DR,Barnham KJ,Werkmeister JA,Kirkpatrick A,Bartone N,Liu ST,Norton RS,Curtain C J Protein Chem. 2002 May;21(4):243-53.'], 'hemolysis': u'50% hemolysis at >80\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2473']}, u'PKDLKETLQEKKP': {'modifications': [], 'references': [u'A synthetic peptide corresponding to the NH2 terminus of vesicular stomatitis virus glycoprotein is a pH-dependent hemolysin. Schlegel R J Biol Chem. 1984 Apr 25;259(8):4691-4.'], 'hemolysis': u'0% hemolysis upto 500\u03bcg/ml (non hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3293']}, u'VeIHVWeGV': {'modifications': [u'Stereochemistry: Mix'], 'references': [u'Therapeutic potential of peptides with neutralizing ability towards the venom and toxin (CaTx-I) of crotalus adamanteus. Samy RP,Thwin MM,Stiles BG,Bow H,Chow VT Curr Top Med Chem. 2011;11(20):2540-55.'], 'hemolysis': u'2.24% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3149']}, u'INLKALAALAKKIL': {'modifications': [], 'references': [u'Antibacterial and antifungal properties of alpha-helical, cationic peptides in the venom of scorpions from southern Africa. Moerman L,Bosteels S,Noppe W,Willems J,Clynen E,Schoofs L,Thevissen K,Tytgat J,Van Eldere J,Van Der Walt J,Verdonck Eur J Biochem. 2002 Oct;269(19):4799-810.'], 'hemolysis': u'~10% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3753']}, u'ILQKAVLDCLKAAGSSLSKAAITAIYNKIT': {'modifications': [], 'references': [u'Dicynthaurin: an antimicrobial peptide from hemocytes of the solitary tunicate, Halocynthia aurantium. Lee IH,Lee YS,Kim CH,Kim CR,Hong T,Menzel L,Boo LM,Pohl J,Sherman MA,Waring A Biochim Biophys Acta. 2001 Aug 15;1527(3):141-8.'], 'hemolysis': u'20% hemolysis at 100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3531']}, u'GIINTLQKYYSRVRGGRSAVLSSLPKEEQIGKSSTRGRKSSRRKK': {'modifications': [], 'references': [u'Linear analogues of human beta-defensin 3: concepts for design of antimicrobial peptides with reduced cytotoxicity to mammalian cells. Liu S,Zhou L,Li J,Suresh A,Verma C,Foo YH,Yap EP,Tan DT Chembiochem. 2008 Apr 14;9(6):964-73. doi: 10.1002/cbic.200700560.'], 'hemolysis': u'<1% hemolysis at 3-100 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1158']}, u'KWKLFKKIEKVGQNIRDGIIKAGPGIGAVLKVLTTGL': {'modifications': ['C-Terminal'], 'references': [u'Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids. Boman HG,Wade D,Boman IA,Wahlin B FEBS Lett. 1989 Dec 18;259(1):103-6.'], 'hemolysis': u'Lethal concentration calculated from zone of inhibition >200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3560']}, u'FFHHIFRPIVHVGKTIHRLVTG': {'modifications': [], 'references': [u'Solution structure and cell selectivity of piscidin 1 and its analogues. Lee SA,Kim YK,Lim SS,Zhu WL,Ko H,Shin SY,Hahm KS Biochemistry. 2007 Mar 27;46(12):3653-63. Epub 2007 Mar 1.'], 'hemolysis': u'HC50 >200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1113']}, u'KWFRVYRGIYRRR': {'modifications': ['C-Terminal'], 'references': [u'Structure, activity and interactions of the cysteine deleted analog of tachyplesin-1 with lipopolysaccharide micelle: Mechanistic insights into outer-membrane permeabilization and endotoxin neutralization. Saravanan R,Mohanram H,Joshi M,Domadia PN,Torres J,Ruedl C Biochim Biophys Acta. 2012 Jul;1818(7):1613-24.'], 'hemolysis': u'0% hemolysis at 200\xb5g/ml (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2083']}, u'GLAANFLPKIFCKITKRC': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity analysis of brevinin 1E amide, an antimicrobial peptide from Rana esculenta. Kwon MY,Hong SY Biochim Biophys Acta. 1998 Sep 8;1387(1-2):239-48.'], 'hemolysis': u'HD50=230\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3290']}, u'GCKKWFKKAAHVGKNVGKVALNAYL': {'modifications': ['C-Terminal'], 'references': [u'The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents. Morash MG,Douglas SE,Robotham A,Ridley CM,Gallant JW Dis Model Mech. 2011 Sep;4(5):622-33. doi: 10.1242/dmm.007310. Epub 2011 Jul 4.'], 'hemolysis': u'50% hemolytic at >256 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2940']}, u'FLPFLLSALPKVFCFFSKKC': {'modifications': ['Cyclic'], 'references': [u'Molecular cloning and functional characterization of novel antimicrobial peptides from the skin of brown frog, Rana zhenhaiensis. Xu B,Che H,Kang L,Zheng S,Mu S,Wan Zoolog Sci. 2012 Sep;29(9):553-8. doi: 10.2108/zsj.29.553.'], 'hemolysis': u'HC50 =3\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3161']}, u'ALWMTLLKKVLKAAAKAALNAVLVGANA': {'modifications': [], 'references': [u'The vertebrate peptide antibiotics dermaseptins have overlapping structural features but target specific microorganisms. Mor A,Hani K J Biol Chem. 1994 Dec 16;269(50):31635-41.'], 'hemolysis': u'100% hemolysis at 1\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3693']}, u'GSPALISWIKRKRQQ': {'modifications': ['C-Terminal'], 'references': [u"Individual substitution analogs of Mel(12-26), melittin's C-terminal 15-residue peptide: their antimicrobial and hemolytic actions. Yan H,Li S,Sun X,Mi H FEBS Lett. 2003 Nov 6;554(1-2):100-4."], 'hemolysis': u'HC10  = 1588 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2357']}, u'LKLNSIVSWAKKVL': {'modifications': ['C-Terminal'], 'references': [u'Structural requirements for the edema-inducing and hemolytic activities of mastoparan B isolated from the hornet (Vespa basalis) venom. Ho CL,Lin YL,Chen WC,Hwang LL,Yu HM Toxicon. 1996 Sep;34(9):1027-35.'], 'hemolysis': u'>75% hemolysis at 20\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3502']}, u'KWKSFAKTFKSAKKTVLHTALKAISS': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides. Chen Y,Guarnieri MT,Vasil AI,Vasil ML,Mant CT Antimicrob Agents Chemother. 2007 Apr;51(4):1398-406. Epub 2006 Dec 11.'], 'hemolysis': u'MHC =1000\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1084']}, u'VOL2nalPVOL2nalP': {'modifications': ['Cyclic', u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'Therapeutic index of gramicidin S is strongly modulated by D-phenylalanine analogues at the beta-turn. Solanas C,de la Torre BG,Fernandez-Reyes M,Santiveri CM,Jimenez MA,Rivas L,Jimenez AI,Andreu D J Med Chem. 2009 Feb 12;52(3):664-74. doi: 10.1021/jm800886n.'], 'hemolysis': u'HC50=7.1(\xb13.5)\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1286']}, u'ISRLAGLLRKGGEKIGEKLKKIGQKIKNFFQKLVPQPE': {'modifications': [], 'references': [u'CRAMP analogues having potent antibiotic activity against bacterial, fungal, and tumor cells without hemolytic activity. Shin SY,Kang SW,Lee DG,Eom SH,Song WK Biochem Biophys Res Commun. 2000 Sep 7;275(3):904-9.'], 'hemolysis': u'2.2% hemolytic at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2514']}, u'INWKKIASIGKEVLKA': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 >>100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3928']}, u'RRWPWWPWKWPLI': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship of indolicidin, a Trp-rich antibacterial peptide. Ando S,Mitsuyasu K,Soeda Y,Hidaka M,Ito Y,Matsubara K,Shindo M,Uchida Y J Pept Sci. 2010 Apr;16(4):171-7. doi: 10.1002/psc.1217.'], 'hemolysis': u'36% hemolysis at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1490']}, u'SIITMTREAKLPQLWKQIACRLYNTC': {'modifications': ['Cyclic'], 'references': [u'A new family of antimicrobial peptides from skin secretions of Rana pleuraden. Wang X,Song Y,Li J,Liu H,Xu X,Lai R Peptides. 2007 Oct;28(10):2069-74. Epub 2007 Jul 22.'], 'hemolysis': u'Little hemolysis at 200mg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3640']}, u'GLWSTIKNVGKEAAIAAGKAALGAL': {'modifications': ['C-Terminal'], 'references': [u'Isolation and biochemical characterization of peptides presenting antimicrobial activity from the skin of Phyllomedusa hypochondrialis. Conceicao K,Konno K,Richardson M,Antoniazzi MM,Jared C,Daffre S,Camargo AC Peptides. 2006 Dec;27(12):3092-9. Epub 2006 Sep 11.'], 'hemolysis': u'No hemolysis at 6\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1915']}, u'FIKRIARLLRKIF': {'modifications': [], 'references': [u'Antibacterial activity and mechanism of a scorpion venom peptide derivative in vitro and in vivo. Cao L,Dai C,Li Z,Fan Z,Song Y,Wu Y,Cao Z PLoS One. 2012;7(7):e40135. doi: 10.1371/journal.pone.0040135. Epub 2012 Jul 5.'], 'hemolysis': u'HC50= 90.27 \xb5g/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2671']}, u'GLLKKLLKIAAKVGKKLL': {'modifications': ['C-Terminal'], 'references': [u'Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7. Conlon JM,Galadari S,Raza H Chem Biol Drug Des. 2008 Jul;72(1):58-64. doi: 10.1111/j.1747-0285.2008.00671.x. Epub 2008 Jun 12.'], 'hemolysis': u'LD50 = 25\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1966']}, u'RWCVYAYVRVRGVLVRYRRCW': {'modifications': [], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC >1\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3938']}, u'GWGSFFKKAAAVGKAVGKAALTAYL': {'modifications': [], 'references': [u'Interaction of pleurocidin and its analogs with phospholipid membrane and their antibacterial activity. Yoshida K,Mukai Y,Niidome T,Takashi C,Tokunaga Y,Hatakeyama T J Pept Res. 2001 Feb;57(2):119-26.'], 'hemolysis': u'45% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2109']}, u'CGESCVWIPCISSAIGCSCKSKVCYRNGIP': {'modifications': ['Cyclic'], 'references': [u'Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif. Craik DJ,Daly NL,Bond T J Mol Biol. 1999 Dec 17;294(5):1327-36.'], 'hemolysis': u'50% hemolysis at ~20\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3998']}, u'WLRRIGKGVKIIGGAALDHL': {'modifications': ['C-Terminal'], 'references': [u'The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents. Morash MG,Douglas SE,Robotham A,Ridley CM,Gallant JW Dis Model Mech. 2011 Sep;4(5):622-33. doi: 10.1242/dmm.007310. Epub 2011 Jul 4.'], 'hemolysis': u'50% hemolytic at >256 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2917']}, u'GFLSSLKKSLGKSXAHSK': {'modifications': ['C-Terminal'], 'references': [u'Effect of hydrocarbon stapling on the properties of ?-helical antimicrobial peptides isolated from the venom of hymenoptera. Chapuis H,Slaninova J,Bednarova L,Monincova L,Budesinsky M Amino Acids. 2012 Nov;43(5):2047-58. doi: 10.1007/s00726-012-1283-1. Epub 2012 Apr 17.'], 'hemolysis': u'LC50  = 29\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2753']}, u'KWKLFKKIGPGKFLHSAKKF': {'modifications': ['C-Terminal'], 'references': [u'Effects of the hinge region of cecropin A(1-8)-magainin 2(1-12), a synthetic antimicrobial peptide, on liposomes, bacterial and tumor cells. Shin SY,Kang JH,Jang SY,Kim Y,Kim KL Biochim Biophys Acta. 2000 Feb 15;1463(2):209-18.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2026']}, u'KLKLKfKLKQ': {'modifications': ['Cyclic', u'Stereochemistry: D'], 'references': [u'De novo designed cyclic cationic peptides as inhibitors of plant pathogenic bacteria. Monroc S,Badosa E,Feliu L,Planas M,Montesinos E Peptides. 2006 Nov;27(11):2567-74. Epub 2006 May 30.'], 'hemolysis': u'42\xb1 6.8% hemolysis at 360\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1688']}, u'GLPRKILAAIAKKKGKAKGPLKLVAKA': {'modifications': [], 'references': [u'Lasiocepsin, a novel cyclic antimicrobial peptide from the venom of eusocial bee Lasioglossum laticeps (Hymenoptera: Halictidae). Monincova L,Slaninova J,Fucik V,Hovorka O,Voburka Z,Bednarova L,Malon P,Stokrova J Amino Acids. 2012 Aug;43(2):751-61. doi: 10.1007/s00726-011-1125-6. Epub 2011 Oct 29.'], 'hemolysis': u'<1% hemolytic at 200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2742']}, u'RWSVYAYVRVRGVLVRYRRSW': {'modifications': [], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC >1\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3939']}, u'GFKLKGMARISCLPNGQWSNFPPKCIRECAMVSS': {'modifications': [], 'references': [u'High therapeutic index of factor C Sushi peptides: potent antimicrobials against Pseudomonas aeruginosa. Yau YH,Ho B,Tan NS,Ng ML Antimicrob Agents Chemother. 2001 Oct;45(10):2820-5.'], 'hemolysis': u'0% hemolysis at 100 \xb5g/ml (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2131']}, u'FKKLKKIANIINSIFKK': {'modifications': [], 'references': [u'Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEa. Yang QZ,Wang C,Lang L,Zhou Y,Wang H Arch Pharm Res. 2013 Apr 23.'], 'hemolysis': u'LC50 =4,649\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2574']}, u'FIHHIIGGLFSAGKAIHRLIRRRRR': {'modifications': [], 'references': [u'Five different piscidins from Nile tilapia, Oreochromis niloticus: analysis of their expressions and biological functions. Peng KC,Lee SH,Hour AL,Pan CY,Lee LH PLoS One. 2012;7(11):e50263. doi: 10.1371/journal.pone.0050263. Epub 2012 Nov 30.'], 'hemolysis': u'100% hemolytic at 100 \xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2610']}, u'ILPWKWPWLPWKK': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship of indolicidin, a Trp-rich antibacterial peptide. Ando S,Mitsuyasu K,Soeda Y,Hidaka M,Ito Y,Matsubara K,Shindo M,Uchida Y J Pept Sci. 2010 Apr;16(4):171-7. doi: 10.1002/psc.1217.'], 'hemolysis': u'8% hemolysis at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1489']}, u'KKKAAAFAAWAAFAKKK': {'modifications': ['C-Terminal'], 'references': [u'Cationic hydrophobic peptides with antimicrobial activity. Stark M,Liu LP Antimicrob Agents Chemother. 2002 Nov;46(11):3585-90.'], 'hemolysis': u'0% hemolysis at 50\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2241']}, u'kklalhalkkwlhalkklahlalkk': {'modifications': ['C-Terminal', u'Stereochemistry: D'], 'references': [u'Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic ?-helical peptides. Vermeer LS,Lan Y,Abbate V,Ruh E,Bui TT,Wilkinson LJ,Kanno T,Jumagulova E,Kozlowska J,Patel J,McIntyre CA,Yam WC,Siu G,Atkinson RA,Lam JK,Bansal SS, Drake, Alex ,Drake AF,Mitchell GH J Biol Chem. 2012 Oct 5;287(41):34120-33. doi: 10.1074/jbc.M112.359067. Epub 2012 Aug 6.'], 'hemolysis': u'HC50 = 20.29\xb12.42\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2628']}, u'GFFALIpKIISSPLFKTllSAV': {'modifications': [u'C-Terminal Non-Amidation: NH(CH2)2NH2', u'Stereochemistry: Mix'], 'references': [u'A comparative study on the structure and function of a cytolytic alpha-helical peptide and its antimicrobial beta-sheet diastereomer. Oren Z,Hong J Eur J Biochem. 1999 Jan;259(1-2):360-9.'], 'hemolysis': u'1% hemolysis at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3834']}, u'LRCKKRRWKCRV': {'modifications': ['Cyclic'], 'references': [u'Macrocyclic hairpin mimetics of the cationic antimicrobial peptide protegrin I: a new family of broad-spectrum antibiotics. Shankaramma SC,Athanassiou Z,Zerbe O,Moehle K,Mouton C,Bernardini F,Vrijbloed JW,Obrecht D Chembiochem. 2002 Nov 4;3(11):1126-33.'], 'hemolysis': u'1% hemolysis at 100\xb5g ml-1', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2277']}, u'IKIPPIVKDTLKKVAKGVLSTIAGALST': {'modifications': [], 'references': [u'The hymenochirins: a family of host-defense peptides from the Congo dwarf clawed frog Hymenochirus boettgeri (Pipidae). Mechkarska M,Prajeep M,Coquet L,Leprince J,Jouenne T,Vaudry H,King JD Peptides. 2012 Jun;35(2):269-75. doi: 10.1016/j.peptides.2012.03.029. Epub 2012 Apr 3.'], 'hemolysis': u'Non-hemolytic', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2094']}, u'ALWKTLLKKVLKAAAKAALKAVLVGANA': {'modifications': [], 'references': [u'Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity. Feder R,Dagan A J Biol Chem. 2000 Feb 11;275(6):4230-8.'], 'hemolysis': u'LC50 =0.5\xb10.1\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1007']}, u'ALWKTLLKKV': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity. Feder R,Dagan A J Biol Chem. 2000 Feb 11;275(6):4230-8.'], 'hemolysis': u'LC50  >100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1019']}, u'KWKLFKKIPFLHLAKKF': {'modifications': ['C-Terminal'], 'references': [u'Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs. Shin SY,Lee SH,Yang ST,Park EJ,Lee DG,Lee MK,Eom SH,Song WK,Kim Y,Hahm KS J Pept Res. 2001 Dec;58(6):504-14.'], 'hemolysis': u'30.3% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2166']}, u'GWGSFFKKAAHVGKHVAKAALTHYL': {'modifications': [], 'references': [u'Effects of two glycine residues in positions 13 and 17 of pleurocidin on structure and bacterial cell selectivity. Lim SS,Song YM,Jang MH,Kim Y,Hahm KS Protein Pept Lett. 2004 Feb;11(1):35-40.'], 'hemolysis': u'15.4% hemolytic at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2504']}, u'VLPKVMAHMK': {'modifications': ['C-Terminal'], 'references': [u'Melectin: a novel antimicrobial peptide from the venom of the cleptoparasitic bee Melecta albifrons. Cerovsky V,Hovorka O,Cvacka J,Voburka Z,Bednarova L,Borovickova L,Slaninova J Chembiochem. 2008 Nov 24;9(17):2815-21. doi: 10.1002/cbic.200800476.'], 'hemolysis': u'LC50 >100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3629']}, u'FIQYLAPLIPHAVKAISDLI': {'modifications': ['C-Terminal'], 'references': [u'A family of kassinatuerin-2 related peptides from the skin secretion of the African hyperoliid frog, Kassina maculata. Wang L,Zhou M,McGrath S,Chen T,Gorman SP,Walker B Peptides. 2009 Aug;30(8):1428-33. doi: 10.1016/j.peptides.2009.04.021. Epub 2009 May 7.'], 'hemolysis': u'45-50% hemolysis at 120\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3488']}, u'kwksflktfkslkktvlhtllkaiss': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', u'Stereochemistry: D'], 'references': [u'Anti-tuberculosis activity of ?-helical antimicrobial peptides: de novo designed L- and D-enantiomers versus L- and D-LL-37. Jiang Z,Higgins MP,Whitehurst J,Kisich KO,Voskuil MI Protein Pept Lett. 2011 Mar;18(3):241-52.'], 'hemolysis': u'HC50 = 14\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2802']}, u'KWCFRVCYRGICYRRC': {'modifications': [], 'references': [u'Trypanocidal and leishmanicidal activities of different antimicrobial peptides (AMPs) isolated from aquatic animals. Lofgren SE,Miletti LC,Steindel M,Bachere E Exp Parasitol. 2008 Feb;118(2):197-202. Epub 2007 Aug 15.'], 'hemolysis': u'10% hemolysis 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1940']}, u'KWFKKIPKFLHLAKKF': {'modifications': ['C-Terminal'], 'references': [u'Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs. Shin SY,Lee SH,Yang ST,Park EJ,Lee DG,Lee MK,Eom SH,Song WK,Kim Y,Hahm KS J Pept Res. 2001 Dec;58(6):504-14.'], 'hemolysis': u'1.8% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2160']}, u'GIMSLFKGVLKTAGKHVAGSLVDQLKCKITGGC': {'modifications': [], 'references': [u'Antimicrobial peptides from the skin of the Tsushima brown frog Rana tsushimensis. Conlon JM,Al-Ghaferi N,Abraham B,Sonnevend A,Coquet L,Leprince J,Jouenne T,Vaudry H Comp Biochem Physiol C Toxicol Pharmacol. 2006 May;143(1):42-9. Epub 2006 Jan 18.'], 'hemolysis': u'LD50 =100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1054']}, u'GRFKRFRKKFKKLFKKLS': {'modifications': ['C-Terminal'], 'references': [u'Cell selectivity, mechanism of action and LPS-neutralizing activity of bovine myeloid antimicrobial peptide-18 (BMAP-18) and its analogs. Lee EK,Kim YC,Nan YH Peptides. 2011 Jun;32(6):1123-30. doi: 10.1016/j.peptides.2011.03.024. Epub 2011 Apr 8.'], 'hemolysis': u'10% hemolysis at >400\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3128']}, u'AKKVFKRLGIGAVLKVLKKG': {'modifications': [], 'references': [u'Design of novel analogues with potent antibiotic activity based on the antimicrobial peptide, HP(2-9)-ME(1-12). Park Y,Kim HN,Park SN,Jang SH,Choi CH,Lim HT Biotechnol Lett. 2004 Mar;26(6):493-8.'], 'hemolysis': u'0% hemolysis upto 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4184']}, u'FLPLAVSLAANFLPKLFCKITKKC': {'modifications': [], 'references': [u'Two families of antimicrobial peptides with multiple functions from skin of rufous-spotted torrent frog, Amolops loloensis. Lu Y,Li J,Yu H,Xu X,Liang J,Tian Y,Ma D,Lin G,Huang G Peptides. 2006 Dec;27(12):3085-91. Epub 2006 Sep 26.'], 'hemolysis': u'96%  hemolysis at 20  \xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1720']}, u'ILGKLLKTAAGLLSNL': {'modifications': ['C-Terminal'], 'references': [u'Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent. Conlon JM,Mechkarska M,Prajeep M,Arafat K,Zaric M,Lukic ML Amino Acids. 2013 Feb;44(2):715-23. doi: 10.1007/s00726-012-1395-7. Epub 2012 Sep 11.'], 'hemolysis': u'LC50 =28\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3170']}, u'ISSPLFKTLLSAVGSALSSSGGQE': {'modifications': [u'C-Terminal Non-Amidation: [NH(CH2)2NH2]2'], 'references': [u'A class of highly potent antibacterial peptides derived from pardaxin, a pore-forming peptide isolated from Moses sole fish Pardachirus marmoratus. Oren Z Eur J Biochem. 1996 Apr 1;237(1):303-10.'], 'hemolysis': u'No hemolysis (Non hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3680']}, u'fPVOLfPVOL': {'modifications': ['Cyclic', u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'Modulation of structure and antibacterial and hemolytic activity by ring size in cyclic gramicidin S analogs. Kondejewski LH,Farmer SW,Wishart DS,Kay CM,Hancock RE J Biol Chem. 1996 Oct 11;271(41):25261-8.'], 'hemolysis': u'100% hemolysis at 39\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3662']}, u'KKFLHSAKKWLKAFVKLKKNW': {'modifications': [], 'references': [u'Augmentation of the antibacterial activity of magainin by positive-charge chain extension. Bessalle R,Haas H,Goria A,Shalit I Antimicrob Agents Chemother. 1992 Feb;36(2):313-7.'], 'hemolysis': u'41% hemolysis at 200\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3450']}, u'KLllKWLlKlLK': {'modifications': ['C-Terminal', u'N-Terminal Modification: Palmitoylation', u'Stereochemistry: Mix'], 'references': [u'A new group of antifungal and antibacterial lipopeptides derived from non-membrane active peptides conjugated to palmitic acid. Avrahami D J Biol Chem. 2004 Mar 26;279(13):12277-85. Epub 2004 Jan 6.'], 'hemolysis': u'>75% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1567']}, u'VNRKKILGKSIKVVK': {'modifications': ['C-Terminal'], 'references': [u'Effect of hydrocarbon stapling on the properties of ?-helical antimicrobial peptides isolated from the venom of hymenoptera. Chapuis H,Slaninova J,Bednarova L,Monincova L,Budesinsky M Amino Acids. 2012 Nov;43(5):2047-58. doi: 10.1007/s00726-012-1283-1. Epub 2012 Apr 17.'], 'hemolysis': u'LC50  >100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2761']}, u'PKLLKFLKWIG': {'modifications': [], 'references': [u'Addition and omission analogs of the 13-residue antibacterial and hemolytic peptide PKLLKTFLSKWIG: structural preferences, model membrane binding and biological activities. Bikshapathy E,Sitaram N J Pept Res. 1999 Jan;53(1):47-55.'], 'hemolysis': u'100% hemolysis at 365\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3842']}, u'LLKWLLK': {'modifications': ['C-Terminal'], 'references': [u'De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface. Kang SJ,Won HS,Choi WS J Pept Sci. 2009 Sep;15(9):583-8. doi: 10.1002/psc.1149.'], 'hemolysis': u'4.61% hemolysis at 6.3\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1393']}, u'LKLKNIVSWAKKVL': {'modifications': ['C-Terminal'], 'references': [u'Evaluating antioxidative activities of amino acid substitutions on mastoparan-B. Yang MJ,Lin WY,Lu KH Peptides. 2011 Oct;32(10):2037-43. doi: 10.1016/j.peptides.2011.08.026. Epub 2011 Sep 8.'], 'hemolysis': u'Non-hemolytic', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2002']}, u'FIGSALKVLAGVLPSVISWVKQ': {'modifications': ['C-Terminal'], 'references': [u'Temporins, antimicrobial peptides from the European red frog Rana temporaria. Simmaco M,Mignogna G,Canofeni S,Miele R,Mangoni ML Eur J Biochem. 1996 Dec 15;242(3):788-92.'], 'hemolysis': u'Lethal concentration =0.5\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3375']}, u'VCGETCEGGTCNTPGCSCSWPVCTRNGLP': {'modifications': ['Cyclic'], 'references': [u'Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif. Craik DJ,Daly NL,Bond T J Mol Biol. 1999 Dec 17;294(5):1327-36.'], 'hemolysis': u'51% hemolysis at ~20\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4018']}, u'FIHHIFRGIVHAGRSIGRFLTG': {'modifications': [], 'references': [u'Peptide antibiotics in mast cells of fish. Silphaduang U Nature. 2001 Nov 15;414(6861):268-9.'], 'hemolysis': u'~5% hemolysis at 100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3414']}, u'VRRFPFFFPFLRR': {'modifications': [], 'references': [u'Conformation-dependent antibiotic activity of tritrpticin, a cathelicidin-derived antimicrobial peptide. Yang ST,Yub Shin SY,Kim YC,Kim Y,Hahm KS Biochem Biophys Res Commun. 2002 Sep 6;296(5):1044-50.'], 'hemolysis': u'0% hemolysis at 200\xb5g/ml (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2210']}, u'CGESCVWIPCISSAVGCSCKNKVCYKNGTP': {'modifications': ['Cyclic'], 'references': [u'Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif. Craik DJ,Daly NL,Bond T J Mol Biol. 1999 Dec 17;294(5):1327-36.'], 'hemolysis': u'50% hemolysis at ~20\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4001']}, u'GEKLKKIGQKIKKFFQKL': {'modifications': [], 'references': [u'CRAMP analogues having potent antibiotic activity against bacterial, fungal, and tumor cells without hemolytic activity. Shin SY,Kang SW,Lee DG,Eom SH,Song WK Biochem Biophys Res Commun. 2000 Sep 7;275(3):904-9.'], 'hemolysis': u'0% hemolytic at 100\u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2518']}, u'IDWKKIFEKVKDLV': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 >100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3897']}, u'LKLASIVSWAKKVL': {'modifications': ['C-Terminal'], 'references': [u'Relationship between the tertiary structures of mastoparan B and its analogs and their lytic activities studied by NMR spectroscopy. Yu K,Kang S,Park N,Shin J J Pept Res. 2000 Jan;55(1):51-62.'], 'hemolysis': u'60.1% hemolysis at 50\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2018']}, u'GKMKEYFKKFGASFKRRFANLKKRL': {'modifications': ['C-Terminal'], 'references': [u'N-terminal amphipathic helix as a trigger of hemolytic activity in antimicrobial peptides: a case study in latarcins. Polyansky AA,Vassilevski AA,Volynsky PE,Vorontsova OV,Samsonova OV,Egorova NS,Krylov NA,Feofanov AV,Arseniev AS,Grishin EV FEBS Lett. 2009 Jul 21;583(14):2425-8. doi: 10.1016/j.febslet.2009.06.044. Epub 2009 Jun 27.'], 'hemolysis': u'EC50  >36\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1449']}, u'GIRKWFKKAAHVGKEVGKVALNACL': {'modifications': [], 'references': [u'The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents. Morash MG,Douglas SE,Robotham A,Ridley CM,Gallant JW Dis Model Mech. 2011 Sep;4(5):622-33. doi: 10.1242/dmm.007310. Epub 2011 Jul 4.'], 'hemolysis': u'50% hemolytic at >256 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2937']}, u'SIGSALKKALPVAKKIGKIALPIAKAALP': {'modifications': [], 'references': [u'Purification and primary structure of ceratotoxin A and B, two antibacterial peptides from the female reproductive accessory glands of the medfly Ceratitis capitata (Insecta:Diptera). Marchini D,Giordano PC,Amons R, Bernini, L ,Bernini LF Insect Biochem Mol Biol. 1993 Jul;23(5):591-8.'], 'hemolysis': u'Area of inhibition ~25mm2 at 5 nmol', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3705']}, u'KWLLKWL': {'modifications': ['C-Terminal'], 'references': [u'De novo generation of short antimicrobial peptides with simple amino acid composition. Lee SH,Kim SJ,Lee YS,Song MD,Kim IH Regul Pept. 2011 Jan 17;166(1-3):36-41. doi: 10.1016/j.regpep.2010.08.010. Epub 2010 Aug 22.'], 'hemolysis': u'10% hemolysis at 320\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3104']}, u'INWKKLGKKILGAL': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 >140\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3910']}, u'KNWKGIAGMAKKLLGKNWELMEK': {'modifications': [], 'references': [u'Design of a novel membrane-destabilizing peptide selectively acting on acidic liposomes. Machida S,Niimi S,Shi X,Ando Y Biosci Biotechnol Biochem. 2000 May;64(5):985-94.'], 'hemolysis': u'6.3% hemolytic at 10\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2528']}, u'GLLGKLLKIAAKVGSNLL': {'modifications': ['C-Terminal'], 'references': [u'Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7. Conlon JM,Galadari S,Raza H Chem Biol Drug Des. 2008 Jul;72(1):58-64. doi: 10.1111/j.1747-0285.2008.00671.x. Epub 2008 Jun 12.'], 'hemolysis': u'LD50 = 15\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1960']}, u'LCYCRRRFCFCV': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'>50% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1217']}, u'Kklfkkilkyl': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Improvement of the efficacy of linear undecapeptides against plant-pathogenic bacteria by incorporation of D-amino acids. Guell I,Cabrefiga J,Badosa E,Ferre R,Talleda M,Bardaji E,Planas M,Feliu L Appl Environ Microbiol. 2011 Apr;77(8):2667-75. doi: 10.1128/AEM.02759-10. Epub 2011 Feb 18.'], 'hemolysis': u'66\xb12.9% hemolytic at 250\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2870']}, u'RVKRVWPLVIRTVIAGYNLYRAIKKK': {'modifications': [], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC =1->440\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3942']}, u'CVKVRVKVGSGVKVRVKVC': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', 'Cyclic'], 'references': [u'De novo design of potent antimicrobial peptides. Frecer V,Ho B Antimicrob Agents Chemother. 2004 Sep;48(9):3349-57.'], 'hemolysis': u'EC50 = 590000 nM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2375']}, u'VDIHVWeGV': {'modifications': [u'Stereochemistry: Mix'], 'references': [u'Therapeutic potential of peptides with neutralizing ability towards the venom and toxin (CaTx-I) of crotalus adamanteus. Samy RP,Thwin MM,Stiles BG,Bow H,Chow VT Curr Top Med Chem. 2011;11(20):2540-55.'], 'hemolysis': u'9.9% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3148']}, u'KWLNALLHHGLNCAKGVLA': {'modifications': ['C-Terminal'], 'references': [u'Biological activities of synthetic analogs of halocidin, an antimicrobial peptide from the tunicate Halocynthia aurantium. Jang WS,Kim CH,Kim KN,Park SY,Lee JH,Son SM Antimicrob Agents Chemother. 2003 Aug;47(8):2481-6.'], 'hemolysis': u'~10% hemolysis at 100\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2403']}, u'KWKLFKKIGKVLKVL': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Lysine-enriched cecropin-mellitin antimicrobial peptides with enhanced selectivity. Sato H Antimicrob Agents Chemother. 2008 Dec;52(12):4463-5. doi: 10.1128/AAC.00810-08. Epub 2008 Oct 13.'], 'hemolysis': u'67% hemolysis at 64\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1260']}, u'GIFPKIIGKGIVNGIKSLAKGVGMKVFKAGLNNIGNTGCNNRDEC': {'modifications': [], 'references': [u'Antimicrobial peptides and protease inhibitors in the skin secretions of the crawfish frog, Rana areolata. Ali, Mohamed ,Ali MF,Lips KR,Knoop FC,Fritzsch B,Miller C Biochim Biophys Acta. 2002 Nov 19;1601(1):55-63.'], 'hemolysis': u'HC50 = 200\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2477']}, u'KLALKLALKALKAALKLA': {'modifications': [], 'references': [u'Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes. Dathe M,Schumann M,Wieprecht T,Winkler A,Beyermann M,Krause E,Matsuzaki K,Murase O Biochemistry. 1996 Sep 24;35(38):12612-22.'], 'hemolysis': u'EC50 = 10\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3457']}, u'LCYTRPRFTVCV': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'0-3% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1184']}, u'RGGRLCYARRRFAVCVGR': {'modifications': ['C-Terminal'], 'references': [u'Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides. Yasin B,Pang M,Turner JS,Cho Y,Dinh NN,Waring AJ,Lehrer RI Eur J Clin Microbiol Infect Dis. 2000 Mar;19(3):187-94.'], 'hemolysis': u'14.7% hemolysis at 80\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2438']}, u'KFFRKLKKSVKKRAKEFFKKPRVIGVSIPF': {'modifications': [], 'references': [u'Snake cathelicidin from Bungarus fasciatus is a potent peptide antibiotics. Wang Y,Hong J,Liu X,Yang H,Liu R,Wu J,Wang A,Lin D PLoS One. 2008 Sep 16;3(9):e3217. doi: 10.1371/journal.pone.0003217.'], 'hemolysis': u'Little hemolysis up to 400 mg/ml (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1248']}, u'RRGWALRLVlAY': {'modifications': [u'Stereochemistry: Mix'], 'references': [u'Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity. Rathinakumar R, Walkenhorst, William ,Walkenhorst WF J Am Chem Soc. 2009 Jun 10;131(22):7609-17. doi: 10.1021/ja8093247.'], 'hemolysis': u'10\xb112 % hemolysis at 15\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1361']}, u'FVLPLVMCKILRKC': {'modifications': [], 'references': [u'Novel families of antimicrobial peptides with multiple functions from skin of Xizang plateau frog, Nanorana parkeri. Lu Z,Zhai L,Wang H,Che Q,Wang D,Feng F,Zhao Z Biochimie. 2010 May;92(5):475-81. doi: 10.1016/j.biochi.2010.01.025. Epub 2010 Feb 12.'], 'hemolysis': u'3.40% hemolysis at 80\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1073']}, u'DAACAAKCLWR': {'modifications': ['C-Terminal'], 'references': [u'Design and synthesis of novel antimicrobial peptides on the basis of alpha helical domain of Tenecin 1, an insect defensin protein, and structure-activity relationship study. Ahn HS,Cho W,Kang SH,Ko SS,Park MS,Cho H Peptides. 2006 Apr;27(4):640-8. Epub 2005 Oct 13.'], 'hemolysis': u'0% hemolysis at 200\u03bcg/ml (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1898']}, u'KKALLOHPLHOLALLAOHLAHOLKKA': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Structural determinants of antimicrobial and antiplasmodial activity and selectivity in histidine-rich amphipathic cationic peptides. Mason AJ,Moussaoui W,Abdelrahman T,Boukhari A,Bertani P,Marquette A,Shooshtarizaheh P,Moulay G,Boehm N,Guerold B,Sawers RJ,Kichler A,Metz-Boutigue MH,Candolfi E,Prevost G J Biol Chem. 2009 Jan 2;284(1):119-33. doi: 10.1074/jbc.M806201200. Epub 2008 Nov 4.'], 'hemolysis': u'HC50 =89.6\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3573']}, u'GNleAibOrnOrnNleAibOrnOrnAibOrnOrnGY': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Amphipathic alpha helical antimicrobial peptides. Giangaspero A,Sandri L Eur J Biochem. 2001 Nov;268(21):5589-600.'], 'hemolysis': u'30% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2142']}, u'DSHAKRHHGYKRKFHEKHHSHRGY': {'modifications': ['C-Terminal'], 'references': [u'In vitro assessment of antifungal therapeutic potential of salivary histatin-5, two variants of histatin-5, and salivary mucin (MUC7) domain 1. Situ H Antimicrob Agents Chemother. 2000 Jun;44(6):1485-93.'], 'hemolysis': u'<10% hemolysis at 200\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2027']}, u'FLPIIGQLLSGLL': {'modifications': ['C-Terminal'], 'references': [u'Host-defense peptides isolated from the skin secretions of the Northern red-legged frog Rana aurora aurora. Conlon JM,Sonnevend A,Davidson C,Demandt A Dev Comp Immunol. 2005;29(1):83-90.'], 'hemolysis': u'HC50 >300\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1618']}, u'RWCVYAYVRVAGVLVRYRRCW': {'modifications': [], 'references': [u'The characteristic region of arenicin-1 involved with a bacterial membrane targeting mechanism. Cho J Biochem Biophys Res Commun. 2011 Feb 18;405(3):422-7. doi: 10.1016/j.bbrc.2011.01.046. Epub 2011 Jan 15.'], 'hemolysis': u'45% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3126']}, u'IKIPAFVKDTLKKVAKGVISAVAGALTQ': {'modifications': [], 'references': [u'The hymenochirins: a family of host-defense peptides from the Congo dwarf clawed frog Hymenochirus boettgeri (Pipidae). Mechkarska M,Prajeep M,Coquet L,Leprince J,Jouenne T,Vaudry H,King JD Peptides. 2012 Jun;35(2):269-75. doi: 10.1016/j.peptides.2012.03.029. Epub 2012 Apr 3.'], 'hemolysis': u'LC50 = 160\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2093']}, u'LLKWLKKWLKK': {'modifications': ['C-Terminal'], 'references': [u'De novo generation of short antimicrobial peptides with simple amino acid composition. Lee SH,Kim SJ,Lee YS,Song MD,Kim IH Regul Pept. 2011 Jan 17;166(1-3):36-41. doi: 10.1016/j.regpep.2010.08.010. Epub 2010 Aug 22.'], 'hemolysis': u'10% hemolysis at 160\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3111']}, u'RWKIFKKIEKVGQNIRDGIVKAGPAVAVVGQAATI': {'modifications': [], 'references': [u'A cationic amphiphilic peptide ABP-CM4 exhibits selective cytotoxicity against leukemia cells. Chen YQ,Min C,Sang M,Han YY,Ma X,Xue XQ Peptides. 2010 Aug;31(8):1504-10. doi: 10.1016/j.peptides.2010.05.010. Epub 2010 May 21.'], 'hemolysis': u'5% hemolysis at 400\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3073']}, u'STVLTSKYR': {'modifications': [], 'references': [u'Isolation and characterization of four antibacterial peptides from bovine hemoglobin. Nedjar-Arroume N,Dubois-Delval V,Miloudi K,Daoud R,Krier F,Kouach M,Briand G Peptides. 2006 Sep;27(9):2082-9. Epub 2006 May 30.'], 'hemolysis': u'Non-hemolytic', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1912']}, u'TQTVYEWCGDATQLLAAYILL': {'modifications': [], 'references': [u'A peptide derived from the putative transmembrane domain in the tail region of E. coli toxin hemolysin E assembles in phospholipid membrane and exhibits lytic activity to human red blood cells: plausible implications in the toxic activity of the protein. Yadav SP,Ahmad A,Pandey BK,Singh D,Asthana N,Verma R,Tripathi RK Biochim Biophys Acta. 2009 Feb;1788(2):538-50. doi: 10.1016/j.bbamem.2008.11.013. Epub 2008 Nov 28.'], 'hemolysis': u'~2% hemolysis at 0.8\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1273']}, u'LLRRLLRRLLRR': {'modifications': ['C-Terminal'], 'references': [u'Synthetic cationic amphiphilic ?-helical peptides as antimicrobial agents. Wiradharma N,Khoe U,Hauser CA,Seow SV,Zhang S Biomaterials. 2011 Mar;32(8):2204-12. doi: 10.1016/j.biomaterials.2010.11.054. Epub 2010 Dec 18.'], 'hemolysis': u'HC50 > 500', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2050']}, u'AKKVFKRLGIGAVLKVLTTG': {'modifications': [], 'references': [u'Design of novel analogues with potent antibiotic activity based on the antimicrobial peptide, HP(2-9)-ME(1-12). Park Y,Kim HN,Park SN,Jang SH,Choi CH,Lim HT Biotechnol Lett. 2004 Mar;26(6):493-8.'], 'hemolysis': u'0% hemolysis upto 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4168']}, u'KNWGKILKHIIK': {'modifications': ['C-Terminal'], 'references': [u'Panurgines, novel antimicrobial peptides from the venom of communal bee Panurgus calcaratus (Hymenoptera: Andrenidae). Cujova S,Slaninova J,Monincova L,Fucik V,Bednarova L,Stokrova J,Hovorka O,Voburka Z,Straka J Amino Acids. 2013 Jul;45(1):143-57. doi: 10.1007/s00726-013-1482-4. Epub 2013 Mar 13.'], 'hemolysis': u'LC50 >200\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3729']}, u'KPLLKKLLKKL': {'modifications': ['C-Terminal'], 'references': [u'Antibiotic activity of Leu-Lys rich model peptides. Park Y,Lee DG Biotechnol Lett. 2003 Aug;25(16):1305-10.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2321']}, u'GLFGVLAKVAAHVVAAIAEHF': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship of an antibacterial peptide, maculatin 1.1, from the skin glands of the tree frog, Litoria genimaculata. Niidome T,Kobayashi K,Arakawa H,Hatakeyama T J Pept Sci. 2004 Jul;10(7):414-22.'], 'hemolysis': u'100% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1611']}, u'AKKVSKRLEKLFSKIQNDK': {'modifications': [], 'references': [u'Design of novel analogue peptides with potent antibiotic activity based on the antimicrobial peptide, HP (2-20), derived from N-terminus of Helicobacter pylori ribosomal protein L1. Lee DG,Kim HN,Park Y,Kim HK,Choi BH,Choi CH Biochim Biophys Acta. 2002 Jul 29;1598(1-2):185-94.'], 'hemolysis': u'0% hemolysis at 100\u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2386']}, u'FSEAIKKIIDFLGEGLFDIIKKIAESF': {'modifications': [], 'references': [u'Dimerization of aurein 1.2: effects in structure, antimicrobial activity and aggregation of C\xe2ndida albicans cells. Lorenzon EN,Sanches PR,Nogueira LG,Bauab TM Amino Acids. 2013 Jun;44(6):1521-8. doi: 10.1007/s00726-013-1475-3. Epub 2013 Mar 22.'], 'hemolysis': u'0% hemolytic at  4 -32\u03bcmol/L', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2589']}, u'PAICQRATATLGTVGSNTSGTTAIEACILL': {'modifications': [], 'references': [u'Potent inhibition of the classical pathway of complement by a novel C1q-binding peptide derived from the human astrovirus coat protein. Gronemus JQ,Hair PS,Crawford KB,Nyalwidhe JO,Cunnion KM Mol Immunol. 2010 Nov-Dec;48(1-3):305-13. doi: 10.1016/j.molimm.2010.07.012. Epub 2010 Aug 21.'], 'hemolysis': u'80% hemolysis at 0.77mM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1535']}, u'alKlK': {'modifications': [u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'Antiplasmodial activity of lauryl-lysine oligomers. Radzishevsky I,Krugliak M,Ginsburg H Antimicrob Agents Chemother. 2007 May;51(5):1753-9. Epub 2007 Feb 16.'], 'hemolysis': u'0.14\xb10.3% hemolysis at 100 \u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1106']}, u'TlekTleaTleaTlea': {'modifications': ['Cyclic', u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'Pharmacodynamic synergy strictly dependent on the co-operative aggregation of enantiomers of cyclic peptides in the bacterial cell membrane. Danielsson M,Rosenthal-Aizman K,Bergsson G Bioorg Med Chem Lett. 2011 Sep 15;21(18):5262-5. doi: 10.1016/j.bmcl.2011.07.032. Epub 2011 Jul 19.'], 'hemolysis': u'HC50 =17\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2961']}, u'SAPRGCWTKSYPPKPCK': {'modifications': ['C-Terminal', 'Cyclic'], 'references': [u'Ranacyclins, a new family of short cyclic antimicrobial peptides: biological function, mode of action, and parameters involved in target specificity. Mangoni ML,Papo N,Mignogna G,Andreu D,Shai Y,Barra D Biochemistry. 2003 Dec 2;42(47):14023-35.'], 'hemolysis': u'55% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3771']}, u'KWKKLLKKLLKLLKKLLKKLK': {'modifications': ['C-Terminal'], 'references': [u'Contribution of a central proline in model amphipathic alpha-helical peptides to self-association, interaction with phospholipids, and antimicrobial mode of action. Yang ST,Lee JY,Kim HJ,Eu YJ,Shin SY,Hahm KS FEBS J. 2006 Sep;273(17):4040-54. Epub 2006 Aug 2.'], 'hemolysis': u'65% hemolysis at 50\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1705']}, u'KWllKLKlKlLK': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Structure and organization of hemolytic and nonhemolytic diastereomers of antimicrobial peptides in membranes. Hong J,Oren Z Biochemistry. 1999 Dec 21;38(51):16963-73.'], 'hemolysis': u'0% hemolysis at 50\u03bcM (Non hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3761']}, u'ILGKIAEGIKSLF': {'modifications': ['C-Terminal'], 'references': [u'Antibiotic activity and structural analysis of the scorpion-derived antimicrobial peptide IsCT and its analogs. Lee K,Shin SY,Kim K,Lim SS,Hahm KS Biochem Biophys Res Commun. 2004 Oct 15;323(2):712-9.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2396']}, u'GSKKPVPIIYCNRRATGKCQRM': {'modifications': [], 'references': [u'Role of amino acid residues within the disulfide loop of thanatin, a potent antibiotic peptide. Lee MK,Cha L,Lee SH J Biochem Mol Biol. 2002 May 31;35(3):291-6.'], 'hemolysis': u'0% hemolysis at 20.8\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2217']}, u'KVMAHMK': {'modifications': ['C-Terminal'], 'references': [u'Melectin: a novel antimicrobial peptide from the venom of the cleptoparasitic bee Melecta albifrons. Cerovsky V,Hovorka O,Cvacka J,Voburka Z,Bednarova L,Borovickova L,Slaninova J Chembiochem. 2008 Nov 24;9(17):2815-21. doi: 10.1002/cbic.200800476.'], 'hemolysis': u'LC50 >100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3626']}, u'RRWQWRMKKLG': {'modifications': [], 'references': [u'Comparative antimicrobial activity and mechanism of action of bovine lactoferricin-derived synthetic peptides. Liu Y,Han F,Xie Y Biometals. 2011 Dec;24(6):1069-78. doi: 10.1007/s10534-011-9465-y. Epub 2011 May 24.'], 'hemolysis': u'~6% hemolytic at 256mg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2914']}, u'SWLRDIWDWVCEVLSDFK': {'modifications': [], 'references': [u'Rational design of peptides with anti-HCV/HIV activities and enhanced specificity. Li GR,He LY,Liu XY,Liu AP,Huang YB,Qiu C,Zhang XY,Xu JQ,Yang W Chem Biol Drug Des. 2011 Nov;78(5):835-43. doi: 10.1111/j.1747-0285.2011.01201.x. Epub 2011 Sep 26.'], 'hemolysis': u'MHC =13.93\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2954']}, u'fPChgOChafPChgOCha': {'modifications': ['Cyclic', u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'An adamantyl amino acid containing gramicidin S analogue with broad spectrum antibacterial activity and reduced hemolytic activity. Kapoerchan VV,Knijnenburg AD,Niamat M,Spalburg E,de Neeling AJ,Nibbering PH,Mars-Groenendijk RH,Noort D,Otero JM,Llamas-Saiz AL,van Raaij MJ,van der Marel GA,Overkleeft HS Chemistry. 2010 Oct 25;16(40):12174-81. doi: 10.1002/chem.201001686.'], 'hemolysis': u'HC50 =9.12\xb11.13\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2797']}, u'KLALklALKALKAALKLA': {'modifications': [u'Stereochemistry: Mix'], 'references': [u'Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes. Dathe M,Schumann M,Wieprecht T,Winkler A,Beyermann M,Krause E,Matsuzaki K,Murase O Biochemistry. 1996 Sep 24;35(38):12612-22.'], 'hemolysis': u'EC50 = 160\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3460']}, u'GFKDLLKKAAKALVKTVLF': {'modifications': ['C-Terminal'], 'references': [u'Activities of the frog skin peptide, ascaphin-8 and its lysine-substituted analogs against clinical isolates of extended-spectrum beta-lactamase (ESBL) producing bacteria. Eley A,Ibrahim M,Kurdi SE Peptides. 2008 Jan;29(1):25-30. Epub 2007 Nov 9.'], 'hemolysis': u'LC50 =11\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2550']}, u'KFGKIVGKVLKQLKKVSAVAKVAMKKG': {'modifications': [], 'references': [u'Lytic activity and structural differences of amphipathic peptides derived from trialysin. Martins RM,Sforca ML,Amino R,Juliano MA,Oyama S Jr,Juliano L,Pertinhez TA,Spisni A Biochemistry. 2006 Feb 14;45(6):1765-74.'], 'hemolysis': u'50% hemolysis at 274\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1671']}, u'FRFGSFLKKVWKSKLAKKLRSKGKQLLKDYANKVLNGPEEEAAAPAE': {'modifications': [], 'references': [u'Characterization of BmKbpp, a multifunctional peptide from the Chinese scorpion Mesobuthus martensii Karsch: gaining insight into a new mechanism for the functional diversification of scorpion venom peptides. Zeng XC,Wang S,Nie Y,Zhang L Peptides. 2012 Jan;33(1):44-51. doi: 10.1016/j.peptides.2011.11.012. Epub 2011 Nov 18.'], 'hemolysis': u'39.9% hemolysis at 50 \xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2007']}, u'GLLDFVTGVGKDIFAQLIKQI': {'modifications': ['C-Terminal'], 'references': [u'Purification, characterization and homology analysis of ocellatin 4, a cytolytic peptide from the skin secretion of the frog Leptodactylus ocellatus. Nascimento A,Chapeaurouge A,Perales J,Sebben A,Sousa MV,Fontes W Toxicon. 2007 Dec 15;50(8):1095-104. Epub 2007 Aug 3.'], 'hemolysis': u'HC50 =14.3 mM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3637']}, u'tlektleAtleAtleA': {'modifications': ['Cyclic', u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'Pharmacodynamic synergy strictly dependent on the co-operative aggregation of enantiomers of cyclic peptides in the bacterial cell membrane. Danielsson M,Rosenthal-Aizman K,Bergsson G Bioorg Med Chem Lett. 2011 Sep 15;21(18):5262-5. doi: 10.1016/j.bmcl.2011.07.032. Epub 2011 Jul 19.'], 'hemolysis': u'HC50 =316\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2962']}, u'GLLGPLLKIAAKVGSNLL': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae). Ali, M ,Ali MF,Soto A,Knoop FC Biochim Biophys Acta. 2001 Nov 26;1550(1):81-9.'], 'hemolysis': u'HC50 =70\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3480']}, u'KIGAKIKIGAKLCF3BpgKIGAKI': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Stereochemical effects on the aggregation and biological properties of the fibril-forming peptide [KIGAKI]3 in membranes. Wadhwani P,Reichert J,Strandberg E,Burck J,Misiewicz J,Afonin S,Heidenreich N,Fanghanel S,Mykhailiuk PK,Komarov IV Phys Chem Chem Phys. 2013 Jun 21;15(23):8962-71. doi: 10.1039/c3cp50896j. Epub 2013 May 7.'], 'hemolysis': u'~38% hemolytic at 60\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2684']}, u'FSKYERQKDKRPYSQRKNQYTGPQFLYPPERIPPQKVIKWNEEGLPIYEIPGEGGHAEPAAA': {'modifications': [], 'references': [u'Lumbricin I, a novel proline-rich antimicrobial peptide from the earthworm: purification, cDNA cloning and molecular characterization. Cho JH,Park CB,Yoon YG Biochim Biophys Acta. 1998 Oct 22;1408(1):67-76.'], 'hemolysis': u'0.23% hemolysis at 100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3390']}, u'K\u03a8[CH2NH]LLLKLWLKLLK': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Synthesis of antibacterial pseudopeptides with less hemolytic activity from a cytotoxic peptide and their pH-dependent activity. Kim SM,Kim JM,Cho H Bioorg Med Chem Lett. 2009 Oct 1;19(19):5627-31. doi: 10.1016/j.bmcl.2009.08.031. Epub 2009 Aug 12.'], 'hemolysis': u'100% hemolysis at 150\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1456']}, u'CVISAGWNHKIRCKLTGNC': {'modifications': [], 'references': [u'Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata. Ma Y,Liu C,Liu X,Wu J,Yang H,Wang Y,Li J,Yu H Genomics. 2010 Jan;95(1):66-71. doi: 10.1016/j.ygeno.2009.09.004. Epub 2009 Sep 22.'], 'hemolysis': u'0% hemolysis at 100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4021']}, u'GFKLLLKGAAKALVKTVLF': {'modifications': ['C-Terminal'], 'references': [u'Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7. Conlon JM,Galadari S,Raza H Chem Biol Drug Des. 2008 Jul;72(1):58-64. doi: 10.1111/j.1747-0285.2008.00671.x. Epub 2008 Jun 12.'], 'hemolysis': u'LD50 = 24\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1946']}, u'HFLLKLVNLAKKIL': {'modifications': ['C-Terminal'], 'references': [u'Strategies for transformation of naturally-occurring amphibian antimicrobial peptides into therapeutically valuable anti-infective agents. Conlon JM,Al-Ghaferi N,Abraham B Methods. 2007 Aug;42(4):349-57.'], 'hemolysis': u'LD50 = 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1796']}, u'SWLRDIWDWSCEVLSDFK': {'modifications': [], 'references': [u'Rational design of peptides with anti-HCV/HIV activities and enhanced specificity. Li GR,He LY,Liu XY,Liu AP,Huang YB,Qiu C,Zhang XY,Xu JQ,Yang W Chem Biol Drug Des. 2011 Nov;78(5):835-43. doi: 10.1111/j.1747-0285.2011.01201.x. Epub 2011 Sep 26.'], 'hemolysis': u'MHC =28.00\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2957']}, u'GRPNPVNNKPT*PHPRL': {'modifications': ['Non-Natural'], 'references': [u'Glycosylated analogs of formaecin I and drosocin exhibit differential pattern of antibacterial activity. Talat S,Thiruvikraman M,Kumari S Glycoconj J. 2011 Dec;28(8-9):537-55. doi: 10.1007/s10719-011-9353-2. Epub 2011 Oct 4.'], 'hemolysis': u'<5% hemolytic at 100 \u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2973']}, u'ACGILHDNCVYVPAQNPCCRGLQCRYGKCLVQV': {'modifications': ['C-Terminal'], 'references': [u'Isolation and characterization of Psalmopeotoxin I and II: two novel antimalarial peptides from the venom of the tarantula Psalmopoeus cambridgei. Choi SJ,Parent R,Guillaume C,Deregnaucourt C,Delarbre C,Ojcius DM,Montagne JJ,Celerier ML,Phelipot A,Amiche M,Molgo J,Camadro JM FEBS Lett. 2004 Aug 13;572(1-3):109-17.'], 'hemolysis': u'No hemolysis at 10\u03bcM (non hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3567']}, u'VkLkVyPLKVKLyP': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Dissociation of antimicrobial and hemolytic activities in cyclic peptide diastereomers by systematic alterations in amphipathicity. Kondejewski LH,Jelokhani-Niaraki M,Farmer SW,Lix B,Kay CM,Sykes BD,Hancock RE J Biol Chem. 1999 May 7;274(19):13181-92.'], 'hemolysis': u'100% hemolytic at >200 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2567']}, u'MESQSNAVQLMLGFGTFVLMLLGLVVELIKNSNKK': {'modifications': [], 'references': [u'Functional characterization of a new holin-like antibacterial protein coding gene tmp1 from goat skin surface metagenome. Rajesh T,Anthony T,Saranya S,Pushpam PL Appl Microbiol Biotechnol. 2011 Feb;89(4):1061-73. doi: 10.1007/s00253-010-2907-6. Epub 2010 Oct 7.'], 'hemolysis': u'0% hemolysis at 50\u03bcM  (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1548']}, u'FAKWAFKWAKK': {'modifications': ['C-Terminal'], 'references': [u'Activity optimization of an undecapeptide analogue derived from a frog-skin antimicrobial peptide. Won HS,Kang SJ,Choi WS Mol Cells. 2011 Jan;31(1):49-54. doi: 10.1007/s10059-011-0005-y. Epub 2010 Nov 23.'], 'hemolysis': u'MHC \u2265200\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1559']}, u'GFMKYIGPLIPHAVKAIKKLI': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial and cytolytic properties of the frog skin peptide, kassinatuerin-1 and its L- and D-lysine-substituted derivatives. Conlon JM,Abraham B,Galadari S,Knoop FC,Sonnevend A Peptides. 2005 Nov;26(11):2104-10.'], 'hemolysis': u'LD50 =25\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4075']}, u'KNWGAILKHIIK': {'modifications': ['C-Terminal'], 'references': [u'Panurgines, novel antimicrobial peptides from the venom of communal bee Panurgus calcaratus (Hymenoptera: Andrenidae). Cujova S,Slaninova J,Monincova L,Fucik V,Bednarova L,Stokrova J,Hovorka O,Voburka Z,Straka J Amino Acids. 2013 Jul;45(1):143-57. doi: 10.1007/s00726-013-1482-4. Epub 2013 Mar 13.'], 'hemolysis': u'LC50 >200\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3719']}, u'KWKSFLRTFKSPVRTVFHTALKPISS': {'modifications': [], 'references': [u'Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides. Zhang L,Benz R Biochemistry. 1999 Jun 22;38(25):8102-11.'], 'hemolysis': u'MHC=32\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3595']}, u'RKLRRLKRKIAHKVKKY': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity analysis of SMAP-29, a sheep leukocytes-derived antimicrobial peptide. Shin SY,Park EJ,Yang ST,Jung HJ,Eom SH,Song WK,Kim Y,Hahm KS Biochem Biophys Res Commun. 2001 Jul 27;285(4):1046-51.'], 'hemolysis': u'0% hemolysis at 100\u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1050']}, u'GLLDTLKGAAKNVVGSLASKVMEKL': {'modifications': ['C-Terminal'], 'references': [u'Pentadactylin: an antimicrobial peptide from the skin secretions of the South American bullfrog Leptodactylus pentadactylus. King JD,Al-Ghaferi N,Abraham B,Sonnevend A,Leprince J, Nielsen, Per ,Nielsen PF Comp Biochem Physiol C Toxicol Pharmacol. 2005 Aug;141(4):393-7. Epub 2005 Oct 19.'], 'hemolysis': u'LD50 >400\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1053']}, u'CVKVKVKVGSGVKVKVKVC': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', 'Cyclic'], 'references': [u'De novo design of potent antimicrobial peptides. Frecer V,Ho B Antimicrob Agents Chemother. 2004 Sep;48(9):3349-57.'], 'hemolysis': u'EC50 = 880000 nM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2373']}, u'VRRF(Nleu)WWW(Nleu)FLRR': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC >1\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3970']}, u'GIGKFIHSAKKFGKLFVGEIMNS': {'modifications': ['C-Terminal'], 'references': [u'Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes. Wieprecht T,Dathe M,Beyermann M,Krause E,Maloy WL,MacDonald DL Biochemistry. 1997 May 20;36(20):6124-32.'], 'hemolysis': u'40% hemolysis at 150\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3524']}, u'DSHEKRHHGYKRKFHEKHHSHRGY': {'modifications': [], 'references': [u'Fungicidal effect of three new synthetic cationic peptides against Candida albicans. Nikawa H,Fukushima H,Makihira S,Hamada T Oral Dis. 2004 Jul;10(4):221-8.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1872']}, u'LLIILRRRIRKQAHAHSK': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial activity, bactericidal mechanism and LPS-neutralizing activity of the cell-penetrating peptide pVEC and its analogs. Nan YH,Park IS,Hahm KS J Pept Sci. 2011 Dec;17(12):812-7. doi: 10.1002/psc.1408. Epub 2011 Sep 29.'], 'hemolysis': u'>10% hemolytic at 200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2968']}, u'KKLFKKIlKYL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Improvement of the efficacy of linear undecapeptides against plant-pathogenic bacteria by incorporation of D-amino acids. Guell I,Cabrefiga J,Badosa E,Ferre R,Talleda M,Bardaji E,Planas M,Feliu L Appl Environ Microbiol. 2011 Apr;77(8):2667-75. doi: 10.1128/AEM.02759-10. Epub 2011 Feb 18.'], 'hemolysis': u'4 \xb10.3% hemolytic at 250\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2851']}, u'RRRAAFAAWAAFAARRR': {'modifications': ['C-Terminal'], 'references': [u'Cationic hydrophobic peptides with antimicrobial activity. Stark M,Liu LP Antimicrob Agents Chemother. 2002 Nov;46(11):3585-90.'], 'hemolysis': u'0% hemolysis at 50\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2245']}, u'LCYCRFRRCVCV': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'3-6% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1193']}, u'VKLKVyplKVKLyP': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Structure-activity relationships of de novo designed cyclic antimicrobial peptides based on gramicidin S. Lee DL Biopolymers. 2003;71(1):28-48.'], 'hemolysis': u'100% hemolysis at <15\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2299']}, u'ALWMTLLKKVLK': {'modifications': [], 'references': [u'Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity. Feder R,Dagan A J Biol Chem. 2000 Feb 11;275(6):4230-8.'], 'hemolysis': u'LC50 =100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1010']}, u'KILRGVSKKIMRTFLRRILTGKK': {'modifications': [], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC <10\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3953']}, u'RRRAAfAAwAAfAARRR': {'modifications': ['C-Terminal'], 'references': [u'Cationic hydrophobic peptides with antimicrobial activity. Stark M,Liu LP Antimicrob Agents Chemother. 2002 Nov;46(11):3585-90.'], 'hemolysis': u'2% hemolysis at 200\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2242']}, u'LKKWLKKWLKK': {'modifications': ['C-Terminal'], 'references': [u'De novo generation of short antimicrobial peptides with simple amino acid composition. Lee SH,Kim SJ,Lee YS,Song MD,Kim IH Regul Pept. 2011 Jan 17;166(1-3):36-41. doi: 10.1016/j.regpep.2010.08.010. Epub 2010 Aug 22.'], 'hemolysis': u'negligible hemolysis at 320\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3100']}, u'FLPILAGLAANILPKVFCSITKKC': {'modifications': [], 'references': [u'Host-defense peptides isolated from the skin secretions of the Northern red-legged frog Rana aurora aurora. Conlon JM,Sonnevend A,Davidson C,Demandt A Dev Comp Immunol. 2005;29(1):83-90.'], 'hemolysis': u'HC50 =7\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1617']}, u'EWGRRCCGWGPGRRYCVRWC': {'modifications': ['Cyclic'], 'references': [u'Antifungal activity of synthetic peptides derived from Impatiens balsamina antimicrobial peptides Ib-AMP1 and Ib-AMP4. Thevissen K,Francois IE,Sijtsma L,van Amerongen A,Schaaper WM,Meloen R,Posthuma-Trumpie T, Broekaert, Willem ,Broekaert WF Peptides. 2005 Jul;26(7):1113-9. Epub 2005 Feb 16.'], 'hemolysis': u'no hemolysis upto 100\u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1892']}, u'DCTRWIIGINGRICRD': {'modifications': [], 'references': [u'Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata. Ma Y,Liu C,Liu X,Wu J,Yang H,Wang Y,Li J,Yu H Genomics. 2010 Jan;95(1):66-71. doi: 10.1016/j.ygeno.2009.09.004. Epub 2009 Sep 22.'], 'hemolysis': u'7.62\xb11.60% hemolysis at 100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4024']}, u'GIGKFLHSAKKFGKAFVGEIMNS': {'modifications': [], 'references': [u'Antimicrobial properties of peptides from Xenopus granular gland secretions. Soravia E,Martini G FEBS Lett. 1988 Feb 15;228(2):337-40.'], 'hemolysis': u'6% hemolysis at 1000\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4086']}, u'KWKSFLKTFKSLKkTVLHTLLkAISS': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', u'Stereochemistry: Mix'], 'references': [u'Role of helicity on the anticancer mechanism of action of cationic-helical peptides. Huang YB,He LY,Jiang HY Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849. Epub 2012 Jun 5.'], 'hemolysis': u'MHC = 20.81 \xb1 0.06\u03bcmol/L', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2639']}, u'KKLFKKILKYl': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Improvement of the efficacy of linear undecapeptides against plant-pathogenic bacteria by incorporation of D-amino acids. Guell I,Cabrefiga J,Badosa E,Ferre R,Talleda M,Bardaji E,Planas M,Feliu L Appl Environ Microbiol. 2011 Apr;77(8):2667-75. doi: 10.1128/AEM.02759-10. Epub 2011 Feb 18.'], 'hemolysis': u'23 \xb10.9% hemolytic at 250\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2849']}, u'LLlLLkKkkKKLlLL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'The consequence of sequence alteration of an amphipathic alpha-helical antimicrobial peptide and its diastereomers. Papo N,Oren Z,Pag U,Sahl HG J Biol Chem. 2002 Sep 13;277(37):33913-21. Epub 2002 Jul 10.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2206']}, u'KIGAKIKIGAKIKIGAKI': {'modifications': ['C-Terminal'], 'references': [u'Stereochemical effects on the aggregation and biological properties of the fibril-forming peptide [KIGAKI]3 in membranes. Wadhwani P,Reichert J,Strandberg E,Burck J,Misiewicz J,Afonin S,Heidenreich N,Fanghanel S,Mykhailiuk PK,Komarov IV Phys Chem Chem Phys. 2013 Jun 21;15(23):8962-71. doi: 10.1039/c3cp50896j. Epub 2013 May 7.'], 'hemolysis': u'~54% hemolytic at 60\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2674']}, u'GLKEIFKAGLGSLVKGIAAHVAS': {'modifications': [u'N-Terminal Modification: palmitate(pal)'], 'references': [u'Potent and rapid bactericidal action of alyteserin-1c and its [E4K] analog against multidrug-resistant strains of Acinetobacter baumannii. Conlon JM,Ahmed E,Pal T Peptides. 2010 Oct;31(10):1806-10. doi: 10.1016/j.peptides.2010.06.032. Epub 2010 Jul 11.'], 'hemolysis': u'LC50 =10\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3084']}, u'FKLFKKIPKFLHLAKKF': {'modifications': ['C-Terminal'], 'references': [u'Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs. Shin SY,Lee SH,Yang ST,Park EJ,Lee DG,Lee MK,Eom SH,Song WK,Kim Y,Hahm KS J Pept Res. 2001 Dec;58(6):504-14.'], 'hemolysis': u'0.6% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2159']}, u'INWKKIFESVKNLV': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 >100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3903']}, u'MAQDIISTIGDLVKWIIDTVNKFPKK': {'modifications': [], 'references': [u'Interaction of staphylococcal delta-toxin and synthetic analogues with erythrocytes and phospholipid vesicles. Biological and physical properties of the amphipathic peptides. Alouf JE,Dufourcq J,Siffert O,Thiaudiere E Eur J Biochem. 1989 Aug 1;183(2):381-90.'], 'hemolysis': u'8% hemolysis at 75\u03bcg', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3336']}, u'KLALKLalKALKAALKLA': {'modifications': [u'Stereochemistry: Mix'], 'references': [u'Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes. Dathe M,Schumann M,Wieprecht T,Winkler A,Beyermann M,Krause E,Matsuzaki K,Murase O Biochemistry. 1996 Sep 24;35(38):12612-22.'], 'hemolysis': u'EC50 = 180\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3461']}, u'IALKALAALAKKIL': {'modifications': ['C-Terminal'], 'references': [u'Novel biologically active peptides from the venom of Polistes rothneyi iwatai. Murata K,Shinada T,Ohfune Y,Hisada M,Yasuda A,Naoki H Biol Pharm Bull. 2006 Dec;29(12):2493-7.'], 'hemolysis': u'18 % of hemolysis at 50mM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1732']}, u'GLPVCGEKCVGGTCNTPGCTCSWPVCTRN': {'modifications': ['Cyclic'], 'references': [u'Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities. Henriques ST,Huang YH,Rosengren KJ,Franquelim HG,Carvalho FA,Johnson A,Sonza S,Tachedjian G,Castanho MA,Daly NL J Biol Chem. 2011 Jul 8;286(27):24231-41. doi: 10.1074/jbc.M111.253393. Epub 2011 May 16.'], 'hemolysis': u'3.4\xb10.7% hemolytic at 25\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3005']}, u'KKLFKKILKYL': {'modifications': ['C-Terminal'], 'references': [u'Improvement of the efficacy of linear undecapeptides against plant-pathogenic bacteria by incorporation of D-amino acids. Guell I,Cabrefiga J,Badosa E,Ferre R,Talleda M,Bardaji E,Planas M,Feliu L Appl Environ Microbiol. 2011 Apr;77(8):2667-75. doi: 10.1128/AEM.02759-10. Epub 2011 Feb 18.'], 'hemolysis': u'54 \xb10.1% hemolytic at 250\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2847']}, u'I*LPWKWPWWPWRR': {'modifications': ['C-Terminal', 'Cyclic', 'Non-Natural'], 'references': [u'Indolicidin-derived antimicrobial peptide analogs with greater bacterial selectivity and requirements for antibacterial and hemolytic activities. Kim SM,Kim JM,Joshi BP,Cho H Biochim Biophys Acta. 2009 Feb;1794(2):185-92. doi: 10.1016/j.bbapap.2008.10.009. Epub 2008 Nov 6.'], 'hemolysis': u'30% hemolysis at 200\u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3039']}, u'GWGSFFKKAAHVAKHVAKAALTHYL': {'modifications': [], 'references': [u'Effects of two glycine residues in positions 13 and 17 of pleurocidin on structure and bacterial cell selectivity. Lim SS,Song YM,Jang MH,Kim Y,Hahm KS Protein Pept Lett. 2004 Feb;11(1):35-40.'], 'hemolysis': u'37.4% hemolytic at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2505']}, u'GLMSLFRGVLKTAGKHIFKNVGGSLLDQAKCKITGEC': {'modifications': [], 'references': [u'A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica. Conlon JM,Sonnevend A,Patel M,Al-Dhaheri K, Nielsen, Per ,Nielsen PF,Kolodziejek J,Nowotny N,Iwamuro S Regul Pept. 2004 May 15;118(3):135-41.'], 'hemolysis': u'HC50 = 65\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1990']}, u'GLLSGILGAGKHIVCGLTGCAKA': {'modifications': [], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC >100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3954']}, u'RLEKLFSKIQNDK': {'modifications': [], 'references': [u'Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions. Park SC,Kim MH,Hossain MA,Shin SY,Kim Y,Stella L,Wade JD,Park Y Biochim Biophys Acta. 2008 Jan;1778(1):229-41. Epub 2007 Oct 2.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1928']}, u'lklksivswakkvl': {'modifications': ['C-Terminal', u'Stereochemistry: D'], 'references': [u'Enhancing the hypotensive effect and diminishing the cytolytic activity of hornet mastoparan B by D-amino acid substitution. Ho CL,Shih YP,Wang KT Toxicon. 2001 Oct;39(10):1561-6.'], 'hemolysis': u'83-85% hemolysis at 15 \xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1976']}, u'TQTVYEWCDDATQLLAAYILL': {'modifications': [], 'references': [u'A peptide derived from the putative transmembrane domain in the tail region of E. coli toxin hemolysin E assembles in phospholipid membrane and exhibits lytic activity to human red blood cells: plausible implications in the toxic activity of the protein. Yadav SP,Ahmad A,Pandey BK,Singh D,Asthana N,Verma R,Tripathi RK Biochim Biophys Acta. 2009 Feb;1788(2):538-50. doi: 10.1016/j.bbamem.2008.11.013. Epub 2008 Nov 28.'], 'hemolysis': u'0% hemolysis at 0.8\u03bcM  (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1274']}, u'GFKDLLKkAAKALVKTVLF': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7. Conlon JM,Galadari S,Raza H Chem Biol Drug Des. 2008 Jul;72(1):58-64. doi: 10.1111/j.1747-0285.2008.00671.x. Epub 2008 Jun 12.'], 'hemolysis': u'LD50 = 150\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1952']}, u'KLLKWLLKL': {'modifications': ['C-Terminal'], 'references': [u'De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface. Kang SJ,Won HS,Choi WS J Pept Sci. 2009 Sep;15(9):583-8. doi: 10.1002/psc.1149.'], 'hemolysis': u'4.84% hemolysis at 6.3\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1411']}, u'FLPLLAGLAANFLPTIICKISYKC': {'modifications': [], 'references': [u'Antimicrobial peptides from the skin of a Korean frog, Rana rugosa. Park JM,Jung JE Biochem Biophys Res Commun. 1994 Nov 30;205(1):948-54.'], 'hemolysis': u'0.86% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3704']}, u'GFOicGKOicGFOicGKKKKK': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', 'Non-Natural'], 'references': [u'De novo design of selective antibiotic peptides by incorporation of unnatural amino acids. Hicks RP,Bhonsle JB,Venugopal D,Koser BW J Med Chem. 2007 Jun 28;50(13):3026-36. Epub 2007 Jun 5.'], 'hemolysis': u'3.2% hemolysis at 25\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1772']}, u'FRWCFRVCYKGRCRYKCR': {'modifications': ['C-Terminal'], 'references': [u'Interaction of polyphemusin I and structural analogs with bacterial membranes, lipopolysaccharide, and lipid monolayers. Zhang L,Scott MG,Yan H,Mayer LD Biochemistry. 2000 Nov 28;39(47):14504-14.'], 'hemolysis': u'100% hemolysis at 85\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1045']}, u'IDWLKLGKMVMDVL': {'modifications': ['C-Terminal'], 'references': [u'Mass spectrometric characterization of two novel inflammatory peptides from the venom of the social wasp Polybia paulista. de Souza BM,Marques MR,Tomazela DM,Eberlin MN,Mendes MA Rapid Commun Mass Spectrom. 2004;18(10):1095-102.'], 'hemolysis': u'100% hemolysis at 6.2x10-5 M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1597']}, u'KIGAKI12DKIGAKIKIGAKDCF3BpgKIGAKI': {'modifications': ['C-Terminal', u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'Stereochemical effects on the aggregation and biological properties of the fibril-forming peptide [KIGAKI]3 in membranes. Wadhwani P,Reichert J,Strandberg E,Burck J,Misiewicz J,Afonin S,Heidenreich N,Fanghanel S,Mykhailiuk PK,Komarov IV Phys Chem Chem Phys. 2013 Jun 21;15(23):8962-71. doi: 10.1039/c3cp50896j. Epub 2013 May 7.'], 'hemolysis': u'~7% hemolysis at 60\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2686']}, u'GFLSILKKVLPKVMAHMK': {'modifications': ['C-Terminal'], 'references': [u'Melectin: a novel antimicrobial peptide from the venom of the cleptoparasitic bee Melecta albifrons. Cerovsky V,Hovorka O,Cvacka J,Voburka Z,Bednarova L,Borovickova L,Slaninova J Chembiochem. 2008 Nov 24;9(17):2815-21. doi: 10.1002/cbic.200800476.'], 'hemolysis': u'LC50 >100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3621']}, u'INWLKLGKKLLSAL': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 =44\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3916']}, u'FLGALLGPLMNLLQ': {'modifications': ['C-Terminal'], 'references': [u'Host-defense peptides in skin secretions of the tetraploid frog Silurana epitropicalis with potent activity against methicillin-resistant Staphylococcus aureus (MRSA). Conlon JM,Mechkarska M,Prajeep M,Sonnevend A,Coquet L,Leprince J,Jouenne T,Vaudry H Peptides. 2012 Sep;37(1):113-9. doi: 10.1016/j.peptides.2012.07.005. Epub 2012 Jul 16.'], 'hemolysis': u'LC50 =105\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3160']}, u'ILGTILGLLKSL': {'modifications': ['C-Terminal'], 'references': [u'Structural and functional characterization of two novel peptide toxins isolated from the venom of the social wasp Polybia paulista. Souza BM,Mendes MA,Santos LD,Marques MR,Cesar LM,Almeida RN,Pagnocca FC,Konno K Peptides. 2005 Nov;26(11):2157-64. Epub 2005 Aug 29.'], 'hemolysis': u'EC50 =4 X10-6M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3994']}, u'KKLfkkilkyl': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Improvement of the efficacy of linear undecapeptides against plant-pathogenic bacteria by incorporation of D-amino acids. Guell I,Cabrefiga J,Badosa E,Ferre R,Talleda M,Bardaji E,Planas M,Feliu L Appl Environ Microbiol. 2011 Apr;77(8):2667-75. doi: 10.1128/AEM.02759-10. Epub 2011 Feb 18.'], 'hemolysis': u'58\xb15.7% hemolytic at 250\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2868']}, u'RRWCFRVCYKGFCRYKCR': {'modifications': ['C-Terminal'], 'references': [u'Interaction of polyphemusin I and structural analogs with bacterial membranes, lipopolysaccharide, and lipid monolayers. Zhang L,Scott MG,Yan H,Mayer LD Biochemistry. 2000 Nov 28;39(47):14504-14.'], 'hemolysis': u'100% hemolysis at 85\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1044']}, u'IDWKKIFEKVKNLV': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 >100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3896']}, u'WKKIPKFLHLAKKF': {'modifications': ['C-Terminal'], 'references': [u'Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs. Shin SY,Lee SH,Yang ST,Park EJ,Lee DG,Lee MK,Eom SH,Song WK,Kim Y,Hahm KS J Pept Res. 2001 Dec;58(6):504-14.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2162']}, u'KKLFKKILKKL': {'modifications': ['C-Terminal'], 'references': [u'A library of linear undecapeptides with bactericidal activity against phytopathogenic bacteria. Badosa E,Ferre R,Planas M,Feliu L,Besalu E,Cabrefiga J,Bardaji E Peptides. 2007 Dec;28(12):2276-85. Epub 2007 Sep 25.'], 'hemolysis': u'14\xb12.9% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1856']}, u'CGESCVFIPCVTALLGCSCKSKVCYKNSIP': {'modifications': ['Cyclic'], 'references': [u'Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif. Craik DJ,Daly NL,Bond T J Mol Biol. 1999 Dec 17;294(5):1327-36.'], 'hemolysis': u'50% hemolysis at ~20\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4012']}, u'CIGAVLKVLTTGLPALISWIKRKRQQ': {'modifications': [], 'references': [u'Dioleoylmelittin as a novel serum-insensitive reagent for efficient transfection of mammalian cells. Legendre JY,Trzeciak A,Bohrmann B,Deuschle U,Kitas E Bioconjug Chem. 1997 Jan-Feb;8(1):57-63.'], 'hemolysis': u'100% hemolysis at 10\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3518']}, u'VOLRfPVOLfP': {'modifications': ['Cyclic', u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'Antimicrobially active cycloundecapeptides related to gramicidin S having a novel turn structure with cis D-Phe-Pro peptide bond. Tamaki M,Sasaki I,Kokuno M,Shindo M,Kimura M Org Biomol Chem. 2010 Apr 21;8(8):1791-7. doi: 10.1039/b922159j.'], 'hemolysis': u'15% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1506']}, u'GIIKKI': {'modifications': ['C-Terminal'], 'references': [u'Designed antimicrobial and antitumor peptides with high selectivity. Hu J,Chen C,Zhang S,Zhao X,Xu H,Zhao X Biomacromolecules. 2011 Nov 14;12(11):3839-43. doi: 10.1021/bm201098j. Epub 2011 Oct 3.'], 'hemolysis': u'Non-hemolytic up to 250 \u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2964']}, u'FIHHIIGGLFSVGKHIHSLIHGH': {'modifications': [], 'references': [u'Five different piscidins from Nile tilapia, Oreochromis niloticus: analysis of their expressions and biological functions. Peng KC,Lee SH,Hour AL,Pan CY,Lee LH PLoS One. 2012;7(11):e50263. doi: 10.1371/journal.pone.0050263. Epub 2012 Nov 30.'], 'hemolysis': u'42% hemolytic at 100 \xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2609']}, u'LTCDLLSFEAKGFAANHSLCAAHCLAIGRKGGACQNGVCVCRR': {'modifications': [], 'references': [u'Antibacterial activity and mechanism of action of tick defensin against Gram-positive bacteria. Nakajima Y,Ishibashi J,Yukuhiro F,Asaoka A,Taylor D Biochim Biophys Acta. 2003 Dec 5;1624(1-3):125-30.'], 'hemolysis': u'EC50   >100 (\xb5g/ml)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2333']}, u'FLPVILPVIGKLLSGIL': {'modifications': ['C-Terminal'], 'references': [u'Molecular cloning and sequence analyses of preprotemporin mRNAs containing premature stop codons from extradermal tissues of Rana tagoi. Iwamuro S,Nakamura M,Ohnuma A Peptides. 2006 Sep;27(9):2124-8. Epub 2006 May 3.'], 'hemolysis': u'LD50 =50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4050']}, u'FLPVIAGAANFLPKLFCAISKKC': {'modifications': [], 'references': [u'Primary structures of skin antimicrobial peptides indicate a close, but not conspecific, phylogenetic relationship between the leopard frogs Lithobates onca and Lithobates yavapaiensis (Ranidae). Conlon JM,Coquet L,Leprince J,Jouenne T,Vaudry H Comp Biochem Physiol C Toxicol Pharmacol. 2010 Apr;151(3):313-7. doi: 10.1016/j.cbpc.2009.12.004. Epub 2009 Dec 31.'], 'hemolysis': u'LD50 =14\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1070']}, u'KWKLFKKIGAVLKKL': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Lysine-enriched cecropin-mellitin antimicrobial peptides with enhanced selectivity. Sato H Antimicrob Agents Chemother. 2008 Dec;52(12):4463-5. doi: 10.1128/AAC.00810-08. Epub 2008 Oct 13.'], 'hemolysis': u'4% hemolysis at 64\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1261']}, u'FLPVLAGIAAKVVPALFCKITKKC': {'modifications': [], 'references': [u'Novel antimicrobial peptides from skin secretion of the European frog Rana esculenta. Simmaco M,Mignogna G,Barra D, Bossa FEBS Lett. 1993 Jun 14;324(2):159-61.'], 'hemolysis': u'LC50 >100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3684']}, u'VKLKvyPLKVKLyP': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Dissociation of antimicrobial and hemolytic activities in cyclic peptide diastereomers by systematic alterations in amphipathicity. Kondejewski LH,Jelokhani-Niaraki M,Farmer SW,Lix B,Kay CM,Sykes BD,Hancock RE J Biol Chem. 1999 May 7;274(19):13181-92.'], 'hemolysis': u'100% hemolytic at 150 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2559']}, u'KWKLFKKLPLIGRVL': {'modifications': ['C-Terminal'], 'references': [u'Hematological and antifungal properties of temporin A and a cecropin A-temporin A hybrid. Wade D,Silveira A,Rollins-Smith L,Bergman T,Silberring J Acta Biochim Pol. 2001;48(4):1185-9.'], 'hemolysis': u'100% hemolysis at 225 \xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2154']}, u'kwksflktfksavktvlhtalkaiss': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', u'Stereochemistry: D'], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC =7.8\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3975']}, u'K\u03a8[CH2OCONH]KVVFKVKFKk': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'The comparison of characteristics between membrane-active antifungal peptide and its pseudopeptides. Oh JE,Hong SY Bioorg Med Chem. 1999 Nov;7(11):2509-15.'], 'hemolysis': u'0% hemolysis upto 500 \u03bcg/mL (Non hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3769']}, u'INWKKIASIGKEVLK': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 >>100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3929']}, u'LLPALISWIKRKRQQ': {'modifications': ['C-Terminal'], 'references': [u"Individual substitution analogs of Mel(12-26), melittin's C-terminal 15-residue peptide: their antimicrobial and hemolytic actions. Yan H,Li S,Sun X,Mi H FEBS Lett. 2003 Nov 6;554(1-2):100-4."], 'hemolysis': u'HC10 = 192 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2356']}, u'GWGSFFKKAAHVAKHVGKAALTHYL': {'modifications': [], 'references': [u'Effects of two glycine residues in positions 13 and 17 of pleurocidin on structure and bacterial cell selectivity. Lim SS,Song YM,Jang MH,Kim Y,Hahm KS Protein Pept Lett. 2004 Feb;11(1):35-40.'], 'hemolysis': u'16.6% hemolytic at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2503']}, u'VKVGINGFGRIGRLVTRAAFHGKKVEVVAIND': {'modifications': ['C-Terminal'], 'references': [u'Purification and characterization of YFGAP, a GAPDH-related novel antimicrobial peptide, from the skin of yellowfin tuna, Thunnus albacares. Seo JK,Lee MJ,Go HJ,Park TH Fish Shellfish Immunol. 2012 Oct;33(4):743-52. doi: 10.1016/j.fsi.2012.06.023. Epub 2012 Jul 5.'], 'hemolysis': u'2.7 % hemolytic at 100mg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2663']}, u'CVKVSVKVGSGVKVSVKVC': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', 'Cyclic'], 'references': [u'De novo design of potent antimicrobial peptides. Frecer V,Ho B Antimicrob Agents Chemother. 2004 Sep;48(9):3349-57.'], 'hemolysis': u'EC50 = 5,89,000 nM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2374']}, u'GIGKLFLHAAKKFAKAFVAEKMNS': {'modifications': [], 'references': [u'Augmentation of the antibacterial activity of magainin by positive-charge chain extension. Bessalle R,Haas H,Goria A,Shalit I Antimicrob Agents Chemother. 1992 Feb;36(2):313-7.'], 'hemolysis': u'0% hemolysis upto 200\u03bcg/ml (non hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3451']}, u'MFTMKKSLLFLFFLGTISLSFCEEERGADEDDEVEMTEEEKRGVLDTFKDVAIGVAKGAGTGVLKALLCKLDKSC': {'modifications': [], 'references': [u'Molecular cloning and characterization of antimicrobial peptides from skin of the broad-folded frog, Hylarana latouchii. Wang H,Yu Z,Hu Y,Yu H,Ran R,Xia J,Wang D,Yang S,Yang X Biochimie. 2012 Jun;94(6):1317-26. doi: 10.1016/j.biochi.2012.02.032. Epub 2012 Mar 8.'], 'hemolysis': u'LD50 > 480\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2078']}, u'GKKLKKIGQKIKNFFQKL': {'modifications': [], 'references': [u'CRAMP analogues having potent antibiotic activity against bacterial, fungal, and tumor cells without hemolytic activity. Shin SY,Kang SW,Lee DG,Eom SH,Song WK Biochem Biophys Res Commun. 2000 Sep 7;275(3):904-9.'], 'hemolysis': u'0% hemolytic at 100\u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2516']}, u'CIGAVLKVLTTGLPALISWIKRKRQQC': {'modifications': [], 'references': [u'Gene transfer with poly-melittin peptides. Chen CP,Kim JS,Steenblock E,Liu D Bioconjug Chem. 2006 Jul-Aug;17(4):1057-62.'], 'hemolysis': u'HL50 = 1 \u03bcM at pH 4.5', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1695']}, u'KWKWKWKW': {'modifications': ['C-Terminal'], 'references': [u'Effect of repetitive lysine-tryptophan motifs on the bactericidal activity of antimicrobial peptides. Gopal R,Seo CH,Song PI Amino Acids. 2013 Feb;44(2):645-60. doi: 10.1007/s00726-012-1388-6. Epub 2012 Aug 23.'], 'hemolysis': u'8% hemolytic at 200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2605']}, u'GLPALISWIKRKRQQ': {'modifications': ['C-Terminal'], 'references': [u"Individual substitution analogs of Mel(12-26), melittin's C-terminal 15-residue peptide: their antimicrobial and hemolytic actions. Yan H,Li S,Sun X,Mi H FEBS Lett. 2003 Nov 6;554(1-2):100-4."], 'hemolysis': u'HC10  = 4500 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2355']}, u'LLLFLLKKRKKRKY': {'modifications': [], 'references': [u"Human antimicrobial peptides' antifungal activity against Aspergillus fumigatus. Lupetti A,van Dissel JT,Brouwer CP Eur J Clin Microbiol Infect Dis. 2008 Nov;27(11):1125-9. doi: 10.1007/s10096-008-0553-z. Epub 2008 Jun 20."], 'hemolysis': u'>2-3% at \u226516\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1225']}, u'RIIDLLWRVRRPQKPKFVTVWVR': {'modifications': [], 'references': [u'Structural studies of porcine myeloid antibacterial peptide PMAP-23 and its analogues in DPC micelles by NMR spectroscopy. Park K,Oh D,Shin SY,Hahm KS Biochem Biophys Res Commun. 2002 Jan 11;290(1):204-12.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2471']}, u'KKLFKKllkyl': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Improvement of the efficacy of linear undecapeptides against plant-pathogenic bacteria by incorporation of D-amino acids. Guell I,Cabrefiga J,Badosa E,Ferre R,Talleda M,Bardaji E,Planas M,Feliu L Appl Environ Microbiol. 2011 Apr;77(8):2667-75. doi: 10.1128/AEM.02759-10. Epub 2011 Feb 18.'], 'hemolysis': u'49\xb11.2% hemolytic at 250\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2865']}, u'ILPKKKPWWPWRR': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship of indolicidin, a Trp-rich antibacterial peptide. Ando S,Mitsuyasu K,Soeda Y,Hidaka M,Ito Y,Matsubara K,Shindo M,Uchida Y J Pept Sci. 2010 Apr;16(4):171-7. doi: 10.1002/psc.1217.'], 'hemolysis': u'8% hemolysis at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1480']}, u'GFKDLLKGAKKALVKTVLF': {'modifications': ['C-Terminal'], 'references': [u'Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7. Conlon JM,Galadari S,Raza H Chem Biol Drug Des. 2008 Jul;72(1):58-64. doi: 10.1111/j.1747-0285.2008.00671.x. Epub 2008 Jun 12.'], 'hemolysis': u'LD50 >500\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1948']}, u'LKLKSIVSWAKAVL': {'modifications': ['C-Terminal'], 'references': [u'Relationship between the tertiary structures of mastoparan B and its analogs and their lytic activities studied by NMR spectroscopy. Yu K,Kang S,Park N,Shin J J Pept Res. 2000 Jan;55(1):51-62.'], 'hemolysis': u'59.1% hemolysis at 50\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2022']}, u'CGESCVYIPCLTSAIGCSCKSKVCYRNGIP': {'modifications': ['Cyclic'], 'references': [u'Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif. Craik DJ,Daly NL,Bond T J Mol Biol. 1999 Dec 17;294(5):1327-36.'], 'hemolysis': u'50% hemolysis at ~20\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4008']}, u'KKLfKKILKYL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Improvement of the efficacy of linear undecapeptides against plant-pathogenic bacteria by incorporation of D-amino acids. Guell I,Cabrefiga J,Badosa E,Ferre R,Talleda M,Bardaji E,Planas M,Feliu L Appl Environ Microbiol. 2011 Apr;77(8):2667-75. doi: 10.1128/AEM.02759-10. Epub 2011 Feb 18.'], 'hemolysis': u'5\xb1 0.8% hemolysis at 250\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2853']}, u'ALWMTLLKKVLKAAAKAALDAVLVGANA': {'modifications': [], 'references': [u'Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity. Feder R,Dagan A J Biol Chem. 2000 Feb 11;275(6):4230-8.'], 'hemolysis': u'LC50 =1.2\xb10.1\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1002']}, u'WALRLYLVY': {'modifications': [], 'references': [u'Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity. Rathinakumar R, Walkenhorst, William ,Walkenhorst WF J Am Chem Soc. 2009 Jun 10;131(22):7609-17. doi: 10.1021/ja8093247.'], 'hemolysis': u'0.14 fractions hemolysis at 15\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1349']}, u'KWCFRVCYRGICYRRCRX': {'modifications': [], 'references': [u'Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework. Tam JP,Lu YA Biochem Biophys Res Commun. 2000 Jan 27;267(3):783-90.'], 'hemolysis': u'EC25 = 29\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2536']}, u'GLLGPLLKIAAKVGSKLL': {'modifications': ['C-Terminal'], 'references': [u'Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7. Conlon JM,Galadari S,Raza H Chem Biol Drug Des. 2008 Jul;72(1):58-64. doi: 10.1111/j.1747-0285.2008.00671.x. Epub 2008 Jun 12.'], 'hemolysis': u'LD50 = 80\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1963']}, u'KKAAAFAAAAAFAAWAAFAAAKKKK': {'modifications': ['C-Terminal'], 'references': [u'Cationic hydrophobic peptides with antimicrobial activity. Stark M,Liu LP Antimicrob Agents Chemother. 2002 Nov;46(11):3585-90.'], 'hemolysis': u'0% hemolysis at 50\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2225']}, u'MDFIIDIIKKIVGLFTGK': {'modifications': [], 'references': [u'The amino acid sequences and activities of synergistic hemolysins from Staphylococcus cohnii. Mak P,Maszewska A FEMS Microbiol Lett. 2008 Oct;287(2):230-5. doi: 10.1111/j.1574-6968.2008.01321.x. Epub 2008 Aug 22.'], 'hemolysis': u'HD50  =6.34\xb13.54mM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1237']}, u'FWGALAKGALKLIVGSLFSSFSKKD': {'modifications': [], 'references': [u'Amino acid substitutions in an alpha-helical antimicrobial arachnid peptide affect its chemical properties and biological activity towards pathogenic bacteria but improves its therapeutic index. Rodriguez A,Villegas E,Satake H,Possani LD Amino Acids. 2011 Jan;40(1):61-8. doi: 10.1007/s00726-009-0449-y. Epub 2009 Dec 24.'], 'hemolysis': u'IC50 =8.8\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1278']}, u'GLPASISWIKRKRQQ': {'modifications': ['C-Terminal'], 'references': [u"Individual substitution analogs of Mel(12-26), melittin's C-terminal 15-residue peptide: their antimicrobial and hemolytic actions. Yan H,Li S,Sun X,Mi H FEBS Lett. 2003 Nov 6;554(1-2):100-4."], 'hemolysis': u'HC10  = 3840 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2361']}, u'FVDLKKIANIINSIFKK': {'modifications': [], 'references': [u'Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEa. Yang QZ,Wang C,Lang L,Zhou Y,Wang H Arch Pharm Res. 2013 Apr 23.'], 'hemolysis': u'LC50 =1,467\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2571']}, u'KKKKKKLLFAAWAAFAA': {'modifications': ['C-Terminal', 'Cyclic'], 'references': [u'Membrane interactions of designed cationic antimicrobial peptides: the two thresholds. Glukhov E,Burrows LL Biopolymers. 2008 May;89(5):360-71. doi: 10.1002/bip.20917.'], 'hemolysis': u'MHC <81\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1152']}, u'fPVOLfPAdaGOL': {'modifications': ['Cyclic', u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'An adamantyl amino acid containing gramicidin S analogue with broad spectrum antibacterial activity and reduced hemolytic activity. Kapoerchan VV,Knijnenburg AD,Niamat M,Spalburg E,de Neeling AJ,Nibbering PH,Mars-Groenendijk RH,Noort D,Otero JM,Llamas-Saiz AL,van Raaij MJ,van der Marel GA,Overkleeft HS Chemistry. 2010 Oct 25;16(40):12174-81. doi: 10.1002/chem.201001686.'], 'hemolysis': u'HC50=10.1\xb11.11\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2792']}, u'IISTIGKLVKWIIDTV': {'modifications': [], 'references': [u'Generation of analogs having potent antimicrobial and hemolytic activities with minimal changes from an inactive 16-residue peptide corresponding to the helical region of Staphylococcus aureus delta-toxin. Dhople VM Protein Eng. 1995 Mar;8(3):315-8.'], 'hemolysis': u'100% hemolysis at ~25\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3599']}, u'STIGDLVKWIIDTVNKFTKK': {'modifications': [], 'references': [u'Conformation and activity of delta-lysin and its analogs. Dhople VM Peptides. 2005 Feb;26(2):217-25.'], 'hemolysis': u'~100% hemolysis at 20\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1630']}, u'CFKFKFKFGSGFKFKFKFC': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', 'Cyclic'], 'references': [u'De novo design of potent antimicrobial peptides. Frecer V,Ho B Antimicrob Agents Chemother. 2004 Sep;48(9):3349-57.'], 'hemolysis': u'EC50 = 35000 nM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2378']}, u'GRRKRKWLRRIGKGVKIIGGAALDHL': {'modifications': ['C-Terminal', u'N-Terminal Modification: Biotin'], 'references': [u'The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents. Morash MG,Douglas SE,Robotham A,Ridley CM,Gallant JW Dis Model Mech. 2011 Sep;4(5):622-33. doi: 10.1242/dmm.007310. Epub 2011 Jul 4.'], 'hemolysis': u'50% hemolytic at >256 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2943']}, u'LKLKSIVSWAKKVL': {'modifications': ['C-Terminal'], 'references': [u'Structural requirements for the edema-inducing and hemolytic activities of mastoparan B isolated from the hornet (Vespa basalis) venom. Ho CL,Lin YL,Chen WC,Hwang LL,Yu HM Toxicon. 1996 Sep;34(9):1027-35.'], 'hemolysis': u'80% hemolysis at 20\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3498']}, u'kKLFKKILKYL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Improvement of the efficacy of linear undecapeptides against plant-pathogenic bacteria by incorporation of D-amino acids. Guell I,Cabrefiga J,Badosa E,Ferre R,Talleda M,Bardaji E,Planas M,Feliu L Appl Environ Microbiol. 2011 Apr;77(8):2667-75. doi: 10.1128/AEM.02759-10. Epub 2011 Feb 18.'], 'hemolysis': u'71\xb10.4% hemolytic at 250\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2857']}, u'TCYCRRRFCVCVGR': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'12-25% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1196']}, u'VSWKKSLGKIIKVVK': {'modifications': ['C-Terminal'], 'references': [u'Effect of hydrocarbon stapling on the properties of ?-helical antimicrobial peptides isolated from the venom of hymenoptera. Chapuis H,Slaninova J,Bednarova L,Monincova L,Budesinsky M Amino Acids. 2012 Nov;43(5):2047-58. doi: 10.1007/s00726-012-1283-1. Epub 2012 Apr 17.'], 'hemolysis': u'LC50  = 30\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2758']}, u'KVvvKWVvKvVK': {'modifications': ['C-Terminal', u'N-Terminal Modification: Palmitoylation', u'Stereochemistry: Mix'], 'references': [u'A new group of antifungal and antibacterial lipopeptides derived from non-membrane active peptides conjugated to palmitic acid. Avrahami D J Biol Chem. 2004 Mar 26;279(13):12277-85. Epub 2004 Jan 6.'], 'hemolysis': u'100% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1566']}, u'ELSKAVRLIK': {'modifications': [], 'references': [u'Effects of positively charged arginine residues on membrane pore forming activity of Rev-NIS peptide in bacterial cells. Lee J,Choi H,Cho J Biochim Biophys Acta. 2011 Oct;1808(10):2421-7. doi: 10.1016/j.bbamem.2011.06.024. Epub 2011 Jul 6.'], 'hemolysis': u'0% hemolytic upto 100\u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3001']}, u'KWKKLLKKaLKLLKKLLK': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues. Song YM,Park Y,Lim SS,Yang ST,Woo ER,Park IS,Lee JS,Kim JI,Hahm KS,Kim Y Biochemistry. 2005 Sep 13;44(36):12094-106.'], 'hemolysis': u'>5% hemolysis at 50\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1654']}, u'kkalkhalakwlpalkalahklakk': {'modifications': ['C-Terminal', u'Stereochemistry: D'], 'references': [u'Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic ?-helical peptides. Vermeer LS,Lan Y,Abbate V,Ruh E,Bui TT,Wilkinson LJ,Kanno T,Jumagulova E,Kozlowska J,Patel J,McIntyre CA,Yam WC,Siu G,Atkinson RA,Lam JK,Bansal SS, Drake, Alex ,Drake AF,Mitchell GH J Biol Chem. 2012 Oct 5;287(41):34120-33. doi: 10.1074/jbc.M112.359067. Epub 2012 Aug 6.'], 'hemolysis': u'HC50 = 185.0\xb118.65\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2631']}, u'KIGAKIKDCF3BpgGAKIKIGAKI': {'modifications': ['C-Terminal', u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'Stereochemical effects on the aggregation and biological properties of the fibril-forming peptide [KIGAKI]3 in membranes. Wadhwani P,Reichert J,Strandberg E,Burck J,Misiewicz J,Afonin S,Heidenreich N,Fanghanel S,Mykhailiuk PK,Komarov IV Phys Chem Chem Phys. 2013 Jun 21;15(23):8962-71. doi: 10.1039/c3cp50896j. Epub 2013 May 7.'], 'hemolysis': u'~8% hemolytic at 60\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2682']}, u'KEKLKLKCKAPKCYNDKLACT': {'modifications': [], 'references': [u'Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs. Yang X,Lee WH J Proteome Res. 2012 Jan 1;11(1):306-19. doi: 10.1021/pr200782u. Epub 2011 Nov 18.'], 'hemolysis': u'Non-hemolytic upto 50 \u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3021']}, u'GFFALIPKIISSPLFKTL': {'modifications': ['C-Terminal'], 'references': [u'Solution conformations of peptides representing the sequence of the toxin pardaxin and analogues in trifluoroethanol-water mixtures: analysis of CD spectra. Thennarasu S Biopolymers. 1997 May;41(6):635-45.'], 'hemolysis': u'No hemolysis (Non hemolysis)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3796']}, u'RRGWVLALVlRYGRR': {'modifications': [u'Stereochemistry: Mix'], 'references': [u'Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity. Rathinakumar R, Walkenhorst, William ,Walkenhorst WF J Am Chem Soc. 2009 Jun 10;131(22):7609-17. doi: 10.1021/ja8093247.'], 'hemolysis': u'0 % hemolysis at 15\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1357']}, u'XNHGDATQLLAAYILLFDEYNEKKASAQKDILIKVL': {'modifications': ['C-Terminal', u'N-Terminal Modification: X=H, NBD, Rhodamine'], 'references': [u'A peptide derived from the putative transmembrane domain in the tail region of E. coli toxin hemolysin E assembles in phospholipid membrane and exhibits lytic activity to human red blood cells: plausible implications in the toxic activity of the protein. Yadav SP,Ahmad A,Pandey BK,Singh D,Asthana N,Verma R,Tripathi RK Biochim Biophys Acta. 2009 Feb;1788(2):538-50. doi: 10.1016/j.bbamem.2008.11.013. Epub 2008 Nov 28.'], 'hemolysis': u'0% hemolysis at 0.8\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4167']}, u'WYSEMKRNVQRLERAIEE': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Amphipathic alpha-helices in proteins: results from analysis of protein structures. Sharadadevi A,Sivakamasundari C Proteins. 2005 Jun 1;59(4):791-801.'], 'hemolysis': u'18% hemolysis at 10\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1640']}, u'KKLLKWLKKLL': {'modifications': ['C-Terminal'], 'references': [u'Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities. Kim SJ,Kim JS,Lee YS,Sim DW,Lee SH,Bahk YY,Lee KH,Kim EH,Park SJ,Lee BJ Molecules. 2013 Jan 11;18(1):859-76. doi: 10.3390/molecules18010859.'], 'hemolysis': u'MHC = 32\u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2597']}, u'ILPWKWPLWPWRR': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship of indolicidin, a Trp-rich antibacterial peptide. Ando S,Mitsuyasu K,Soeda Y,Hidaka M,Ito Y,Matsubara K,Shindo M,Uchida Y J Pept Sci. 2010 Apr;16(4):171-7. doi: 10.1002/psc.1217.'], 'hemolysis': u'63% hemolysis at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1473']}, u'KDGYLVGNDGCKYSCFTRPGTYCANECSRVKGKDGYCYAWMACYCYSMPNWVKTWNRATNRCGR': {'modifications': ['Cyclic'], 'references': [u"Antibacterial activity of six novel peptides from Tityus discrepans scorpion venom. A fluorescent probe study of microbial membrane Na+ permeability changes. Diaz P,D'Suze G,Salazar V,Sevcik C,Shannon JD,Sherman NE Toxicon. 2009 Nov;54(6):802-17. doi: 10.1016/j.toxicon.2009.06.014. Epub 2009 Jun 21."], 'hemolysis': u'21.0% hemolysis at 180\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3698']}, u'ALAGTIIAGASLTFQVLDKVLEELGKVSRK': {'modifications': [], 'references': [u'Correlations between differences in amino-terminal sequences and different hemolytic activity of sticholysins. Cilli EM,Pigossi FT,Crusca E Jr,Ros U,Martinez D,Lanio ME,Alvarez C Toxicon. 2007 Dec 15;50(8):1201-4. Epub 2007 Aug 3.'], 'hemolysis': u'Hemolytic activity expresssed as the initial rate (\u2206A/\u2206t, min- 1) i.e. at above 100 \xb5M activity is  above 0.010 min-1', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1818']}, u'PKLLKTFLSKWIG': {'modifications': [], 'references': [u'Addition and omission analogs of the 13-residue antibacterial and hemolytic peptide PKLLKTFLSKWIG: structural preferences, model membrane binding and biological activities. Bikshapathy E,Sitaram N J Pept Res. 1999 Jan;53(1):47-55.'], 'hemolysis': u'100% hemolysis at 40\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3836']}, u'RRGWVLALVLRYGRR': {'modifications': [], 'references': [u'Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity. Rathinakumar R, Walkenhorst, William ,Walkenhorst WF J Am Chem Soc. 2009 Jun 10;131(22):7609-17. doi: 10.1021/ja8093247.'], 'hemolysis': u'0.28 fractions hemolysis in 15\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1313']}, u'LLQWLSKLLGRWL': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship, conformational and biological studies of temporin L analogues. Mangoni ML,Carotenuto A,Auriemma L,Saviello MR,Campiglia P,Gomez-Monterrey I,Malfi S,Marcellini L,Barra D,Novellino E J Med Chem. 2011 Mar 10;54(5):1298-307. doi: 10.1021/jm1012853. Epub 2011 Feb 14.'], 'hemolysis': u'78% hemolytic at 6\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2833']}, u'SLFSLIKAGAKFLGKNLLKQGACYAACKASKQC': {'modifications': [], 'references': [u'Antimicrobial peptides from the skin of a Korean frog, Rana rugosa. Park JM,Jung JE Biochem Biophys Res Commun. 1994 Nov 30;205(1):948-54.'], 'hemolysis': u'0.59% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3699']}, u'FIGTALGIASAIPAIVKLFK': {'modifications': ['C-Terminal'], 'references': [u'Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii. Orivel J,Redeker V,Le Caer JP, Krier, ,Krier F,Revol-Junelles AM,Longeon A,Chaffotte A,Dejean A J Biol Chem. 2001 May 25;276(21):17823-9. Epub 2001 Feb 22.'], 'hemolysis': u'zone of inhibition (1 mm) at 0.4-0.5mM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2120']}, u'VRRFPWWWAFLRR': {'modifications': ['C-Terminal'], 'references': [u'Structure-function analysis of tritrpticin analogs: potential relationships between antimicrobial activities, model membrane interactions, and their micelle-bound NMR structures. Schibli DJ,Nguyen LT,Kernaghan SD,Rekdal O Biophys J. 2006 Dec 15;91(12):4413-26. Epub 2006 Sep 22.'], 'hemolysis': u'EC50 =354\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1718']}, u'HFLLTKVNLAKKIL': {'modifications': ['C-Terminal'], 'references': [u'Strategies for transformation of naturally-occurring amphibian antimicrobial peptides into therapeutically valuable anti-infective agents. Conlon JM,Al-Ghaferi N,Abraham B Methods. 2007 Aug;42(4):349-57.'], 'hemolysis': u'LD50 = 500\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1797']}, u'GLPALISLIKRKRQQ': {'modifications': ['C-Terminal'], 'references': [u"Individual substitution analogs of Mel(12-26), melittin's C-terminal 15-residue peptide: their antimicrobial and hemolytic actions. Yan H,Li S,Sun X,Mi H FEBS Lett. 2003 Nov 6;554(1-2):100-4."], 'hemolysis': u'HC10  = 9350  \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2364']}, u'WFRKQLKW': {'modifications': [], 'references': [u'A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: design, synthesis, activity against multidrug-resistant bacteria and Candida. Mishra B,Leishangthem GD,Gill K,Singh AK,Das S,Singh K,Xess I,Dinda A,Kapil A,Patro IK Biochim Biophys Acta. 2013 Feb;1828(2):677-86. doi: 10.1016/j.bbamem.2012.09.021. Epub 2012 Sep 29.'], 'hemolysis': u'No hemolysis upto 800\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3237']}, u'KLKLKFKLKQ': {'modifications': ['Cyclic'], 'references': [u'De novo designed cyclic cationic peptides as inhibitors of plant pathogenic bacteria. Monroc S,Badosa E,Feliu L,Planas M,Montesinos E Peptides. 2006 Nov;27(11):2567-74. Epub 2006 May 30.'], 'hemolysis': u'81 \xb1  5.3% hemolysis at 360\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1686']}, u'MKLGLLVVLAVAVLVPSLSEGQNVPSCQLKDPNQTPVEAGNMRNKREADDSSEESDLAEI': {'modifications': [], 'references': [u'Molecular cloning of grammistins, peptide toxins from the soapfish Pogonoperca punctata, by hemolytic screening of a cDNA library. Kaji T,Sugiyama N,Ishizaki S,Nagashima Y Peptides. 2006 Dec;27(12):3069-76. Epub 2006 Oct 25.'], 'hemolysis': u'3.2 HU/mg', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1724']}, u'LKIPGFVKDTLKKVAKGIFSAVAGAMTPS': {'modifications': [], 'references': [u'The hymenochirins: a family of host-defense peptides from the Congo dwarf clawed frog Hymenochirus boettgeri (Pipidae). Mechkarska M,Prajeep M,Coquet L,Leprince J,Jouenne T,Vaudry H,King JD Peptides. 2012 Jun;35(2):269-75. doi: 10.1016/j.peptides.2012.03.029. Epub 2012 Apr 3.'], 'hemolysis': u'LC50 > 300\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2091']}, u'LKLKSIVSYAKKVL': {'modifications': ['C-Terminal'], 'references': [u'Structural requirements for the edema-inducing and hemolytic activities of mastoparan B isolated from the hornet (Vespa basalis) venom. Ho CL,Lin YL,Chen WC,Hwang LL,Yu HM Toxicon. 1996 Sep;34(9):1027-35.'], 'hemolysis': u'~2% hemolysis at 20\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3510']}, u'KlKkLlKkWlKlLkKlLk': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich alpha-helical model antimicrobial peptide and its diastereomeric peptides. Wang P,Nan YH,Yang ST,Kang SW,Kim Y,Park IS,Hahm KS Peptides. 2010 Jul;31(7):1251-61. doi: 10.1016/j.peptides.2010.03.032. Epub 2010 Apr 2.'], 'hemolysis': u'HC50 =800\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3059']}, u'ILKKLLSTAAGLLSNL': {'modifications': ['C-Terminal'], 'references': [u'Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent. Conlon JM,Mechkarska M,Prajeep M,Arafat K,Zaric M,Lukic ML Amino Acids. 2013 Feb;44(2):715-23. doi: 10.1007/s00726-012-1395-7. Epub 2012 Sep 11.'], 'hemolysis': u'LC50 =105\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3169']}, u'LLKKLLKK': {'modifications': ['C-Terminal'], 'references': [u'Synthetic cationic amphiphilic ?-helical peptides as antimicrobial agents. Wiradharma N,Khoe U,Hauser CA,Seow SV,Zhang S Biomaterials. 2011 Mar;32(8):2204-12. doi: 10.1016/j.biomaterials.2010.11.054. Epub 2010 Dec 18.'], 'hemolysis': u'HC50 > 500', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2047']}, u'FKCKKVVISLRRY': {'modifications': [], 'references': [u'Fungicidal effect of three new synthetic cationic peptides against Candida albicans. Nikawa H,Fukushima H,Makihira S,Hamada T Oral Dis. 2004 Jul;10(4):221-8.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1877']}, u'KLKfKLKQ': {'modifications': ['Cyclic', u'Stereochemistry: D'], 'references': [u'De novo designed cyclic cationic peptides as inhibitors of plant pathogenic bacteria. Monroc S,Badosa E,Feliu L,Planas M,Montesinos E Peptides. 2006 Nov;27(11):2567-74. Epub 2006 May 30.'], 'hemolysis': u'37\xb15.2% hemolysis at 360\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1687']}, u'yPLKVKyPKLKV': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Modulation of structure and antibacterial and hemolytic activity by ring size in cyclic gramicidin S analogs. Kondejewski LH,Farmer SW,Wishart DS,Kay CM,Hancock RE J Biol Chem. 1996 Oct 11;271(41):25261-8.'], 'hemolysis': u'100% hemolysis at 92\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3669']}, u'GLFDIIKKIAESF': {'modifications': [], 'references': [u'Dimerization of aurein 1.2: effects in structure, antimicrobial activity and aggregation of C\xe2ndida albicans cells. Lorenzon EN,Sanches PR,Nogueira LG,Bauab TM Amino Acids. 2013 Jun;44(6):1521-8. doi: 10.1007/s00726-013-1475-3. Epub 2013 Mar 22.'], 'hemolysis': u'0% hemolytic at 4 -16\u03bcmol/L', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2587']}, u'LDVKKIIAbuVAAbuKIKPNPAAbuKKIAbuPK': {'modifications': ['Non-Natural'], 'references': [u'Panurgines, novel antimicrobial peptides from the venom of communal bee Panurgus calcaratus (Hymenoptera: Andrenidae). Cujova S,Slaninova J,Monincova L,Fucik V,Bednarova L,Stokrova J,Hovorka O,Voburka Z,Straka J Amino Acids. 2013 Jul;45(1):143-57. doi: 10.1007/s00726-013-1482-4. Epub 2013 Mar 13.'], 'hemolysis': u'LC50 >200\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3741']}, u'GLVTSLIKGAGKLLGGLFGSVTGGQS': {'modifications': [], 'references': [u'Membrane association, electrostatic sequestration, and cytotoxicity of Gly-Leu-rich peptide orthologs with differing functions. Vanhoye D,Bruston F,El Amri S,Ladram A,Amiche M Biochemistry. 2004 Jul 6;43(26):8391-409.'], 'hemolysis': u'75% hemolytic at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2493']}, u'MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLR': {'modifications': [], 'references': [u'Purification and antimicrobial function of ubiquitin isolated from the gill of Pacific oyster, Crassostrea gigas. Seo JK,Lee MJ,Go HJ,Kim GD,Jeong HD,Nam BH Mol Immunol. 2013 Jan;53(1-2):88-98. doi: 10.1016/j.molimm.2012.07.003. Epub 2012 Aug 2.'], 'hemolysis': u'0% hemolytic at 100\u03bcg/ml (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2633']}, u'MGIIAGIIKVIKSLIEQFTGK': {'modifications': [], 'references': [u'Novel phenol-soluble modulin derivatives in community-associated methicillin-resistant Staphylococcus aureus identified through imaging mass spectrometry. Gonzalez DJ,Okumura CY,Hollands A,Kersten R,Akong-Moore K,Pence MA,Malone CL,Derieux J,Moore BS,Horswill AR,Dixon JE,Dorrestein PC J Biol Chem. 2012 Apr 20;287(17):13889-98. doi: 10.1074/jbc.M112.349860. Epub 2012 Feb 27.'], 'hemolysis': u'58% hemolytic at 10 \u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2708']}, u'FQWQRNIRKVR': {'modifications': ['C-Terminal'], 'references': [u'Influence of N-acylation of a peptide derived from human lactoferricin on membrane selectivity. Zweytick D,Pabst G,Abuja PM,Jilek A,Blondelle SE,Andra J,Jerala R,Monreal D,Martinez de Tejada G Biochim Biophys Acta. 2006 Sep;1758(9):1426-35. Epub 2006 Mar 27.'], 'hemolysis': u'Non-hemolytic', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1905']}, u'KKLLKWLLKLL': {'modifications': ['C-Terminal'], 'references': [u'De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface. Kang SJ,Won HS,Choi WS J Pept Sci. 2009 Sep;15(9):583-8. doi: 10.1002/psc.1149.'], 'hemolysis': u'4.73% hemolysis at 6.3\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1423']}, u'GFLSILKKVLPKVXAHXK': {'modifications': ['C-Terminal'], 'references': [u'Effect of hydrocarbon stapling on the properties of ?-helical antimicrobial peptides isolated from the venom of hymenoptera. Chapuis H,Slaninova J,Bednarova L,Monincova L,Budesinsky M Amino Acids. 2012 Nov;43(5):2047-58. doi: 10.1007/s00726-012-1283-1. Epub 2012 Apr 17.'], 'hemolysis': u'LC50 = 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2747']}, u'LLGMIPVAISAISALSKL': {'modifications': [], 'references': [u'Medusins: a new class of antimicrobial peptides from the skin secretions of phyllomedusine frogs. Xi X,Li R,Jiang Y,Lin Y,Wu Y,Zhou M,Xu J,Wang L,Chen T Biochimie. 2013 Jun;95(6):1288-96. doi: 10.1016/j.biochi.2013.02.005. Epub 2013 Feb 14.'], 'hemolysis': u'1.9% hemolysis at 128mg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3715']}, u'ALWKTMLKKLGTMALHAGKAALGAAADTISQGTQ': {'modifications': [], 'references': [u'Isolation and structure of novel defensive peptides from frog skin. Mor A Eur J Biochem. 1994 Jan 15;219(1-2):145-54.'], 'hemolysis': u'100% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3986']}, u'KWKLFKKIKFLHSAKKF': {'modifications': ['C-Terminal'], 'references': [u'Effects of the hinge region of cecropin A(1-8)-magainin 2(1-12), a synthetic antimicrobial peptide, on liposomes, bacterial and tumor cells. Shin SY,Kang JH,Jang SY,Kim Y,Kim KL Biochim Biophys Acta. 2000 Feb 15;1463(2):209-18.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2024']}, u'GRLKRLRKKLKKLLKKLS': {'modifications': ['C-Terminal'], 'references': [u'Cell selectivity, mechanism of action and LPS-neutralizing activity of bovine myeloid antimicrobial peptide-18 (BMAP-18) and its analogs. Lee EK,Kim YC,Nan YH Peptides. 2011 Jun;32(6):1123-30. doi: 10.1016/j.peptides.2011.03.024. Epub 2011 Apr 8.'], 'hemolysis': u'10% hemolysis at 300\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3130']}, u'KLLLK': {'modifications': ['C-Terminal', u'N-Terminal Modification: Dansylation'], 'references': [u'The amphipathic helix concept: length effects on ideally amphipathic LiKj(i=2j) peptides to acquire optimal hemolytic activity. Castano S,Cornut I,Buttner K,Dasseux JL Biochim Biophys Acta. 1999 Jan 12;1416(1-2):161-75.'], 'hemolysis': u'LD50 =90\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3825']}, u'kkkkkkaafaawaafaa': {'modifications': ['C-Terminal', u'Stereochemistry: D'], 'references': [u'Cationic hydrophobic peptides with antimicrobial activity. Stark M,Liu LP Antimicrob Agents Chemother. 2002 Nov;46(11):3585-90.'], 'hemolysis': u'0% hemolysis at 50\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2253']}, u'SWLRDIWDWGCEVLSDFK': {'modifications': [], 'references': [u'Rational design of peptides with anti-HCV/HIV activities and enhanced specificity. Li GR,He LY,Liu XY,Liu AP,Huang YB,Qiu C,Zhang XY,Xu JQ,Yang W Chem Biol Drug Des. 2011 Nov;78(5):835-43. doi: 10.1111/j.1747-0285.2011.01201.x. Epub 2011 Sep 26.'], 'hemolysis': u'MHC = 28.38\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2956']}, u'PKLLKKFLKKWIG': {'modifications': [], 'references': [u'Addition and omission analogs of the 13-residue antibacterial and hemolytic peptide PKLLKTFLSKWIG: structural preferences, model membrane binding and biological activities. Bikshapathy E,Sitaram N J Pept Res. 1999 Jan;53(1):47-55.'], 'hemolysis': u'100% hemolysis at 175\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3837']}, u'FLPLLAGLAANFLPKIFCKITKRC': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity analysis of brevinin 1E amide, an antimicrobial peptide from Rana esculenta. Kwon MY,Hong SY Biochim Biophys Acta. 1998 Sep 8;1387(1-2):239-48.'], 'hemolysis': u'HD50=1.6\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3286']}, u'ILPWKWPWLPKRR': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship of indolicidin, a Trp-rich antibacterial peptide. Ando S,Mitsuyasu K,Soeda Y,Hidaka M,Ito Y,Matsubara K,Shindo M,Uchida Y J Pept Sci. 2010 Apr;16(4):171-7. doi: 10.1002/psc.1217.'], 'hemolysis': u'3% hemolysis at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1486']}, u'ENMFNIKSSVESDSFWG': {'modifications': [], 'references': [u'Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs. Yang X,Lee WH J Proteome Res. 2012 Jan 1;11(1):306-19. doi: 10.1021/pr200782u. Epub 2011 Nov 18.'], 'hemolysis': u'Non-hemolytic upto 50 \u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3022']}, u'LKLLLLKLLKLKLWK': {'modifications': [], 'references': [u'The amphipathic helix concept: length effects on ideally amphipathic LiKj(i=2j) peptides to acquire optimal hemolytic activity. Castano S,Cornut I,Buttner K,Dasseux JL Biochim Biophys Acta. 1999 Jan 12;1416(1-2):161-75.'], 'hemolysis': u'LD50 =5 \u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3832']}, u'ALWKTLLKKVLKA': {'modifications': ['C-Terminal', u'N-Terminal Modification: H2N-C((CH2)4-NH2)H-CO-P'], 'references': [u'Direct interaction of dermaseptin S4 aminoheptanoyl derivative with intraerythrocytic malaria parasite leading to increased specific antiparasitic activity in culture. Efron L,Dagan A,Gaidukov L,Ginsburg H J Biol Chem. 2002 Jul 5;277(27):24067-72. Epub 2002 Apr 5.'], 'hemolysis': u'5% hemolysis at 10\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4103']}, u'RFGRFLRKIRRFRPKVTITIQGSARFG': {'modifications': [], 'references': [u'Identification of chicken cathelicidin-2 core elements involved in antibacterial and immunomodulatory activities. van Dijk A,Molhoek EM,Veldhuizen EJ,Bokhoven JL,Wagendorp E,Bikker F Mol Immunol. 2009 Aug;46(13):2465-73. doi: 10.1016/j.molimm.2009.05.019. Epub 2009 Jun 12.'], 'hemolysis': u'50% hemolysis at 40\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1365']}, u'kkalakalkhwlpalhklakalakk': {'modifications': ['C-Terminal', u'Stereochemistry: D'], 'references': [u'Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic ?-helical peptides. Vermeer LS,Lan Y,Abbate V,Ruh E,Bui TT,Wilkinson LJ,Kanno T,Jumagulova E,Kozlowska J,Patel J,McIntyre CA,Yam WC,Siu G,Atkinson RA,Lam JK,Bansal SS, Drake, Alex ,Drake AF,Mitchell GH J Biol Chem. 2012 Oct 5;287(41):34120-33. doi: 10.1074/jbc.M112.359067. Epub 2012 Aug 6.'], 'hemolysis': u'HC50 = 8.61\xb10.35\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2630']}, u'GLPVCGETCVGGTCKTPGCTCSWPVCTRN': {'modifications': ['Cyclic'], 'references': [u'Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities. Henriques ST,Huang YH,Rosengren KJ,Franquelim HG,Carvalho FA,Johnson A,Sonza S,Tachedjian G,Castanho MA,Daly NL J Biol Chem. 2011 Jul 8;286(27):24231-41. doi: 10.1074/jbc.M111.253393. Epub 2011 May 16.'], 'hemolysis': u'2.1\xb10.4% hemolytic at 25\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3007']}, u'FLPIIGKLLSGLL': {'modifications': ['C-Terminal'], 'references': [u'Peptide defenses of the Cascades frog Rana cascadae: implications for the evolutionary history of frogs of the Amerana species group. Conlon JM,Al-Dhaheri A,Al-Mutawa E,Al-Kharrge R,Ahmed E,Kolodziejek J,Nowotny N, Nielsen, Per ,Nielsen PF Peptides. 2007 Jun;28(6):1268-74. Epub 2007 Mar 27.'], 'hemolysis': u'LD50 =95\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1131']}, u'LGRVDIHVWDaVYIRGR': {'modifications': [u'Stereochemistry: Mix'], 'references': [u'Therapeutic potential of peptides with neutralizing ability towards the venom and toxin (CaTx-I) of crotalus adamanteus. Samy RP,Thwin MM,Stiles BG,Bow H,Chow VT Curr Top Med Chem. 2011;11(20):2540-55.'], 'hemolysis': u'3% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3144']}, u'GFKkLLKGAAKALVKTVLF': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7. Conlon JM,Galadari S,Raza H Chem Biol Drug Des. 2008 Jul;72(1):58-64. doi: 10.1111/j.1747-0285.2008.00671.x. Epub 2008 Jun 12.'], 'hemolysis': u'LD50 = 300\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1951']}, u'GWGSFFKKAAHVGKHVGKA': {'modifications': ['C-Terminal'], 'references': [u'Influence of the hydrophobic amino acids in the N- and C-terminal regions of pleurocidin on antifungal activity. Lee J J Microbiol Biotechnol. 2010 Aug;20(8):1192-5.'], 'hemolysis': u'0% hemolytic at 100\u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2790']}, u'GFMDTAKNVAKNVAVTLLDNLKCKITKAC': {'modifications': [], 'references': [u'Anti-infection peptidomics of amphibian skin. Li J,Xu X,Xu C,Zhou W,Zhang K,Yu H,Zhang Y,Zheng Y,Rees HH,Lai R,Yang D Mol Cell Proteomics. 2007 May;6(5):882-94. Epub 2007 Jan 31.'], 'hemolysis': u'15.4\xb13.5% hemolysis at 50\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3646']}, u'CKKIGAVLKVLTTGLPALISWIKRKRQQKKC': {'modifications': [], 'references': [u'Gene transfer with poly-melittin peptides. Chen CP,Kim JS,Steenblock E,Liu D Bioconjug Chem. 2006 Jul-Aug;17(4):1057-62.'], 'hemolysis': u'HL50 = 2.5 \u03bcM at pH 7.4', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1696']}, u'GIGAVLKVLSTGLPALISWIKRKRQQ': {'modifications': [], 'references': [u'Identification of a novel melittin isoform from Africanized Apis mellifera venom. Sciani JM,Marques-Porto R,Lourenco Junior A,Orsi Rde O,Ferreira Junior RS,Barraviera B Peptides. 2010 Aug;31(8):1473-9. doi: 10.1016/j.peptides.2010.05.001. Epub 2010 May 21.'], 'hemolysis': u'35% hemolysis at', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3071']}, u'APCLAPCLACPCKACPCLACPCLAPCLACPCKACPC': {'modifications': ['C-Terminal', 'Cyclic', 'Non-Natural'], 'references': [u'Interplay among folding, sequence, and lipophilicity in the antibacterial and hemolytic activities of alpha/beta-peptides. Schmitt MA,Weisblum B J Am Chem Soc. 2007 Jan 17;129(2):417-28.'], 'hemolysis': u'>10% hemolysis at 100 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1094']}, u'GLPRKILAAIAKKK': {'modifications': ['C-Terminal'], 'references': [u'Lasiocepsin, a novel cyclic antimicrobial peptide from the venom of eusocial bee Lasioglossum laticeps (Hymenoptera: Halictidae). Monincova L,Slaninova J,Fucik V,Hovorka O,Voburka Z,Bednarova L,Malon P,Stokrova J Amino Acids. 2012 Aug;43(2):751-61. doi: 10.1007/s00726-011-1125-6. Epub 2011 Oct 29.'], 'hemolysis': u'<1% hemolytic at 200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2745']}, u'PICTRNGLPVCGETCFGGTCNTPGCTCTW': {'modifications': ['Cyclic'], 'references': [u'Cyclic peptides from Oldenlandia affinis DC. Molecular and biological properties. Gran L,Sletten K Chem Biodivers. 2008 Oct;5(10):2014-22. doi: 10.1002/cbdv.200890184.'], 'hemolysis': u'100% hemolysis at >0.5 mg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1265']}, u'LEKGLDGAKKAVGGLGKLGKDAVEDLESVGKGAVHDVKDVLDSVL': {'modifications': [], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC >100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3951']}, u'KWKLFKKIPKFLHLA': {'modifications': ['C-Terminal'], 'references': [u'Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs. Shin SY,Lee SH,Yang ST,Park EJ,Lee DG,Lee MK,Eom SH,Song WK,Kim Y,Hahm KS J Pept Res. 2001 Dec;58(6):504-14.'], 'hemolysis': u'6.7% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2171']}, u'GSKKPVPIIYANRRTGKAQRM': {'modifications': [], 'references': [u'Role of amino acid residues within the disulfide loop of thanatin, a potent antibiotic peptide. Lee MK,Cha L,Lee SH J Biochem Mol Biol. 2002 May 31;35(3):291-6.'], 'hemolysis': u'0% hemolysis at 20.8\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2219']}, u'RQRVEELSKFSKKGAAARRRK': {'modifications': [], 'references': [u'A novel antimicrobial peptide from the loach, Misgurnus anguillicaudatus. Park CB,Lee JH,Park IY,Kim MS FEBS Lett. 1997 Jul 14;411(2-3):173-8.'], 'hemolysis': u'0.46% hemolysis at 100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3805']}, u'FLKWLFKWAKK': {'modifications': ['C-Terminal'], 'references': [u'Activity optimization of an undecapeptide analogue derived from a frog-skin antimicrobial peptide. Won HS,Kang SJ,Choi WS Mol Cells. 2011 Jan;31(1):49-54. doi: 10.1007/s10059-011-0005-y. Epub 2010 Nov 23.'], 'hemolysis': u'MHC =6.3\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1557']}, u'FLSSIGKILGNLL': {'modifications': ['C-Terminal'], 'references': [u'Purification and characterization of antimicrobial peptides from the skin secretions of the carpenter frog Rana virgatipes (Ranidae, Aquarana). Conlon JM,Abraham B,Sonnevend A,Jouenne T,Cosette P,Leprince J,Vaudry H Regul Pept. 2005 Nov;131(1-3):38-45.'], 'hemolysis': u'LD50 =120\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3890']}, u'VRRFPYYYPFLRR': {'modifications': ['C-Terminal'], 'references': [u'Structure-function analysis of tritrpticin analogs: potential relationships between antimicrobial activities, model membrane interactions, and their micelle-bound NMR structures. Schibli DJ,Nguyen LT,Kernaghan SD,Rekdal O Biophys J. 2006 Dec 15;91(12):4413-26. Epub 2006 Sep 22.'], 'hemolysis': u'EC50 >1000\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1714']}, u'KWKSFLKTFKSLKKTVLHTLLKAISS': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', u'Stereochemistry: Mix'], 'references': [u'Role of helicity on the anticancer mechanism of action of cationic-helical peptides. Huang YB,He LY,Jiang HY Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849. Epub 2012 Jun 5.'], 'hemolysis': u'MHC = 5.20 \xb1 0.02\u03bcmol/L', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2634']}, u'FKIKPGKVLDKFGKIVGKVLKQLKKVS': {'modifications': [], 'references': [u'Lytic activity and structural differences of amphipathic peptides derived from trialysin. Martins RM,Sforca ML,Amino R,Juliano MA,Oyama S Jr,Juliano L,Pertinhez TA,Spisni A Biochemistry. 2006 Feb 14;45(6):1765-74.'], 'hemolysis': u'50% hemolysis at 296\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1674']}, u'KPTFRRLKWKYK': {'modifications': ['Cyclic'], 'references': [u'Cyclic antimicrobial peptides based on Limulus anti-lipopolysaccharide factor for neutralization of lipopolysaccharide. Andra J,Lamata M,Martinez de Tejada G,Bartels R,Koch MH Biochem Pharmacol. 2004 Oct 1;68(7):1297-307.'], 'hemolysis': u'~5% hemolysis at 100\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2392']}, u'KRLFRRWQWRMKKY': {'modifications': [], 'references': [u'Fungicidal effect of three new synthetic cationic peptides against Candida albicans. Nikawa H,Fukushima H,Makihira S,Hamada T Oral Dis. 2004 Jul;10(4):221-8.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1875']}, u'RKKRRQRRR': {'modifications': [], 'references': [u'A cancer specific cell-penetrating peptide, BR2, for the efficient delivery of an scFv into cancer cells. Lim KJ,Sung BH,Shin JR,Lee YW,Kim da J,Yang KS PLoS One. 2013 Jun 11;8(6):e66084. doi: 10.1371/journal.pone.0066084. Print 2013.'], 'hemolysis': u'Inactive', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3278']}, u'GIIKKIIKKIIKKI': {'modifications': ['C-Terminal'], 'references': [u'Designed antimicrobial and antitumor peptides with high selectivity. Hu J,Chen C,Zhang S,Zhao X,Xu H,Zhao X Biomacromolecules. 2011 Nov 14;12(11):3839-43. doi: 10.1021/bm201098j. Epub 2011 Oct 3.'], 'hemolysis': u'EC50 >250\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2966']}, u'FLGSIVGALASALPSLISKIRN': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial peptides from the skin of the Tsushima brown frog Rana tsushimensis. Conlon JM,Al-Ghaferi N,Abraham B,Sonnevend A,Coquet L,Leprince J,Jouenne T,Vaudry H Comp Biochem Physiol C Toxicol Pharmacol. 2006 May;143(1):42-9. Epub 2006 Jan 18.'], 'hemolysis': u'LD50 =12\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1055']}, u'FWGALIKGAAKLIPSVVGLFKKKQ': {'modifications': [], 'references': [u'Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii. Orivel J,Redeker V,Le Caer JP, Krier, ,Krier F,Revol-Junelles AM,Longeon A,Chaffotte A,Dejean A J Biol Chem. 2001 May 25;276(21):17823-9. Epub 2001 Feb 22.'], 'hemolysis': u'zone of inhibition (1.5 mm) at 0.4-0.5mM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2118']}, u'GKGLTicOicGLTicOicGKTicOicGLTicOicGKTicOicGLTicOicGLR': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'De novo design of selective antibiotic peptides by incorporation of unnatural amino acids. Hicks RP,Bhonsle JB,Venugopal D,Koser BW J Med Chem. 2007 Jun 28;50(13):3026-36. Epub 2007 Jun 5.'], 'hemolysis': u'100% hemolysis at 25\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1740']}, u'MSDFVNAISEAVKAGLSADWVTMGTSIADALAKGADFILGFFN': {'modifications': [], 'references': [u'The amino acid sequences and activities of synergistic hemolysins from Staphylococcus cohnii. Mak P,Maszewska A FEMS Microbiol Lett. 2008 Oct;287(2):230-5. doi: 10.1111/j.1574-6968.2008.01321.x. Epub 2008 Aug 22.'], 'hemolysis': u'HD50  =2.07\xb10.05mM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1242']}, u'GFFGKMKEYFKKFGASFKRRFANLKKRL': {'modifications': ['C-Terminal'], 'references': [u'Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity. Kozlov SA,Vassilevski AA,Feofanov AV,Surovoy AY,Karpunin DV J Biol Chem. 2006 Jul 28;281(30):20983-92. Epub 2006 May 30.'], 'hemolysis': u'20% hemolysis at 40\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4057']}, u'KWARLWRWFRITRWLWYIK': {'modifications': ['C-Terminal'], 'references': [u'Design of a novel tryptophan-rich membrane-active antimicrobial peptide from the membrane-proximal region of the HIV glycoprotein, gp41. Haney, Evan ,Haney EF,Nguyen LT,Schibli DJ Beilstein J Org Chem. 2012;8:1172-84. Epub 2012 Jul 24.'], 'hemolysis': u'EC50 = 7-14\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2617']}, u'GIFSKLGRKKIKNLLISGLKNVGKEVGMDVVRTGIDIAGCKIKGEC': {'modifications': [], 'references': [u'Novel antimicrobial peptides from skin secretion of the European frog Rana esculenta. Simmaco M,Mignogna G,Barra D, Bossa FEBS Lett. 1993 Jun 14;324(2):159-61.'], 'hemolysis': u'LC50 >100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3685']}, u'KLLKKPLKLKL': {'modifications': ['C-Terminal'], 'references': [u'Antibiotic activity of Leu-Lys rich model peptides. Park Y,Lee DG Biotechnol Lett. 2003 Aug;25(16):1305-10.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2322']}, u'IWRIFRRIFRIFIRF': {'modifications': ['C-Terminal'], 'references': [u'Biochemical property and membrane-peptide interactions of de novo antimicrobial peptides designed by helix-forming units. Ma QQ,Dong N,Shan AS,Lv YF,Li YZ,Chen ZH,Cheng BJ Amino Acids. 2012 Dec;43(6):2527-36. doi: 10.1007/s00726-012-1334-7. Epub 2012 Jun 15.'], 'hemolysis': u'MHC = 15 \u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2665']}, u'ELSTicOicGKGTicOicLKES': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'De novo design of selective antibiotic peptides by incorporation of unnatural amino acids. Hicks RP,Bhonsle JB,Venugopal D,Koser BW J Med Chem. 2007 Jun 28;50(13):3026-36. Epub 2007 Jun 5.'], 'hemolysis': u'23% hemolysis at 25\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1752']}, u'KWKSFLKTFKSlKKTVLHTlLKAISS': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', u'Stereochemistry: Mix'], 'references': [u'Role of helicity on the anticancer mechanism of action of cationic-helical peptides. Huang YB,He LY,Jiang HY Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849. Epub 2012 Jun 5.'], 'hemolysis': u'MHC =81.31 \xb1 0.43\u03bcmol/L', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2648']}, u'GLGSVFGRLARIGRVIPKV': {'modifications': ['C-Terminal'], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC <10\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3959']}, u'ILGKIWEGIKS': {'modifications': [], 'references': [u'Purification, structure-function analysis, and molecular characterization of novel linear peptides from scorpion Opisthacanthus madagascariensis. Dai L,Corzo G,Naoki H,Andriantsiferana M Biochem Biophys Res Commun. 2002 May 24;293(5):1514-22.'], 'hemolysis': u'~0% hemolysis at 200\u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2195']}, u'KKFPWWWPFKK': {'modifications': ['C-Terminal'], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC =100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3971']}, u'FWGALAKGALKLIGVGSLFSSFSKKD': {'modifications': [], 'references': [u'Amino acid substitutions in an alpha-helical antimicrobial arachnid peptide affect its chemical properties and biological activity towards pathogenic bacteria but improves its therapeutic index. Rodriguez A,Villegas E,Satake H,Possani LD Amino Acids. 2011 Jan;40(1):61-8. doi: 10.1007/s00726-009-0449-y. Epub 2009 Dec 24.'], 'hemolysis': u'IC50 =11.5\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1279']}, u'LKAKSIVSWAKKVL': {'modifications': ['C-Terminal'], 'references': [u'Relationship between the tertiary structures of mastoparan B and its analogs and their lytic activities studied by NMR spectroscopy. Yu K,Kang S,Park N,Shin J J Pept Res. 2000 Jan;55(1):51-62.'], 'hemolysis': u'11.9% hemolysis at 50\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2016']}, u'FLPLIGRALSGIL': {'modifications': ['C-Terminal'], 'references': [u'Alanine scanning analysis and structure-function relationships of the frog-skin antimicrobial peptide temporin-1Ta. Grieco P,Luca V,Auriemma L,Carotenuto A,Saviello MR,Campiglia P,Barra D,Novellino E J Pept Sci. 2011 May;17(5):358-65. doi: 10.1002/psc.1350. Epub 2011 Feb 18.'], 'hemolysis': u'1.5% hemolytic at 1.25\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2896']}, u'GWASKIGQTLGKIAKVGLKELIQPK': {'modifications': [], 'references': [u'Antimicrobial properties of peptides from Xenopus granular gland secretions. Soravia E,Martini G FEBS Lett. 1988 Feb 15;228(2):337-40.'], 'hemolysis': u'6% hemolysis at 1000\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4091']}, u'GAGALAKFLAKKVAKTVAKQAAKQGAKYVVNKQME': {'modifications': ['C-Terminal'], 'references': [u'N-terminal aromatic residues closely impact the cytolytic activity of cupiennin 1a, a major spider venom peptide. Kuhn-Nentwig L,Sheynis T,Kolusheva S,Nentwig W Toxicon. 2013 Mar 21. pii: S0041-0101(13)00089-5. doi: 10.1016/j.toxicon.2013.03.003.'], 'hemolysis': u'EC50 >40\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3262']}, u'VOLLfPVOLfP': {'modifications': ['Cyclic', u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'Antimicrobially active cycloundecapeptides related to gramicidin S having a novel turn structure with cis D-Phe-Pro peptide bond. Tamaki M,Sasaki I,Kokuno M,Shindo M,Kimura M Org Biomol Chem. 2010 Apr 21;8(8):1791-7. doi: 10.1039/b922159j.'], 'hemolysis': u'100% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1502']}, u'FLPLLLAGLPKLLCLFFKKC': {'modifications': [], 'references': [u'Cytolytic peptides belonging to the brevinin-1 and brevinin-2 families isolated from the skin of the Japanese brown frog, Rana dybowskii. Conlon JM,Kolodziejek J,Nowotny N,Leprince J,Vaudry H,Coquet L,Jouenne T Toxicon. 2007 Nov;50(6):746-56. Epub 2007 Jul 4.'], 'hemolysis': u'LC50 <5\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3645']}, u'RLYRRLYR': {'modifications': [], 'references': [u'Antimicrobial dendrimeric peptides. Tam JP,Lu YA Eur J Biochem. 2002 Feb;269(3):923-32.'], 'hemolysis': u'EC50 = 1950\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2407']}, u'FFFLSRIF': {'modifications': ['C-Terminal'], 'references': [u'Temporin-SHf, a new type of phe-rich and hydrophobic ultrashort antimicrobial peptide. Abbassi F,Lequin O,Piesse C,Goasdoue N,Foulon T,Nicolas P J Biol Chem. 2010 May 28;285(22):16880-92. doi: 10.1074/jbc.M109.097204. Epub 2010 Mar 22.'], 'hemolysis': u'LC50 = 200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1501']}, u'GFLSILKKVLKKVMAHMK': {'modifications': ['C-Terminal'], 'references': [u'Melectin: a novel antimicrobial peptide from the venom of the cleptoparasitic bee Melecta albifrons. Cerovsky V,Hovorka O,Cvacka J,Voburka Z,Bednarova L,Borovickova L,Slaninova J Chembiochem. 2008 Nov 24;9(17):2815-21. doi: 10.1002/cbic.200800476.'], 'hemolysis': u'LC50 = 27.3\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3622']}, u'RGGRLCYCRRRFCVCI': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'>50% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1207']}, u'LNWGANleLKHNleNleK': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Panurgines, novel antimicrobial peptides from the venom of communal bee Panurgus calcaratus (Hymenoptera: Andrenidae). Cujova S,Slaninova J,Monincova L,Fucik V,Bednarova L,Stokrova J,Hovorka O,Voburka Z,Straka J Amino Acids. 2013 Jul;45(1):143-57. doi: 10.1007/s00726-013-1482-4. Epub 2013 Mar 13.'], 'hemolysis': u'LC50 =40\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3737']}, u'HVDKKVADKVLLLKQLRIMRLLTRL': {'modifications': [], 'references': [u'Solution structure of termite-derived antimicrobial peptide, spinigerin, as determined in SDS micelle by NMR spectroscopy. Lee KH,Shin SY,Hong JE,Yang ST,Kim JI,Hahm KS Biochem Biophys Res Commun. 2003 Sep 26;309(3):591-7.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2315']}, u'KWKSFIKKLTDKFLHSAKKF': {'modifications': ['C-Terminal'], 'references': [u'The Design and Construction of K11: A Novel ?-Helical Antimicrobial Peptide. Jin-Jiang H,Jin-Chun L,Min L,Qing-Shan H Int J Microbiol. 2012;2012:764834. doi: 10.1155/2012/764834. Epub 2012 Feb 16.'], 'hemolysis': u'MHC >500\u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2725']}, u'FLGAIAAALPHVINAVTNAL': {'modifications': ['C-Terminal'], 'references': [u'A family of kassinatuerin-2 related peptides from the skin secretion of the African hyperoliid frog, Kassina maculata. Wang L,Zhou M,McGrath S,Chen T,Gorman SP,Walker B Peptides. 2009 Aug;30(8):1428-33. doi: 10.1016/j.peptides.2009.04.021. Epub 2009 May 7.'], 'hemolysis': u'45-50% hemolysis at 120\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3484']}, u'GWLDVAKKIGKAAFNVAKNFL': {'modifications': ['C-Terminal'], 'references': [u'Effects of dimerization on the structure and biological activity of antimicrobial peptide Ctx-Ha. Lorenzon EN, Cespedes, G ,Cespedes GF, Vicente, E ,Vicente EF,Nogueira LG,Bauab TM,Castro MS Antimicrob Agents Chemother. 2012 Jun;56(6):3004-10. doi: 10.1128/AAC.06262-11. Epub 2012 Mar 5.'], 'hemolysis': u'HC50 = 37.3\xb1 1.4 \u03bcmol/L', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2712']}, u'AKKVFKRLEKLFSKIQN': {'modifications': [], 'references': [u'Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions. Park SC,Kim MH,Hossain MA,Shin SY,Kim Y,Stella L,Wade JD,Park Y Biochim Biophys Acta. 2008 Jan;1778(1):229-41. Epub 2007 Oct 2.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1929']}, u'OOFF': {'modifications': ['C-Terminal', u'N-Terminal Modification: pHCA= Hydroxy cinnamic acid', 'Non-Natural'], 'references': [u'Antimicrobial activity of rationally designed amino terminal modified peptides. Bisht GS,Rawat DS,Kumar A,Kumar R Bioorg Med Chem Lett. 2007 Aug 1;17(15):4343-6. Epub 2007 May 13.'], 'hemolysis': u'No hemolysis at 1000\xb5g/ml (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1923']}, u'AKKVFKRLEKLFSKIQNDK': {'modifications': ['C-Terminal'], 'references': [u'Antibiotic activity and synergistic effect of antimicrobial peptide against pathogens from a patient with gallstones. Park Y,Park SN,Park SC,Park JY,Park YH,Hahm JS Biochem Biophys Res Commun. 2004 Aug 27;321(3):631-7.'], 'hemolysis': u'0% hemolysis at 140\xb5g/ml (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2394']}, u'WLKKLLKKLLK': {'modifications': ['C-Terminal'], 'references': [u'Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities. Kim SJ,Kim JS,Lee YS,Sim DW,Lee SH,Bahk YY,Lee KH,Kim EH,Park SJ,Lee BJ Molecules. 2013 Jan 11;18(1):859-76. doi: 10.3390/molecules18010859.'], 'hemolysis': u'MHC = 32 \u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2592']}, u'GFKKLLKGAAKALVKTVLF': {'modifications': ['C-Terminal'], 'references': [u'Activities of the frog skin peptide, ascaphin-8 and its lysine-substituted analogs against clinical isolates of extended-spectrum beta-lactamase (ESBL) producing bacteria. Eley A,Ibrahim M,Kurdi SE Peptides. 2008 Jan;29(1):25-30. Epub 2007 Nov 9.'], 'hemolysis': u'LC50 =24\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2549']}, u'ILPILGNLLNSLL': {'modifications': ['C-Terminal'], 'references': [u'A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica. Conlon JM,Sonnevend A,Patel M,Al-Dhaheri K, Nielsen, Per ,Nielsen PF,Kolodziejek J,Nowotny N,Iwamuro S Regul Pept. 2004 May 15;118(3):135-41.'], 'hemolysis': u'HC50 >300\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1997']}, u'KLllLWKlLlLK': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Structure and organization of hemolytic and nonhemolytic diastereomers of antimicrobial peptides in membranes. Hong J,Oren Z Biochemistry. 1999 Dec 21;38(51):16963-73.'], 'hemolysis': u'39.4% hemolysis at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3759']}, u'KISKKIMRTFLRRILTGKK': {'modifications': ['C-Terminal'], 'references': [u'Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens. Andra J,Monreal D,Martinez de Tejada G,Olak C,Brezesinski G,Gomez SS,Goldmann T,Bartels R,Brandenburg K J Biol Chem. 2007 May 18;282(20):14719-28. Epub 2007 Mar 27.'], 'hemolysis': u'~9% hemolysis at 100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1122']}, u'ZSRRLSYKQRSVTYSRGR': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Structure-activity relationship studies of gomesin: importance of the disulfide bridges for conformation, bioactivities, and serum stability. Fazio MA,Oliveira VX Jr,Bulet P,Miranda MT,Daffre S Biopolymers. 2006;84(2):205-18.'], 'hemolysis': u'<10% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4195']}, u'KWKKLLKKpLKLLKKLLK': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Effects of L- or D-Pro incorporation into hydrophobic or hydrophilic helix face of amphipathic alpha-helical model peptide on structure and cell selectivity. Song YM,Yang ST,Lim SS,Kim Y,Hahm KS,Kim JI Biochem Biophys Res Commun. 2004 Feb 6;314(2):615-21.'], 'hemolysis': u'~5% hemolysis  at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1573']}, u'GFLSILKKVLPKVNleAHNleK': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Melectin MAPs: the influence of dendrimerization on antimicrobial and hemolytic activity. Niederhafner P,Bednarova L,Budesinsky M,Safarik M,Ehala S,Jezek J,Borovickova L,Fucik V,Cerovsky V Amino Acids. 2010 Nov;39(5):1553-61. doi: 10.1007/s00726-010-0626-z. Epub 2010 May 25.'], 'hemolysis': u'LC50 =50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1510']}, u'KKklKKLkKkLK': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation (CH3(CH2)6CO)', u'Stereochemistry: Mix'], 'references': [u'Effect of the hydrophobicity to net positive charge ratio on antibacterial and anti-endotoxin activities of structurally similar antimicrobial peptides. Rosenfeld Y,Lev N Biochemistry. 2010 Feb 9;49(5):853-61. doi: 10.1021/bi900724x.'], 'hemolysis': u'0% hemolytic at 100\u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2785']}, u'GFFALIAKIISSPLFKTL': {'modifications': ['C-Terminal'], 'references': [u'Solution conformations of peptides representing the sequence of the toxin pardaxin and analogues in trifluoroethanol-water mixtures: analysis of CD spectra. Thennarasu S Biopolymers. 1997 May;41(6):635-45.'], 'hemolysis': u'Conc. Required for hemolysis =7.1nmols', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3797']}, u'DSHAKRHHGYKIKFHEKHHSLRGY': {'modifications': ['C-Terminal'], 'references': [u'In vitro assessment of antifungal therapeutic potential of salivary histatin-5, two variants of histatin-5, and salivary mucin (MUC7) domain 1. Situ H Antimicrob Agents Chemother. 2000 Jun;44(6):1485-93.'], 'hemolysis': u'<10% hemolysis at 200\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2029']}, u'ILPWKWPLLPWRR': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship of indolicidin, a Trp-rich antibacterial peptide. Ando S,Mitsuyasu K,Soeda Y,Hidaka M,Ito Y,Matsubara K,Shindo M,Uchida Y J Pept Sci. 2010 Apr;16(4):171-7. doi: 10.1002/psc.1217.'], 'hemolysis': u'18% hemolysis at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1481']}, u'VOL1nalPVOL1nalP': {'modifications': ['Cyclic', u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'Therapeutic index of gramicidin S is strongly modulated by D-phenylalanine analogues at the beta-turn. Solanas C,de la Torre BG,Fernandez-Reyes M,Santiveri CM,Jimenez MA,Rivas L,Jimenez AI,Andreu D J Med Chem. 2009 Feb 12;52(3):664-74. doi: 10.1021/jm800886n.'], 'hemolysis': u'HC50=5.0(\xb10.1)\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1285']}, u'GCASRCKAKCAGRRCKGWASASFRGRCYCKCFRC': {'modifications': [], 'references': [u'Trypanocidal and leishmanicidal activities of different antimicrobial peptides (AMPs) isolated from aquatic animals. Lofgren SE,Miletti LC,Steindel M,Bachere E Exp Parasitol. 2008 Feb;118(2):197-202. Epub 2007 Aug 15.'], 'hemolysis': u'10% hemolysis 100 \xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1943']}, u'SELAGTIIDGASLTFEVLDKVLGELGKVSRK': {'modifications': [], 'references': [u'Correlations between differences in amino-terminal sequences and different hemolytic activity of sticholysins. Cilli EM,Pigossi FT,Crusca E Jr,Ros U,Martinez D,Lanio ME,Alvarez C Toxicon. 2007 Dec 15;50(8):1201-4. Epub 2007 Aug 3.'], 'hemolysis': u'Hemolytic activity expresssed as the initial rate (\u2206A/\u2206t, min- 1) i.e. at above 100 \xb5M activity is above 0.002 min-1', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1815']}, u'KWCFRVCYRGICYRRCR': {'modifications': ['C-Terminal'], 'references': [u'Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides. Yasin B,Pang M,Turner JS,Cho Y,Dinh NN,Waring AJ,Lehrer RI Eur J Clin Microbiol Infect Dis. 2000 Mar;19(3):187-94.'], 'hemolysis': u'66.5% hemolysis at 80\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2435']}, u'AibPAibAAibAQAibVAibGLAibPVAibAibEQ': {'modifications': [u'C-Terminal Non-Amidation: Phenol', u'N-Terminal Modification: Acetylation', 'Non-Natural'], 'references': [u'Proline at position 14 of alamethicin is essential for hemolytic activity, catecholamine secretion from chromaffin cells and enhanced metabolic activity in endothelial cells. Dathe M,Kaduk C,Tachikawa E, Melzig, M ,Melzig MF,Wenschuh H Biochim Biophys Acta. 1998 Mar 6;1370(1):175-83.'], 'hemolysis': u'EC50 =30\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3808']}, u'FVGAIAAALPHVISAIKNAL': {'modifications': ['C-Terminal'], 'references': [u'A family of kassinatuerin-2 related peptides from the skin secretion of the African hyperoliid frog, Kassina maculata. Wang L,Zhou M,McGrath S,Chen T,Gorman SP,Walker B Peptides. 2009 Aug;30(8):1428-33. doi: 10.1016/j.peptides.2009.04.021. Epub 2009 May 7.'], 'hemolysis': u'45-50% hemolysis at 120\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3486']}, u'GFLSILKKVLPKVNleAHMet(O)K': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Melectin MAPs: the influence of dendrimerization on antimicrobial and hemolytic activity. Niederhafner P,Bednarova L,Budesinsky M,Safarik M,Ehala S,Jezek J,Borovickova L,Fucik V,Cerovsky V Amino Acids. 2010 Nov;39(5):1553-61. doi: 10.1007/s00726-010-0626-z. Epub 2010 May 25.'], 'hemolysis': u'LC50  >200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1512']}, u'GFLGSLLKTGLKVGSNLL': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae). Ali, M ,Ali MF,Soto A,Knoop FC Biochim Biophys Acta. 2001 Nov 26;1550(1):81-9.'], 'hemolysis': u'HC50 >150\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3479']}, u'KLKLKLKLKLKLKLK': {'modifications': ['C-Terminal', u'N-Terminal Modification: Dansylation'], 'references': [u'Ideally amphipathic beta-sheeted peptides at interfaces: structure, orientation, affinities for lipids and hemolytic activity of (KL)(m)K peptides. Castano S,Desbat B Biochim Biophys Acta. 2000 Jan 15;1463(1):65-80.'], 'hemolysis': u'~90% hemolysis at 10\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2011']}, u'GFKLKGKAKISCLPNGQWSNFPPKCIRECAMVSS': {'modifications': [], 'references': [u'High therapeutic index of factor C Sushi peptides: potent antimicrobials against Pseudomonas aeruginosa. Yau YH,Ho B,Tan NS,Ng ML Antimicrob Agents Chemother. 2001 Oct;45(10):2820-5.'], 'hemolysis': u'0% hemolysis at 100 \xb5g/ml (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2132']}, u'KKlFKKILKYL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Improvement of the efficacy of linear undecapeptides against plant-pathogenic bacteria by incorporation of D-amino acids. Guell I,Cabrefiga J,Badosa E,Ferre R,Talleda M,Bardaji E,Planas M,Feliu L Appl Environ Microbiol. 2011 Apr;77(8):2667-75. doi: 10.1128/AEM.02759-10. Epub 2011 Feb 18.'], 'hemolysis': u'7\xb10.4% hemolytic at 250\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2854']}, u'FVPWFSKFLGRiL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'The effect of d-amino acid substitution on the selectivity of temporin L towards target cells: identification of a potent anti-Candida peptide. Grieco P,Carotenuto A,Auriemma L,Saviello MR,Campiglia P,Gomez-Monterrey IM,Marcellini L,Luca V,Barra D,Novellino E Biochim Biophys Acta. 2013 Feb;1828(2):652-60. doi: 10.1016/j.bbamem.2012.08.027. Epub 2012 Sep 10.'], 'hemolysis': u'2% hemolysis at 1.5\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3229']}, u'LLKLLKWLLKLLK': {'modifications': ['C-Terminal'], 'references': [u'De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface. Kang SJ,Won HS,Choi WS J Pept Sci. 2009 Sep;15(9):583-8. doi: 10.1002/psc.1149.'], 'hemolysis': u'4.44% hemolysis at 6.3\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1441']}, u'AKKKGKCKGPLKLVAKC': {'modifications': ['C-Terminal', 'Cyclic'], 'references': [u'Lasiocepsin, a novel cyclic antimicrobial peptide from the venom of eusocial bee Lasioglossum laticeps (Hymenoptera: Halictidae). Monincova L,Slaninova J,Fucik V,Hovorka O,Voburka Z,Bednarova L,Malon P,Stokrova J Amino Acids. 2012 Aug;43(2):751-61. doi: 10.1007/s00726-011-1125-6. Epub 2011 Oct 29.'], 'hemolysis': u'<1% hemolytic at 200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2744']}, u'KLalKLALKALKAALKLA': {'modifications': [u'Stereochemistry: Mix'], 'references': [u'Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes. Dathe M,Schumann M,Wieprecht T,Winkler A,Beyermann M,Krause E,Matsuzaki K,Murase O Biochemistry. 1996 Sep 24;35(38):12612-22.'], 'hemolysis': u'EC50 = 33\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3459']}, u'RRWPLKPKKWPLI': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship of indolicidin, a Trp-rich antibacterial peptide. Ando S,Mitsuyasu K,Soeda Y,Hidaka M,Ito Y,Matsubara K,Shindo M,Uchida Y J Pept Sci. 2010 Apr;16(4):171-7. doi: 10.1002/psc.1217.'], 'hemolysis': u'7% hemolysis at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1493']}, u'GIIKKIIKKI': {'modifications': ['C-Terminal'], 'references': [u'Designed antimicrobial and antitumor peptides with high selectivity. Hu J,Chen C,Zhang S,Zhao X,Xu H,Zhao X Biomacromolecules. 2011 Nov 14;12(11):3839-43. doi: 10.1021/bm201098j. Epub 2011 Oct 3.'], 'hemolysis': u'Non-hemolytic up to 250 \u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2965']}, u'KWKSFIKKLTSKFLHLAKKF': {'modifications': ['C-Terminal'], 'references': [u'The Design and Construction of K11: A Novel ?-Helical Antimicrobial Peptide. Jin-Jiang H,Jin-Chun L,Min L,Qing-Shan H Int J Microbiol. 2012;2012:764834. doi: 10.1155/2012/764834. Epub 2012 Feb 16.'], 'hemolysis': u'MHC = 250 \u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2717']}, u'IWRIFRRIF': {'modifications': ['C-Terminal'], 'references': [u'Biochemical property and membrane-peptide interactions of de novo antimicrobial peptides designed by helix-forming units. Ma QQ,Dong N,Shan AS,Lv YF,Li YZ,Chen ZH,Cheng BJ Amino Acids. 2012 Dec;43(6):2527-36. doi: 10.1007/s00726-012-1334-7. Epub 2012 Jun 15.'], 'hemolysis': u'MHC = 101.4\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4190']}, u'EWESFLETFESAKETVLHTALEAISS': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Effects of net charge and the number of positively charged residues on the biological activity of amphipathic alpha-helical cationic antimicrobial peptides. Jiang Z,Vasil AI,Hale JD,Hancock RE,Vasil ML Biopolymers. 2008;90(3):369-83.'], 'hemolysis': u'MHC  >1000.0\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1137']}, u'GLKKIFKAGLGSLVKGIK*AHVAS': {'modifications': ['Non-Natural'], 'references': [u'Potent and rapid bactericidal action of alyteserin-1c and its [E4K] analog against multidrug-resistant strains of Acinetobacter baumannii. Conlon JM,Ahmed E,Pal T Peptides. 2010 Oct;31(10):1806-10. doi: 10.1016/j.peptides.2010.06.032. Epub 2010 Jul 11.'], 'hemolysis': u'LC50 =30\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3085']}, u'RGLRRLGRKIAHGVKKY': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity analysis of SMAP-29, a sheep leukocytes-derived antimicrobial peptide. Shin SY,Park EJ,Yang ST,Jung HJ,Eom SH,Song WK,Kim Y,Hahm KS Biochem Biophys Res Commun. 2001 Jul 27;285(4):1046-51.'], 'hemolysis': u'0% hemolysis at 100\u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1049']}, u'GLKkIFKAGLGSLVKGIKAHVAS': {'modifications': [u'Stereochemistry: Mix'], 'references': [u'Potent and rapid bactericidal action of alyteserin-1c and its [E4K] analog against multidrug-resistant strains of Acinetobacter baumannii. Conlon JM,Ahmed E,Pal T Peptides. 2010 Oct;31(10):1806-10. doi: 10.1016/j.peptides.2010.06.032. Epub 2010 Jul 11.'], 'hemolysis': u'LC50 >400\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3083']}, u'GIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK': {'modifications': [], 'references': [u'Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. Harder J,Bartels J,Christophers E J Biol Chem. 2001 Feb 23;276(8):5707-13. Epub 2000 Nov 20.'], 'hemolysis': u'<0.5% hemolysis upto 500\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3408']}, u'VOLflgPVOLflgP': {'modifications': ['Cyclic', u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'Therapeutic index of gramicidin S is strongly modulated by D-phenylalanine analogues at the beta-turn. Solanas C,de la Torre BG,Fernandez-Reyes M,Santiveri CM,Jimenez MA,Rivas L,Jimenez AI,Andreu D J Med Chem. 2009 Feb 12;52(3):664-74. doi: 10.1021/jm800886n.'], 'hemolysis': u'HC50=6.2(\xb10.3)\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1288']}, u'LDPKVVQSLL': {'modifications': ['C-Terminal'], 'references': [u'Venom peptides from solitary hunting wasps induce feeding disorder in lepidopteran larvae. Baek JH,Ji Y,Shin JS,Lee S Peptides. 2011 Mar;32(3):568-72. doi: 10.1016/j.peptides.2010.12.007. Epub 2010 Dec 22.'], 'hemolysis': u'Non-hemolytic', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2058']}, u'GIGKFLHKVKSFGKSWIGEIMNS': {'modifications': ['C-Terminal'], 'references': [u'Influence of the angle subtended by the positively charged helix face on the membrane activity of amphipathic, antibacterial peptides. Wieprecht T,Dathe M,Epand RM,Beyermann M,Krause E,Maloy WL,MacDonald DL Biochemistry. 1997 Oct 21;36(42):12869-80.'], 'hemolysis': u'EC25=20\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3588']}, u'VCYCRRRFCVCVGR': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'>50% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1198']}, u'I/LNWLKLGKAIIDAI/L': {'modifications': ['C-Terminal'], 'references': [u'Structural characterization of novel chemotactic and mastoparan peptides from the venom of the social wasp Agelaiapallipes pallipes by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry. Mendes MA,Monson de Souza B,Delazari dos Santos L Rapid Commun Mass Spectrom. 2004;18(6):636-42.'], 'hemolysis': u'75% hemolysis at 1 x10-6 M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1595']}, u'THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK': {'modifications': [u'Stereochemistry: Mix'], 'references': [u'Immunogenicity and toxicity of transferrin receptor-targeted hybrid peptide as a potent anticancer agent. Kawamoto M,Kohno M,Horibe T Cancer Chemother Pharmacol. 2013 Mar;71(3):799-807. doi: 10.1007/s00280-013-2074-4. Epub 2013 Jan 18.'], 'hemolysis': u'17% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3252']}, u'KKWlKLKlKlKK': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Structure and organization of hemolytic and nonhemolytic diastereomers of antimicrobial peptides in membranes. Hong J,Oren Z Biochemistry. 1999 Dec 21;38(51):16963-73.'], 'hemolysis': u'0% hemolysis at 50\u03bcM (Non hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3764']}, u'AARRAARRAARR': {'modifications': ['C-Terminal'], 'references': [u'Synthetic cationic amphiphilic ?-helical peptides as antimicrobial agents. Wiradharma N,Khoe U,Hauser CA,Seow SV,Zhang S Biomaterials. 2011 Mar;32(8):2204-12. doi: 10.1016/j.biomaterials.2010.11.054. Epub 2010 Dec 18.'], 'hemolysis': u'HC50 > 500', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2049']}, u'KWKSFIKKSTSKFLHSAKKF': {'modifications': ['C-Terminal'], 'references': [u'The Design and Construction of K11: A Novel ?-Helical Antimicrobial Peptide. Jin-Jiang H,Jin-Chun L,Min L,Qing-Shan H Int J Microbiol. 2012;2012:764834. doi: 10.1155/2012/764834. Epub 2012 Feb 16.'], 'hemolysis': u'MHC  >500\u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2721']}, u'LCYCHHHFCVCV': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'6-12% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1214']}, u'GLMDTVKNAAKNLAGQLLDTIKCKMTGC': {'modifications': [], 'references': [u'Antimicrobial peptides and protease inhibitors in the skin secretions of the crawfish frog, Rana areolata. Ali, Mohamed ,Ali MF,Lips KR,Knoop FC,Fritzsch B,Miller C Biochim Biophys Acta. 2002 Nov 19;1601(1):55-63.'], 'hemolysis': u'HC50 = 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2480']}, u'KLTicOicGKTicOicGFTicOicGKTicKKKK': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'De novo design of selective antibiotic peptides by incorporation of unnatural amino acids. Hicks RP,Bhonsle JB,Venugopal D,Koser BW J Med Chem. 2007 Jun 28;50(13):3026-36. Epub 2007 Jun 5.'], 'hemolysis': u'24.9% hemolysis at 25\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1764']}, u'VVCACRRALCLPLERRAGFCRIRGRIHPLCCRR': {'modifications': [], 'references': [u'Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides. Yasin B,Pang M,Turner JS,Cho Y,Dinh NN,Waring AJ,Lehrer RI Eur J Clin Microbiol Infect Dis. 2000 Mar;19(3):187-94.'], 'hemolysis': u'1.9% hemolysis at 80\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2434']}, u'SWASMAKKLKEYMEKLKQRA': {'modifications': ['C-Terminal'], 'references': [u'Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity. Kozlov SA,Vassilevski AA,Feofanov AV,Surovoy AY,Karpunin DV J Biol Chem. 2006 Jul 28;281(30):20983-92. Epub 2006 May 30.'], 'hemolysis': u'20% hemolysis at >120\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4054']}, u'PKLlETFlSKWIG': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Biological activities of retro and diastereo analogs of a 13-residue peptide with antimicrobial and hemolytic activities. Subbalakshmi C,Nagaraj R J Pept Res. 2001 Jan;57(1):59-67.'], 'hemolysis': u'~40 % hemolysis at 60 \xb5g/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2099']}, u'VKLKVyPLKVKLyP': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Effects of single D-amino acid substitutions on disruption of beta-sheet structure and hydrophobicity in cyclic 14-residue antimicrobial peptide analogs related to gramicidin S. Lee DL,Powers JP,Pflegerl K,Vasil ML,Hancock RE J Pept Res. 2004 Feb;63(2):69-84.'], 'hemolysis': u'MHC =2 \xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4160']}, u'VSAVAKVAMKKGAALLKKMGVKISPLK': {'modifications': [], 'references': [u'Lytic activity and structural differences of amphipathic peptides derived from trialysin. Martins RM,Sforca ML,Amino R,Juliano MA,Oyama S Jr,Juliano L,Pertinhez TA,Spisni A Biochemistry. 2006 Feb 14;45(6):1765-74.'], 'hemolysis': u'50% hemolysis at >900\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1668']}, u'WKSYVRRWRSRY': {'modifications': [], 'references': [u'Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide. Wu YS,Liao ZJ,Wang KS Bioorg Med Chem Lett. 2013 May 15;23(10):2929-32. doi: 10.1016/j.bmcl.2013.03.053. Epub 2013 Mar 25.'], 'hemolysis': u'1.5 \xb11.4%hemolytic at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2578']}, u'SSLLEKGLDGAKKAVGGLGKLGKDAVEDL': {'modifications': [], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC >100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3964']}, u'KWKSFLKTFKSLKKTVLHTLLKLISS': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides. Chen Y,Guarnieri MT,Vasil AI,Vasil ML,Mant CT Antimicrob Agents Chemother. 2007 Apr;51(4):1398-406. Epub 2006 Dec 11.'], 'hemolysis': u'MHC =4\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1090']}, u'GMASKAGSIVGKIKIALGAL': {'modifications': [], 'references': [u'Antimicrobial peptides with therapeutic potential from skin secretions of the Marsabit clawed frog Xenopus borealis (Pipidae). Mechkarska M,Ahmed E,Coquet L,Leprince J,Jouenne T,Vaudry H,King JD Comp Biochem Physiol C Toxicol Pharmacol. 2010 Nov;152(4):467-72. doi: 10.1016/j.cbpc.2010.07.007. Epub 2010 Jul 23.'], 'hemolysis': u'27% hemolysis at 200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3777']}, u'KFKLKQ': {'modifications': ['Cyclic'], 'references': [u'De novo designed cyclic cationic peptides as inhibitors of plant pathogenic bacteria. Monroc S,Badosa E,Feliu L,Planas M,Montesinos E Peptides. 2006 Nov;27(11):2567-74. Epub 2006 May 30.'], 'hemolysis': u'11\xb14.6% hemolysis at 360\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1684']}, u'KGFFALIPKIISSPLFKTLLSAV': {'modifications': [u'C-Terminal Non-Amidation: [NH(CH2)2NH2]2'], 'references': [u'A class of highly potent antibacterial peptides derived from pardaxin, a pore-forming peptide isolated from Moses sole fish Pardachirus marmoratus. Oren Z Eur J Biochem. 1996 Apr 1;237(1):303-10.'], 'hemolysis': u'No hemolysis (Non hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3678']}, u'KFKQ': {'modifications': ['Cyclic'], 'references': [u'De novo designed cyclic cationic peptides as inhibitors of plant pathogenic bacteria. Monroc S,Badosa E,Feliu L,Planas M,Montesinos E Peptides. 2006 Nov;27(11):2567-74. Epub 2006 May 30.'], 'hemolysis': u'0% hemolysis at 360\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1906']}, u'KRAKKFFKKPK': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial and antibiofilm activity of cathelicidins and short, synthetic peptides against Francisella. Amer LS,Bishop BM Biochem Biophys Res Commun. 2010 May 28;396(2):246-51. doi: 10.1016/j.bbrc.2010.04.073. Epub 2010 Apr 23.'], 'hemolysis': u'EC50 =107\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3063']}, u'AWKVFKRLGIGAVLWVLTWG': {'modifications': [], 'references': [u'Design of novel analogues with potent antibiotic activity based on the antimicrobial peptide, HP(2-9)-ME(1-12). Park Y,Kim HN,Park SN,Jang SH,Choi CH,Lim HT Biotechnol Lett. 2004 Mar;26(6):493-8.'], 'hemolysis': u'0% hemolysis at 0.78\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4183']}, u'VKLKVyPLKVKLyp': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Dissociation of antimicrobial and hemolytic activities in cyclic peptide diastereomers by systematic alterations in amphipathicity. Kondejewski LH,Jelokhani-Niaraki M,Farmer SW,Lix B,Kay CM,Sykes BD,Hancock RE J Biol Chem. 1999 May 7;274(19):13181-92.'], 'hemolysis': u'100% hemolytic at 6.2 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2555']}, u'GLFDIIKKIAESFKFSEAIKKIIDFLG': {'modifications': [], 'references': [u'Dimerization of aurein 1.2: effects in structure, antimicrobial activity and aggregation of C\xe2ndida albicans cells. Lorenzon EN,Sanches PR,Nogueira LG,Bauab TM Amino Acids. 2013 Jun;44(6):1521-8. doi: 10.1007/s00726-013-1475-3. Epub 2013 Mar 22.'], 'hemolysis': u'10% hemolytic at 4\u03bcmol/L', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2591']}, u'IIKVPLKKFKSMREVMRDHGIKAPVVDPATKY': {'modifications': [], 'references': [u'Antimicrobial peptides derived from pepsinogens in the stomach of the bullfrog, Rana catesbeiana. Minn I,Kim HS Biochim Biophys Acta. 1998 Jul 1;1407(1):31-9.'], 'hemolysis': u'0.36% hemolysis at 200\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3810']}, u'LALILRKIVTAL': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial and hemolytic activities of crabrolin, a 13-residue peptide from the venom of the European hornet, Vespa crabro, and its analogs. Krishnakumari V J Pept Res. 1997 Aug;50(2):88-93.'], 'hemolysis': u'~90% hemolysis at 80\u03bcg', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3379']}, u'GFFGKRKEYFKKFGASFKRRFANLKKRL': {'modifications': ['C-Terminal'], 'references': [u'N-terminal amphipathic helix as a trigger of hemolytic activity in antimicrobial peptides: a case study in latarcins. Polyansky AA,Vassilevski AA,Volynsky PE,Vorontsova OV,Samsonova OV,Egorova NS,Krylov NA,Feofanov AV,Arseniev AS,Grishin EV FEBS Lett. 2009 Jul 21;583(14):2425-8. doi: 10.1016/j.febslet.2009.06.044. Epub 2009 Jun 27.'], 'hemolysis': u'EC50 >36\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1448']}, u'kklallalkkwllalkklallalkk': {'modifications': ['C-Terminal', u'Stereochemistry: D'], 'references': [u'Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic ?-helical peptides. Vermeer LS,Lan Y,Abbate V,Ruh E,Bui TT,Wilkinson LJ,Kanno T,Jumagulova E,Kozlowska J,Patel J,McIntyre CA,Yam WC,Siu G,Atkinson RA,Lam JK,Bansal SS, Drake, Alex ,Drake AF,Mitchell GH J Biol Chem. 2012 Oct 5;287(41):34120-33. doi: 10.1074/jbc.M112.359067. Epub 2012 Aug 6.'], 'hemolysis': u'HC50 = 4.06\xb11.30\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2624']}, u'RGGGLCYCRRRFCVCVGR': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'>50% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1164']}, u'KLLLKLLLK': {'modifications': ['C-Terminal', u'N-Terminal Modification: Dansylation'], 'references': [u'The amphipathic helix concept: length effects on ideally amphipathic LiKj(i=2j) peptides to acquire optimal hemolytic activity. Castano S,Cornut I,Buttner K,Dasseux JL Biochim Biophys Acta. 1999 Jan 12;1416(1-2):161-75.'], 'hemolysis': u'LD50 =2.5 \u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3827']}, u'YGAAKKAAKAAKKAAKAA': {'modifications': [u'N-Terminal Modification: Conjugated with lauric acid'], 'references': [u'Promotion of peptide antimicrobial activity by fatty acid conjugation. Chu-Kung, Alexander ,Chu-Kung AF,Bozzelli KN,Lockwood NA,Haseman JR,Mayo KH Bioconjug Chem. 2004 May-Jun;15(3):530-5.'], 'hemolysis': u'<15% hemolysis at 500\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1022']}, u'FVKLKKILNIILSIFKK': {'modifications': [], 'references': [u'Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEa. Yang QZ,Wang C,Lang L,Zhou Y,Wang H Arch Pharm Res. 2013 Apr 23.'], 'hemolysis': u'LC50 =28.34\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2576']}, u'RLCYTRGRFTVCVR': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'12-25% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1213']}, u'FLPLLAGLCAcmKITRKCAcmAANFLPKIF': {'modifications': ['Non-Natural'], 'references': [u'Structure-function studies on the amphibian peptide brevinin 1E: translocating the cationic segment from the C-terminal end to a central position favors selective antibacterial activity. Kumari VK J Pept Res. 2001 Nov;58(5):433-41.'], 'hemolysis': u'Non-hemolytic', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2150']}, u'GFISTVKNLATNVAGTVIDTIKCKVTGGC': {'modifications': [], 'references': [u'Antimicrobial peptides and protease inhibitors in the skin secretions of the crawfish frog, Rana areolata. Ali, Mohamed ,Ali MF,Lips KR,Knoop FC,Fritzsch B,Miller C Biochim Biophys Acta. 2002 Nov 19;1601(1):55-63.'], 'hemolysis': u'HC50 > 300\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2482']}, u'LKLKSIVSWALLVL': {'modifications': ['C-Terminal'], 'references': [u'Structural requirements for the edema-inducing and hemolytic activities of mastoparan B isolated from the hornet (Vespa basalis) venom. Ho CL,Lin YL,Chen WC,Hwang LL,Yu HM Toxicon. 1996 Sep;34(9):1027-35.'], 'hemolysis': u'~55% hemolysis at 20\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3516']}, u'VRRFKWWWKFLRR': {'modifications': ['C-Terminal'], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC >5\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3969']}, u'RWRW': {'modifications': ['C-Terminal'], 'references': [u'Length effects in antimicrobial peptides of the (RW)n series. Liu Z,Brady A,Young A,Rasimick B,Chen K,Zhou C Antimicrob Agents Chemother. 2007 Feb;51(2):597-603. Epub 2006 Dec 4.'], 'hemolysis': u'HD50  =3.7x103\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1078']}, u'TLLKKVLKAAAKAALNAVLVGANA': {'modifications': [], 'references': [u'Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity. Feder R,Dagan A J Biol Chem. 2000 Feb 11;275(6):4230-8.'], 'hemolysis': u'LC50 =16.5\xb10.5\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1012']}, u'SNWLKLGKKMMSAL': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 >>100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3918']}, u'GCRFCCNCCPNMSGCGVCCRF': {'modifications': [], 'references': [u'Bass hepcidin synthesis, solution structure, antimicrobial activities and synergism, and in vivo hepatic response to bacterial infections. Lauth X,Babon JJ,Stannard JA,Singh S,Nizet V,Carlberg JM,Ostland VE,Pennington MW,Norton RS J Biol Chem. 2005 Mar 11;280(10):9272-82. Epub 2004 Nov 16.'], 'hemolysis': u'0% hemolysis at 100 \xb5g/ml (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2389']}, u'KKLKKLKKKWKKLKKKLK': {'modifications': [], 'references': [u'Design and synthesis of amphiphilic alpha-helical model peptides with systematically varied hydrophobic-hydrophilic balance and their interaction with lipid- and bio-membranes. Kiyota T,Lee S Biochemistry. 1996 Oct 8;35(40):13196-204.'], 'hemolysis': u'0% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3467']}, u'KKVVFKVKFK': {'modifications': ['C-Terminal'], 'references': [u'Identification and characterization of novel antimicrobial decapeptides generated by combinatorial chemistry. Hong SY,Oh JE,Kwon M,Choi MJ,Lee JH,Lee BL,Moon HM Antimicrob Agents Chemother. 1998 Oct;42(10):2534-41.'], 'hemolysis': u'0% hemolysis at 500\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3813']}, u'FLPIIAGAAAKVVQKIFCAISKKC': {'modifications': [], 'references': [u'Primary structures of skin antimicrobial peptides indicate a close, but not conspecific, phylogenetic relationship between the leopard frogs Lithobates onca and Lithobates yavapaiensis (Ranidae). Conlon JM,Coquet L,Leprince J,Jouenne T,Vaudry H Comp Biochem Physiol C Toxicol Pharmacol. 2010 Apr;151(3):313-7. doi: 10.1016/j.cbpc.2009.12.004. Epub 2009 Dec 31.'], 'hemolysis': u'LD50 =10\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1071']}, u'VNSKKISGKSIKVSK': {'modifications': ['C-Terminal'], 'references': [u'Effect of hydrocarbon stapling on the properties of ?-helical antimicrobial peptides isolated from the venom of hymenoptera. Chapuis H,Slaninova J,Bednarova L,Monincova L,Budesinsky M Amino Acids. 2012 Nov;43(5):2047-58. doi: 10.1007/s00726-012-1283-1. Epub 2012 Apr 17.'], 'hemolysis': u'LC50  >100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2759']}, u'KKKKKKAAFALWAAFAA': {'modifications': ['C-Terminal', 'Cyclic'], 'references': [u'Membrane interactions of designed cationic antimicrobial peptides: the two thresholds. Glukhov E,Burrows LL Biopolymers. 2008 May;89(5):360-71. doi: 10.1002/bip.20917.'], 'hemolysis': u'MHC =81\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1147']}, u'VKLYyYPLKVKLyP': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Effects of single D-amino acid substitutions on disruption of beta-sheet structure and hydrophobicity in cyclic 14-residue antimicrobial peptide analogs related to gramicidin S. Lee DL,Powers JP,Pflegerl K,Vasil ML,Hancock RE J Pept Res. 2004 Feb;63(2):69-84.'], 'hemolysis': u'MHC =8 \xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4163']}, u'FFGWLIKGAIHAGKAIHGLIHRRRH': {'modifications': ['C-Terminal'], 'references': [u'Purification and characterization of three isoforms of chrysophsin, a novel antimicrobial peptide in the gills of the red sea bream, Chrysophrys major. Iijima N,Tanimoto N,Emoto Y,Morita Y,Uematsu K,Murakami T Eur J Biochem. 2003 Feb;270(4):675-86.'], 'hemolysis': u'100% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3544']}, u'GFREKHFQRFVKYAVPESTLRTVLQTVVHKVGKTQFGCPAYQGYCDDHCQDIEKKEGFCHGFKCKCGIPMGF': {'modifications': [], 'references': [u'MeuTXKbeta1, a scorpion venom-derived two-domain potassium channel toxin-like peptide with cytolytic activity. Zhu S,Gao B,Aumelas A,del Carmen Rodriguez M,Lanz-Mendoza H,Peigneur S,Diego-Garcia E,Martin-Eauclaire MF,Tytgat J Biochim Biophys Acta. 2010 Apr;1804(4):872-83. doi: 10.1016/j.bbapap.2009.12.017. Epub 2010 Jan 4.'], 'hemolysis': u'14.8% hemolysis at 20\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3713']}, u'KWKKLLKKLLKLLKKLLKKLKKLLK': {'modifications': ['C-Terminal'], 'references': [u'Contribution of a central proline in model amphipathic alpha-helical peptides to self-association, interaction with phospholipids, and antimicrobial mode of action. Yang ST,Lee JY,Kim HJ,Eu YJ,Shin SY,Hahm KS FEBS J. 2006 Sep;273(17):4040-54. Epub 2006 Aug 2.'], 'hemolysis': u'75% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1703']}, u'FFPLALLCKVFKKC': {'modifications': [], 'references': [u'Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii. Jin LL,Li Q,Song SS,Feng K,Zhang DB,Wang QY Comp Biochem Physiol B Biochem Mol Biol. 2009 Oct;154(2):174-8. doi: 10.1016/j.cbpb.2009.05.015. Epub 2009 Jun 17.'], 'hemolysis': u'HC50 >300\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3491']}, u'cklllkwllkllkc': {'modifications': ['Cyclic', u'Stereochemistry: D'], 'references': [u'Cyclization of a cytolytic amphipathic alpha-helical peptide and its diastereomer: effect on structure, interaction with model membranes, and biological function. Oren Z Biochemistry. 2000 May 23;39(20):6103-14.'], 'hemolysis': u'90% hemolytic at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2534']}, u'GILKTIKSIASKLKRKAK': {'modifications': [], 'references': [u'Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin. Sanchez-Vasquez L,Silva-Sanchez J,Jimenez-Vargas JM,Rodriguez-Romero A,Munoz-Garay C,Rodriguez MC,Gurrola GB Biochim Biophys Acta. 2013 Jun;1830(6):3427-36. doi: 10.1016/j.bbagen.2013.01.028. Epub 2013 Feb 9.'], 'hemolysis': u'EC50 =80\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3255']}, u'VKLNVyPLKVKLyP': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Effects of single D-amino acid substitutions on disruption of beta-sheet structure and hydrophobicity in cyclic 14-residue antimicrobial peptide analogs related to gramicidin S. Lee DL,Powers JP,Pflegerl K,Vasil ML,Hancock RE J Pept Res. 2004 Feb;63(2):69-84.'], 'hemolysis': u'MHC =3 \xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4165']}, u'LNLNSIVSWAKKVL': {'modifications': ['C-Terminal'], 'references': [u'Structural requirements for the edema-inducing and hemolytic activities of mastoparan B isolated from the hornet (Vespa basalis) venom. Ho CL,Lin YL,Chen WC,Hwang LL,Yu HM Toxicon. 1996 Sep;34(9):1027-35.'], 'hemolysis': u'~3% hemolysis at 20\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3506']}, u'DVNDLKNLCAKTHNLLPMCAMF': {'modifications': ['C-Terminal'], 'references': [u"Cloning and expression of genes enocoding antimicrobial peptides and bradykinin from the skin and brain of Oki Tago's brown frog, Rana tagoi okiensis. Tazato S,Conlon JM Peptides. 2010 Aug;31(8):1480-7. doi: 10.1016/j.peptides.2010.04.031. Epub 2010 May 10."], 'hemolysis': u'no hemolysis upto <400\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3068']}, u'VRRFAWWWPFLRR': {'modifications': ['C-Terminal'], 'references': [u'Structure-function analysis of tritrpticin analogs: potential relationships between antimicrobial activities, model membrane interactions, and their micelle-bound NMR structures. Schibli DJ,Nguyen LT,Kernaghan SD,Rekdal O Biophys J. 2006 Dec 15;91(12):4413-26. Epub 2006 Sep 22.'], 'hemolysis': u'EC50 >1000\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1717']}, u'MLSVSDAVQLMLGFGTFVLMLLGLVVELIKNSNKK': {'modifications': [], 'references': [u'Functional characterization of a new holin-like antibacterial protein coding gene tmp1 from goat skin surface metagenome. Rajesh T,Anthony T,Saranya S,Pushpam PL Appl Microbiol Biotechnol. 2011 Feb;89(4):1061-73. doi: 10.1007/s00253-010-2907-6. Epub 2010 Oct 7.'], 'hemolysis': u'0% hemolysis at 50\u03bcM  (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1542']}, u'LLKKLLKWLKK': {'modifications': ['C-Terminal'], 'references': [u'Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities. Kim SJ,Kim JS,Lee YS,Sim DW,Lee SH,Bahk YY,Lee KH,Kim EH,Park SJ,Lee BJ Molecules. 2013 Jan 11;18(1):859-76. doi: 10.3390/molecules18010859.'], 'hemolysis': u'MHC = 128\u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2599']}, u'fPAdaGOAdaAfPAdaGOAdaA': {'modifications': ['Cyclic', u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'An adamantyl amino acid containing gramicidin S analogue with broad spectrum antibacterial activity and reduced hemolytic activity. Kapoerchan VV,Knijnenburg AD,Niamat M,Spalburg E,de Neeling AJ,Nibbering PH,Mars-Groenendijk RH,Noort D,Otero JM,Llamas-Saiz AL,van Raaij MJ,van der Marel GA,Overkleeft HS Chemistry. 2010 Oct 25;16(40):12174-81. doi: 10.1002/chem.201001686.'], 'hemolysis': u'HC50 =7.55\xb11.10\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2795']}, u'kklfkkilkYL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Improvement of the efficacy of linear undecapeptides against plant-pathogenic bacteria by incorporation of D-amino acids. Guell I,Cabrefiga J,Badosa E,Ferre R,Talleda M,Bardaji E,Planas M,Feliu L Appl Environ Microbiol. 2011 Apr;77(8):2667-75. doi: 10.1128/AEM.02759-10. Epub 2011 Feb 18.'], 'hemolysis': u'21\xb17.4% hemolytic at 250\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2876']}, u'GLFGKLQKKFGRKAISYAVKKARGKH': {'modifications': [], 'references': [u'N-terminal amphipathic helix as a trigger of hemolytic activity in antimicrobial peptides: a case study in latarcins. Polyansky AA,Vassilevski AA,Volynsky PE,Vorontsova OV,Samsonova OV,Egorova NS,Krylov NA,Feofanov AV,Arseniev AS,Grishin EV FEBS Lett. 2009 Jul 21;583(14):2425-8. doi: 10.1016/j.febslet.2009.06.044. Epub 2009 Jun 27.'], 'hemolysis': u'EC50 >36\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1443']}, u'GSKKPVPIIYCNRRAATGKCQRM': {'modifications': [], 'references': [u'Role of amino acid residues within the disulfide loop of thanatin, a potent antibiotic peptide. Lee MK,Cha L,Lee SH J Biochem Mol Biol. 2002 May 31;35(3):291-6.'], 'hemolysis': u'0% hemolysis at 20.8\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2218']}, u'KAYSMPRCKGGFRAVMCWL': {'modifications': ['C-Terminal'], 'references': [u'Three novel antimicrobial peptides from the skin of Rana shuchinae. Pei J,Zhao G,Wang B Gene. 2013 Jun 1;521(2):234-7. doi: 10.1016/j.gene.2013.03.054. Epub 2013 Apr 2.'], 'hemolysis': u'1.7% hemolysis at 200\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3747']}, u'KWAKKWKWFAKAAWKWYKK': {'modifications': ['C-Terminal'], 'references': [u'Design of a novel tryptophan-rich membrane-active antimicrobial peptide from the membrane-proximal region of the HIV glycoprotein, gp41. Haney, Evan ,Haney EF,Nguyen LT,Schibli DJ Beilstein J Org Chem. 2012;8:1172-84. Epub 2012 Jul 24.'], 'hemolysis': u'EC50 = 42\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2618']}, u'KWKKLLKKPLLKK': {'modifications': ['C-Terminal'], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC >100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3956']}, u'GLVDVLGKVGGLIKKLLP': {'modifications': ['C-Terminal'], 'references': [u'Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii. Orivel J,Redeker V,Le Caer JP, Krier, ,Krier F,Revol-Junelles AM,Longeon A,Chaffotte A,Dejean A J Biol Chem. 2001 May 25;276(21):17823-9. Epub 2001 Feb 22.'], 'hemolysis': u'zone of inhibition not detected at 0.4-0.5mM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2128']}, u'KLALKLALkaLKAALKLA': {'modifications': [u'Stereochemistry: Mix'], 'references': [u'Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes. Dathe M,Schumann M,Wieprecht T,Winkler A,Beyermann M,Krause E,Matsuzaki K,Murase O Biochemistry. 1996 Sep 24;35(38):12612-22.'], 'hemolysis': u'EC50 = 56\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3462']}, u'HFLGTLVNLAKKIL': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial peptides from the skin secretions of the New World frogs Lithobates capito and Lithobates warszewitschii (Ranidae). Conlon JM,Meetani MA,Coquet L,Jouenne T,Leprince J,Vaudry H,Kolodziejek J,Nowotny N Peptides. 2009 Oct;30(10):1775-81. doi: 10.1016/j.peptides.2009.07.011. Epub 2009 Jul 25.'], 'hemolysis': u'LC50 =65\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4147']}, u'GKVWDWIKSAAKKIWSSEPVSQLKGQVLNAAKNYVAEKIGATPT': {'modifications': [], 'references': [u'Characterization of unique amphipathic antimicrobial peptides from venom of the scorpion Pandinus imperator. Corzo G,Escoubas P,Villegas E,Barnham KJ,He W,Norton RS Biochem J. 2001 Oct 1;359(Pt 1):35-45.'], 'hemolysis': u'0.2\xb10.1% hemolysis at 2.7\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3553']}, u'KWKSFIKKLTSKFLHSKKKF': {'modifications': ['C-Terminal'], 'references': [u'The Design and Construction of K11: A Novel ?-Helical Antimicrobial Peptide. Jin-Jiang H,Jin-Chun L,Min L,Qing-Shan H Int J Microbiol. 2012;2012:764834. doi: 10.1155/2012/764834. Epub 2012 Feb 16.'], 'hemolysis': u'MHC >500\u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2728']}, u'LLGDEFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES': {'modifications': ['C-Terminal'], 'references': [u'Anti-tuberculosis activity of ?-helical antimicrobial peptides: de novo designed L- and D-enantiomers versus L- and D-LL-37. Jiang Z,Higgins MP,Whitehurst J,Kisich KO,Voskuil MI Protein Pept Lett. 2011 Mar;18(3):241-52.'], 'hemolysis': u'HC50 = 43.5\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2805']}, u'KWKKFKKIGAVLKKL': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Lysine-enriched cecropin-mellitin antimicrobial peptides with enhanced selectivity. Sato H Antimicrob Agents Chemother. 2008 Dec;52(12):4463-5. doi: 10.1128/AAC.00810-08. Epub 2008 Oct 13.'], 'hemolysis': u'3% hemolysis at 64\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1263']}, u'AKKVFKRLEKLFSKIQNWK': {'modifications': [], 'references': [u'Design of novel analogue peptides with potent antibiotic activity based on the antimicrobial peptide, HP (2-20), derived from N-terminus of Helicobacter pylori ribosomal protein L1. Lee DG,Kim HN,Park Y,Kim HK,Choi BH,Choi CH Biochim Biophys Acta. 2002 Jul 29;1598(1-2):185-94.'], 'hemolysis': u'0% hemolysis at 100\u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2382']}, u'GEKLKKIGKKIKNFFQKL': {'modifications': [], 'references': [u'CRAMP analogues having potent antibiotic activity against bacterial, fungal, and tumor cells without hemolytic activity. Shin SY,Kang SW,Lee DG,Eom SH,Song WK Biochem Biophys Res Commun. 2000 Sep 7;275(3):904-9.'], 'hemolysis': u'0% hemolytic at 100\u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2517']}, u'FLPAIAGILSQLF': {'modifications': ['C-Terminal'], 'references': [u'Novel antimicrobial peptides from skin secretion of the European frog Rana esculenta. Simmaco M,Mignogna G,Barra D, Bossa FEBS Lett. 1993 Jun 14;324(2):159-61.'], 'hemolysis': u'LC50 ~20\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3686']}, u'KWllLLKlLlLK': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Structure and organization of hemolytic and nonhemolytic diastereomers of antimicrobial peptides in membranes. Hong J,Oren Z Biochemistry. 1999 Dec 21;38(51):16963-73.'], 'hemolysis': u'31% hemolysis at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3758']}, u'GWKKWFNRAKKVGKTVGGLAVDHYL': {'modifications': ['C-Terminal'], 'references': [u'The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents. Morash MG,Douglas SE,Robotham A,Ridley CM,Gallant JW Dis Model Mech. 2011 Sep;4(5):622-33. doi: 10.1242/dmm.007310. Epub 2011 Jul 4.'], 'hemolysis': u'50% hemolytic at >256 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2927']}, u'CSCKNKVCYRNGIPCGESCVWIPCISAALG': {'modifications': ['Cyclic'], 'references': [u'An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides. Tam JP,Lu YA,Yang JL Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):8913-8.'], 'hemolysis': u'50% hemolysis at >400\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3397']}, u'KAYSTPRCKGLFRALMCWL': {'modifications': ['C-Terminal'], 'references': [u'Three novel antimicrobial peptides from the skin of Rana shuchinae. Pei J,Zhao G,Wang B Gene. 2013 Jun 1;521(2):234-7. doi: 10.1016/j.gene.2013.03.054. Epub 2013 Apr 2.'], 'hemolysis': u'2.5% hemolysis at 200\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3748']}, u'KNWKGIAGMAKKLLGKNWKLM': {'modifications': ['C-Terminal'], 'references': [u'Design of a novel membrane-destabilizing peptide selectively acting on acidic liposomes. Machida S,Niimi S,Shi X,Ando Y Biosci Biotechnol Biochem. 2000 May;64(5):985-94.'], 'hemolysis': u'12.3% hemolytic at 10\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2531']}, u'FKRLKKLFSKIWNWK': {'modifications': [], 'references': [u'Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions. Park SC,Kim MH,Hossain MA,Shin SY,Kim Y,Stella L,Wade JD,Park Y Biochim Biophys Acta. 2008 Jan;1778(1):229-41. Epub 2007 Oct 2.'], 'hemolysis': u'9.65% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1825']}, u'KWKFKKIPKFLHLAKKF': {'modifications': ['C-Terminal'], 'references': [u'Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs. Shin SY,Lee SH,Yang ST,Park EJ,Lee DG,Lee MK,Eom SH,Song WK,Kim Y,Hahm KS J Pept Res. 2001 Dec;58(6):504-14.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2155']}, u'VKLKVyPLKVKlyP': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Dissociation of antimicrobial and hemolytic activities in cyclic peptide diastereomers by systematic alterations in amphipathicity. Kondejewski LH,Jelokhani-Niaraki M,Farmer SW,Lix B,Kay CM,Sykes BD,Hancock RE J Biol Chem. 1999 May 7;274(19):13181-92.'], 'hemolysis': u'100% hemolytic at 25 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2558']}, u'HFLKTLVNLAKKIL': {'modifications': ['C-Terminal'], 'references': [u'Strategies for transformation of naturally-occurring amphibian antimicrobial peptides into therapeutically valuable anti-infective agents. Conlon JM,Al-Ghaferi N,Abraham B Methods. 2007 Aug;42(4):349-57.'], 'hemolysis': u'LD50 = 42\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1795']}, u'VOLdipPVOLdipP': {'modifications': ['Cyclic', u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'Therapeutic index of gramicidin S is strongly modulated by D-phenylalanine analogues at the beta-turn. Solanas C,de la Torre BG,Fernandez-Reyes M,Santiveri CM,Jimenez MA,Rivas L,Jimenez AI,Andreu D J Med Chem. 2009 Feb 12;52(3):664-74. doi: 10.1021/jm800886n.'], 'hemolysis': u'HC50=8.6(\xb11.1)\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1287']}, u'IGDLVKWIIDTVNKFTKK': {'modifications': [], 'references': [u'Conformation and activity of delta-lysin and its analogs. Dhople VM Peptides. 2005 Feb;26(2):217-25.'], 'hemolysis': u'<50% hemolysis at 30\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1631']}, u'GILDTIKNAAKTVAVGLLEKIKCKMTGC': {'modifications': [], 'references': [u'Antimicrobial peptides and protease inhibitors in the skin secretions of the crawfish frog, Rana areolata. Ali, Mohamed ,Ali MF,Lips KR,Knoop FC,Fritzsch B,Miller C Biochim Biophys Acta. 2002 Nov 19;1601(1):55-63.'], 'hemolysis': u'HC50 = 150\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2481']}, u'KWKKLLKKPLKLKL': {'modifications': ['C-Terminal'], 'references': [u'Antibiotic activity of Leu-Lys rich model peptides. Park Y,Lee DG Biotechnol Lett. 2003 Aug;25(16):1305-10.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2320']}, u'WLKKW': {'modifications': ['C-Terminal'], 'references': [u'De novo generation of short antimicrobial peptides with simple amino acid composition. Lee SH,Kim SJ,Lee YS,Song MD,Kim IH Regul Pept. 2011 Jan 17;166(1-3):36-41. doi: 10.1016/j.regpep.2010.08.010. Epub 2010 Aug 22.'], 'hemolysis': u'negligible hemolysis at 320\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3092']}, u'KWKKFKKIGKVLKVL': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Lysine-enriched cecropin-mellitin antimicrobial peptides with enhanced selectivity. Sato H Antimicrob Agents Chemother. 2008 Dec;52(12):4463-5. doi: 10.1128/AAC.00810-08. Epub 2008 Oct 13.'], 'hemolysis': u'9% hemolysis at 64\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1262']}, u'CESCVWIPCISSVVGCSCKSKVCYKNGTLP': {'modifications': ['Cyclic'], 'references': [u'Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif. Craik DJ,Daly NL,Bond T J Mol Biol. 1999 Dec 17;294(5):1327-36.'], 'hemolysis': u'50% hemolysis at ~20\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4004']}, u'INWLKLGKAVIDAL': {'modifications': ['C-Terminal'], 'references': [u'Structural and biological characterization of three novel mastoparan peptides from the venom of the neotropical social wasp Protopolybia exigua (Saussure). Mendes MA,de Souza BM Toxicon. 2005 Jan;45(1):101-6.'], 'hemolysis': u'No hemolysis at 10\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1884']}, u'VkLKVyPLKVKLyP': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Dissociation of antimicrobial and hemolytic activities in cyclic peptide diastereomers by systematic alterations in amphipathicity. Kondejewski LH,Jelokhani-Niaraki M,Farmer SW,Lix B,Kay CM,Sykes BD,Hancock RE J Biol Chem. 1999 May 7;274(19):13181-92.'], 'hemolysis': u'100% hemolytic at 50 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2563']}, u'ILGKILEGIKSLF': {'modifications': ['C-Terminal'], 'references': [u'Antibiotic activity and structural analysis of the scorpion-derived antimicrobial peptide IsCT and its analogs. Lee K,Shin SY,Kim K,Lim SS,Hahm KS Biochem Biophys Res Commun. 2004 Oct 15;323(2):712-9.'], 'hemolysis': u'~20% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2397']}, u'LKKWLKK': {'modifications': ['C-Terminal'], 'references': [u'De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface. Kang SJ,Won HS,Choi WS J Pept Sci. 2009 Sep;15(9):583-8. doi: 10.1002/psc.1149.'], 'hemolysis': u'4.90% hemolysis at 6.3\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1381']}, u'GFMKYIKPLIPHAVKAIKKLI': {'modifications': [], 'references': [u'Antimicrobial and cytolytic properties of the frog skin peptide, kassinatuerin-1 and its L- and D-lysine-substituted derivatives. Conlon JM,Abraham B,Galadari S,Knoop FC,Sonnevend A Peptides. 2005 Nov;26(11):2104-10.'], 'hemolysis': u'LD50 =200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4081']}, u'QRSVSNAATRVCRT': {'modifications': [], 'references': [u'Hemolysis of erythrocytes by granulysin-derived peptides but not by granulysin. Li Q,Dong C,Deng A,Katsumata M,Nakadai A,Kawada T,Okada S,Clayberger C Antimicrob Agents Chemother. 2005 Jan;49(1):388-97.'], 'hemolysis': u'No hemolysis at 10\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1888']}, u'KWKSFLRTLKSPAKTVFHTALKAISS': {'modifications': [], 'references': [u'Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides. Zhang L,Benz R Biochemistry. 1999 Jun 22;38(25):8102-11.'], 'hemolysis': u'MHC >128\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3592']}, u'GWGSFFKKAAHVGKHVGKAALTHYL': {'modifications': ['C-Terminal'], 'references': [u'The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents. Morash MG,Douglas SE,Robotham A,Ridley CM,Gallant JW Dis Model Mech. 2011 Sep;4(5):622-33. doi: 10.1242/dmm.007310. Epub 2011 Jul 4.'], 'hemolysis': u'50% hemolytic at >256 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2919']}, u'LISWIKRKRQQGIGAVLKVLTTGL': {'modifications': ['C-Terminal'], 'references': [u'Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids. Boman HG,Wade D,Boman IA,Wahlin B FEBS Lett. 1989 Dec 18;259(1):103-6.'], 'hemolysis': u'Lethal concentration calculated from zone of inhibition  >200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3564']}, u'ILAWKWAWWAWRR': {'modifications': ['C-Terminal'], 'references': [u'Requirements for antibacterial and hemolytic activities in the bovine neutrophil derived 13-residue peptide indolicidin. Subbalakshmi C,Krishnakumari V,Nagaraj R FEBS Lett. 1996 Oct 14;395(1):48-52.'], 'hemolysis': u'100% hemolysis at 20\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3659']}, u'RRGWVLALYlRYGRR': {'modifications': [u'Stereochemistry: Mix'], 'references': [u'Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity. Rathinakumar R, Walkenhorst, William ,Walkenhorst WF J Am Chem Soc. 2009 Jun 10;131(22):7609-17. doi: 10.1021/ja8093247.'], 'hemolysis': u'15\xb120% hemolysis at 15\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1359']}, u'GIFSKLAGKKIKNLLISGLKNIGKEVGMDVVRTGIDIAGCKIKGEC': {'modifications': [], 'references': [u'Structure-activity relationships of antimicrobial peptides from the skin of Rana esculenta inhabiting in Korea. Won HS,Kim SS,Jung SJ,Son WS,Lee B Mol Cells. 2004 Jun 30;17(3):469-76.'], 'hemolysis': u'0.06% hemolysis at 100\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1604']}, u'KWKLFKKINalaKFLHLAKKF': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Antimicrobial and anti-inflammatory activities of designed antimicrobial peptide P18 analogues. Nan YH Protein Pept Lett. 2008;15(8):861-5.'], 'hemolysis': u'MHC =200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3984']}, u'GLLNGLALRLGKRALKKIIKRLCR': {'modifications': [], 'references': [u'Isolation and functional analysis of a 24-residue linear alpha-helical antimicrobial peptide from Korean blackish cicada, Cryptotympana dubia (Homoptera). Leem JY,Park DS,Suh EY,Hur JH,Oh HW Arch Insect Biochem Physiol. 2007 Dec;66(4):204-13.'], 'hemolysis': u'5% hemolysis upto 200\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3634']}, u'FVPWFSKfLGRIL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'The effect of d-amino acid substitution on the selectivity of temporin L towards target cells: identification of a potent anti-Candida peptide. Grieco P,Carotenuto A,Auriemma L,Saviello MR,Campiglia P,Gomez-Monterrey IM,Marcellini L,Luca V,Barra D,Novellino E Biochim Biophys Acta. 2013 Feb;1828(2):652-60. doi: 10.1016/j.bbamem.2012.08.027. Epub 2012 Sep 10.'], 'hemolysis': u'4% hemolysis at 1.5\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3211']}, u'GRKKRRQRRRPPQ': {'modifications': ['C-Terminal'], 'references': [u'Cell-penetrating peptides: a comparative membrane toxicity study. Saar K,Lindgren M,Hansen M,Eiriksdottir E,Jiang Y,Rosenthal-Aizman K,Sassian M Anal Biochem. 2005 Oct 1;345(1):55-65.'], 'hemolysis': u'11.2\xb11.5% hemolysis at 50\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1644']}, u'CAESCVYIPCTVTALLGCSCSNRVCYNGIP': {'modifications': ['Cyclic'], 'references': [u'Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif. Craik DJ,Daly NL,Bond T J Mol Biol. 1999 Dec 17;294(5):1327-36.'], 'hemolysis': u'50% hemolysis at ~20\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3997']}, u'G\u0394FRK\u0394FKA\u0394FWH': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', 'Non-Natural'], 'references': [u'Synergy with rifampin and kanamycin enhances potency, kill kinetics, and selectivity of de novo-designed antimicrobial peptides. Anantharaman A,Rizvi MS Antimicrob Agents Chemother. 2010 May;54(5):1693-9. doi: 10.1128/AAC.01231-09. Epub 2010 Feb 22.'], 'hemolysis': u'0% hemolysis upto 679\u03bcg/ml  (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1465']}, u'akklohalhoallalohlahollakk': {'modifications': ['C-Terminal', u'Stereochemistry: D', 'Non-Natural'], 'references': [u'Structural determinants of antimicrobial and antiplasmodial activity and selectivity in histidine-rich amphipathic cationic peptides. Mason AJ,Moussaoui W,Abdelrahman T,Boukhari A,Bertani P,Marquette A,Shooshtarizaheh P,Moulay G,Boehm N,Guerold B,Sawers RJ,Kichler A,Metz-Boutigue MH,Candolfi E,Prevost G J Biol Chem. 2009 Jan 2;284(1):119-33. doi: 10.1074/jbc.M806201200. Epub 2008 Nov 4.'], 'hemolysis': u'HC50 =716.8\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3574']}, u'KKAFAAAAAFAAWAAFAKKKK': {'modifications': ['C-Terminal'], 'references': [u'Cationic hydrophobic peptides with antimicrobial activity. Stark M,Liu LP Antimicrob Agents Chemother. 2002 Nov;46(11):3585-90.'], 'hemolysis': u'0% hemolysis at 50\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2237']}, u'FVKLKKIANIINSIFKK': {'modifications': [], 'references': [u'Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEa. Yang QZ,Wang C,Lang L,Zhou Y,Wang H Arch Pharm Res. 2013 Apr 23.'], 'hemolysis': u'LC50 =1,993\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2573']}, u'ILPWKWPWLPLRR': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship of indolicidin, a Trp-rich antibacterial peptide. Ando S,Mitsuyasu K,Soeda Y,Hidaka M,Ito Y,Matsubara K,Shindo M,Uchida Y J Pept Sci. 2010 Apr;16(4):171-7. doi: 10.1002/psc.1217.'], 'hemolysis': u'3% hemolysis at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1484']}, u'LPLILRKIVTAL': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial and hemolytic activities of crabrolin, a 13-residue peptide from the venom of the European hornet, Vespa crabro, and its analogs. Krishnakumari V J Pept Res. 1997 Aug;50(2):88-93.'], 'hemolysis': u'Non-hemolytic', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3383']}, u'GLLGPLLKIAAKVGKKLL': {'modifications': ['C-Terminal'], 'references': [u'Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7. Conlon JM,Galadari S,Raza H Chem Biol Drug Des. 2008 Jul;72(1):58-64. doi: 10.1111/j.1747-0285.2008.00671.x. Epub 2008 Jun 12.'], 'hemolysis': u'LD50 = 60\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1964']}, u'ILPWKWKWWPWRR': {'modifications': ['C-Terminal'], 'references': [u'Coupling molecular dynamics simulations with experiments for the rational design of indolicidin-analogous antimicrobial peptides. Tsai CW,Hsu NY,Wang CH,Lu CY,Chang Y,Tsai HH J Mol Biol. 2009 Sep 25;392(3):837-54. doi: 10.1016/j.jmb.2009.06.071. Epub 2009 Jul 2.'], 'hemolysis': u'41.8% hemolysis at 64\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1451']}, u'CKTRTSTNTDHLWIAKSKARLSET': {'modifications': [], 'references': [u'A synthetic peptide corresponding to the NH2 terminus of vesicular stomatitis virus glycoprotein is a pH-dependent hemolysin. Schlegel R J Biol Chem. 1984 Apr 25;259(8):4691-4.'], 'hemolysis': u'0% hemolysis upto 500\u03bcg/ml (non hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3292']}, u'GOrnOrnNleAibOrnOrnAibOrnOrnAibNleOrnOrnNleGY': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Amphipathic alpha helical antimicrobial peptides. Giangaspero A,Sandri L Eur J Biochem. 2001 Nov;268(21):5589-600.'], 'hemolysis': u'35% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2138']}, u'GASLSFKILKTVLEALGNV': {'modifications': [], 'references': [u'Structure and activity of the N-terminal region of the eukaryotic cytolysin equinatoxin II. Drechsler A,Potrich C,Sabo JK,Frisanco M,Guella G,Dalla Serra M,Anderluh G,Separovic F Biochemistry. 2006 Feb 14;45(6):1818-28.'], 'hemolysis': u'10% hemolysis at 25\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1675']}, u'WKKIPKFLHLLKKF': {'modifications': ['C-Terminal'], 'references': [u'Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs. Shin SY,Lee SH,Yang ST,Park EJ,Lee DG,Lee MK,Eom SH,Song WK,Kim Y,Hahm KS J Pept Res. 2001 Dec;58(6):504-14.'], 'hemolysis': u'9.4% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2165']}, u'LLLKLLKLLLKLLLKLLK': {'modifications': [u'C-Terminal Non-Amidation: Dansylation'], 'references': [u'The amphipathic alpha-helix concept. Application to the de novo design of ideally amphipathic Leu, Lys peptides with hemolytic activity higher than that of melittin. Cornut I,Buttner K,Dasseux JL FEBS Lett. 1994 Jul 25;349(1):29-33.'], 'hemolysis': u'LD50 =4.7\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3688']}, u'RRGWRLVLALVY': {'modifications': [], 'references': [u'Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity. Rathinakumar R, Walkenhorst, William ,Walkenhorst WF J Am Chem Soc. 2009 Jun 10;131(22):7609-17. doi: 10.1021/ja8093247.'], 'hemolysis': u'0.3 fractions hemolysis at 15\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1337']}, u'FLALIGRVLSGIL': {'modifications': ['C-Terminal'], 'references': [u'Alanine scanning analysis and structure-function relationships of the frog-skin antimicrobial peptide temporin-1Ta. Grieco P,Luca V,Auriemma L,Carotenuto A,Saviello MR,Campiglia P,Barra D,Novellino E J Pept Sci. 2011 May;17(5):358-65. doi: 10.1002/psc.1350. Epub 2011 Feb 18.'], 'hemolysis': u'0% hemolytic at 1.25\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2886']}, u'KWKLFKKIPKFLHSAKKF': {'modifications': ['C-Terminal'], 'references': [u'Effects of the hinge region of cecropin A(1-8)-magainin 2(1-12), a synthetic antimicrobial peptide, on liposomes, bacterial and tumor cells. Shin SY,Kang JH,Jang SY,Kim Y,Kim KL Biochim Biophys Acta. 2000 Feb 15;1463(2):209-18.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2025']}, u'IWLTALKFLGKHAAKHLAKQQLSKL': {'modifications': ['C-Terminal'], 'references': [u'Lycotoxins, antimicrobial peptides from venom of the wolf spider Lycosa carolinensis. Yan L J Biol Chem. 1998 Jan 23;273(4):2059-66.'], 'hemolysis': u'55% hemolysis at 200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3384']}, u'WKSYVRRWRSR': {'modifications': [], 'references': [u'Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide. Wu YS,Liao ZJ,Wang KS Bioorg Med Chem Lett. 2013 May 15;23(10):2929-32. doi: 10.1016/j.bmcl.2013.03.053. Epub 2013 Mar 25.'], 'hemolysis': u'-1.2 \xb1 2.6%hemolytic at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2579']}, u'LDVKKIICVACKIRPNPACKKICPK': {'modifications': [], 'references': [u'Panurgines, novel antimicrobial peptides from the venom of communal bee Panurgus calcaratus (Hymenoptera: Andrenidae). Cujova S,Slaninova J,Monincova L,Fucik V,Bednarova L,Stokrova J,Hovorka O,Voburka Z,Straka J Amino Acids. 2013 Jul;45(1):143-57. doi: 10.1007/s00726-013-1482-4. Epub 2013 Mar 13.'], 'hemolysis': u'LC50 >200\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3742']}, u'CGESCVFIPCISTLLGCSCKNKVCYRNGVIP': {'modifications': ['Cyclic'], 'references': [u'Chemical synthesis and folding pathways of large cyclic polypeptides: studies of the cystine knot polypeptide kalata B1. Daly NL,Love S, Alewood, P ,Alewood PF Biochemistry. 1999 Aug 10;38(32):10606-14.'], 'hemolysis': u'HD50 =30\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4136']}, u'KIAEKFSGTRRG': {'modifications': [], 'references': [u'Processing of chromogranin B in bovine adrenal medulla. Identification of secretolytin, the endogenous C-terminal fragment of residues 614-626 with antibacterial activity. Strub JM,Garcia-Sablone P,Lonning K,Taupenot L,Hubert P,Van Dorsselaer A,Aunis D Eur J Biochem. 1995 Apr 15;229(2):356-68.'], 'hemolysis': u'No hemolysis (Non hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3612']}, u'IISTIGDLVKWIIDTVNKFTKK': {'modifications': [], 'references': [u'Conformation and activity of delta-lysin and its analogs. Dhople VM Peptides. 2005 Feb;26(2):217-25.'], 'hemolysis': u'100% hemolysis at 5\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1629']}, u'IDWKKLLDAAKQIL': {'modifications': ['C-Terminal'], 'references': [u'Structural and functional characterization of two novel peptide toxins isolated from the venom of the social wasp Polybia paulista. Souza BM,Mendes MA,Santos LD,Marques MR,Cesar LM,Almeida RN,Pagnocca FC,Konno K Peptides. 2005 Nov;26(11):2157-64. Epub 2005 Aug 29.'], 'hemolysis': u'EC50 =4.5 X10-5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3993']}, u'GIWGTLAKIGIKAVPRVISMLKKKKQ': {'modifications': [], 'references': [u'Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii. Orivel J,Redeker V,Le Caer JP, Krier, ,Krier F,Revol-Junelles AM,Longeon A,Chaffotte A,Dejean A J Biol Chem. 2001 May 25;276(21):17823-9. Epub 2001 Feb 22.'], 'hemolysis': u'zone of inhibition not detected at 0.4-0.5mM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2114']}, u'GLPVCGETCVGGTCNTPGCTCSWPKCTRN': {'modifications': ['Cyclic'], 'references': [u'Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities. Henriques ST,Huang YH,Rosengren KJ,Franquelim HG,Carvalho FA,Johnson A,Sonza S,Tachedjian G,Castanho MA,Daly NL J Biol Chem. 2011 Jul 8;286(27):24231-41. doi: 10.1074/jbc.M111.253393. Epub 2011 May 16.'], 'hemolysis': u'1.1\xb11.0% hemolytic at 25\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3010']}, u'GSKKPVPIIYCNRRTKCQRM': {'modifications': [], 'references': [u'Role of amino acid residues within the disulfide loop of thanatin, a potent antibiotic peptide. Lee MK,Cha L,Lee SH J Biochem Mol Biol. 2002 May 31;35(3):291-6.'], 'hemolysis': u'0% hemolysis at 20.8\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2215']}, u'GGTIFDCGETCFLGTCYTPGCSCGNYGFCYGTN': {'modifications': ['Cyclic'], 'references': [u'Anti-HIV cyclotides from the Chinese medicinal herb Viola yedoensis. Wang CK,Colgrave ML,Gustafson KR,Ireland DC,Goransson U J Nat Prod. 2008 Jan;71(1):47-52. Epub 2007 Dec 15.'], 'hemolysis': u'Poor hemolytic', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1027']}, u'LRLQYRRFQYRV': {'modifications': ['Cyclic'], 'references': [u'Macrocyclic hairpin mimetics of the cationic antimicrobial peptide protegrin I: a new family of broad-spectrum antibiotics. Shankaramma SC,Athanassiou Z,Zerbe O,Moehle K,Mouton C,Bernardini F,Vrijbloed JW,Obrecht D Chembiochem. 2002 Nov 4;3(11):1126-33.'], 'hemolysis': u'27% hemolysis at 100\xb5g ml-1', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2272']}, u'FLPLVTGLLSGLL': {'modifications': ['C-Terminal'], 'references': [u'Peptide defenses of the Cascades frog Rana cascadae: implications for the evolutionary history of frogs of the Amerana species group. Conlon JM,Al-Dhaheri A,Al-Mutawa E,Al-Kharrge R,Ahmed E,Kolodziejek J,Nowotny N, Nielsen, Per ,Nielsen PF Peptides. 2007 Jun;28(6):1268-74. Epub 2007 Mar 27.'], 'hemolysis': u'LD50  >300\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1132']}, u'KKKKKKAAAAFWAAAAF': {'modifications': ['C-Terminal'], 'references': [u'Cationic hydrophobic peptides with antimicrobial activity. Stark M,Liu LP Antimicrob Agents Chemother. 2002 Nov;46(11):3585-90.'], 'hemolysis': u'0% hemolysis at 50\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2261']}, u'LNLKGIFKKVASLLT': {'modifications': [], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC <1000\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3941']}, u'GLMSVLKGVLKTAGKHIFKNVGGSLLDQAKCKISGQC': {'modifications': [], 'references': [u'A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica. Conlon JM,Sonnevend A,Patel M,Al-Dhaheri K, Nielsen, Per ,Nielsen PF,Kolodziejek J,Nowotny N,Iwamuro S Regul Pept. 2004 May 15;118(3):135-41.'], 'hemolysis': u'HC50 = 125\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1991']}, u'FFHHIFRPIVHVPKTIHRLVTG': {'modifications': [], 'references': [u'Solution structure and cell selectivity of piscidin 1 and its analogues. Lee SA,Kim YK,Lim SS,Zhu WL,Ko H,Shin SY,Hahm KS Biochemistry. 2007 Mar 27;46(12):3653-63. Epub 2007 Mar 1.'], 'hemolysis': u'HC50 >200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1115']}, u'WKKVFKRLEKLFSKIWNWK': {'modifications': [], 'references': [u'Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions. Park SC,Kim MH,Hossain MA,Shin SY,Kim Y,Stella L,Wade JD,Park Y Biochim Biophys Acta. 2008 Jan;1778(1):229-41. Epub 2007 Oct 2.'], 'hemolysis': u'94.69% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1827']}, u'GLLRASSVWGRKYYVDLAGCAKA': {'modifications': [], 'references': [u'An antimicrobial peptide with antimicrobial activity against Helicobacter pylori. Chen L,Li Y,Li J,Xu X,Lai R Peptides. 2007 Aug;28(8):1527-31. Epub 2007 Jul 14.'], 'hemolysis': u'Little hemolysis at 100\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3642']}, u'FLGWLFKWAKK': {'modifications': ['C-Terminal'], 'references': [u'Activity optimization of an undecapeptide analogue derived from a frog-skin antimicrobial peptide. Won HS,Kang SJ,Choi WS Mol Cells. 2011 Jan;31(1):49-54. doi: 10.1007/s10059-011-0005-y. Epub 2010 Nov 23.'], 'hemolysis': u'MHC =50\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1556']}, u'KWKSFlKTFKSlKKTVLHTLLKAISS': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', u'Stereochemistry: Mix'], 'references': [u'Role of helicity on the anticancer mechanism of action of cationic-helical peptides. Huang YB,He LY,Jiang HY Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849. Epub 2012 Jun 5.'], 'hemolysis': u'MHC =20.81 \xb1 0.10 \u03bcmol/L', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2647']}, u'GRPNPVNNKPTPHPRL': {'modifications': [], 'references': [u'Glycosylated analogs of formaecin I and drosocin exhibit differential pattern of antibacterial activity. Talat S,Thiruvikraman M,Kumari S Glycoconj J. 2011 Dec;28(8-9):537-55. doi: 10.1007/s10719-011-9353-2. Epub 2011 Oct 4.'], 'hemolysis': u'<5% hemolytic at 100 \u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2974']}, u'KRFKKFFKKLKNSVKKRAKKFFKKPKVIGVTFPF': {'modifications': [], 'references': [u'Antimicrobial and antibiofilm activity of cathelicidins and short, synthetic peptides against Francisella. Amer LS,Bishop BM Biochem Biophys Res Commun. 2010 May 28;396(2):246-51. doi: 10.1016/j.bbrc.2010.04.073. Epub 2010 Apr 23.'], 'hemolysis': u'EC50 =0.37\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3061']}, u'LLIILRRRWRKQARARSK': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial activity, bactericidal mechanism and LPS-neutralizing activity of the cell-penetrating peptide pVEC and its analogs. Nan YH,Park IS,Hahm KS J Pept Sci. 2011 Dec;17(12):812-7. doi: 10.1002/psc.1408. Epub 2011 Sep 29.'], 'hemolysis': u'>10% hemolytic at 200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2969']}, u'APCLACPCLAPCLACPCKACPCLACPCKACPCLAPC': {'modifications': ['C-Terminal', 'Cyclic', 'Non-Natural'], 'references': [u'Interplay among folding, sequence, and lipophilicity in the antibacterial and hemolytic activities of alpha/beta-peptides. Schmitt MA,Weisblum B J Am Chem Soc. 2007 Jan 17;129(2):417-28.'], 'hemolysis': u'>10% hemolysis at 1.6 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1092']}, u'VTCDVLSFEAKGIAVNHSACALHCIALRKKGGSCQNGVCVCRN': {'modifications': [], 'references': [u'Insight into the antimicrobial activities of coprisin isolated from the dung beetle, Copris tripartitus, revealed by structure-activity relationships. Lee E,Kim JK,Shin S,Jeong KW,Shin A,Lee J,Lee DG,Hwang JS Biochim Biophys Acta. 2013 Feb;1828(2):271-83. doi: 10.1016/j.bbamem.2012.10.028. Epub 2012 Nov 6.'], 'hemolysis': u'0% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3245']}, u'VFQFLGKIIHHVGNFVHGFSHVF': {'modifications': [], 'references': [u'Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides. Yasin B,Pang M,Turner JS,Cho Y,Dinh NN,Waring AJ,Lehrer RI Eur J Clin Microbiol Infect Dis. 2000 Mar;19(3):187-94.'], 'hemolysis': u'0% hemolysis at 80\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2447']}, u'SAISCGETCFKFKCYTPRCSCSYPVCK': {'modifications': ['Cyclic'], 'references': [u'Discovery and characterization of a linear cyclotide from Viola odorata: implications for the processing of circular proteins. Ireland DC,Colgrave ML,Nguyencong P,Daly NL J Mol Biol. 2006 Apr 14;357(5):1522-35. Epub 2006 Feb 2.'], 'hemolysis': u'30% hemolysis at 1.5\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3996']}, u'RFGRFLRKIRRFRPKVTITIQ': {'modifications': [], 'references': [u'Identification of chicken cathelicidin-2 core elements involved in antibacterial and immunomodulatory activities. van Dijk A,Molhoek EM,Veldhuizen EJ,Bokhoven JL,Wagendorp E,Bikker F Mol Immunol. 2009 Aug;46(13):2465-73. doi: 10.1016/j.molimm.2009.05.019. Epub 2009 Jun 12.'], 'hemolysis': u'40% hemolysis at 40\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1367']}, u'MSVSDAVQLMLGFGTFVLMLLGLVVELIKNSNKK': {'modifications': [], 'references': [u'Functional characterization of a new holin-like antibacterial protein coding gene tmp1 from goat skin surface metagenome. Rajesh T,Anthony T,Saranya S,Pushpam PL Appl Microbiol Biotechnol. 2011 Feb;89(4):1061-73. doi: 10.1007/s00253-010-2907-6. Epub 2010 Oct 7.'], 'hemolysis': u'0% hemolysis at 50\u03bcM  (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1540']}, u'GIGKFLHSAGKFGKAFIGEIMKS': {'modifications': [], 'references': [u'Peptidomic analysis of skin secretions demonstrates that the allopatric populations of Xenopus muelleri (Pipidae) are not conspecific. Mechkarska M,Ahmed E,Coquet L,Leprince J,Jouenne T,Vaudry H,King JD Peptides. 2011 Jul;32(7):1502-8. doi: 10.1016/j.peptides.2011.05.025. Epub 2011 Jun 1.'], 'hemolysis': u'LC50 =180\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3133']}, u'GFLGILFHGVHHGRKKALHMNSERRS': {'modifications': [], 'references': [u'The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents. Morash MG,Douglas SE,Robotham A,Ridley CM,Gallant JW Dis Model Mech. 2011 Sep;4(5):622-33. doi: 10.1242/dmm.007310. Epub 2011 Jul 4.'], 'hemolysis': u'50% hemolytic at >256 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2935']}, u'KLKLLKLLKLLKLLK': {'modifications': ['C-Terminal'], 'references': [u'The consequence of sequence alteration of an amphipathic alpha-helical antimicrobial peptide and its diastereomers. Papo N,Oren Z,Pag U,Sahl HG J Biol Chem. 2002 Sep 13;277(37):33913-21. Epub 2002 Jul 10.'], 'hemolysis': u'82% hemolysis at 100 \xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2199']}, u'KNWKAILKHIIK': {'modifications': ['C-Terminal'], 'references': [u'Panurgines, novel antimicrobial peptides from the venom of communal bee Panurgus calcaratus (Hymenoptera: Andrenidae). Cujova S,Slaninova J,Monincova L,Fucik V,Bednarova L,Stokrova J,Hovorka O,Voburka Z,Straka J Amino Acids. 2013 Jul;45(1):143-57. doi: 10.1007/s00726-013-1482-4. Epub 2013 Mar 13.'], 'hemolysis': u'LC50 >200\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3730']}, u'QLQGKQVSGEVVQKVLQELIQSVAKP': {'modifications': [], 'references': [u'Five different piscidins from Nile tilapia, Oreochromis niloticus: analysis of their expressions and biological functions. Peng KC,Lee SH,Hour AL,Pan CY,Lee LH PLoS One. 2012;7(11):e50263. doi: 10.1371/journal.pone.0050263. Epub 2012 Nov 30.'], 'hemolysis': u'0% hemolytic at 100\u03bcg/ml (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2611']}, u'GVVDILKGAAKDLAGHLATKVMNKL': {'modifications': [], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC <400\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3950']}, u'KKLFKKiLKYL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Improvement of the efficacy of linear undecapeptides against plant-pathogenic bacteria by incorporation of D-amino acids. Guell I,Cabrefiga J,Badosa E,Ferre R,Talleda M,Bardaji E,Planas M,Feliu L Appl Environ Microbiol. 2011 Apr;77(8):2667-75. doi: 10.1128/AEM.02759-10. Epub 2011 Feb 18.'], 'hemolysis': u'0\xb10% hemolytic at 250\u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2858']}, u'INQKKIASIGKEV': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 >>100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3931']}, u'KIGAKIKIGAKIKDCF3BpgGAKI': {'modifications': ['C-Terminal', u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'Stereochemical effects on the aggregation and biological properties of the fibril-forming peptide [KIGAKI]3 in membranes. Wadhwani P,Reichert J,Strandberg E,Burck J,Misiewicz J,Afonin S,Heidenreich N,Fanghanel S,Mykhailiuk PK,Komarov IV Phys Chem Chem Phys. 2013 Jun 21;15(23):8962-71. doi: 10.1039/c3cp50896j. Epub 2013 May 7.'], 'hemolysis': u'~7% hemolysis at 60\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2690']}, u'FVPWFSKFLpRIL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Structure-activity relationship, conformational and biological studies of temporin L analogues. Mangoni ML,Carotenuto A,Auriemma L,Saviello MR,Campiglia P,Gomez-Monterrey I,Malfi S,Marcellini L,Barra D,Novellino E J Med Chem. 2011 Mar 10;54(5):1298-307. doi: 10.1021/jm1012853. Epub 2011 Feb 14.'], 'hemolysis': u'0.6% hemolytic at 6\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2838']}, u'KWKLFKK\u0394FGAVLKVL': {'modifications': ['Non-Natural'], 'references': [u'Alpha,beta-dehydrophenylalanine containing cecropin-melittin hybrid peptides: conformation and activity. Mathur P,Jagannathan NR J Pept Sci. 2007 Apr;13(4):253-62.'], 'hemolysis': u'~25% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1125']}, u'LCYCRRRFCWCV': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'25-50% hemolysis at 80\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1220']}, u'GIGAILKVLATGLPTLISWIKNKRKQ': {'modifications': [], 'references': [u'Truncated peptides from melittin and its analog with high lytic activity at endosomal pH enhance branched polyethylenimine-mediated gene transfection. Tan YX,Chen C,Wang YL,Lin S,Wang Y,Li SB,Jin XP,Gao HW,Du FS,Gong F J Gene Med. 2012 Apr;14(4):241-50. doi: 10.1002/jgm.2609.'], 'hemolysis': u'~80% hemolytic at 25\u03bcM at pH 8', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2705']}, u'SLTFQVLDKVLEELGKVSRK': {'modifications': [], 'references': [u'Correlations between differences in amino-terminal sequences and different hemolytic activity of sticholysins. Cilli EM,Pigossi FT,Crusca E Jr,Ros U,Martinez D,Lanio ME,Alvarez C Toxicon. 2007 Dec 15;50(8):1201-4. Epub 2007 Aug 3.'], 'hemolysis': u'Hemolytic activity expresssed as the initial rate (\u2206A/\u2206t, min- 1) i.e. at above 100 \xb5M activity is  ~0.002 min-1', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1819']}, u'WCPPMIPLCSRF': {'modifications': ['C-Terminal', 'Cyclic'], 'references': [u'Peptidomic analysis of skin secretions demonstrates that the allopatric populations of Xenopus muelleri (Pipidae) are not conspecific. Mechkarska M,Ahmed E,Coquet L,Leprince J,Jouenne T,Vaudry H,King JD Peptides. 2011 Jul;32(7):1502-8. doi: 10.1016/j.peptides.2011.05.025. Epub 2011 Jun 1.'], 'hemolysis': u'LC50 >500\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3134']}, u'YVPPVQKPHPNGPKFPTFP': {'modifications': [], 'references': [u'Characterization of an abaecin-like antimicrobial peptide identified from a Pteromalus puparum cDNA clone. Shen X,Ye G,Cheng X,Yu C,Altosaar I J Invertebr Pathol. 2010 Sep;105(1):24-9. doi: 10.1016/j.jip.2010.05.006. Epub 2010 May 11.'], 'hemolysis': u'3.8% hemolysis at 250\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3070']}, u'FFRRFFRRFFRRFFRR': {'modifications': ['C-Terminal'], 'references': [u'Synthetic cationic amphiphilic ?-helical peptides as antimicrobial agents. Wiradharma N,Khoe U,Hauser CA,Seow SV,Zhang S Biomaterials. 2011 Mar;32(8):2204-12. doi: 10.1016/j.biomaterials.2010.11.054. Epub 2010 Dec 18.'], 'hemolysis': u'HC50 > ~26', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2052']}, u'ILPWKKPKLPWRR': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship of indolicidin, a Trp-rich antibacterial peptide. Ando S,Mitsuyasu K,Soeda Y,Hidaka M,Ito Y,Matsubara K,Shindo M,Uchida Y J Pept Sci. 2010 Apr;16(4):171-7. doi: 10.1002/psc.1217.'], 'hemolysis': u'11% hemolysis at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1488']}, u'KWLRRVWRWWR': {'modifications': ['C-Terminal'], 'references': [u'Discovery of potent antimicrobial peptide analogs of Ixosin-B. Lung FD,Wang KS,Liao ZJ,Hsu SK,Song FY,Liou CC Bioorg Med Chem Lett. 2012 Jun 15;22(12):4185-8. doi: 10.1016/j.bmcl.2012.04.018. Epub 2012 Apr 20.'], 'hemolysis': u'100% hemolytic at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2767']}, u'HFLLkLVNLAKKIL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Strategies for transformation of naturally-occurring amphibian antimicrobial peptides into therapeutically valuable anti-infective agents. Conlon JM,Al-Ghaferi N,Abraham B Methods. 2007 Aug;42(4):349-57.'], 'hemolysis': u'LD50 = 500\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1805']}, u'FVPWFSKFLPRIL': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship, conformational and biological studies of temporin L analogues. Mangoni ML,Carotenuto A,Auriemma L,Saviello MR,Campiglia P,Gomez-Monterrey I,Malfi S,Marcellini L,Barra D,Novellino E J Med Chem. 2011 Mar 10;54(5):1298-307. doi: 10.1021/jm1012853. Epub 2011 Feb 14.'], 'hemolysis': u'4.5% hemolytic at 6\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2837']}, u'LNWGAIKKHIIK': {'modifications': ['C-Terminal'], 'references': [u'Panurgines, novel antimicrobial peptides from the venom of communal bee Panurgus calcaratus (Hymenoptera: Andrenidae). Cujova S,Slaninova J,Monincova L,Fucik V,Bednarova L,Stokrova J,Hovorka O,Voburka Z,Straka J Amino Acids. 2013 Jul;45(1):143-57. doi: 10.1007/s00726-013-1482-4. Epub 2013 Mar 13.'], 'hemolysis': u'LC50 >200\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3725']}, u'RRWCFRVCYRGFCYRKCR': {'modifications': ['C-Terminal'], 'references': [u'Interaction of polyphemusin I and structural analogs with bacterial membranes, lipopolysaccharide, and lipid monolayers. Zhang L,Scott MG,Yan H,Mayer LD Biochemistry. 2000 Nov 28;39(47):14504-14.'], 'hemolysis': u'100% hemolysis at 21.3\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1042']}, u'MAQDIISTIGDLVKWIIDTVNKFTKK': {'modifications': [], 'references': [u'Conformation and activity of delta-lysin and its analogs. Dhople VM Peptides. 2005 Feb;26(2):217-25.'], 'hemolysis': u'~95% hemolysis at 30\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1627']}, u'APCLACPCLAPCLACPCLAPCLACPCKACPCLAPC': {'modifications': ['C-Terminal', 'Cyclic', 'Non-Natural'], 'references': [u'Interplay among folding, sequence, and lipophilicity in the antibacterial and hemolytic activities of alpha/beta-peptides. Schmitt MA,Weisblum B J Am Chem Soc. 2007 Jan 17;129(2):417-28.'], 'hemolysis': u'>10% hemolysis at 1.6 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1095']}, u'HFLLTLKNLAKKIL': {'modifications': ['C-Terminal'], 'references': [u'Strategies for transformation of naturally-occurring amphibian antimicrobial peptides into therapeutically valuable anti-infective agents. Conlon JM,Al-Ghaferi N,Abraham B Methods. 2007 Aug;42(4):349-57.'], 'hemolysis': u'LD50 = 330\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1798']}, u'INWLKLGKAIIDAL': {'modifications': ['C-Terminal'], 'references': [u'Structural and biological characterization of two novel peptides from the venom of the neotropical social wasp Agelaia pallipes pallipes. Mendes MA,de Souza BM,Marques MR Toxicon. 2004 Jul;44(1):67-74.'], 'hemolysis': u'~90% hemolysis  at 10-4 M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1599']}, u'GIPCAESCVWIPCTVTALVGCSCSDKVCYN': {'modifications': ['Cyclic'], 'references': [u'Anti-HIV cyclotides from the Chinese medicinal herb Viola yedoensis. Wang CK,Colgrave ML,Gustafson KR,Ireland DC,Goransson U J Nat Prod. 2008 Jan;71(1):47-52. Epub 2007 Dec 15.'], 'hemolysis': u'HD50 = 8.7\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1029']}, u'GILSSFKGVAKGVAKNLAGKLLDELKCKITGC': {'modifications': [], 'references': [u'Host-defense peptides isolated from the skin secretions of the Northern red-legged frog Rana aurora aurora. Conlon JM,Sonnevend A,Davidson C,Demandt A Dev Comp Immunol. 2005;29(1):83-90.'], 'hemolysis': u'HC50 =290\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1615']}, u'MFTLKKSLLFLFFLGTISLSFCEEERGADEDDEVEMTEEEKRSILDKIKNVALGVARGAGTGILKALLCKLDKSC': {'modifications': [], 'references': [u'Molecular cloning and characterization of antimicrobial peptides from skin of the broad-folded frog, Hylarana latouchii. Wang H,Yu Z,Hu Y,Yu H,Ran R,Xia J,Wang D,Yang S,Yang X Biochimie. 2012 Jun;94(6):1317-26. doi: 10.1016/j.biochi.2012.02.032. Epub 2012 Mar 8.'], 'hemolysis': u'LD50 = 480\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2077']}, u'KLALKLALKALKAALKla': {'modifications': [u'Stereochemistry: Mix'], 'references': [u'Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes. Dathe M,Schumann M,Wieprecht T,Winkler A,Beyermann M,Krause E,Matsuzaki K,Murase O Biochemistry. 1996 Sep 24;35(38):12612-22.'], 'hemolysis': u'EC50 = 70\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3466']}, u'KKllKWKlKlKK': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Structure and organization of hemolytic and nonhemolytic diastereomers of antimicrobial peptides in membranes. Hong J,Oren Z Biochemistry. 1999 Dec 21;38(51):16963-73.'], 'hemolysis': u'0% hemolysis at 50\u03bcM (Non hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3765']}, u'VKLfVyPLKVKLyP': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Effects of single D-amino acid substitutions on disruption of beta-sheet structure and hydrophobicity in cyclic 14-residue antimicrobial peptide analogs related to gramicidin S. Lee DL,Powers JP,Pflegerl K,Vasil ML,Hancock RE J Pept Res. 2004 Feb;63(2):69-84.'], 'hemolysis': u'MHC =2 \xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1586']}, u'VDIHVWDGVVDIHVWDGV': {'modifications': [], 'references': [u'Therapeutic potential of peptides with neutralizing ability towards the venom and toxin (CaTx-I) of crotalus adamanteus. Samy RP,Thwin MM,Stiles BG,Bow H,Chow VT Curr Top Med Chem. 2011;11(20):2540-55.'], 'hemolysis': u'1.16% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3141']}, u'RDAKELVELFFEEIRRAL': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Amphipathic alpha-helices in proteins: results from analysis of protein structures. Sharadadevi A,Sivakamasundari C Proteins. 2005 Jun 1;59(4):791-801.'], 'hemolysis': u'46% hemolysis at 10\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1641']}, u'KRFKQDGGWSHWSPWSS': {'modifications': [], 'references': [u'Bacterial killing by heparin-binding peptides from PRELP and thrombospondin. Malmsten M,Davoudi M Matrix Biol. 2006 Jul;25(5):294-300. Epub 2006 Apr 25.'], 'hemolysis': u'~3% hemolysis at 60\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2075']}, u'fPVOLfPVOAdaA': {'modifications': ['Cyclic', u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'An adamantyl amino acid containing gramicidin S analogue with broad spectrum antibacterial activity and reduced hemolytic activity. Kapoerchan VV,Knijnenburg AD,Niamat M,Spalburg E,de Neeling AJ,Nibbering PH,Mars-Groenendijk RH,Noort D,Otero JM,Llamas-Saiz AL,van Raaij MJ,van der Marel GA,Overkleeft HS Chemistry. 2010 Oct 25;16(40):12174-81. doi: 10.1002/chem.201001686.'], 'hemolysis': u'HC50 =5.20\xb11.13\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2793']}, u'FLPLIGAVLSGIL': {'modifications': ['C-Terminal'], 'references': [u'Alanine scanning analysis and structure-function relationships of the frog-skin antimicrobial peptide temporin-1Ta. Grieco P,Luca V,Auriemma L,Carotenuto A,Saviello MR,Campiglia P,Barra D,Novellino E J Pept Sci. 2011 May;17(5):358-65. doi: 10.1002/psc.1350. Epub 2011 Feb 18.'], 'hemolysis': u'6% hemolytic at 1.25\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2894']}, u'VKLKVYPLKVKLyP': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Dissociation of antimicrobial and hemolytic activities in cyclic peptide diastereomers by systematic alterations in amphipathicity. Kondejewski LH,Jelokhani-Niaraki M,Farmer SW,Lix B,Kay CM,Sykes BD,Hancock RE J Biol Chem. 1999 May 7;274(19):13181-92.'], 'hemolysis': u'100% hemolytic at 25 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2562']}, u'FFHHIFRGIVHVPKTIHRLVTG': {'modifications': [], 'references': [u'Solution structure and cell selectivity of piscidin 1 and its analogues. Lee SA,Kim YK,Lim SS,Zhu WL,Ko H,Shin SY,Hahm KS Biochemistry. 2007 Mar 27;46(12):3653-63. Epub 2007 Mar 1.'], 'hemolysis': u'HC50 >200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1114']}, u'INWLKLGKKMMSAL': {'modifications': [u'C-Terminal Non-Amidation: OH'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 >>100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3921']}, u'LDVKKIICVACKIKPNPACKKICPK': {'modifications': [], 'references': [u'Panurgines, novel antimicrobial peptides from the venom of communal bee Panurgus calcaratus (Hymenoptera: Andrenidae). Cujova S,Slaninova J,Monincova L,Fucik V,Bednarova L,Stokrova J,Hovorka O,Voburka Z,Straka J Amino Acids. 2013 Jul;45(1):143-57. doi: 10.1007/s00726-013-1482-4. Epub 2013 Mar 13.'], 'hemolysis': u'LC50 >200\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3740']}, u'VLSAADKGNVKAAWGKVGGHAAE': {'modifications': [], 'references': [u'Antibacterial activity of a pepsin-derived bovine hemoglobin fragment. Froidevaux R, Krier, ,Krier F,Nedjar-Arroume N,Vercaigne-Marko D,Kosciarz E,Ruckebusch C,Dhulster P FEBS Lett. 2001 Feb 23;491(1-2):159-63.'], 'hemolysis': u'0% hemolysis upto 2.013 mM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2110']}, u'CSCKSKVCYKNSIPCGESCVFIPCTVTALLG': {'modifications': ['Cyclic'], 'references': [u'An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides. Tam JP,Lu YA,Yang JL Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):8913-8.'], 'hemolysis': u'50% hemolysis at >400\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3399']}, u'GRSRWRDVCRNFMRRYQSRVIQGLV': {'modifications': [], 'references': [u'Hemolysis of erythrocytes by granulysin-derived peptides but not by granulysin. Li Q,Dong C,Deng A,Katsumata M,Nakadai A,Kawada T,Okada S,Clayberger C Antimicrob Agents Chemother. 2005 Jan;49(1):388-97.'], 'hemolysis': u'>80% hemolysis 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1625']}, u'ICGETCVGGTCNTPGCSCSWPVCTRNGLP': {'modifications': ['Cyclic'], 'references': [u'Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif. Craik DJ,Daly NL,Bond T J Mol Biol. 1999 Dec 17;294(5):1327-36.'], 'hemolysis': u'50% hemolysis at ~20\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4014']}, u'LKWLKKLLKKL': {'modifications': ['C-Terminal'], 'references': [u'Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities. Kim SJ,Kim JS,Lee YS,Sim DW,Lee SH,Bahk YY,Lee KH,Kim EH,Park SJ,Lee BJ Molecules. 2013 Jan 11;18(1):859-76. doi: 10.3390/molecules18010859.'], 'hemolysis': u'MHC =  64\u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2594']}, u'CYCRIPACIAGERRYGTCIYQGRLWAFCC': {'modifications': [], 'references': [u'Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides. Yasin B,Pang M,Turner JS,Cho Y,Dinh NN,Waring AJ,Lehrer RI Eur J Clin Microbiol Infect Dis. 2000 Mar;19(3):187-94.'], 'hemolysis': u'0.9% hemolysis at 80\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2433']}, u'KWKKLLKKLLPLLKKLLK': {'modifications': ['C-Terminal'], 'references': [u'Effects of L- or D-Pro incorporation into hydrophobic or hydrophilic helix face of amphipathic alpha-helical model peptide on structure and cell selectivity. Song YM,Yang ST,Lim SS,Kim Y,Hahm KS,Kim JI Biochem Biophys Res Commun. 2004 Feb 6;314(2):615-21.'], 'hemolysis': u'50% hemolysis  at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1575']}, u'ELMNSTicOicGLTicOicGKTicOicGLTicOicGKTicOicELMNS': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'De novo design of selective antibiotic peptides by incorporation of unnatural amino acids. Hicks RP,Bhonsle JB,Venugopal D,Koser BW J Med Chem. 2007 Jun 28;50(13):3026-36. Epub 2007 Jun 5.'], 'hemolysis': u'3% hemolysis at 25\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1748']}, u'RLYRRLYRK': {'modifications': [], 'references': [u'Antimicrobial dendrimeric peptides. Tam JP,Lu YA Eur J Biochem. 2002 Feb;269(3):923-32.'], 'hemolysis': u'EC50 = 3700\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2410']}, u'FGPVIGLLSGILKSLL': {'modifications': [], 'references': [u'Venom peptides from solitary hunting wasps induce feeding disorder in lepidopteran larvae. Baek JH,Ji Y,Shin JS,Lee S Peptides. 2011 Mar;32(3):568-72. doi: 10.1016/j.peptides.2010.12.007. Epub 2010 Dec 22.'], 'hemolysis': u'Non-hemolytic', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2067']}, u'ILPLKLPLLPLRR': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship of indolicidin, a Trp-rich antibacterial peptide. Ando S,Mitsuyasu K,Soeda Y,Hidaka M,Ito Y,Matsubara K,Shindo M,Uchida Y J Pept Sci. 2010 Apr;16(4):171-7. doi: 10.1002/psc.1217.'], 'hemolysis': u'100% hemolysis at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1476']}, u'FLKWLFKWLKK': {'modifications': ['C-Terminal'], 'references': [u'Activity optimization of an undecapeptide analogue derived from a frog-skin antimicrobial peptide. Won HS,Kang SJ,Choi WS Mol Cells. 2011 Jan;31(1):49-54. doi: 10.1007/s10059-011-0005-y. Epub 2010 Nov 23.'], 'hemolysis': u'MHC =12.5\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1558']}, u'KWKSFLkTFKSLKKTVLHTLLKAISS': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', u'Stereochemistry: Mix'], 'references': [u'Role of helicity on the anticancer mechanism of action of cationic-helical peptides. Huang YB,He LY,Jiang HY Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849. Epub 2012 Jun 5.'], 'hemolysis': u'MHC = 10.4 \xb1 0.04\u03bcmol/L', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2635']}, u'KKLFKKIlkyl': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Improvement of the efficacy of linear undecapeptides against plant-pathogenic bacteria by incorporation of D-amino acids. Guell I,Cabrefiga J,Badosa E,Ferre R,Talleda M,Bardaji E,Planas M,Feliu L Appl Environ Microbiol. 2011 Apr;77(8):2667-75. doi: 10.1128/AEM.02759-10. Epub 2011 Feb 18.'], 'hemolysis': u'3\xb10.1% hemolytic at 250\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2864']}, u'KWKKLLKKLLpLLKKLLK': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Effects of L- or D-Pro incorporation into hydrophobic or hydrophilic helix face of amphipathic alpha-helical model peptide on structure and cell selectivity. Song YM,Yang ST,Lim SS,Kim Y,Hahm KS,Kim JI Biochem Biophys Res Commun. 2004 Feb 6;314(2):615-21.'], 'hemolysis': u'>30% hemolysis  at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1577']}, u'ILGIITSLLKSL': {'modifications': ['C-Terminal'], 'references': [u'Venom peptides from solitary hunting wasps induce feeding disorder in lepidopteran larvae. Baek JH,Ji Y,Shin JS,Lee S Peptides. 2011 Mar;32(3):568-72. doi: 10.1016/j.peptides.2010.12.007. Epub 2010 Dec 22.'], 'hemolysis': u'EC50 = 31 (23\u201341)\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2056']}, u'MKLSCLLLTLTIIFVLTIVHAPNVEAKDLADPESEAVGFADAVGEADPGLGS': {'modifications': [], 'references': [u'Molecular cloning and biological characterization of novel antimicrobial peptides, pilosulin 3 and pilosulin 4, from a species of the Australian ant genus Myrmecia. Inagaki H,Akagi M,Imai HT,Taylor RW Arch Biochem Biophys. 2004 Aug 15;428(2):170-8.'], 'hemolysis': u'No hemolysis at 50\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1879']}, u'ILGKILKGIKKLF': {'modifications': ['C-Terminal'], 'references': [u'Antibiotic activity and structural analysis of the scorpion-derived antimicrobial peptide IsCT and its analogs. Lee K,Shin SY,Kim K,Lim SS,Hahm KS Biochem Biophys Res Commun. 2004 Oct 15;323(2):712-9.'], 'hemolysis': u'~20% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2399']}, u'KkLFKKILKYL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Improvement of the efficacy of linear undecapeptides against plant-pathogenic bacteria by incorporation of D-amino acids. Guell I,Cabrefiga J,Badosa E,Ferre R,Talleda M,Bardaji E,Planas M,Feliu L Appl Environ Microbiol. 2011 Apr;77(8):2667-75. doi: 10.1128/AEM.02759-10. Epub 2011 Feb 18.'], 'hemolysis': u'51\xb10.5% hemolytic at 250\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2855']}, u'FAKWAFKWLKK': {'modifications': ['C-Terminal'], 'references': [u'Activity optimization of an undecapeptide analogue derived from a frog-skin antimicrobial peptide. Won HS,Kang SJ,Choi WS Mol Cells. 2011 Jan;31(1):49-54. doi: 10.1007/s10059-011-0005-y. Epub 2010 Nov 23.'], 'hemolysis': u'MHC \u2265200\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1560']}, u'KWKSFIKKLLSKFLHSAKKF': {'modifications': ['C-Terminal'], 'references': [u'The Design and Construction of K11: A Novel ?-Helical Antimicrobial Peptide. Jin-Jiang H,Jin-Chun L,Min L,Qing-Shan H Int J Microbiol. 2012;2012:764834. doi: 10.1155/2012/764834. Epub 2012 Feb 16.'], 'hemolysis': u'MHC <125 \u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2723']}, u'GFLSSLKKSLPKVXAHXK': {'modifications': ['C-Terminal'], 'references': [u'Effect of hydrocarbon stapling on the properties of ?-helical antimicrobial peptides isolated from the venom of hymenoptera. Chapuis H,Slaninova J,Bednarova L,Monincova L,Budesinsky M Amino Acids. 2012 Nov;43(5):2047-58. doi: 10.1007/s00726-012-1283-1. Epub 2012 Apr 17.'], 'hemolysis': u'LC50  = 14.7\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2749']}, u'INWLKLGKKILGAI': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 =75\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3907']}, u'GLMDTVKNAAKNLAGQMLDKLKCKITGSC': {'modifications': [], 'references': [u'Primary structures of skin antimicrobial peptides indicate a close, but not conspecific, phylogenetic relationship between the leopard frogs Lithobates onca and Lithobates yavapaiensis (Ranidae). Conlon JM,Coquet L,Leprince J,Jouenne T,Vaudry H Comp Biochem Physiol C Toxicol Pharmacol. 2010 Apr;151(3):313-7. doi: 10.1016/j.cbpc.2009.12.004. Epub 2009 Dec 31.'], 'hemolysis': u'LD50 =90\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1069']}, u'ILPYKYPYYPYRR': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship of indolicidin, a Trp-rich antibacterial peptide. Ando S,Mitsuyasu K,Soeda Y,Hidaka M,Ito Y,Matsubara K,Shindo M,Uchida Y J Pept Sci. 2010 Apr;16(4):171-7. doi: 10.1002/psc.1217.'], 'hemolysis': u'4% hemolysis at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1478']}, u'FLPLLAGLAANFLPKIFCKITRKC': {'modifications': [], 'references': [u'Novel antimicrobial peptides from skin secretion of the European frog Rana esculenta. Simmaco M,Mignogna G,Barra D, Bossa FEBS Lett. 1993 Jun 14;324(2):159-61.'], 'hemolysis': u'LC50 =5\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3683']}, u'RGGRLCYCRPRFCVCVGR': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'>50% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1166']}, u'FVKLKKILNIINSIFKK': {'modifications': [], 'references': [u'Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEa. Yang QZ,Wang C,Lang L,Zhou Y,Wang H Arch Pharm Res. 2013 Apr 23.'], 'hemolysis': u'LC50 =86.99\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2575']}, u'FFGHLFKLATKIIPSLFQ': {'modifications': [], 'references': [u'Structural and functional characterization of two genetically related meucin peptides highlights evolutionary divergence and convergence in antimicrobial peptides. Gao B,Sherman P,Luo L,Bowie J FASEB J. 2009 Apr;23(4):1230-45. doi: 10.1096/fj.08-122317. Epub 2008 Dec 16.'], 'hemolysis': u'>95% hemolysis at 25\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3618']}, u'GIHDILKYGKPS': {'modifications': [], 'references': [u'Myxinidin, a novel antimicrobial peptide from the epidermal mucus of hagfish, Myxine glutinosa L. Subramanian S,Ross NW Mar Biotechnol (NY). 2009 Nov-Dec;11(6):748-57. doi: 10.1007/s10126-009-9189-y. Epub 2009 Mar 31.'], 'hemolysis': u'0% hemolysis at 1-500\u03bcg/ml  (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1290']}, u'KRFKKFFKKLK': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial and antibiofilm activity of cathelicidins and short, synthetic peptides against Francisella. Amer LS,Bishop BM Biochem Biophys Res Commun. 2010 May 28;396(2):246-51. doi: 10.1016/j.bbrc.2010.04.073. Epub 2010 Apr 23.'], 'hemolysis': u'EC50 =5.98\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3062']}, u'SWLRDLWDWICEVLSDFK': {'modifications': [], 'references': [u'Rational design of peptides with anti-HCV/HIV activities and enhanced specificity. Li GR,He LY,Liu XY,Liu AP,Huang YB,Qiu C,Zhang XY,Xu JQ,Yang W Chem Biol Drug Des. 2011 Nov;78(5):835-43. doi: 10.1111/j.1747-0285.2011.01201.x. Epub 2011 Sep 26.'], 'hemolysis': u'MHC = 13.84\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2946']}, u'KWKSFIKKAKTSFLHSAKKF': {'modifications': ['C-Terminal'], 'references': [u'The Design and Construction of K11: A Novel ?-Helical Antimicrobial Peptide. Jin-Jiang H,Jin-Chun L,Min L,Qing-Shan H Int J Microbiol. 2012;2012:764834. doi: 10.1155/2012/764834. Epub 2012 Feb 16.'], 'hemolysis': u'MHC >500\u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2722']}, u'GFLSILKKVLPKSXAHSK': {'modifications': ['C-Terminal'], 'references': [u'Effect of hydrocarbon stapling on the properties of ?-helical antimicrobial peptides isolated from the venom of hymenoptera. Chapuis H,Slaninova J,Bednarova L,Monincova L,Budesinsky M Amino Acids. 2012 Nov;43(5):2047-58. doi: 10.1007/s00726-012-1283-1. Epub 2012 Apr 17.'], 'hemolysis': u'LC50 = 18.1\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2748']}, u'IWRIFR': {'modifications': ['C-Terminal'], 'references': [u'Biochemical property and membrane-peptide interactions of de novo antimicrobial peptides designed by helix-forming units. Ma QQ,Dong N,Shan AS,Lv YF,Li YZ,Chen ZH,Cheng BJ Amino Acids. 2012 Dec;43(6):2527-36. doi: 10.1007/s00726-012-1334-7. Epub 2012 Jun 15.'], 'hemolysis': u'MHC > 256 \u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4189']}, u'RGGRLVYTRp*RFTVIVGR': {'modifications': ['C-Terminal', u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'Roles of salt and conformation in the biological and physicochemical behavior of protegrin-1 and designed analogues: correlation of antimicrobial, hemolytic, and lipid bilayer-perturbing activities. Lai JR, Epand, Raquel ,Epand RF,Weisblum B,Epand RM Biochemistry. 2006 Dec 26;45(51):15718-30. Epub 2006 Dec 1.'], 'hemolysis': u'~20% hemolysis at above 100\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1735']}, u'FALLGDFFRKSKEKIGKEFKRIVKRIKDFFRNLVPRTES': {'modifications': [], 'references': [u'PCR-based site-specific mutagenesis of peptide antibiotics FALL-39 and its biologic activities. Yang YX,Feng Y,Wang BY Acta Pharmacol Sin. 2004 Feb;25(2):239-45.'], 'hemolysis': u'>35% hemolysis at 400g/l', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1583']}, u'ILGKLLSTAAKLLSNL': {'modifications': ['C-Terminal'], 'references': [u'Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent. Conlon JM,Mechkarska M,Prajeep M,Arafat K,Zaric M,Lukic ML Amino Acids. 2013 Feb;44(2):715-23. doi: 10.1007/s00726-012-1395-7. Epub 2012 Sep 11.'], 'hemolysis': u'LC50 =24\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3172']}, u'ILPWKWPAAPARR': {'modifications': ['C-Terminal'], 'references': [u'The effects of tryptophan and hydrophobicity on the structure and bioactivity of novel indolicidin derivatives with promising pharmaceutical potential. Podorieszach AP Org Biomol Chem. 2010 Apr 7;8(7):1679-87. doi: 10.1039/b921248e. Epub 2010 Feb 11.'], 'hemolysis': u'MHC = >6.7x10-3 g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1498']}, u'WLGSALKIGAKLLPSVVGLFKKKKQ': {'modifications': [], 'references': [u'Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii. Orivel J,Redeker V,Le Caer JP, Krier, ,Krier F,Revol-Junelles AM,Longeon A,Chaffotte A,Dejean A J Biol Chem. 2001 May 25;276(21):17823-9. Epub 2001 Feb 22.'], 'hemolysis': u'zone of inhibition (1 mm) at 0.4-0.5mM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2112']}, u'GFLSILKKVLP': {'modifications': ['C-Terminal'], 'references': [u'Melectin: a novel antimicrobial peptide from the venom of the cleptoparasitic bee Melecta albifrons. Cerovsky V,Hovorka O,Cvacka J,Voburka Z,Bednarova L,Borovickova L,Slaninova J Chembiochem. 2008 Nov 24;9(17):2815-21. doi: 10.1002/cbic.200800476.'], 'hemolysis': u'LC50 >100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3630']}, u'SSLLEKGLDGAKKAVGGLGKLGKDA': {'modifications': [], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC >100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3963']}, u'GFFALIPKIISSPLFKTLLSAVGSALSSSGG': {'modifications': [], 'references': [u'A class of highly potent antibacterial peptides derived from pardaxin, a pore-forming peptide isolated from Moses sole fish Pardachirus marmoratus. Oren Z Eur J Biochem. 1996 Apr 1;237(1):303-10.'], 'hemolysis': u'>50% hemolysis at 50\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3674']}, u'RLRKAVRLIK': {'modifications': [], 'references': [u'Effects of positively charged arginine residues on membrane pore forming activity of Rev-NIS peptide in bacterial cells. Lee J,Choi H,Cho J Biochim Biophys Acta. 2011 Oct;1808(10):2421-7. doi: 10.1016/j.bbamem.2011.06.024. Epub 2011 Jul 6.'], 'hemolysis': u'0% hemolytic upto 100\u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3000']}, u'CSCKNKVCYRNGVIPCGESCVFIPCISTLLG': {'modifications': ['Cyclic'], 'references': [u'An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides. Tam JP,Lu YA,Yang JL Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):8913-8.'], 'hemolysis': u'50% hemolysis at >400\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3398']}, u'LKWKSIVSWAKKVL': {'modifications': ['C-Terminal'], 'references': [u'Evaluating antioxidative activities of amino acid substitutions on mastoparan-B. Yang MJ,Lin WY,Lu KH Peptides. 2011 Oct;32(10):2037-43. doi: 10.1016/j.peptides.2011.08.026. Epub 2011 Sep 8.'], 'hemolysis': u'Non-hemolytic', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2001']}, u'ILGPVISTIGGVLGGLLKNL': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima. Lai R,Zheng YT,Shen JH,Liu GJ,Liu H,Lee WH,Tang SZ Peptides. 2002 Mar;23(3):427-35.'], 'hemolysis': u'90-100% hemolysis at 50\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3428']}, u'ILGKIWKIKKLF': {'modifications': ['C-Terminal'], 'references': [u'Antibiotic activity and structural analysis of the scorpion-derived antimicrobial peptide IsCT and its analogs. Lee K,Shin SY,Kim K,Lim SS,Hahm KS Biochem Biophys Res Commun. 2004 Oct 15;323(2):712-9.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2400']}, u'GLNALKKVFQGIHEAIKLINNHVQ': {'modifications': [], 'references': [u'Pseudin-2: an antimicrobial peptide with low hemolytic activity from the skin of the paradoxical frog. Olson L 3rd,Soto AM,Knoop FC Biochem Biophys Res Commun. 2001 Nov 9;288(4):1001-5.'], 'hemolysis': u'EC50 >300\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3527']}, u'GLMDVFKGAAKNLLASALDKIRCKVTKC': {'modifications': [], 'references': [u'A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica. Conlon JM,Sonnevend A,Patel M,Al-Dhaheri K, Nielsen, Per ,Nielsen PF,Kolodziejek J,Nowotny N,Iwamuro S Regul Pept. 2004 May 15;118(3):135-41.'], 'hemolysis': u'HC50 = 150\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1994']}, u'KSLRRVWRSWR': {'modifications': ['C-Terminal'], 'references': [u'Discovery of potent antimicrobial peptide analogs of Ixosin-B. Lung FD,Wang KS,Liao ZJ,Hsu SK,Song FY,Liou CC Bioorg Med Chem Lett. 2012 Jun 15;22(12):4185-8. doi: 10.1016/j.bmcl.2012.04.018. Epub 2012 Apr 20.'], 'hemolysis': u'0% hemolytic at 100\u03bcM (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2766']}, u'LNWGAVLKHVVK': {'modifications': ['C-Terminal'], 'references': [u'Panurgines, novel antimicrobial peptides from the venom of communal bee Panurgus calcaratus (Hymenoptera: Andrenidae). Cujova S,Slaninova J,Monincova L,Fucik V,Bednarova L,Stokrova J,Hovorka O,Voburka Z,Straka J Amino Acids. 2013 Jul;45(1):143-57. doi: 10.1007/s00726-013-1482-4. Epub 2013 Mar 13.'], 'hemolysis': u'LC50 >200\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3731']}, u'GMATAAGTTLGKLAKFVIGAV': {'modifications': ['C-Terminal'], 'references': [u'Host-defense peptides in skin secretions of the tetraploid frog Silurana epitropicalis with potent activity against methicillin-resistant Staphylococcus aureus (MRSA). Conlon JM,Mechkarska M,Prajeep M,Sonnevend A,Coquet L,Leprince J,Jouenne T,Vaudry H Peptides. 2012 Sep;37(1):113-9. doi: 10.1016/j.peptides.2012.07.005. Epub 2012 Jul 16.'], 'hemolysis': u'LC50 >160\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3153']}, u'LNWGAAbuLKHAbuAbuK': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Panurgines, novel antimicrobial peptides from the venom of communal bee Panurgus calcaratus (Hymenoptera: Andrenidae). Cujova S,Slaninova J,Monincova L,Fucik V,Bednarova L,Stokrova J,Hovorka O,Voburka Z,Straka J Amino Acids. 2013 Jul;45(1):143-57. doi: 10.1007/s00726-013-1482-4. Epub 2013 Mar 13.'], 'hemolysis': u'LC50 >200\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3732']}, u'FLWWLFKWAWK': {'modifications': ['C-Terminal'], 'references': [u'Activity optimization of an undecapeptide analogue derived from a frog-skin antimicrobial peptide. Won HS,Kang SJ,Choi WS Mol Cells. 2011 Jan;31(1):49-54. doi: 10.1007/s10059-011-0005-y. Epub 2010 Nov 23.'], 'hemolysis': u'MHC =25\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1555']}, u'GLFGKLIKKKGRKAISYAVKKARGKH': {'modifications': [], 'references': [u'N-terminal amphipathic helix as a trigger of hemolytic activity in antimicrobial peptides: a case study in latarcins. Polyansky AA,Vassilevski AA,Volynsky PE,Vorontsova OV,Samsonova OV,Egorova NS,Krylov NA,Feofanov AV,Arseniev AS,Grishin EV FEBS Lett. 2009 Jul 21;583(14):2425-8. doi: 10.1016/j.febslet.2009.06.044. Epub 2009 Jun 27.'], 'hemolysis': u'EC50 >36\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1444']}, u'GFLSILKKVLPKVMet(O)AHMet(O)K': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Melectin MAPs: the influence of dendrimerization on antimicrobial and hemolytic activity. Niederhafner P,Bednarova L,Budesinsky M,Safarik M,Ehala S,Jezek J,Borovickova L,Fucik V,Cerovsky V Amino Acids. 2010 Nov;39(5):1553-61. doi: 10.1007/s00726-010-0626-z. Epub 2010 May 25.'], 'hemolysis': u'LC50 >200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1508']}, u'ICYCRRRFCVCVGR': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'>50% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1199']}, u'RGGRLCYCRRRFCVCY': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'>50% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1203']}, u'GVVDILKGAAKDIAGHLASKVMNKL': {'modifications': ['C-Terminal'], 'references': [u'An antimicrobial peptide from the skin secretions of the mountain chicken frog Leptodactylus fallax (Anura:Leptodactylidae). Rollins-Smith LA,King JD, Nielsen, Per ,Nielsen PF,Sonnevend A Regul Pept. 2005 Jan 15;124(1-3):173-8.'], 'hemolysis': u'HC50 >200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1052']}, u'RGGRLCYCRRRFCVCR': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'3-6% hemolysis at 80\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1173']}, u'RGGRLCYCRRRFCVCW': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'>50% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1209']}, u'RGGRLCYCRRRFCVCV': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'>50% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1171']}, u'RGGRLCYCRRRFCVCT': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'12-25% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1204']}, u'KWKSFIKKLASKFLHSAKKF': {'modifications': ['C-Terminal'], 'references': [u'The Design and Construction of K11: A Novel ?-Helical Antimicrobial Peptide. Jin-Jiang H,Jin-Chun L,Min L,Qing-Shan H Int J Microbiol. 2012;2012:764834. doi: 10.1155/2012/764834. Epub 2012 Feb 16.'], 'hemolysis': u'MHC= 250 \u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2724']}, u'KLKLKLKLK': {'modifications': ['C-Terminal', u'N-Terminal Modification: Dansylation'], 'references': [u'Ideally amphipathic beta-sheeted peptides at interfaces: structure, orientation, affinities for lipids and hemolytic activity of (KL)(m)K peptides. Castano S,Desbat B Biochim Biophys Acta. 2000 Jan 15;1463(1):65-80.'], 'hemolysis': u'>20% hemolysis at 10\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2009']}, u'AAAAAAAAAAGIGKFLHSAKKFGKAFVGEIMNS': {'modifications': [], 'references': [u'Augmentation of the antibacterial activity of magainin by positive-charge chain extension. Bessalle R,Haas H,Goria A,Shalit I Antimicrob Agents Chemother. 1992 Feb;36(2):313-7.'], 'hemolysis': u'9% hemolysis upto 200\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3436']}, u'RGGRLCYCRRRFCVCL': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'>50% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1206']}, u'RGGRLCYCRRRFCVCA': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'25-50% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1205']}, u'FKTWKRPPFQTSCSGIIKE': {'modifications': [], 'references': [u'Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata. Ma Y,Liu C,Liu X,Wu J,Yang H,Wang Y,Li J,Yu H Genomics. 2010 Jan;95(1):66-71. doi: 10.1016/j.ygeno.2009.09.004. Epub 2009 Sep 22.'], 'hemolysis': u'0% hemolysis at 100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4022']}, u'RGGRLCYCRRRFCVCF': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'>50% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1208']}, u'RGGRLCYCRRRFCVCE': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'0-3% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1210']}, u'KWKKLLKKLLPLLKKLLKKLK': {'modifications': ['C-Terminal'], 'references': [u'Contribution of a central proline in model amphipathic alpha-helical peptides to self-association, interaction with phospholipids, and antimicrobial mode of action. Yang ST,Lee JY,Kim HJ,Eu YJ,Shin SY,Hahm KS FEBS J. 2006 Sep;273(17):4040-54. Epub 2006 Aug 2.'], 'hemolysis': u'21%  hemolysis at 50\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1706']}, u'FPtBuGlyOtBuAlafPtBuGlyOtBuAla': {'modifications': ['Cyclic', u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'An adamantyl amino acid containing gramicidin S analogue with broad spectrum antibacterial activity and reduced hemolytic activity. Kapoerchan VV,Knijnenburg AD,Niamat M,Spalburg E,de Neeling AJ,Nibbering PH,Mars-Groenendijk RH,Noort D,Otero JM,Llamas-Saiz AL,van Raaij MJ,van der Marel GA,Overkleeft HS Chemistry. 2010 Oct 25;16(40):12174-81. doi: 10.1002/chem.201001686.'], 'hemolysis': u'HC50 =9.30\xb11.07\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2796']}, u'FCYCRRRFCVCVGR': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'>50% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1200']}, u'kklfkKILKYL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Improvement of the efficacy of linear undecapeptides against plant-pathogenic bacteria by incorporation of D-amino acids. Guell I,Cabrefiga J,Badosa E,Ferre R,Talleda M,Bardaji E,Planas M,Feliu L Appl Environ Microbiol. 2011 Apr;77(8):2667-75. doi: 10.1128/AEM.02759-10. Epub 2011 Feb 18.'], 'hemolysis': u'8\xb15.0% hemolytic at 250\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2872']}, u'CGETCVGGTCNTPGCTCSWPVCTRNGLPV': {'modifications': ['Cyclic'], 'references': [u'Chemical synthesis and folding pathways of large cyclic polypeptides: studies of the cystine knot polypeptide kalata B1. Daly NL,Love S, Alewood, P ,Alewood PF Biochemistry. 1999 Aug 10;38(32):10606-14.'], 'hemolysis': u'HD50 =50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4135']}, u'KLLKKLLKLWKKLLKKLK': {'modifications': [], 'references': [u'Design and synthesis of amphiphilic alpha-helical model peptides with systematically varied hydrophobic-hydrophilic balance and their interaction with lipid- and bio-membranes. Kiyota T,Lee S Biochemistry. 1996 Oct 8;35(40):13196-204.'], 'hemolysis': u'~60% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3470']}, u'LLIILRRRWRKQAKAKSK': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial activity, bactericidal mechanism and LPS-neutralizing activity of the cell-penetrating peptide pVEC and its analogs. Nan YH,Park IS,Hahm KS J Pept Sci. 2011 Dec;17(12):812-7. doi: 10.1002/psc.1408. Epub 2011 Sep 29.'], 'hemolysis': u'>10% hemolytic at 200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2970']}, u'GFMKYIGPLIPHAVKAISDLI': {'modifications': [], 'references': [u'Antimicrobial and cytolytic properties of the frog skin peptide, kassinatuerin-1 and its L- and D-lysine-substituted derivatives. Conlon JM,Abraham B,Galadari S,Knoop FC,Sonnevend A Peptides. 2005 Nov;26(11):2104-10.'], 'hemolysis': u'39% hemolysis at 400\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4078']}, u'FFHHIFRPIVHVAKTIHRLVTG': {'modifications': [], 'references': [u'Solution structure and cell selectivity of piscidin 1 and its analogues. Lee SA,Kim YK,Lim SS,Zhu WL,Ko H,Shin SY,Hahm KS Biochemistry. 2007 Mar 27;46(12):3653-63. Epub 2007 Mar 1.'], 'hemolysis': u'HC50 =32\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1117']}, u'RHARHD': {'modifications': [], 'references': [u'Hannahpep: A novel fibrinolytic peptide from the Indian King Cobra (Ophiophagus hannah) venom. Gomes A Biochem Biophys Res Commun. 1999 Dec 20;266(2):488-91.'], 'hemolysis': u'No hemolysis (non hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3579']}, u'HFLkTLVNLAKKIL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Strategies for transformation of naturally-occurring amphibian antimicrobial peptides into therapeutically valuable anti-infective agents. Conlon JM,Al-Ghaferi N,Abraham B Methods. 2007 Aug;42(4):349-57.'], 'hemolysis': u'LD50 = 110\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1804']}, u'GLLSGTSVRGSI': {'modifications': [], 'references': [u'Anti-infection peptidomics of amphibian skin. Li J,Xu X,Xu C,Zhou W,Zhang K,Yu H,Zhang Y,Zheng Y,Rees HH,Lai R,Yang D Mol Cell Proteomics. 2007 May;6(5):882-94. Epub 2007 Jan 31.'], 'hemolysis': u'23.9\xb14.7% hemolysis at 50\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3647']}, u'GLPVCGETCVGGTCNTPGCTCSKPVCTRN': {'modifications': ['Cyclic'], 'references': [u'Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities. Henriques ST,Huang YH,Rosengren KJ,Franquelim HG,Carvalho FA,Johnson A,Sonza S,Tachedjian G,Castanho MA,Daly NL J Biol Chem. 2011 Jul 8;286(27):24231-41. doi: 10.1074/jbc.M111.253393. Epub 2011 May 16.'], 'hemolysis': u'2.4\xb10.7% hemolytic at 25\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3012']}, u'PKLLKTFLKWIG': {'modifications': [], 'references': [u'Addition and omission analogs of the 13-residue antibacterial and hemolytic peptide PKLLKTFLSKWIG: structural preferences, model membrane binding and biological activities. Bikshapathy E,Sitaram N J Pept Res. 1999 Jan;53(1):47-55.'], 'hemolysis': u'100% hemolysis at >330\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3840']}, u'PKLLKFLSKWIG': {'modifications': [], 'references': [u'Addition and omission analogs of the 13-residue antibacterial and hemolytic peptide PKLLKTFLSKWIG: structural preferences, model membrane binding and biological activities. Bikshapathy E,Sitaram N J Pept Res. 1999 Jan;53(1):47-55.'], 'hemolysis': u'100% hemolysis at 63\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3839']}, u'FKRLEKLFKKIWNWK': {'modifications': [], 'references': [u'Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions. Park SC,Kim MH,Hossain MA,Shin SY,Kim Y,Stella L,Wade JD,Park Y Biochim Biophys Acta. 2008 Jan;1778(1):229-41. Epub 2007 Oct 2.'], 'hemolysis': u'14.92% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1824']}, u'GKGRWLERIGKAGGIIIGGALDHL': {'modifications': ['C-Terminal'], 'references': [u'The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents. Morash MG,Douglas SE,Robotham A,Ridley CM,Gallant JW Dis Model Mech. 2011 Sep;4(5):622-33. doi: 10.1242/dmm.007310. Epub 2011 Jul 4.'], 'hemolysis': u'50% hemolytic at >256 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2916']}, u'GFTicOicGKTicOicGFTicOicGKTicKKKKK': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', 'Non-Natural'], 'references': [u'De novo design of selective antibiotic peptides by incorporation of unnatural amino acids. Hicks RP,Bhonsle JB,Venugopal D,Koser BW J Med Chem. 2007 Jun 28;50(13):3026-36. Epub 2007 Jun 5.'], 'hemolysis': u'18.9% hemolysis at 25\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1788']}, u'LAYCRRRFCVAV': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'0-3% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1178']}, u'VKLlVyPLKVKLyP': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Effects of single D-amino acid substitutions on disruption of beta-sheet structure and hydrophobicity in cyclic 14-residue antimicrobial peptide analogs related to gramicidin S. Lee DL,Powers JP,Pflegerl K,Vasil ML,Hancock RE J Pept Res. 2004 Feb;63(2):69-84.'], 'hemolysis': u'MHC =5 \xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1585']}, u'fPVKLKfPKVKL': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Modulation of structure and antibacterial and hemolytic activity by ring size in cyclic gramicidin S analogs. Kondejewski LH,Farmer SW,Wishart DS,Kay CM,Hancock RE J Biol Chem. 1996 Oct 11;271(41):25261-8.'], 'hemolysis': u'100% hemolysis at 400\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3670']}, u'VFQFLGKIIKKVGNFVKGFSKVF': {'modifications': [], 'references': [u'Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides. Yasin B,Pang M,Turner JS,Cho Y,Dinh NN,Waring AJ,Lehrer RI Eur J Clin Microbiol Infect Dis. 2000 Mar;19(3):187-94.'], 'hemolysis': u'30.6% hemolysis at 80\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2448']}, u'FVQWFSKFLGOIL': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Structure-activity relationship, conformational and biological studies of temporin L analogues. Mangoni ML,Carotenuto A,Auriemma L,Saviello MR,Campiglia P,Gomez-Monterrey I,Malfi S,Marcellini L,Barra D,Novellino E J Med Chem. 2011 Mar 10;54(5):1298-307. doi: 10.1021/jm1012853. Epub 2011 Feb 14.'], 'hemolysis': u'22% hemolytic at 6\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2840']}, u'LKLkSIVSWAKKVL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'Enhancing the hypotensive effect and diminishing the cytolytic activity of hornet mastoparan B by D-amino acid substitution. Ho CL,Shih YP,Wang KT Toxicon. 2001 Oct;39(10):1561-6.'], 'hemolysis': u'87-85% hemolysis at 15 \xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1980']}, u'GIFSKINKKKAKTGLFNIIKTVGKEAGMDVIRAGIDTISCKIKGEC': {'modifications': [], 'references': [u'Antimicrobial peptides and protease inhibitors in the skin secretions of the crawfish frog, Rana areolata. Ali, Mohamed ,Ali MF,Lips KR,Knoop FC,Fritzsch B,Miller C Biochim Biophys Acta. 2002 Nov 19;1601(1):55-63.'], 'hemolysis': u'HC50 = 180\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2478']}, u'GASLSFKILKTVLEALGNVKRK': {'modifications': [], 'references': [u'Structure and activity of the N-terminal region of the eukaryotic cytolysin equinatoxin II. Drechsler A,Potrich C,Sabo JK,Frisanco M,Guella G,Dalla Serra M,Anderluh G,Separovic F Biochemistry. 2006 Feb 14;45(6):1818-28.'], 'hemolysis': u'Non-hemolytic', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1904']}, u'SFHVFPPWMCKSLKKC': {'modifications': [], 'references': [u'Limnonectins: a new class of antimicrobial peptides from the skin secretion of the Fujian large-headed frog (Limnonectes fujianensis). Wu Y,Wang L,Zhou M,Ma C,Chen X,Bai B,Chen T Biochimie. 2011 Jun;93(6):981-7. doi: 10.1016/j.biochi.2011.03.003. Epub 2011 Mar 17.'], 'hemolysis': u'0% hemolysis upto 160\u03bcM (Non hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3781']}, u'KILRGVCKKIMRTFLRRISKDILTGKK': {'modifications': ['C-Terminal'], 'references': [u'The antimicrobial peptide NK-2, the core region of mammalian NK-lysin, kills intraerythrocytic Plasmodium falciparum. Gelhaus C,Jacobs T,Andra J Antimicrob Agents Chemother. 2008 May;52(5):1713-20. doi: 10.1128/AAC.01342-07. Epub 2008 Mar 10.'], 'hemolysis': u'No hemolysis upto 10\u03bcM (non hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3576']}, u'ACYCRRRFCVCVGR': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'25-50% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1197']}, u'VOLhpaPVOLhpaP': {'modifications': ['Cyclic', u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'Therapeutic index of gramicidin S is strongly modulated by D-phenylalanine analogues at the beta-turn. Solanas C,de la Torre BG,Fernandez-Reyes M,Santiveri CM,Jimenez MA,Rivas L,Jimenez AI,Andreu D J Med Chem. 2009 Feb 12;52(3):664-74. doi: 10.1021/jm800886n.'], 'hemolysis': u'HC50=7.0(\xb10.3)\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1284']}, u'GLWDTIKQAGKKFFLNVLDKIRCKVAGGCRT': {'modifications': [], 'references': [u'Effects of thioredoxin: SUMO and intein on soluble fusion expression of an antimicrobial peptide OG2 in Escherichia coli. Xie YG,Luan C,Zhang HW,Han FF,Feng J,Choi YJ,Groleau D Protein Pept Lett. 2013 Jan;20(1):54-60.'], 'hemolysis': u'10% hemolytic at 4 \u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2667']}, u'ILPLKLPWLPLRR': {'modifications': ['C-Terminal'], 'references': [u'Antibacterial and hemolytic activities of single tryptophan analogs of indolicidin. Subbalakshmi C,Bikshapathy E,Sitaram N Biochem Biophys Res Commun. 2000 Aug 11;274(3):714-6.'], 'hemolysis': u'0% hemolysis at 100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1040']}, u'KLKLKLKLKLK': {'modifications': ['C-Terminal', u'N-Terminal Modification: Dansylation'], 'references': [u'Ideally amphipathic beta-sheeted peptides at interfaces: structure, orientation, affinities for lipids and hemolytic activity of (KL)(m)K peptides. Castano S,Desbat B Biochim Biophys Acta. 2000 Jan 15;1463(1):65-80.'], 'hemolysis': u'60% hemolysis at 10\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2010']}, u'lKlKlKlK': {'modifications': [u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'Antiplasmodial activity of lauryl-lysine oligomers. Radzishevsky I,Krugliak M,Ginsburg H Antimicrob Agents Chemother. 2007 May;51(5):1753-9. Epub 2007 Feb 16.'], 'hemolysis': u'26.1\xb14.5% hemolysis at 100 \u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1101']}, u'FLFSLIPKAIGGLISAFK': {'modifications': [], 'references': [u'Antimicrobial/cytolytic peptides from the venom of the North African scorpion, Androctonus amoreuxi: biochemical and functional characterization of natural peptides and a single site-substituted analog. Almaaytah A,Zhou M,Wang L,Chen T,Walker B Peptides. 2012 Jun;35(2):291-9. doi: 10.1016/j.peptides.2012.03.016. Epub 2012 Mar 28.'], 'hemolysis': u'53% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2089']}, u'FKDLKKIANIINSIFKK': {'modifications': [], 'references': [u'Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEa. Yang QZ,Wang C,Lang L,Zhou Y,Wang H Arch Pharm Res. 2013 Apr 23.'], 'hemolysis': u'LC50 =1,186\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2572']}, u'CH3ScklllkwllkllkcSCH3': {'modifications': [u'Stereochemistry: D'], 'references': [u'Cyclization of a cytolytic amphipathic alpha-helical peptide and its diastereomer: effect on structure, interaction with model membranes, and biological function. Oren Z Biochemistry. 2000 May 23;39(20):6103-14.'], 'hemolysis': u'5% hemolytic at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2535']}, u'LLKKLLKKLLKKLLKK': {'modifications': ['C-Terminal'], 'references': [u'Synthetic cationic amphiphilic ?-helical peptides as antimicrobial agents. Wiradharma N,Khoe U,Hauser CA,Seow SV,Zhang S Biomaterials. 2011 Mar;32(8):2204-12. doi: 10.1016/j.biomaterials.2010.11.054. Epub 2010 Dec 18.'], 'hemolysis': u'HC50 > ~24', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2054']}, u'CYCFRRFCVC': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'0-3% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1190']}, u'KfKLKQ': {'modifications': ['Cyclic', u'Stereochemistry: D'], 'references': [u'De novo designed cyclic cationic peptides as inhibitors of plant pathogenic bacteria. Monroc S,Badosa E,Feliu L,Planas M,Montesinos E Peptides. 2006 Nov;27(11):2567-74. Epub 2006 May 30.'], 'hemolysis': u'0% hemolysis at 360\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1908']}, u'WKSDVRRWRSRY': {'modifications': [], 'references': [u'Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide. Wu YS,Liao ZJ,Wang KS Bioorg Med Chem Lett. 2013 May 15;23(10):2929-32. doi: 10.1016/j.bmcl.2013.03.053. Epub 2013 Mar 25.'], 'hemolysis': u'0.3 \xb10.9% hemolytic at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2577']}, u'GLKkIFKAGLGSLVKGIAAHVAS': {'modifications': [u'Stereochemistry: Mix'], 'references': [u'Potent and rapid bactericidal action of alyteserin-1c and its [E4K] analog against multidrug-resistant strains of Acinetobacter baumannii. Conlon JM,Ahmed E,Pal T Peptides. 2010 Oct;31(10):1806-10. doi: 10.1016/j.peptides.2010.06.032. Epub 2010 Jul 11.'], 'hemolysis': u'LC50 >400\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3077']}, u'GrrkrkWLrrIGkGVkIIGGAALDHL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents. Morash MG,Douglas SE,Robotham A,Ridley CM,Gallant JW Dis Model Mech. 2011 Sep;4(5):622-33. doi: 10.1242/dmm.007310. Epub 2011 Jul 4.'], 'hemolysis': u'50% hemolytic at >256 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2942']}, u'IL(Nlys)WKW(Nlys)WW(Nlys)WRR': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC >200\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3948']}, u'GIGAVLKVLTTGLpALISWIKXKRQQ': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', u'Stereochemistry: Mix'], 'references': [u'Structure and activity of D-Pro14 melittin. Hewish DR,Barnham KJ,Werkmeister JA,Kirkpatrick A,Bartone N,Liu ST,Norton RS,Curtain C J Protein Chem. 2002 May;21(4):243-53.'], 'hemolysis': u'50% hemolysis at >200\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2475']}, u'FIGAIARLLSKIF': {'modifications': [], 'references': [u'Antibacterial activity and mechanism of a scorpion venom peptide derivative in vitro and in vivo. Cao L,Dai C,Li Z,Fan Z,Song Y,Wu Y,Cao Z PLoS One. 2012;7(7):e40135. doi: 10.1371/journal.pone.0040135. Epub 2012 Jul 5.'], 'hemolysis': u'HC50= 17.13 \xb5g/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2672']}, u'ALWKTLLKKVLKAAAKAALN': {'modifications': [], 'references': [u'Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity. Feder R,Dagan A J Biol Chem. 2000 Feb 11;275(6):4230-8.'], 'hemolysis': u'LC50 =5\xb11\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1008']}, u'GVFLDALKKFAKGGMNAVLNPK': {'modifications': [], 'references': [u'Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae). Ali, M ,Ali MF,Soto A,Knoop FC Biochim Biophys Acta. 2001 Nov 26;1550(1):81-9.'], 'hemolysis': u'HC50 >150\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3477']}, u'NRLARHFRDIAGRVNQRL': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Amphipathic alpha-helices in proteins: results from analysis of protein structures. Sharadadevi A,Sivakamasundari C Proteins. 2005 Jun 1;59(4):791-801.'], 'hemolysis': u'Non-hemolytic', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1890']}, u'FLPLLLASLPSFLCLVFKKC': {'modifications': ['Cyclic'], 'references': [u'Molecular cloning and functional characterization of novel antimicrobial peptides from the skin of brown frog, Rana zhenhaiensis. Xu B,Che H,Kang L,Zheng S,Mu S,Wan Zoolog Sci. 2012 Sep;29(9):553-8. doi: 10.2108/zsj.29.553.'], 'hemolysis': u'HC50 =5\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3162']}, u'MAARAARLAARLARLALRAL': {'modifications': [], 'references': [u'Modification of a synthetic antimicrobial peptide (ESF1) for improved inhibitory activity. Dykes GA,Aimoto S Biochem Biophys Res Commun. 1998 Jul 20;248(2):268-72.'], 'hemolysis': u'0.8% hemolysis at 200\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3284']}, u'TGRAKRRMQYNRR': {'modifications': [], 'references': [u"Human antimicrobial peptides' antifungal activity against Aspergillus fumigatus. Lupetti A,van Dissel JT,Brouwer CP Eur J Clin Microbiol Infect Dis. 2008 Nov;27(11):1125-9. doi: 10.1007/s10096-008-0553-z. Epub 2008 Jun 20."], 'hemolysis': u'0% hemolysis at \u2265200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1224']}, u'GLMDTLKNLAKTAGKGALQSLLNKASCKLSGQC': {'modifications': [], 'references': [u'Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides. Simmaco M,Mignogna G,Barra D, Bossa, ,Bossa J Biol Chem. 1994 Apr 22;269(16):11956-61.'], 'hemolysis': u'Lethal concentration >100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3303']}, u'KWKLFKKIPKFLH': {'modifications': ['C-Terminal'], 'references': [u'Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs. Shin SY,Lee SH,Yang ST,Park EJ,Lee DG,Lee MK,Eom SH,Song WK,Kim Y,Hahm KS J Pept Res. 2001 Dec;58(6):504-14.'], 'hemolysis': u'7.6% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2175']}, u'GVVKVSRLKGESLRARL': {'modifications': [], 'references': [u'Antimicrobial peptides derived from pepsinogens in the stomach of the bullfrog, Rana catesbeiana. Minn I,Kim HS Biochim Biophys Acta. 1998 Jul 1;1407(1):31-9.'], 'hemolysis': u'0.42% hemolysis at 200\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3809']}, u'GFLGPLLKLGLKGAAKLLPQLLPSRQQ': {'modifications': [], 'references': [u'Host-defense peptides in skin secretions of the tetraploid frog Silurana epitropicalis with potent activity against methicillin-resistant Staphylococcus aureus (MRSA). Conlon JM,Mechkarska M,Prajeep M,Sonnevend A,Coquet L,Leprince J,Jouenne T,Vaudry H Peptides. 2012 Sep;37(1):113-9. doi: 10.1016/j.peptides.2012.07.005. Epub 2012 Jul 16.'], 'hemolysis': u'LC50 =50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3158']}, u'TQTVYEWCGVATQLLAAYILL': {'modifications': [], 'references': [u'A peptide derived from the putative transmembrane domain in the tail region of E. coli toxin hemolysin E assembles in phospholipid membrane and exhibits lytic activity to human red blood cells: plausible implications in the toxic activity of the protein. Yadav SP,Ahmad A,Pandey BK,Singh D,Asthana N,Verma R,Tripathi RK Biochim Biophys Acta. 2009 Feb;1788(2):538-50. doi: 10.1016/j.bbamem.2008.11.013. Epub 2008 Nov 28.'], 'hemolysis': u'~90% hemolysis at 0.8\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1272']}, u'SWLRDLWDWLCEVLSDFK': {'modifications': [], 'references': [u'Rational design of peptides with anti-HCV/HIV activities and enhanced specificity. Li GR,He LY,Liu XY,Liu AP,Huang YB,Qiu C,Zhang XY,Xu JQ,Yang W Chem Biol Drug Des. 2011 Nov;78(5):835-43. doi: 10.1111/j.1747-0285.2011.01201.x. Epub 2011 Sep 26.'], 'hemolysis': u'MHC = 6.92\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2949']}, u'LLGMIPLAISAISSLSKL': {'modifications': [], 'references': [u'Medusins: a new class of antimicrobial peptides from the skin secretions of phyllomedusine frogs. Xi X,Li R,Jiang Y,Lin Y,Wu Y,Zhou M,Xu J,Wang L,Chen T Biochimie. 2013 Jun;95(6):1288-96. doi: 10.1016/j.biochi.2013.02.005. Epub 2013 Feb 14.'], 'hemolysis': u'6.9% hemolysis at 64mg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3716']}, u'GLFGKLIKKFGRKAISYAVKKARGKH': {'modifications': [], 'references': [u'Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity. Kozlov SA,Vassilevski AA,Feofanov AV,Surovoy AY,Karpunin DV J Biol Chem. 2006 Jul 28;281(30):20983-92. Epub 2006 May 30.'], 'hemolysis': u'20% hemolysis at 6.0\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4052']}, u'ILPLKLPWWPWRR': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship of indolicidin, a Trp-rich antibacterial peptide. Ando S,Mitsuyasu K,Soeda Y,Hidaka M,Ito Y,Matsubara K,Shindo M,Uchida Y J Pept Sci. 2010 Apr;16(4):171-7. doi: 10.1002/psc.1217.'], 'hemolysis': u'8% hemolysis at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1479']}, u'ALWKTLLKKVLKAAAKAALNAVLVGANA': {'modifications': [], 'references': [u'Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity. Feder R,Dagan A J Biol Chem. 2000 Feb 11;275(6):4230-8.'], 'hemolysis': u'LC50 =2\xb10.1\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1006']}, u'KWKSFIKKLTSKFLHSANKF': {'modifications': ['C-Terminal'], 'references': [u'The Design and Construction of K11: A Novel ?-Helical Antimicrobial Peptide. Jin-Jiang H,Jin-Chun L,Min L,Qing-Shan H Int J Microbiol. 2012;2012:764834. doi: 10.1155/2012/764834. Epub 2012 Feb 16.'], 'hemolysis': u'MHC >500\u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2730']}, u'KWKKLLKKLLKLLKKLLK': {'modifications': ['C-Terminal'], 'references': [u'Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues. Song YM,Park Y,Lim SS,Yang ST,Woo ER,Park IS,Lee JS,Kim JI,Hahm KS,Kim Y Biochemistry. 2005 Sep 13;44(36):12094-106.'], 'hemolysis': u'<50% hemolysis at 50\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1653']}, u'KKKKKKAAWAAWAAWAA': {'modifications': ['C-Terminal'], 'references': [u'Cationic hydrophobic peptides with antimicrobial activity. Stark M,Liu LP Antimicrob Agents Chemother. 2002 Nov;46(11):3585-90.'], 'hemolysis': u'0% hemolysis at 50\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2270']}, u'GIMSIVKDVAKTAAKEAAKGALSTLSCKLAKTC': {'modifications': [], 'references': [u'Antimicrobial peptides from the skin of a Korean frog, Rana rugosa. Park JM,Jung JE Biochem Biophys Res Commun. 1994 Nov 30;205(1):948-54.'], 'hemolysis': u'1.20% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3701']}, u'VKLkVfPLKVKLfP': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Optimization of microbial specificity in cyclic peptides by modulation of hydrophobicity within a defined structural framework. Kondejewski LH,Lee DL,Jelokhani-Niaraki M,Farmer SW,Hancock RE J Biol Chem. 2002 Jan 4;277(1):67-74. Epub 2001 Oct 26.'], 'hemolysis': u'100% hemolysis at 40\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2428']}, u'AVVKVPLKKFKSIRETMKEKGLLEDF': {'modifications': [], 'references': [u'Antimicrobial peptides derived from pepsinogens in the stomach of the bullfrog, Rana catesbeiana. Minn I,Kim HS Biochim Biophys Acta. 1998 Jul 1;1407(1):31-9.'], 'hemolysis': u'0.49% hemolysis at 200\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3812']}, u'GLLCYCRKGHCKRGERVRGTCGIRFLYCCPRR': {'modifications': [], 'references': [u'Biosynthesis and antimicrobial evaluation of backbone-cyclized ?-defensins. Garcia AE,Tai KP,Puttamadappa SS,Shekhtman A,Ouellette AJ Biochemistry. 2011 Dec 6;50(48):10508-19. doi: 10.1021/bi201430f. Epub 2011 Nov 9.'], 'hemolysis': u'3.1% hemolytic at 100 \u03bc g/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2981']}, u'GILDTLKQFAKGVGKDLVKGAAQGVLSTVSCKLALTC': {'modifications': [], 'references': [u'Antimicrobial peptides from the skin of a Korean frog, Rana rugosa. Park JM,Jung JE Biochem Biophys Res Commun. 1994 Nov 30;205(1):948-54.'], 'hemolysis': u'1.67% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3702']}, u'WCYCRRRFCVCVGR': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'>50% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1201']}, u'GLPVCGETCVGGTCNTPGCKCSWPVCTRN': {'modifications': ['Cyclic'], 'references': [u'Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities. Henriques ST,Huang YH,Rosengren KJ,Franquelim HG,Carvalho FA,Johnson A,Sonza S,Tachedjian G,Castanho MA,Daly NL J Biol Chem. 2011 Jul 8;286(27):24231-41. doi: 10.1074/jbc.M111.253393. Epub 2011 May 16.'], 'hemolysis': u'51.3\xb11.6% hemolytic at 25\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3009']}, u'FLPILASLAAKFGPKLFCLVTKKC': {'modifications': [], 'references': [u'Isolation of peptides of the brevinin-1 family with potent candidacidal activity from the skin secretions of the frog Rana boylii. Conlon JM,Sonnevend A,Patel M,Davidson C, Nielsen, P ,Nielsen PF,Pal T J Pept Res. 2003 Nov;62(5):207-13.'], 'hemolysis': u'HC50  =  4\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2323']}, u'AKAkAyPAKAKAyP': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Optimization of microbial specificity in cyclic peptides by modulation of hydrophobicity within a defined structural framework. Kondejewski LH,Lee DL,Jelokhani-Niaraki M,Farmer SW,Hancock RE J Biol Chem. 2002 Jan 4;277(1):67-74. Epub 2001 Oct 26.'], 'hemolysis': u'100% hemolysis at >800\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2432']}, u'WLNALLHHGLNCAKGVLA': {'modifications': [], 'references': [u'Halocidin: a new antimicrobial peptide from hemocytes of the solitary tunicate, Halocynthia aurantium. Jang WS,Kim KN,Lee YS,Nam MH FEBS Lett. 2002 Jun 19;521(1-3):81-6.'], 'hemolysis': u'~10% hemolysis at 100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3538']}, u'KKKLFWKIPKFLHLAKKF': {'modifications': ['C-Terminal'], 'references': [u'Antimicrobial and anti-inflammatory activities of designed antimicrobial peptide P18 analogues. Nan YH Protein Pept Lett. 2008;15(8):861-5.'], 'hemolysis': u'MHC <200\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3981']}, u'RFGRFLRKIRRFRPKVTITIQGSARF': {'modifications': ['C-Terminal'], 'references': [u'Identification of chicken cathelicidin-2 core elements involved in antibacterial and immunomodulatory activities. van Dijk A,Molhoek EM,Veldhuizen EJ,Bokhoven JL,Wagendorp E,Bikker F Mol Immunol. 2009 Aug;46(13):2465-73. doi: 10.1016/j.molimm.2009.05.019. Epub 2009 Jun 12.'], 'hemolysis': u'60% hemolysis at 40\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1366']}, u'KRGFGCNGPWNEDDLRCHNHCKSIKGYKGGYCAKGGFVCKCY': {'modifications': [], 'references': [u'High expression of a plectasin-derived peptide NZ2114 in Pichia pastoris and its pharmacodynamics, postantibiotic and synergy against Staphylococcus aureus. Zhang Y,Teng D,Mao R,Wang X,Xi D,Hu X Appl Microbiol Biotechnol. 2013 Apr 30.'], 'hemolysis': u'>0.1% hemolytic  upto 128\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2569']}, u'XALWKNMLKGIGKLAGKAALGAVKKLVGAES': {'modifications': ['Non-Natural'], 'references': [u'Selective cytotoxicity of dermaseptin S3 toward intraerythrocytic Plasmodium falciparum and the underlying molecular basis. Ghosh JK,Shaool D,Guillaud P,Ciceron L,Mazier D,Kustanovich I,Shai Y J Biol Chem. 1997 Dec 12;272(50):31609-16.'], 'hemolysis': u'No hemolysis at 34\u03bcM (non hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3565']}, u'DAACAAHCLWR': {'modifications': ['C-Terminal'], 'references': [u'Design and synthesis of novel antimicrobial peptides on the basis of alpha helical domain of Tenecin 1, an insect defensin protein, and structure-activity relationship study. Ahn HS,Cho W,Kang SH,Ko SS,Park MS,Cho H Peptides. 2006 Apr;27(4):640-8. Epub 2005 Oct 13.'], 'hemolysis': u'100% hemolysis at 50\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1658']}, u'AKKVFKRLEKLFSKI': {'modifications': [], 'references': [u'Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions. Park SC,Kim MH,Hossain MA,Shin SY,Kim Y,Stella L,Wade JD,Park Y Biochim Biophys Acta. 2008 Jan;1778(1):229-41. Epub 2007 Oct 2.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1930']}, u'ALWKNMLKGIGKLAGKAALGAVKKLVGAES': {'modifications': [], 'references': [u'The vertebrate peptide antibiotics dermaseptins have overlapping structural features but target specific microorganisms. Mor A,Hani K J Biol Chem. 1994 Dec 16;269(50):31635-41.'], 'hemolysis': u'100% hemolysis at 80\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3692']}, u'ILPWKWPYLPWRR': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship of indolicidin, a Trp-rich antibacterial peptide. Ando S,Mitsuyasu K,Soeda Y,Hidaka M,Ito Y,Matsubara K,Shindo M,Uchida Y J Pept Sci. 2010 Apr;16(4):171-7. doi: 10.1002/psc.1217.'], 'hemolysis': u'60% hemolysis at 50\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1482']}, u'FLRFIGSVIHGIGHLVHHIGVAL': {'modifications': ['C-Terminal'], 'references': [u'Clavaspirin, an antibacterial and haemolytic peptide from Styela clava. Lee IH,Zhao C,Nguyen T,Menzel L,Waring AJ,Sherman MA J Pept Res. 2001 Dec;58(6):445-56.'], 'hemolysis': u'75% hemolysis at 80\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3535']}, u'VKLKVypLKVKLyP': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Dissociation of antimicrobial and hemolytic activities in cyclic peptide diastereomers by systematic alterations in amphipathicity. Kondejewski LH,Jelokhani-Niaraki M,Farmer SW,Lix B,Kay CM,Sykes BD,Hancock RE J Biol Chem. 1999 May 7;274(19):13181-92.'], 'hemolysis': u'100% hemolytic at 12.5 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2556']}, u'PKVMAHMK': {'modifications': ['C-Terminal'], 'references': [u'Melectin: a novel antimicrobial peptide from the venom of the cleptoparasitic bee Melecta albifrons. Cerovsky V,Hovorka O,Cvacka J,Voburka Z,Bednarova L,Borovickova L,Slaninova J Chembiochem. 2008 Nov 24;9(17):2815-21. doi: 10.1002/cbic.200800476.'], 'hemolysis': u'LC50 >100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3627']}, u'KNWKGIAGMAKKLLGKNW': {'modifications': [], 'references': [u'Design of a novel membrane-destabilizing peptide selectively acting on acidic liposomes. Machida S,Niimi S,Shi X,Ando Y Biosci Biotechnol Biochem. 2000 May;64(5):985-94.'], 'hemolysis': u'5.1% hemolytic at 10\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2527']}, u'SWLRDLWDWICELLSDFK': {'modifications': [], 'references': [u'Rational design of peptides with anti-HCV/HIV activities and enhanced specificity. Li GR,He LY,Liu XY,Liu AP,Huang YB,Qiu C,Zhang XY,Xu JQ,Yang W Chem Biol Drug Des. 2011 Nov;78(5):835-43. doi: 10.1111/j.1747-0285.2011.01201.x. Epub 2011 Sep 26.'], 'hemolysis': u'MHC = 53.75\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2950']}, u'KWKKLLKKLLaLLKKLLK': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues. Song YM,Park Y,Lim SS,Yang ST,Woo ER,Park IS,Lee JS,Kim JI,Hahm KS,Kim Y Biochemistry. 2005 Sep 13;44(36):12094-106.'], 'hemolysis': u'~50% hemolysis at 50\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1656']}, u'INWSSIFESVKNLV': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 >100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3900']}, u'IISTIGKLVKWIIKTV': {'modifications': [], 'references': [u'Generation of analogs having potent antimicrobial and hemolytic activities with minimal changes from an inactive 16-residue peptide corresponding to the helical region of Staphylococcus aureus delta-toxin. Dhople VM Protein Eng. 1995 Mar;8(3):315-8.'], 'hemolysis': u'100% hemolysis at ~20\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3606']}, u'LTYCRRRFCVTV': {'modifications': [], 'references': [u'Correlation between simulated physicochemical properties and hemolycity of protegrin-like antimicrobial peptides: predicting experimental toxicity. Langham AA,Khandelia H,Schuster B,Waring AJ,Lehrer RI Peptides. 2008 Jul;29(7):1085-93. doi: 10.1016/j.peptides.2008.03.018. Epub 2008 Mar 28.'], 'hemolysis': u'0-3% hemolysis at 80 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1183']}, u'LGRVDIHVWDGVYIRGR': {'modifications': [], 'references': [u'Therapeutic potential of peptides with neutralizing ability towards the venom and toxin (CaTx-I) of crotalus adamanteus. Samy RP,Thwin MM,Stiles BG,Bow H,Chow VT Curr Top Med Chem. 2011;11(20):2540-55.'], 'hemolysis': u'9.5% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3143']}, u'SWKSMAKKLKEYMEKLKQRA': {'modifications': ['C-Terminal'], 'references': [u'Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity. Kozlov SA,Vassilevski AA,Feofanov AV,Surovoy AY,Karpunin DV J Biol Chem. 2006 Jul 28;281(30):20983-92. Epub 2006 May 30.'], 'hemolysis': u'20% hemolysis at >120\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4053']}, u'VKLkVyPLKVKLyP': {'modifications': [u'Stereochemistry: Mix'], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC =200\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3945']}, u'kwksflktfksakktvlhtllkaiss': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', u'Stereochemistry: D'], 'references': [u'Anti-tuberculosis activity of ?-helical antimicrobial peptides: de novo designed L- and D-enantiomers versus L- and D-LL-37. Jiang Z,Higgins MP,Whitehurst J,Kisich KO,Voskuil MI Protein Pept Lett. 2011 Mar;18(3):241-52.'], 'hemolysis': u'HC50 = 83\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2801']}, u'EGRERDHELRHRRHHHQSPK': {'modifications': ['C-Terminal'], 'references': [u'In vitro assessment of antifungal therapeutic potential of salivary histatin-5, two variants of histatin-5, and salivary mucin (MUC7) domain 1. Situ H Antimicrob Agents Chemother. 2000 Jun;44(6):1485-93.'], 'hemolysis': u'<10% hemolysis at 200\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2030']}, u'GKLIKKFGRKAISYAVKKARGKH': {'modifications': [], 'references': [u'N-terminal amphipathic helix as a trigger of hemolytic activity in antimicrobial peptides: a case study in latarcins. Polyansky AA,Vassilevski AA,Volynsky PE,Vorontsova OV,Samsonova OV,Egorova NS,Krylov NA,Feofanov AV,Arseniev AS,Grishin EV FEBS Lett. 2009 Jul 21;583(14):2425-8. doi: 10.1016/j.febslet.2009.06.044. Epub 2009 Jun 27.'], 'hemolysis': u'EC50 >36\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1446']}, u'KKLKKLLKKWKKLLKKLK': {'modifications': [], 'references': [u'Design and synthesis of amphiphilic alpha-helical model peptides with systematically varied hydrophobic-hydrophilic balance and their interaction with lipid- and bio-membranes. Kiyota T,Lee S Biochemistry. 1996 Oct 8;35(40):13196-204.'], 'hemolysis': u'~5% hemolysis upto 100\u03bcM (non hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3468']}, u'VRRF(Nlys)WWW(Nlys)FLRR': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC >200\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3968']}, u'LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES': {'modifications': [], 'references': [u'Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Dawson RM Crit Rev Microbiol. 2008;34(2):89-107. doi: 10.1080/10408410802143808 .'], 'hemolysis': u'MHC ~100\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3952']}, u'FVPWFSKFLGrIL': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'The effect of d-amino acid substitution on the selectivity of temporin L towards target cells: identification of a potent anti-Candida peptide. Grieco P,Carotenuto A,Auriemma L,Saviello MR,Campiglia P,Gomez-Monterrey IM,Marcellini L,Luca V,Barra D,Novellino E Biochim Biophys Acta. 2013 Feb;1828(2):652-60. doi: 10.1016/j.bbamem.2012.08.027. Epub 2012 Sep 10.'], 'hemolysis': u'2% hemolysis at 1.5\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3223']}, u'KWKSFIKKLTSKALHSAKKF': {'modifications': ['C-Terminal'], 'references': [u'The Design and Construction of K11: A Novel ?-Helical Antimicrobial Peptide. Jin-Jiang H,Jin-Chun L,Min L,Qing-Shan H Int J Microbiol. 2012;2012:764834. doi: 10.1155/2012/764834. Epub 2012 Feb 16.'], 'hemolysis': u'MHC >500\u03bcg/mL', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2727']}, u'FDWDSVLKGVEGFVRGYF': {'modifications': [], 'references': [u'Five different piscidins from Nile tilapia, Oreochromis niloticus: analysis of their expressions and biological functions. Peng KC,Lee SH,Hour AL,Pan CY,Lee LH PLoS One. 2012;7(11):e50263. doi: 10.1371/journal.pone.0050263. Epub 2012 Nov 30.'], 'hemolysis': u'0% hemolytic at 100 \xb5g/ml (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2607']}, u'LKLKSIVSWALKVL': {'modifications': ['C-Terminal'], 'references': [u'Structural requirements for the edema-inducing and hemolytic activities of mastoparan B isolated from the hornet (Vespa basalis) venom. Ho CL,Lin YL,Chen WC,Hwang LL,Yu HM Toxicon. 1996 Sep;34(9):1027-35.'], 'hemolysis': u'>70% hemolysis at 20\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3512']}, u'WVLVLRlGY': {'modifications': [u'Stereochemistry: Mix'], 'references': [u'Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity. Rathinakumar R, Walkenhorst, William ,Walkenhorst WF J Am Chem Soc. 2009 Jun 10;131(22):7609-17. doi: 10.1021/ja8093247.'], 'hemolysis': u'11\xb19% hemolysis at 15\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1363']}, u'KLALKLALKAlkAALKLA': {'modifications': [u'Stereochemistry: Mix'], 'references': [u'Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes. Dathe M,Schumann M,Wieprecht T,Winkler A,Beyermann M,Krause E,Matsuzaki K,Murase O Biochemistry. 1996 Sep 24;35(38):12612-22.'], 'hemolysis': u'EC50 = 540\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3463']}, u'INLKGLIKKVASLLT': {'modifications': [], 'references': [u'Venom peptides from solitary hunting wasps induce feeding disorder in lepidopteran larvae. Baek JH,Ji Y,Shin JS,Lee S Peptides. 2011 Mar;32(3):568-72. doi: 10.1016/j.peptides.2010.12.007. Epub 2010 Dec 22.'], 'hemolysis': u'Non-hemolytic', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2059']}, u'FKIKPGKVLDKFGKIVGKVLKQLKKVSAVAKV': {'modifications': [], 'references': [u'Lytic activity and structural differences of amphipathic peptides derived from trialysin. Martins RM,Sforca ML,Amino R,Juliano MA,Oyama S Jr,Juliano L,Pertinhez TA,Spisni A Biochemistry. 2006 Feb 14;45(6):1765-74.'], 'hemolysis': u'50% hemolysis at 90\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1673']}, u'KWKSFLKTFKSAKKTVLHTALKLISS': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides. Chen Y,Guarnieri MT,Vasil AI,Vasil ML,Mant CT Antimicrob Agents Chemother. 2007 Apr;51(4):1398-406. Epub 2006 Dec 11.'], 'hemolysis': u'MHC =62.5\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1085']}, u'NWKKIASIGKEVLKAL': {'modifications': ['C-Terminal'], 'references': [u'New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Cerovsky V,Slaninova J,Fucik V,Hulacova H,Borovickova L,Jezek R Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19.'], 'hemolysis': u'IC50 >100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3924']}, u'GIGKFLKKAKKFGKAFVKMKK': {'modifications': ['C-Terminal'], 'references': [u'Trypanocidal and leishmanicidal activities of different antimicrobial peptides (AMPs) isolated from aquatic animals. Lofgren SE,Miletti LC,Steindel M,Bachere E Exp Parasitol. 2008 Feb;118(2):197-202. Epub 2007 Aug 15.'], 'hemolysis': u'45-50% hemolysis 100 \xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1942']}, u'RRFPWWWPFRR': {'modifications': [], 'references': [u'Selective cytotoxicity following Arg-to-Lys substitution in tritrpticin adopting a unique amphipathic turn structure. Yang ST,Shin SY,Lee CW,Kim YC,Hahm KS FEBS Lett. 2003 Apr 10;540(1-3):229-33.'], 'hemolysis': u'~60% hemolysis at 200 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2285']}, u'MESVSVAVQLMLGFGTFVLMLLGLVVELIKNSNKK': {'modifications': [], 'references': [u'Functional characterization of a new holin-like antibacterial protein coding gene tmp1 from goat skin surface metagenome. Rajesh T,Anthony T,Saranya S,Pushpam PL Appl Microbiol Biotechnol. 2011 Feb;89(4):1061-73. doi: 10.1007/s00253-010-2907-6. Epub 2010 Oct 7.'], 'hemolysis': u'0% hemolysis at 50\u03bcM  (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1544']}, u'GLPVCGETCVGGTCNTPGCTCSWPVCTRN': {'modifications': ['Cyclic'], 'references': [u'Structural and biochemical characteristics of the cyclotide kalata B5 from Oldenlandia affinis. Plan MR,Rosengren KJ,Sando L,Daly NL Biopolymers. 2010;94(5):647-58. doi: 10.1002/bip.21409.'], 'hemolysis': u'HD50 = 20.0\xb11.1\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4158']}, u'GLPVCGETCVGGTCNTPGCTCSWPVCTRK': {'modifications': ['Cyclic'], 'references': [u'Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities. Henriques ST,Huang YH,Rosengren KJ,Franquelim HG,Carvalho FA,Johnson A,Sonza S,Tachedjian G,Castanho MA,Daly NL J Biol Chem. 2011 Jul 8;286(27):24231-41. doi: 10.1074/jbc.M111.253393. Epub 2011 May 16.'], 'hemolysis': u'54.5\xb10.9% hemolytic at 25\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3011']}, u'DVNDLKNLCAKTHNLLPMCAMFGKK': {'modifications': [], 'references': [u"Cloning and expression of genes enocoding antimicrobial peptides and bradykinin from the skin and brain of Oki Tago's brown frog, Rana tagoi okiensis. Tazato S,Conlon JM Peptides. 2010 Aug;31(8):1480-7. doi: 10.1016/j.peptides.2010.04.031. Epub 2010 May 10."], 'hemolysis': u'no hemolysis upto <400\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3067']}, u'FLPLIGRVASGIL': {'modifications': ['C-Terminal'], 'references': [u'Alanine scanning analysis and structure-function relationships of the frog-skin antimicrobial peptide temporin-1Ta. Grieco P,Luca V,Auriemma L,Carotenuto A,Saviello MR,Campiglia P,Barra D,Novellino E J Pept Sci. 2011 May;17(5):358-65. doi: 10.1002/psc.1350. Epub 2011 Feb 18.'], 'hemolysis': u'0% hemolytic at 1.25\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2898']}, u'fPVOLOfPOVOL': {'modifications': ['Cyclic', u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'Modulation of structure and antibacterial and hemolytic activity by ring size in cyclic gramicidin S analogs. Kondejewski LH,Farmer SW,Wishart DS,Kay CM,Hancock RE J Biol Chem. 1996 Oct 11;271(41):25261-8.'], 'hemolysis': u'100% hemolysis at 160\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3671']}, u'KDGYIIEHRGCKYSCFFGTNSWCNTECTLKKGSSGYCAWPACWCYGLPDNVKIFDSNNLKC': {'modifications': ['Cyclic'], 'references': [u"Antibacterial activity of six novel peptides from Tityus discrepans scorpion venom. A fluorescent probe study of microbial membrane Na+ permeability changes. Diaz P,D'Suze G,Salazar V,Sevcik C,Shannon JD,Sherman NE Toxicon. 2009 Nov;54(6):802-17. doi: 10.1016/j.toxicon.2009.06.014. Epub 2009 Jun 21."], 'hemolysis': u'1.0% hemolysis at 180\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3696']}, u'IGGIISFFKRLF': {'modifications': [], 'references': [u'Molecular cloning of grammistins, peptide toxins from the soapfish Pogonoperca punctata, by hemolytic screening of a cDNA library. Kaji T,Sugiyama N,Ishizaki S,Nagashima Y Peptides. 2006 Dec;27(12):3069-76. Epub 2006 Oct 25.'], 'hemolysis': u'<10 HU/mg', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1725']}, u'VKLKVyPLkVKLyP': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Dissociation of antimicrobial and hemolytic activities in cyclic peptide diastereomers by systematic alterations in amphipathicity. Kondejewski LH,Jelokhani-Niaraki M,Farmer SW,Lix B,Kay CM,Sykes BD,Hancock RE J Biol Chem. 1999 May 7;274(19):13181-92.'], 'hemolysis': u'100% hemolytic at 100 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2564']}, u'FLPILASLAAKLGPKLFCLVTKKC': {'modifications': [], 'references': [u'Isolation of peptides of the brevinin-1 family with potent candidacidal activity from the skin secretions of the frog Rana boylii. Conlon JM,Sonnevend A,Patel M,Davidson C, Nielsen, P ,Nielsen PF,Pal T J Pept Res. 2003 Nov;62(5):207-13.'], 'hemolysis': u'HC50  = 4\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2324']}, u'ELAGTIIDGASLTFEVLDKVLGELGKVSRK': {'modifications': [], 'references': [u'Correlations between differences in amino-terminal sequences and different hemolytic activity of sticholysins. Cilli EM,Pigossi FT,Crusca E Jr,Ros U,Martinez D,Lanio ME,Alvarez C Toxicon. 2007 Dec 15;50(8):1201-4. Epub 2007 Aug 3.'], 'hemolysis': u'Hemolytic activity expresssed as the initial rate (\u2206A/\u2206t, min- 1) i.e. at above 100 \xb5M activity is less than 0.002 min-1', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1816']}, u'KKKKKKAAFALWLAFLA': {'modifications': ['C-Terminal', 'Cyclic'], 'references': [u'Membrane interactions of designed cationic antimicrobial peptides: the two thresholds. Glukhov E,Burrows LL Biopolymers. 2008 May;89(5):360-71. doi: 10.1002/bip.20917.'], 'hemolysis': u'MHC <<81\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1154']}, u'KlK': {'modifications': [u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'Antiplasmodial activity of lauryl-lysine oligomers. Radzishevsky I,Krugliak M,Ginsburg H Antimicrob Agents Chemother. 2007 May;51(5):1753-9. Epub 2007 Feb 16.'], 'hemolysis': u'<0.1% hemolysis at 100 \u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1108']}, u'LKLLKKLLKKLLKLL': {'modifications': ['C-Terminal'], 'references': [u'The consequence of sequence alteration of an amphipathic alpha-helical antimicrobial peptide and its diastereomers. Papo N,Oren Z,Pag U,Sahl HG J Biol Chem. 2002 Sep 13;277(37):33913-21. Epub 2002 Jul 10.'], 'hemolysis': u'100% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2198']}, u'OOWW': {'modifications': ['C-Terminal', u'N-Terminal Modification: HPPA= 3-(4-hydroxyphenyl) propionic acid', 'Non-Natural'], 'references': [u'Antimicrobial activity of rationally designed amino terminal modified peptides. Bisht GS,Rawat DS,Kumar A,Kumar R Bioorg Med Chem Lett. 2007 Aug 1;17(15):4343-6. Epub 2007 May 13.'], 'hemolysis': u'No hemolysis at 1000\xb5g/ml (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1922']}, u'VDIHVWD*GV': {'modifications': ['Non-Natural'], 'references': [u'Therapeutic potential of peptides with neutralizing ability towards the venom and toxin (CaTx-I) of crotalus adamanteus. Samy RP,Thwin MM,Stiles BG,Bow H,Chow VT Curr Top Med Chem. 2011;11(20):2540-55.'], 'hemolysis': u'1% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3145']}, u'KWKLFKKIPKFLHL': {'modifications': ['C-Terminal'], 'references': [u'Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs. Shin SY,Lee SH,Yang ST,Park EJ,Lee DG,Lee MK,Eom SH,Song WK,Kim Y,Hahm KS J Pept Res. 2001 Dec;58(6):504-14.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2173']}, u'KIRVRLSA': {'modifications': [], 'references': [u'Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification. Pini A,Giuliani A,Falciani C,Runci Y,Ricci C,Lelli B,Malossi M,Neri P,Rossolini GM Antimicrob Agents Chemother. 2005 Jul;49(7):2665-72.'], 'hemolysis': u'<1% hemolysis at 120\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1895']}, u'SQLGDLGSGAGQGGGGGGSIRAAGGAFGKLEAAREEEFFYKKQKEQLERLKNDQIHQAEFHHQQIKEHEEAIQRHKDFLNNLHK': {'modifications': [], 'references': [u'Isolation, characterization and anti-cancer activity of SK84, a novel glycine-rich antimicrobial peptide from Drosophila virilis. Lu J Peptides. 2010 Jan;31(1):44-50. doi: 10.1016/j.peptides.2009.09.028. Epub 2009 Sep 30.'], 'hemolysis': u'0.01% hemolysis at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1068']}, u'FLPLIGRVLSAIL': {'modifications': ['C-Terminal'], 'references': [u'Alanine scanning analysis and structure-function relationships of the frog-skin antimicrobial peptide temporin-1Ta. Grieco P,Luca V,Auriemma L,Carotenuto A,Saviello MR,Campiglia P,Barra D,Novellino E J Pept Sci. 2011 May;17(5):358-65. doi: 10.1002/psc.1350. Epub 2011 Feb 18.'], 'hemolysis': u'3.5% hemolytic at 1.25\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2902']}, u'GKLNLFLSRLEILKLFVGAL': {'modifications': [], 'references': [u'Isolation and identification of pelteobagrin, a novel antimicrobial peptide from the skin mucus of yellow catfish (Pelteobagrus fulvidraco).  Comp Biochem Physiol B Biochem Mol Biol. 2011 Feb;158(2):149-54. doi: 10.1016/j.cbpb.2010.11.002. Epub 2010 Nov 10.'], 'hemolysis': u'no hemolysis upto <400\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3116']}, u'AINPKSVQSLL': {'modifications': ['C-Terminal'], 'references': [u'Venom peptides from solitary hunting wasps induce feeding disorder in lepidopteran larvae. Baek JH,Ji Y,Shin JS,Lee S Peptides. 2011 Mar;32(3):568-72. doi: 10.1016/j.peptides.2010.12.007. Epub 2010 Dec 22.'], 'hemolysis': u'Non-hemolytic', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2062']}, u'GLKKWFKKAVHVGKKVGKVALNAYL': {'modifications': ['C-Terminal'], 'references': [u'The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents. Morash MG,Douglas SE,Robotham A,Ridley CM,Gallant JW Dis Model Mech. 2011 Sep;4(5):622-33. doi: 10.1242/dmm.007310. Epub 2011 Jul 4.'], 'hemolysis': u'50% hemolytic at >256 \u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2938']}, u'KWLKKWL': {'modifications': ['C-Terminal'], 'references': [u'De novo generation of short antimicrobial peptides with simple amino acid composition. Lee SH,Kim SJ,Lee YS,Song MD,Kim IH Regul Pept. 2011 Jan 17;166(1-3):36-41. doi: 10.1016/j.regpep.2010.08.010. Epub 2010 Aug 22.'], 'hemolysis': u'negligible hemolysis at 320\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3094']}, u'LFGVLAKVAAHVVPAIAEHF': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship of an antibacterial peptide, maculatin 1.1, from the skin glands of the tree frog, Litoria genimaculata. Niidome T,Kobayashi K,Arakawa H,Hatakeyama T J Pept Sci. 2004 Jul;10(7):414-22.'], 'hemolysis': u'~10% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1612']}, u'yPKyPK': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Modulation of structure and antibacterial and hemolytic activity by ring size in cyclic gramicidin S analogs. Kondejewski LH,Farmer SW,Wishart DS,Kay CM,Hancock RE J Biol Chem. 1996 Oct 11;271(41):25261-8.'], 'hemolysis': u'100% hemolysis at >1600\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3664']}, u'GKGLTicOicGRTicOicGFTicOicGRTicOicGFTicOicELMNS': {'modifications': ['C-Terminal', 'Non-Natural'], 'references': [u'De novo design of selective antibiotic peptides by incorporation of unnatural amino acids. Hicks RP,Bhonsle JB,Venugopal D,Koser BW J Med Chem. 2007 Jun 28;50(13):3026-36. Epub 2007 Jun 5.'], 'hemolysis': u'70% hemolysis at 25\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1746']}, u'GLFGVLAKVAAKVVPAIAKHF': {'modifications': ['C-Terminal'], 'references': [u'Structure-activity relationship of an antibacterial peptide, maculatin 1.1, from the skin glands of the tree frog, Litoria genimaculata. Niidome T,Kobayashi K,Arakawa H,Hatakeyama T J Pept Sci. 2004 Jul;10(7):414-22.'], 'hemolysis': u'100% hemolysis at 100\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1610']}, u'RRGWVLDLVLYYGRR': {'modifications': [], 'references': [u'Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity. Rathinakumar R, Walkenhorst, William ,Walkenhorst WF J Am Chem Soc. 2009 Jun 10;131(22):7609-17. doi: 10.1021/ja8093247.'], 'hemolysis': u'0.27 fractions hemolysis at 15\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1301']}, u'KLLLKLWL\u03a8[CH2NH]KLLK': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation'], 'references': [u'Synthesis of antibacterial pseudopeptides with less hemolytic activity from a cytotoxic peptide and their pH-dependent activity. Kim SM,Kim JM,Cho H Bioorg Med Chem Lett. 2009 Oct 1;19(19):5627-31. doi: 10.1016/j.bmcl.2009.08.031. Epub 2009 Aug 12.'], 'hemolysis': u'Low hemolysis upto 200\u03bcg/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1457']}, u'\u03b2AlaFTicOic\u03b2AlaKTicOic\u03b2AlaFTicOic\u03b2AlaKTicKKKK': {'modifications': ['C-Terminal', u'N-Terminal Modification: Acetylation', 'Non-Natural'], 'references': [u'De novo design of selective antibiotic peptides by incorporation of unnatural amino acids. Hicks RP,Bhonsle JB,Venugopal D,Koser BW J Med Chem. 2007 Jun 28;50(13):3026-36. Epub 2007 Jun 5.'], 'hemolysis': u'7.4% hemolysis at 25\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1782']}, u'LKLGTLVNLAKKIL': {'modifications': ['C-Terminal'], 'references': [u'Strategies for transformation of naturally-occurring amphibian antimicrobial peptides into therapeutically valuable anti-infective agents. Conlon JM,Al-Ghaferi N,Abraham B Methods. 2007 Aug;42(4):349-57.'], 'hemolysis': u'LD50 = 500\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1793']}, u'GLPVCGETCVGGTCNKPGCTCSWPVCTRN': {'modifications': ['Cyclic'], 'references': [u'Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities. Henriques ST,Huang YH,Rosengren KJ,Franquelim HG,Carvalho FA,Johnson A,Sonza S,Tachedjian G,Castanho MA,Daly NL J Biol Chem. 2011 Jul 8;286(27):24231-41. doi: 10.1074/jbc.M111.253393. Epub 2011 May 16.'], 'hemolysis': u'4.3\xb10.1% hemolytic at 25\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3008']}, u'KWLNALLKKGLNCAKGVLA': {'modifications': ['C-Terminal'], 'references': [u'Biological activities of synthetic analogs of halocidin, an antimicrobial peptide from the tunicate Halocynthia aurantium. Jang WS,Kim CH,Kim KN,Park SY,Lee JH,Son SM Antimicrob Agents Chemother. 2003 Aug;47(8):2481-6.'], 'hemolysis': u'<10% hemolysis at 100\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2404']}, u'KKKLLLLLLLLLKKK': {'modifications': ['C-Terminal'], 'references': [u'The consequence of sequence alteration of an amphipathic alpha-helical antimicrobial peptide and its diastereomers. Papo N,Oren Z,Pag U,Sahl HG J Biol Chem. 2002 Sep 13;277(37):33913-21. Epub 2002 Jul 10.'], 'hemolysis': u'66% hemolysis at 100 \xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2200']}, u'KLkLLkLlkLLKlLK': {'modifications': ['C-Terminal', u'Stereochemistry: Mix'], 'references': [u'The consequence of sequence alteration of an amphipathic alpha-helical antimicrobial peptide and its diastereomers. Papo N,Oren Z,Pag U,Sahl HG J Biol Chem. 2002 Sep 13;277(37):33913-21. Epub 2002 Jul 10.'], 'hemolysis': u'0% hemolysis at 100\xb5M (non-hemolytic)', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2204']}, u'KNWKGIAGMAKKLLGKNWKLMKK': {'modifications': [], 'references': [u'Design of a novel membrane-destabilizing peptide selectively acting on acidic liposomes. Machida S,Niimi S,Shi X,Ando Y Biosci Biotechnol Biochem. 2000 May;64(5):985-94.'], 'hemolysis': u'7.2% hemolytic at 10\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2530']}, u'FFHHIFRAIVHVGKTIHRLVTG': {'modifications': [], 'references': [u'Solution structure and cell selectivity of piscidin 1 and its analogues. Lee SA,Kim YK,Lim SS,Zhu WL,Ko H,Shin SY,Hahm KS Biochemistry. 2007 Mar 27;46(12):3653-63. Epub 2007 Mar 1.'], 'hemolysis': u'HC50 =4\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1110']}, u'VTLASHLPSDFTPAVHASLDKFLANVSTVL': {'modifications': [], 'references': [u'Isolation and characterization of four antibacterial peptides from bovine hemoglobin. Nedjar-Arroume N,Dubois-Delval V,Miloudi K,Daoud R,Krier F,Kouach M,Briand G Peptides. 2006 Sep;27(9):2082-9. Epub 2006 May 30.'], 'hemolysis': u'Non-hemolytic', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=1913']}, u'ALPLIGRVLSGIL': {'modifications': ['C-Terminal'], 'references': [u'Alanine scanning analysis and structure-function relationships of the frog-skin antimicrobial peptide temporin-1Ta. Grieco P,Luca V,Auriemma L,Carotenuto A,Saviello MR,Campiglia P,Barra D,Novellino E J Pept Sci. 2011 May;17(5):358-65. doi: 10.1002/psc.1350. Epub 2011 Feb 18.'], 'hemolysis': u'2% hemolytic at 1.25\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2882']}, u'LNKGAILKHIIK': {'modifications': ['C-Terminal'], 'references': [u'Panurgines, novel antimicrobial peptides from the venom of communal bee Panurgus calcaratus (Hymenoptera: Andrenidae). Cujova S,Slaninova J,Monincova L,Fucik V,Bednarova L,Stokrova J,Hovorka O,Voburka Z,Straka J Amino Acids. 2013 Jul;45(1):143-57. doi: 10.1007/s00726-013-1482-4. Epub 2013 Mar 13.'], 'hemolysis': u'LC50 >200\xb5M', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=3721']}, u'VKLLVyPLKVKLyP': {'modifications': ['Cyclic', u'Stereochemistry: Mix'], 'references': [u'Effects of single D-amino acid substitutions on disruption of beta-sheet structure and hydrophobicity in cyclic 14-residue antimicrobial peptide analogs related to gramicidin S. Lee DL,Powers JP,Pflegerl K,Vasil ML,Hancock RE J Pept Res. 2004 Feb;63(2):69-84.'], 'hemolysis': u'MHC =3 \xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=4161']}, u'VRRFGWWWGFLRR': {'modifications': [], 'references': [u'Conformation-dependent antibiotic activity of tritrpticin, a cathelicidin-derived antimicrobial peptide. Yang ST,Yub Shin SY,Kim YC,Kim Y,Hahm KS Biochem Biophys Res Commun. 2002 Sep 6;296(5):1044-50.'], 'hemolysis': u'>60% hemolysis at 200\xb5g/ml', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2208']}, u'GEKLKKIGQKIKNFFKKL': {'modifications': [], 'references': [u'CRAMP analogues having potent antibiotic activity against bacterial, fungal, and tumor cells without hemolytic activity. Shin SY,Kang SW,Lee DG,Eom SH,Song WK Biochem Biophys Res Commun. 2000 Sep 7;275(3):904-9.'], 'hemolysis': u'0.2% hemolytic at 100\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2519']}, u'TleKTleaTleaTlea': {'modifications': ['Cyclic', u'Stereochemistry: Mix', 'Non-Natural'], 'references': [u'Pharmacodynamic synergy strictly dependent on the co-operative aggregation of enantiomers of cyclic peptides in the bacterial cell membrane. Danielsson M,Rosenthal-Aizman K,Bergsson G Bioorg Med Chem Lett. 2011 Sep 15;21(18):5262-5. doi: 10.1016/j.bmcl.2011.07.032. Epub 2011 Jul 19.'], 'hemolysis': u'HC50 =316\u03bcM', 'url_sources': ['http://crdd.osdd.net/raghava/hemolytik/display.php?details=2963']}}